data_5x3c_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 5x3c _Structure_validation_residue.Date_analyzed 2017-05-26 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 . . . . . 0 N--CA 1.426 -1.639 0 CA-C-O 121.377 0.608 . . . . 0.0 109.774 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 22.9 t -97.97 171.82 8.02 Favored 'General case' 0 C--N 1.282 -2.345 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.213 -173.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 41.8 t-80 -61.45 132.11 52.37 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 179.078 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . 0.446 ' HA ' ' OE1' ' A' ' 34' ' ' GLN . . . 83.71 0.28 1.04 Allowed 'General case' 0 N--CA 1.48 1.053 0 O-C-N 124.915 1.384 . . . . 0.0 113.011 -177.745 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . 0.408 ' O ' ' HA ' ' A' ' 34' ' ' GLN . . . -96.66 160.25 21.79 Favored Glycine 0 C--O 1.245 0.809 0 C-N-CA 120.474 -0.87 . . . . 0.0 111.914 178.265 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.608 ' HA ' ' O ' ' A' ' 33' ' ' SER . 51.6 tt0 -81.72 104.42 12.1 Favored 'General case' 0 C--O 1.225 -0.235 0 CA-C-O 121.451 0.643 . . . . 0.0 110.851 -179.198 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.769 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 7.7 p -80.8 -41.91 22.56 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 114.384 1.253 . . . . 0.0 114.384 -174.729 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -176.03 81.22 0.07 OUTLIER Glycine 0 CA--C 1.477 -2.324 0 C-N-CA 117.547 -2.263 . . . . 0.0 113.674 -175.432 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.442 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -112.69 175.63 16.98 Favored Glycine 0 C--N 1.283 -2.399 0 N-CA-C 107.989 -2.045 . . . . 0.0 107.989 173.352 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.455 ' HB ' ' CD2' ' A' ' 31' ' ' TYR . 55.1 mt -65.54 133.75 30.39 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 175.853 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 103.86 -16.23 51.12 Favored Glycine 0 C--N 1.311 -0.834 0 N-CA-C 111.251 -0.74 . . . . 0.0 111.251 -177.479 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 67.1 t80 -100.94 109.62 21.58 Favored 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 179.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 11.4 p -101.63 1.31 37.59 Favored 'General case' 0 C--N 1.3 -1.557 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.314 -178.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -79.46 -178.76 51.55 Favored Glycine 0 N--CA 1.441 -1.023 0 CA-C-N 115.887 -0.597 . . . . 0.0 112.317 179.322 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -60.48 122.4 11.24 Favored 'Trans proline' 0 C--O 1.241 0.637 0 C-N-CA 123.194 2.596 . . . . 0.0 111.825 179.536 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.593 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 22.9 p -92.6 9.12 36.05 Favored 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 113.571 0.952 . . . . 0.0 113.571 -173.372 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 7.5 p -91.82 126.79 44.39 Favored 'Isoleucine or valine' 0 C--O 1.248 1.02 0 CA-C-O 121.39 0.614 . . . . 0.0 111.551 -178.117 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 71.2 m -84.26 161.48 20.47 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.847 178.139 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.33 154.46 42.0 Favored 'General case' 0 C--O 1.25 1.088 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.494 176.129 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 3.1 p -60.2 129.13 40.17 Favored 'General case' 0 N--CA 1.433 -1.302 0 CA-C-O 121.263 0.554 . . . . 0.0 111.458 -178.495 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 111.34 -17.67 26.12 Favored Glycine 0 N--CA 1.423 -2.216 0 N-CA-C 110.666 -0.974 . . . . 0.0 110.666 -177.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 77.6 p -123.03 153.29 40.03 Favored 'General case' 0 C--O 1.252 1.215 0 CA-C-O 120.828 0.346 . . . . 0.0 110.983 -178.536 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 34.2 p -119.79 149.56 41.85 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 178.33 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 44.9 t -75.49 105.37 6.49 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 177.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 84.0 mm-40 -100.64 110.82 22.98 Favored 'General case' 0 N--CA 1.415 -2.188 0 CA-C-O 121.718 0.77 . . . . 0.0 110.556 -179.355 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 63.9 t -77.73 121.52 30.57 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.089 0 CA-C-N 114.637 -1.165 . . . . 0.0 108.267 179.493 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 84.6 mt -104.26 -67.72 0.88 Allowed 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 107.324 -1.362 . . . . 0.0 107.324 179.229 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 48.7 m-80 -95.07 163.27 22.34 Favored Pre-proline 0 C--N 1.293 -1.891 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 173.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_exo -63.96 -30.61 67.1 Favored 'Trans proline' 0 CA--C 1.531 0.355 0 C-N-CA 121.204 1.27 . . . . 0.0 111.198 178.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.455 ' CD2' ' HB ' ' A' ' 11' ' ' ILE . 22.3 m-85 -100.31 -25.9 14.08 Favored 'General case' 0 N--CA 1.437 -1.118 0 C-N-CA 120.364 -0.534 . . . . 0.0 110.834 -179.415 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 75.8 t80 -105.96 114.13 28.09 Favored 'General case' 0 C--O 1.243 0.749 0 N-CA-C 112.6 0.592 . . . . 0.0 112.6 178.374 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.608 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 15.1 m -125.55 143.45 51.01 Favored 'General case' 0 C--N 1.293 -1.871 0 N-CA-C 106.631 -1.618 . . . . 0.0 106.631 176.34 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . 0.446 ' OE1' ' HA ' ' A' ' 5' ' ' ALA . 8.4 tt0 -132.08 141.23 49.12 Favored 'General case' 0 C--N 1.298 -1.671 0 CA-C-N 118.02 0.373 . . . . 0.0 110.464 -174.112 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.769 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 77.6 m -74.21 114.75 12.92 Favored 'General case' 0 C--O 1.253 1.245 0 C-N-CA 120.714 -0.394 . . . . 0.0 110.344 175.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 97.2 mt . . . . . 0 N--CA 1.428 -1.566 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 178.602 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 5.9 tp-100 . . . . . 0 N--CA 1.433 -1.324 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 53.3 m -107.61 -176.24 3.01 Favored 'General case' 0 C--N 1.302 -1.471 0 C-N-CA 120.505 -0.478 . . . . 0.0 111.266 -177.011 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . 0.437 ' CD2' ' HA ' ' A' ' 36' ' ' LEU . 47.9 t-80 -57.61 132.7 54.02 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 122.846 0.458 . . . . 0.0 109.957 -177.723 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . 0.451 ' HA ' ' NE2' ' A' ' 34' ' ' GLN . . . 80.15 -4.48 1.88 Allowed 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 125.557 1.543 . . . . 0.0 112.63 -179.253 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -85.68 146.54 21.55 Favored Glycine 0 N--CA 1.437 -1.285 0 C-N-CA 120.37 -0.919 . . . . 0.0 110.912 178.172 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.539 ' HA ' ' O ' ' A' ' 33' ' ' SER . 62.1 tt0 -62.95 108.68 1.25 Allowed 'General case' 0 C--O 1.22 -0.473 0 CA-C-O 121.148 0.499 . . . . 0.0 110.382 178.267 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.726 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 23.3 p -86.04 -43.39 13.16 Favored 'General case' 0 C--N 1.297 -1.678 0 CA-C-N 115.73 -0.668 . . . . 0.0 112.678 -174.806 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -179.03 86.34 0.07 OUTLIER Glycine 0 CA--C 1.473 -2.542 0 C-N-CA 118.188 -1.958 . . . . 0.0 113.326 -174.474 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.517 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -104.7 178.46 24.01 Favored Glycine 0 N--CA 1.42 -2.418 0 N-CA-C 108.736 -1.745 . . . . 0.0 108.736 175.033 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 64.9 mt -66.12 128.03 28.4 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.757 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 176.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 99.51 -17.28 57.89 Favored Glycine 0 N--CA 1.44 -1.035 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.043 -179.666 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 67.7 t80 -87.22 109.07 19.23 Favored 'General case' 0 C--N 1.312 -1.042 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 -178.567 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 37.0 p -99.23 2.31 45.54 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.481 -178.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -74.56 -178.31 39.83 Favored Glycine 0 N--CA 1.436 -1.312 0 CA-C-N 115.357 -0.838 . . . . 0.0 112.486 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_endo -62.38 121.46 9.45 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 122.605 2.203 . . . . 0.0 112.133 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.627 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 29.1 p -92.89 0.67 57.45 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.005 -179.703 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 7.8 p -78.64 110.22 14.14 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.11 0 CA-C-O 121.993 0.901 . . . . 0.0 111.664 -179.36 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 70.9 m -83.79 152.9 24.39 Favored 'General case' 0 C--N 1.302 -1.486 0 CA-C-N 115.115 -0.948 . . . . 0.0 109.644 177.732 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.4 145.33 33.06 Favored 'General case' 0 C--O 1.25 1.079 0 O-C-N 123.459 0.475 . . . . 0.0 110.229 176.533 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 19.3 m -52.83 119.36 4.51 Favored 'General case' 0 C--N 1.318 -0.79 0 O-C-N 123.757 0.661 . . . . 0.0 111.464 -178.012 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 111.88 -11.25 27.38 Favored Glycine 0 N--CA 1.439 -1.126 0 CA-C-N 115.832 -0.622 . . . . 0.0 112.255 -179.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 68.2 p -118.42 147.29 43.72 Favored 'General case' 0 C--O 1.244 0.789 0 N-CA-C 109.808 -0.441 . . . . 0.0 109.808 178.239 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 38.9 p -113.35 149.5 33.92 Favored 'General case' 0 C--N 1.309 -1.192 0 C-N-CA 121.223 -0.191 . . . . 0.0 110.751 -178.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 51.5 t -76.42 103.6 6.51 Favored 'General case' 0 C--N 1.312 -1.047 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 178.367 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 68.6 mt-30 -102.78 120.22 40.21 Favored 'General case' 0 N--CA 1.425 -1.679 0 CA-C-O 121.887 0.851 . . . . 0.0 111.363 -178.222 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 95.2 t -83.42 104.94 12.58 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 CA-C-N 114.385 -1.28 . . . . 0.0 109.829 -178.597 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 56.1 mt -85.48 -72.04 0.5 Allowed 'General case' 0 N--CA 1.433 -1.317 0 N-CA-C 107.748 -1.205 . . . . 0.0 107.748 178.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 47.7 m-80 -96.31 166.8 13.52 Favored Pre-proline 0 C--N 1.302 -1.468 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 174.321 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -58.78 -42.23 55.22 Favored 'Trans proline' 0 CA--C 1.538 0.696 0 C-N-CA 121.741 1.628 . . . . 0.0 112.336 177.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.517 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 49.0 m-85 -96.49 -25.96 15.47 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 120.029 -0.669 . . . . 0.0 110.562 -177.333 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 75.3 t80 -104.15 114.03 27.99 Favored 'General case' 0 N--CA 1.435 -1.196 0 C-N-CA 119.691 -0.804 . . . . 0.0 111.312 178.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.539 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 15.9 m -135.84 139.99 43.84 Favored 'General case' 0 C--N 1.283 -2.308 0 N-CA-C 105.501 -2.037 . . . . 0.0 105.501 178.883 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . 0.451 ' NE2' ' HA ' ' A' ' 5' ' ' ALA . 19.8 pt20 -135.82 153.83 51.38 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 118.853 0.751 . . . . 0.0 111.564 -175.789 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.726 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 63.7 m -72.58 117.0 13.72 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.527 178.438 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.437 ' HA ' ' CD2' ' A' ' 4' ' ' HIS . 96.5 mt . . . . . 0 C--N 1.289 -2.028 0 N-CA-C 106.802 -1.555 . . . . 0.0 106.802 177.328 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 . . . . . 0 N--CA 1.438 -1.059 0 CA-C-O 121.296 0.569 . . . . 0.0 110.369 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 30.0 t -100.21 172.15 7.35 Favored 'General case' 0 C--N 1.286 -2.166 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.072 -175.398 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 18.8 t-80 -59.77 134.27 56.87 Favored 'General case' 0 C--O 1.238 0.48 0 N-CA-C 109.846 -0.428 . . . . 0.0 109.846 177.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 79.21 10.78 1.5 Allowed 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.818 1.247 . . . . 0.0 112.351 179.147 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -105.54 162.3 14.33 Favored Glycine 0 N--CA 1.442 -0.925 0 N-CA-C 110.505 -1.038 . . . . 0.0 110.505 176.182 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.583 ' HA ' ' O ' ' A' ' 33' ' ' SER . 53.4 tt0 -82.26 111.62 18.51 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 -179.66 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.729 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 20.7 p -87.36 -35.08 18.57 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 113.469 0.914 . . . . 0.0 113.469 -175.121 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 173.5 80.51 0.05 OUTLIER Glycine 0 CA--C 1.489 -1.559 0 C-N-CA 117.993 -2.051 . . . . 0.0 113.492 -176.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.417 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -112.48 174.11 15.88 Favored Glycine 0 C--N 1.287 -2.163 0 N-CA-C 107.731 -2.148 . . . . 0.0 107.731 174.232 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 74.5 mt -54.93 111.55 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 117.631 0.716 . . . . 0.0 110.211 178.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 114.34 -8.42 22.64 Favored Glycine 0 N--CA 1.437 -1.251 0 C-N-CA 120.606 -0.807 . . . . 0.0 113.405 179.679 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 70.7 t80 -101.36 110.45 22.46 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 179.03 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 4.8 p -107.72 7.02 28.2 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-N 115.83 -0.623 . . . . 0.0 112.042 -177.258 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -83.0 -165.41 37.56 Favored Glycine 0 N--CA 1.444 -0.809 0 CA-C-N 115.486 -0.779 . . . . 0.0 112.268 178.222 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -60.51 111.02 0.9 Allowed 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 123.12 2.546 . . . . 0.0 112.317 -179.46 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.623 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 6.7 p -87.04 -11.17 51.13 Favored 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 113.205 0.817 . . . . 0.0 113.205 -175.69 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 7.5 p -80.87 130.43 35.9 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.91 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.139 179.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 77.3 m -91.32 169.0 11.17 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-O 120.873 0.368 . . . . 0.0 110.401 179.25 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -59.81 137.67 57.99 Favored 'General case' 0 N--CA 1.438 -1.073 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 174.496 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 54.1 m -59.99 121.08 10.93 Favored 'General case' 0 N--CA 1.432 -1.37 0 CA-C-O 121.14 0.495 . . . . 0.0 110.095 -179.258 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 112.66 -10.0 25.81 Favored Glycine 0 N--CA 1.439 -1.125 0 N-CA-C 111.018 -0.833 . . . . 0.0 111.018 -175.091 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 68.2 p -121.63 142.97 49.6 Favored 'General case' 0 C--O 1.244 0.812 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 174.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 34.2 p -110.83 139.24 46.31 Favored 'General case' 0 C--N 1.295 -1.803 0 C-N-CA 120.819 -0.352 . . . . 0.0 111.652 -176.537 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 41.3 t -77.63 102.96 7.29 Favored 'General case' 0 C--N 1.312 -1.041 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 179.338 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -106.79 126.53 52.41 Favored 'General case' 0 N--CA 1.421 -1.897 0 C-N-CA 120.541 -0.464 . . . . 0.0 110.832 -178.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 51.5 t -79.21 95.18 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.207 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 179.649 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 77.6 mt -75.21 -69.77 0.46 Allowed 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 -178.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 49.0 m-80 -96.31 163.87 19.71 Favored Pre-proline 0 C--N 1.294 -1.842 0 N-CA-C 106.968 -1.493 . . . . 0.0 106.968 174.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -61.7 -33.17 86.53 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 121.374 1.383 . . . . 0.0 112.025 179.517 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.417 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 39.8 m-85 -101.64 -25.18 13.96 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 120.419 -0.512 . . . . 0.0 110.914 -179.18 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 61.5 t80 -106.13 113.78 27.52 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 120.076 -0.65 . . . . 0.0 112.135 178.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.583 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 19.7 m -118.13 143.94 46.08 Favored 'General case' 0 C--N 1.293 -1.855 0 N-CA-C 106.524 -1.658 . . . . 0.0 106.524 174.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 29.7 tt0 -135.93 141.94 44.56 Favored 'General case' 0 C--N 1.3 -1.563 0 C-N-CA 120.768 -0.373 . . . . 0.0 111.613 -173.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.729 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 58.7 m -75.29 116.67 16.26 Favored 'General case' 0 C--O 1.254 1.32 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.02 177.184 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 96.1 mt . . . . . 0 C--N 1.308 -1.204 0 C-N-CA 124.336 1.054 . . . . 0.0 108.686 178.718 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 . . . . . 0 N--CA 1.445 -0.688 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 12.8 m -119.57 179.73 4.13 Favored 'General case' 0 C--N 1.293 -1.887 0 C-N-CA 120.731 -0.388 . . . . 0.0 110.994 -172.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 51.1 t-80 -50.19 133.78 23.18 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 123.71 0.804 . . . . 0.0 111.811 -177.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 75.98 -0.69 3.1 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 125.26 1.424 . . . . 0.0 112.106 179.453 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -90.5 153.09 22.42 Favored Glycine 0 N--CA 1.428 -1.877 0 N-CA-C 111.145 -0.782 . . . . 0.0 111.145 178.348 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.504 ' HA ' ' O ' ' A' ' 33' ' ' SER . 54.5 tt0 -75.27 114.82 14.24 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 178.465 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.754 ' O ' ' HA ' ' A' ' 17' ' ' THR . 9.8 p -86.61 -48.73 8.07 Favored 'General case' 0 C--O 1.195 -1.805 0 N-CA-C 112.822 0.675 . . . . 0.0 112.822 -177.456 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -177.45 97.69 0.11 Allowed Glycine 0 CA--C 1.479 -2.169 0 C-N-CA 117.536 -2.268 . . . . 0.0 113.604 -173.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.581 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -113.23 178.34 18.57 Favored Glycine 0 C--N 1.28 -2.545 0 N-CA-C 107.582 -2.207 . . . . 0.0 107.582 174.164 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 68.6 mt -61.64 113.18 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.056 0 CA-C-N 117.749 0.774 . . . . 0.0 109.827 178.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 95.47 29.81 8.57 Favored Glycine 0 N--CA 1.438 -1.193 0 CA-C-N 116.023 -0.535 . . . . 0.0 113.139 178.039 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 77.6 t80 -114.14 112.15 22.72 Favored 'General case' 0 C--N 1.313 -1.017 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 177.316 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 23.4 p -95.92 -4.29 43.71 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 -176.124 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -76.57 -162.46 14.24 Favored Glycine 0 CA--C 1.532 1.138 0 C-N-CA 121.212 -0.518 . . . . 0.0 112.82 -179.415 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -61.8 112.25 1.43 Allowed 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 123.131 2.554 . . . . 0.0 111.152 178.079 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.754 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 16.2 p -93.21 -15.04 26.35 Favored 'General case' 0 N--CA 1.433 -1.295 0 CA-C-N 115.874 -0.603 . . . . 0.0 112.444 -176.42 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 10.0 p -95.57 139.03 19.73 Favored 'Isoleucine or valine' 0 C--O 1.255 1.382 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 178.719 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 81.1 m -91.61 155.74 18.13 Favored 'General case' 0 C--N 1.291 -1.978 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.935 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -58.86 137.92 57.55 Favored 'General case' 0 C--O 1.25 1.13 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 175.409 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 7.1 p -51.03 124.82 12.2 Favored 'General case' 0 C--N 1.311 -1.094 0 O-C-N 123.864 0.728 . . . . 0.0 111.828 -177.255 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 112.22 -21.05 20.58 Favored Glycine 0 N--CA 1.434 -1.441 0 CA-C-N 115.463 -0.789 . . . . 0.0 111.228 -176.405 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 75.8 p -110.86 149.26 30.85 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 176.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 22.8 p -112.06 142.54 44.36 Favored 'General case' 0 C--N 1.297 -1.698 0 CA-C-N 116.818 -0.173 . . . . 0.0 110.651 -178.196 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 44.3 t -78.6 99.19 6.45 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 176.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 75.4 mt-30 -96.26 119.26 34.42 Favored 'General case' 0 N--CA 1.415 -2.217 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.62 -178.015 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 46.5 t -75.37 102.45 2.6 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 177.114 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 56.5 mt -85.16 -74.51 0.4 Allowed 'General case' 0 N--CA 1.428 -1.55 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 -179.34 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 74.9 m-20 -95.56 166.78 13.95 Favored Pre-proline 0 C--N 1.289 -2.032 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 176.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -59.67 -36.95 90.64 Favored 'Trans proline' 0 CA--C 1.543 0.939 0 C-N-CA 121.89 1.727 . . . . 0.0 112.99 179.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.581 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 69.3 m-85 -102.47 -24.34 13.83 Favored 'General case' 0 C--N 1.315 -0.935 0 C-N-CA 120.192 -0.603 . . . . 0.0 110.876 -178.688 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 69.9 t80 -104.71 114.25 28.34 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 112.505 0.557 . . . . 0.0 112.505 179.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.504 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 26.7 m -121.67 146.37 47.07 Favored 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 175.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . 0.501 ' OE1' HD23 ' A' ' 36' ' ' LEU . 35.8 tt0 -134.98 142.43 46.47 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-N 118.242 0.474 . . . . 0.0 111.363 -172.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.745 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 77.4 m -77.26 113.39 14.97 Favored 'General case' 0 C--O 1.247 0.949 0 CA-C-O 121.164 0.507 . . . . 0.0 110.117 176.664 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.501 HD23 ' OE1' ' A' ' 34' ' ' GLN . 97.1 mt . . . . . 0 C--N 1.291 -1.952 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.01 -179.005 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 . . . . . 0 N--CA 1.445 -0.69 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 14.2 m -123.67 179.39 4.8 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 -176.267 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 36.9 t-80 -56.16 143.62 32.59 Favored 'General case' 0 C--O 1.239 0.532 0 C-N-CA 123.213 0.605 . . . . 0.0 110.128 178.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 71.91 10.01 6.17 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 124.586 1.155 . . . . 0.0 111.188 -178.3 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -109.76 147.56 17.15 Favored Glycine 0 N--CA 1.422 -2.267 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.392 178.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.536 ' HA ' ' O ' ' A' ' 33' ' ' SER . 53.3 tt0 -79.22 115.19 18.72 Favored 'General case' 0 C--N 1.31 -1.138 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 178.22 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.646 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 7.0 p -88.16 -45.7 9.9 Favored 'General case' 0 C--N 1.285 -2.219 0 CA-C-N 115.648 -0.706 . . . . 0.0 112.86 -176.159 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -171.89 91.6 0.09 OUTLIER Glycine 0 N--CA 1.428 -1.875 0 C-N-CA 118.152 -1.975 . . . . 0.0 113.968 -174.171 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.425 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -112.74 178.27 18.75 Favored Glycine 0 N--CA 1.427 -1.955 0 N-CA-C 108.341 -1.904 . . . . 0.0 108.341 175.036 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 85.5 mt -60.01 113.33 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.074 0 CA-C-N 117.526 0.663 . . . . 0.0 111.377 179.199 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 94.57 13.04 55.03 Favored Glycine 0 N--CA 1.434 -1.457 0 CA-C-N 115.233 -0.894 . . . . 0.0 112.878 177.475 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 57.1 t80 -96.72 113.15 24.69 Favored 'General case' 0 N--CA 1.442 -0.835 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 179.415 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 11.2 p -107.3 21.26 17.78 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-O 121.681 0.753 . . . . 0.0 111.981 -177.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -94.23 -154.18 30.8 Favored Glycine 0 C--N 1.298 -1.546 0 C-N-CA 120.626 -0.797 . . . . 0.0 111.402 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -70.39 107.11 1.91 Allowed 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 122.329 2.019 . . . . 0.0 111.374 178.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.618 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 9.8 p -87.22 -18.17 30.91 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-N 115.415 -0.811 . . . . 0.0 111.99 -177.855 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 12.0 p -88.15 129.85 38.7 Favored 'Isoleucine or valine' 0 C--O 1.25 1.115 0 CA-C-O 121.177 0.513 . . . . 0.0 110.509 178.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 82.1 m -93.36 148.48 22.01 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.987 -179.638 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -59.74 147.13 38.96 Favored 'General case' 0 C--O 1.247 0.96 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.323 177.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 9.7 t -54.12 126.5 23.02 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.054 -178.033 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 112.44 -18.17 23.13 Favored Glycine 0 N--CA 1.438 -1.167 0 N-CA-C 110.716 -0.953 . . . . 0.0 110.716 -175.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 57.7 p -127.19 146.2 50.49 Favored 'General case' 0 N--CA 1.443 -0.802 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 176.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 16.4 p -120.97 143.11 49.19 Favored 'General case' 0 C--N 1.296 -1.73 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 178.248 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 42.0 t -69.74 105.38 2.72 Favored 'General case' 0 C--N 1.309 -1.163 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 178.153 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 68.5 mt-30 -107.41 119.01 38.24 Favored 'General case' 0 N--CA 1.423 -1.816 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 179.295 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 52.8 t -75.22 119.41 22.87 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 CA-C-N 115.298 -0.864 . . . . 0.0 108.752 -179.241 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 76.6 mt -100.81 -69.48 0.77 Allowed 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 179.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 88.7 m-20 -95.48 166.66 14.22 Favored Pre-proline 0 C--N 1.304 -1.381 0 N-CA-C 106.782 -1.562 . . . . 0.0 106.782 173.104 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -63.6 -27.15 69.31 Favored 'Trans proline' 0 CA--C 1.534 0.476 0 C-N-CA 121.089 1.193 . . . . 0.0 111.858 177.275 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.425 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 55.8 m-85 -105.55 -26.03 12.06 Favored 'General case' 0 N--CA 1.443 -0.795 0 C-N-CA 119.789 -0.765 . . . . 0.0 110.716 -179.242 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 68.2 t80 -105.28 114.24 28.3 Favored 'General case' 0 N--CA 1.439 -1.0 0 C-N-CA 119.748 -0.781 . . . . 0.0 112.061 178.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.536 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 19.3 m -126.65 134.56 50.71 Favored 'General case' 0 C--N 1.283 -2.315 0 N-CA-C 105.766 -1.939 . . . . 0.0 105.766 176.206 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 7.7 tt0 -122.05 146.92 46.72 Favored 'General case' 0 C--N 1.303 -1.422 0 C-N-CA 120.268 -0.573 . . . . 0.0 110.567 -175.055 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.646 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 85.8 m -73.35 104.9 4.52 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 172.798 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 95.8 mt . . . . . 0 C--N 1.296 -1.743 0 C-N-CA 123.993 0.917 . . . . 0.0 108.649 -177.86 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 . . . . . 0 C--O 1.244 0.795 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 39.4 m -81.09 178.33 8.48 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-O 121.145 0.498 . . . . 0.0 110.906 -178.462 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 55.1 t-80 -63.67 133.35 53.47 Favored 'General case' 0 N--CA 1.444 -0.754 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 175.098 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 65.15 75.66 0.36 Allowed 'General case' 0 C--N 1.322 -0.59 0 O-C-N 124.356 1.035 . . . . 0.0 110.76 -177.502 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . 0.469 ' O ' ' HA ' ' A' ' 34' ' ' GLN . . . -165.75 152.36 21.61 Favored Glycine 0 N--CA 1.42 -2.425 0 N-CA-C 108.454 -1.858 . . . . 0.0 108.454 178.557 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.589 ' HA ' ' O ' ' A' ' 33' ' ' SER . 52.7 tt0 -76.97 111.24 12.3 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 117.486 0.643 . . . . 0.0 110.049 -178.286 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.775 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 2.4 p -86.13 -41.58 14.6 Favored 'General case' 0 C--N 1.296 -1.758 0 CA-C-N 115.2 -0.909 . . . . 0.0 112.66 -177.429 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 169.76 101.68 0.15 Allowed Glycine 0 N--CA 1.423 -2.172 0 C-N-CA 117.895 -2.098 . . . . 0.0 113.778 -177.656 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -112.52 -160.51 14.98 Favored Glycine 0 N--CA 1.422 -2.265 0 N-CA-C 108.157 -1.977 . . . . 0.0 108.157 174.527 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 76.8 mt -65.91 109.69 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 CA-C-N 117.706 0.753 . . . . 0.0 110.994 177.547 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 95.13 20.63 27.4 Favored Glycine 0 N--CA 1.441 -1.027 0 C-N-CA 121.022 -0.608 . . . . 0.0 113.853 175.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 53.1 t80 -114.16 112.08 22.6 Favored 'General case' 0 C--N 1.31 -1.129 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 178.476 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 10.3 p -109.68 18.92 19.75 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-O 121.365 0.602 . . . . 0.0 111.662 -177.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -82.18 -150.79 8.73 Favored Glycine 0 N--CA 1.446 -0.688 0 CA-C-O 119.259 -0.745 . . . . 0.0 111.431 179.629 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -66.61 93.9 0.32 Allowed 'Trans proline' 0 CA--C 1.535 0.541 0 C-N-CA 122.158 1.905 . . . . 0.0 111.912 178.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.585 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 17.3 p -83.34 -13.59 54.73 Favored 'General case' 0 C--O 1.251 1.156 0 CA-C-O 121.905 0.86 . . . . 0.0 111.058 -177.533 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 4.7 p -92.9 121.64 43.74 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.56 0 CA-C-N 114.625 -1.17 . . . . 0.0 110.033 177.783 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 65.5 m -86.07 153.2 22.28 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 179.084 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -68.56 163.87 22.6 Favored 'General case' 0 C--O 1.26 1.64 0 CA-C-O 120.712 0.291 . . . . 0.0 111.062 178.599 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 28.1 m -47.49 115.91 1.27 Allowed 'General case' 0 C--O 1.248 1.004 0 C-N-CA 124.667 1.187 . . . . 0.0 113.276 -176.381 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 108.37 -20.83 29.7 Favored Glycine 0 N--CA 1.437 -1.282 0 CA-C-N 115.482 -0.781 . . . . 0.0 113.407 175.236 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 21.2 p -106.7 146.03 31.3 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 122.214 -0.58 . . . . 0.0 111.702 -178.251 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 14.5 p -118.92 147.65 43.79 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.558 -178.327 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 43.4 t -77.88 100.3 6.32 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-O 121.225 0.536 . . . . 0.0 109.644 -179.466 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 85.1 mm-40 -90.72 119.68 31.15 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.844 -179.063 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 46.7 t -83.76 108.71 16.47 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 -179.056 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 81.4 mt -95.03 -68.46 0.8 Allowed 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 -179.668 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.4 ' HB2' ' HB3' ' A' ' 32' ' ' TYR . 45.6 m-80 -95.61 166.82 13.83 Favored Pre-proline 0 C--N 1.296 -1.745 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 175.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -61.28 -37.91 69.62 Favored 'Trans proline' 0 C--N 1.349 0.558 0 C-N-CA 121.204 1.269 . . . . 0.0 111.009 178.624 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 49.4 m-85 -96.63 -25.03 15.73 Favored 'General case' 0 N--CA 1.441 -0.921 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.817 -178.703 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.4 ' HB3' ' HB2' ' A' ' 29' ' ' ASN . 48.9 t80 -104.6 113.43 27.0 Favored 'General case' 0 C--N 1.315 -0.898 0 C-N-CA 118.977 -1.089 . . . . 0.0 111.314 -177.506 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.589 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 26.6 m -124.68 137.91 54.33 Favored 'General case' 0 C--N 1.286 -2.193 0 N-CA-C 105.906 -1.887 . . . . 0.0 105.906 176.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . 0.469 ' HA ' ' O ' ' A' ' 6' ' ' GLY . 30.1 tt0 -131.47 136.21 47.74 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -173.243 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.775 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 85.5 m -70.2 110.56 5.26 Favored 'General case' 0 C--O 1.245 0.831 0 CA-C-O 121.263 0.554 . . . . 0.0 110.937 177.3 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 95.8 mt . . . . . 0 C--N 1.294 -1.817 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 179.059 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 . . . . . 0 N--CA 1.44 -0.943 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 27.7 t -91.95 -178.08 4.91 Favored 'General case' 0 C--N 1.297 -1.695 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.457 -175.582 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 16.8 t-80 -63.43 118.07 7.59 Favored 'General case' 0 N--CA 1.445 -0.691 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 71.83 91.36 0.09 Allowed 'General case' 0 C--O 1.24 0.576 0 C-N-CA 124.62 1.168 . . . . 0.0 111.141 -174.431 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . 0.57 ' O ' ' HA ' ' A' ' 34' ' ' GLN . . . -177.4 163.68 32.42 Favored Glycine 0 N--CA 1.43 -1.766 0 N-CA-C 107.121 -2.392 . . . . 0.0 107.121 179.801 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.612 ' HA ' ' O ' ' A' ' 33' ' ' SER . 53.3 tt0 -84.31 113.47 21.16 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 118.52 1.16 . . . . 0.0 109.608 -178.745 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.76 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 7.4 p -95.17 -36.6 11.41 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 113.248 0.833 . . . . 0.0 113.248 -176.594 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -164.72 66.02 0.22 Allowed Glycine 0 CA--C 1.478 -2.234 0 C-N-CA 118.523 -1.799 . . . . 0.0 112.345 -176.236 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.527 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -110.15 157.04 15.27 Favored Glycine 0 C--N 1.285 -2.284 0 N-CA-C 108.764 -1.734 . . . . 0.0 108.764 177.324 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 69.0 mt -57.49 115.96 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 CA-C-N 117.32 0.56 . . . . 0.0 110.962 -177.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 114.13 -9.66 22.77 Favored Glycine 0 N--CA 1.451 -0.366 0 CA-C-N 116.022 -0.536 . . . . 0.0 112.027 -179.522 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 91.8 t80 -93.55 120.64 34.07 Favored 'General case' 0 C--N 1.311 -1.072 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 179.008 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 12.4 p -111.5 4.55 18.9 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 112.103 0.409 . . . . 0.0 112.103 -176.088 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -82.73 -160.51 28.52 Favored Glycine 0 CA--C 1.528 0.844 0 C-N-CA 121.127 -0.559 . . . . 0.0 112.525 179.687 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -72.87 126.3 11.19 Favored 'Trans proline' 0 CA--C 1.512 -0.62 0 C-N-CA 122.286 1.991 . . . . 0.0 111.175 179.143 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.573 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 21.7 p -85.1 -14.51 46.92 Favored 'General case' 0 C--N 1.295 -1.804 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.357 -177.155 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 12.3 p -75.42 132.8 32.62 Favored 'Isoleucine or valine' 0 C--O 1.257 1.469 0 CA-C-O 121.794 0.807 . . . . 0.0 111.426 -177.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 80.5 m -93.86 167.78 11.4 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-N 114.886 -1.052 . . . . 0.0 110.182 179.219 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.13 140.89 58.25 Favored 'General case' 0 C--N 1.308 -1.196 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 175.244 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 34.6 t -55.29 125.71 21.86 Favored 'General case' 0 C--N 1.312 -1.04 0 O-C-N 123.504 0.502 . . . . 0.0 109.961 -179.719 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 112.56 -20.68 20.29 Favored Glycine 0 N--CA 1.439 -1.141 0 N-CA-C 110.662 -0.975 . . . . 0.0 110.662 -175.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 72.7 p -114.89 157.54 23.19 Favored 'General case' 0 C--N 1.311 -1.074 0 O-C-N 122.293 -0.534 . . . . 0.0 109.665 177.572 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 16.6 p -126.02 148.98 49.16 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 110.089 -0.338 . . . . 0.0 110.089 177.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 53.2 t -76.63 100.88 5.5 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 62.0 mt-30 -101.0 114.99 29.43 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-O 121.122 0.486 . . . . 0.0 110.384 -178.154 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 48.2 t -71.33 116.51 13.13 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.252 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 178.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 78.6 mt -101.15 -68.69 0.8 Allowed 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 -178.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -95.38 166.07 15.48 Favored Pre-proline 0 C--N 1.301 -1.541 0 N-CA-C 106.915 -1.513 . . . . 0.0 106.915 174.657 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_exo -62.6 -27.41 76.36 Favored 'Trans proline' 0 CA--C 1.536 0.583 0 C-N-CA 121.531 1.487 . . . . 0.0 111.622 176.616 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.527 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 88.1 m-85 -105.31 -25.31 12.46 Favored 'General case' 0 N--CA 1.443 -0.798 0 C-N-CA 120.135 -0.626 . . . . 0.0 111.518 179.254 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 44.7 t80 -105.87 113.73 27.45 Favored 'General case' 0 C--N 1.311 -1.074 0 C-N-CA 119.548 -0.861 . . . . 0.0 112.033 179.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.612 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 16.9 m -120.24 135.01 55.13 Favored 'General case' 0 C--N 1.291 -1.953 0 N-CA-C 105.759 -1.941 . . . . 0.0 105.759 175.134 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . 0.57 ' HA ' ' O ' ' A' ' 6' ' ' GLY . 28.1 tt0 -127.79 138.15 52.64 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 112.694 0.627 . . . . 0.0 112.694 -171.466 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.76 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 68.9 m -71.91 109.9 6.07 Favored 'General case' 0 C--O 1.251 1.158 0 CA-C-O 120.979 0.419 . . . . 0.0 111.073 176.875 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 94.3 mt . . . . . 0 N--CA 1.431 -1.398 0 N-CA-C 107.275 -1.38 . . . . 0.0 107.275 178.762 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 . . . . . 0 N--CA 1.446 -0.637 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 67.7 m -127.31 -170.45 2.22 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 111.602 0.223 . . . . 0.0 111.602 -177.052 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . 0.431 ' HA ' ' O ' ' A' ' 35' ' ' CYS . 37.0 t-80 -60.13 136.64 58.09 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 122.718 0.407 . . . . 0.0 110.936 -173.363 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . 0.472 ' HA ' ' CD ' ' A' ' 34' ' ' GLN . . . 74.4 8.76 4.47 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 124.143 0.977 . . . . 0.0 111.953 -179.814 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . 0.411 ' O ' ' HA ' ' A' ' 34' ' ' GLN . . . -103.92 151.29 17.62 Favored Glycine 0 N--CA 1.431 -1.65 0 N-CA-C 111.386 -0.686 . . . . 0.0 111.386 178.537 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.607 ' HA ' ' O ' ' A' ' 33' ' ' SER . 54.3 tt0 -77.98 114.43 16.84 Favored 'General case' 0 CA--C 1.502 -0.883 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 178.608 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.698 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 8.0 p -94.27 -43.74 8.29 Favored 'General case' 0 C--N 1.288 -2.077 0 N-CA-C 113.549 0.944 . . . . 0.0 113.549 -175.64 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -159.38 69.75 0.25 Allowed Glycine 0 CA--C 1.481 -2.046 0 C-N-CA 118.541 -1.79 . . . . 0.0 112.765 -172.204 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.559 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -112.42 153.63 17.32 Favored Glycine 0 C--N 1.279 -2.584 0 N-CA-C 109.307 -1.517 . . . . 0.0 109.307 178.217 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.424 ' HB ' ' CD1' ' A' ' 31' ' ' TYR . 72.6 mt -56.24 123.89 8.38 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 O-C-N 123.974 0.455 . . . . 0.0 109.909 179.721 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 108.02 -15.27 36.93 Favored Glycine 0 N--CA 1.442 -0.9 0 N-CA-C 111.074 -0.81 . . . . 0.0 111.074 -179.218 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 80.1 t80 -101.78 109.7 21.53 Favored 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 178.602 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 13.5 p -107.68 7.34 28.44 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 112.381 0.511 . . . . 0.0 112.381 -176.629 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -82.41 -152.9 11.28 Favored Glycine 0 CA--C 1.53 0.978 0 CA-C-N 116.071 -0.513 . . . . 0.0 113.079 -179.547 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -64.49 112.25 1.88 Allowed 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 122.993 2.462 . . . . 0.0 112.294 -179.146 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.599 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 14.1 p -95.28 -4.73 45.1 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 115.375 -0.83 . . . . 0.0 113.022 -176.113 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 9.2 p -89.76 127.59 42.28 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.998 0 CA-C-O 120.896 0.379 . . . . 0.0 110.84 -178.648 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.474 ' SG ' ' HB2' ' A' ' 25' ' ' CYS . 72.9 m -87.91 154.1 20.79 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.167 178.789 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.72 143.4 57.46 Favored 'General case' 0 N--CA 1.438 -1.07 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.25 175.528 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.2 p -62.4 127.82 33.11 Favored 'General case' 0 C--N 1.297 -1.688 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.658 -179.15 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 112.5 -5.07 26.41 Favored Glycine 0 N--CA 1.438 -1.172 0 N-CA-C 110.727 -0.949 . . . . 0.0 110.727 -174.141 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 49.3 p -136.26 145.0 45.1 Favored 'General case' 0 C--O 1.239 0.547 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 174.586 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 46.4 p -112.1 145.01 40.51 Favored 'General case' 0 C--N 1.305 -1.338 0 C-N-CA 120.884 -0.326 . . . . 0.0 110.139 -179.518 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.474 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 43.6 t -79.28 97.63 6.35 Favored 'General case' 0 C--N 1.31 -1.144 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 -179.706 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 72.1 mt-30 -93.74 114.75 27.1 Favored 'General case' 0 N--CA 1.424 -1.767 0 CA-C-O 121.303 0.573 . . . . 0.0 110.716 -177.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 48.1 t -76.76 95.12 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 CA-C-N 114.798 -1.092 . . . . 0.0 108.404 177.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 87.7 mt -78.23 -70.91 0.46 Allowed 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 -179.388 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 75.2 m-20 -95.36 166.72 14.17 Favored Pre-proline 0 C--N 1.296 -1.738 0 N-CA-C 106.644 -1.613 . . . . 0.0 106.644 174.66 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_exo -62.95 -35.66 65.17 Favored 'Trans proline' 0 C--O 1.246 0.915 0 C-N-CA 121.171 1.247 . . . . 0.0 111.441 176.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.559 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 73.2 m-85 -97.41 -26.33 14.9 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 120.411 -0.516 . . . . 0.0 111.056 -178.639 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 68.8 t80 -105.68 114.09 28.04 Favored 'General case' 0 C--N 1.311 -1.09 0 C-N-CA 119.879 -0.728 . . . . 0.0 112.512 177.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.607 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 18.6 m -127.01 135.88 51.45 Favored 'General case' 0 C--N 1.295 -1.79 0 N-CA-C 106.45 -1.685 . . . . 0.0 106.45 175.841 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . 0.472 ' CD ' ' HA ' ' A' ' 5' ' ' ALA . 7.9 tt0 -126.22 141.41 51.93 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-N 117.975 0.352 . . . . 0.0 111.022 -174.476 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.698 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 60.3 m -73.55 109.98 7.48 Favored 'General case' 0 C--O 1.253 1.25 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 174.075 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 87.4 mt . . . . . 0 C--N 1.289 -2.036 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 179.503 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 . . . . . 0 N--CA 1.436 -1.144 0 N-CA-C 107.767 -1.198 . . . . 0.0 107.767 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 33.4 t -114.82 179.32 3.98 Favored 'General case' 0 C--N 1.288 -2.088 0 C-N-CA 120.642 -0.423 . . . . 0.0 111.425 -173.538 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 57.4 t-80 -58.15 137.04 57.31 Favored 'General case' 0 CA--C 1.519 -0.243 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 -178.642 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 78.21 -3.69 2.29 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 124.858 1.263 . . . . 0.0 112.059 179.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -90.15 141.91 16.19 Favored Glycine 0 N--CA 1.426 -1.997 0 N-CA-C 110.76 -0.936 . . . . 0.0 110.76 178.313 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.575 ' HA ' ' O ' ' A' ' 33' ' ' SER . 54.0 tt0 -69.26 113.55 6.71 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 176.425 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.711 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 10.5 p -86.29 -40.83 15.11 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 112.764 0.654 . . . . 0.0 112.764 -176.178 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 177.4 93.25 0.09 OUTLIER Glycine 0 CA--C 1.488 -1.653 0 C-N-CA 117.788 -2.148 . . . . 0.0 113.847 -176.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.503 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -112.01 174.85 16.74 Favored Glycine 0 C--N 1.286 -2.238 0 N-CA-C 107.519 -2.232 . . . . 0.0 107.519 174.755 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 65.2 mt -60.55 113.25 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.139 0 CA-C-N 117.912 0.856 . . . . 0.0 109.469 178.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 113.8 -20.09 17.89 Favored Glycine 0 N--CA 1.438 -1.229 0 C-N-CA 121.1 -0.571 . . . . 0.0 112.165 179.206 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 71.0 t80 -81.35 118.97 23.1 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-O 121.038 0.447 . . . . 0.0 110.425 -176.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 11.7 p -102.58 5.79 39.45 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 113.055 0.761 . . . . 0.0 113.055 -175.175 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -87.89 -157.04 31.22 Favored Glycine 0 CA--C 1.524 0.628 0 C-N-CA 120.703 -0.761 . . . . 0.0 113.275 -175.262 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -70.7 113.16 3.44 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.637 2.225 . . . . 0.0 111.805 -179.586 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.635 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 18.5 p -89.04 -3.41 58.7 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.847 -177.36 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 4.0 p -98.91 120.82 48.75 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.953 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.859 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 63.1 m -85.74 164.27 17.71 Favored 'General case' 0 C--N 1.299 -1.621 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.48 179.448 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.42 146.0 55.04 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 174.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 46.1 m -61.67 130.74 47.28 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 178.049 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 112.36 -13.12 25.85 Favored Glycine 0 C--N 1.309 -0.962 0 N-CA-C 110.384 -1.086 . . . . 0.0 110.384 -173.482 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 65.0 p -127.57 155.27 44.09 Favored 'General case' 0 C--O 1.248 0.986 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 175.229 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 33.8 p -120.6 143.26 48.74 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 177.331 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 52.7 t -74.53 99.6 3.64 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 176.644 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 -97.82 119.68 36.85 Favored 'General case' 0 N--CA 1.425 -1.717 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 -177.722 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 43.1 t -77.86 93.88 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 178.091 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 82.7 mt -74.96 -70.77 0.39 Allowed 'General case' 0 C--N 1.306 -1.297 0 CA-C-N 115.278 -0.874 . . . . 0.0 109.092 -177.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 52.1 m-80 -95.58 165.91 15.7 Favored Pre-proline 0 C--N 1.295 -1.802 0 N-CA-C 106.206 -1.776 . . . . 0.0 106.206 174.006 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -63.43 -30.46 72.28 Favored 'Trans proline' 0 C--O 1.239 0.543 0 C-N-CA 121.376 1.384 . . . . 0.0 111.287 178.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.503 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 55.4 m-85 -103.15 -25.71 13.28 Favored 'General case' 0 N--CA 1.438 -1.073 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.464 -179.754 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 40.6 t80 -106.03 114.2 28.2 Favored 'General case' 0 C--N 1.317 -0.843 0 C-N-CA 119.413 -0.915 . . . . 0.0 111.562 178.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.575 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 15.4 m -121.03 141.04 51.12 Favored 'General case' 0 C--N 1.294 -1.824 0 N-CA-C 106.485 -1.672 . . . . 0.0 106.485 176.271 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -136.04 140.93 44.21 Favored 'General case' 0 C--N 1.297 -1.699 0 CA-C-N 118.053 0.388 . . . . 0.0 111.047 -172.623 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.711 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 66.7 m -73.17 111.24 8.1 Favored 'General case' 0 C--O 1.257 1.488 0 CA-C-O 121.108 0.48 . . . . 0.0 110.369 177.63 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 82.2 mt . . . . . 0 C--N 1.303 -1.443 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 -179.844 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . 0.442 ' O ' ' HA ' ' A' ' 19' ' ' CYS . 8.2 tp-100 . . . . . 0 N--CA 1.442 -0.832 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' SER . . . . . 0.406 ' O ' ' HB2' ' A' ' 35' ' ' CYS . 69.7 m -126.06 -165.62 1.46 Allowed 'General case' 0 C--N 1.276 -2.621 0 C-N-CA 120.99 -0.284 . . . . 0.0 111.518 -174.774 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 56.8 t-80 -50.3 130.58 23.35 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 113.647 0.98 . . . . 0.0 113.647 -172.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 71.52 12.06 6.52 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 114.275 -1.33 . . . . 0.0 112.649 175.671 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . 0.407 ' O ' ' HA ' ' A' ' 34' ' ' GLN . . . -100.15 165.57 19.66 Favored Glycine 0 N--CA 1.433 -1.5 0 N-CA-C 110.846 -0.902 . . . . 0.0 110.846 176.225 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.512 ' HA ' ' O ' ' A' ' 33' ' ' SER . 54.0 tt0 -87.82 112.35 22.36 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 110.245 -0.28 . . . . 0.0 110.245 -177.562 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.761 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 14.6 p -83.03 -41.94 18.08 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 112.383 0.512 . . . . 0.0 112.383 -178.226 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 165.14 101.42 0.16 Allowed Glycine 0 CA--C 1.483 -1.923 0 C-N-CA 117.624 -2.227 . . . . 0.0 114.265 -178.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -112.63 -169.98 17.92 Favored Glycine 0 N--CA 1.423 -2.199 0 N-CA-C 107.489 -2.244 . . . . 0.0 107.489 173.4 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 70.3 mt -62.09 122.86 13.73 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.34 0 CA-C-N 117.815 0.807 . . . . 0.0 110.21 179.156 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 99.02 -5.27 59.36 Favored Glycine 0 N--CA 1.444 -0.814 0 C-N-CA 120.834 -0.698 . . . . 0.0 113.24 175.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 69.4 t80 -94.38 113.79 25.72 Favored 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 27.0 p -106.41 -1.18 23.52 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 116.317 -0.402 . . . . 0.0 112.039 -176.736 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -76.02 -156.7 6.54 Favored Glycine 0 CA--C 1.526 0.728 0 CA-C-N 116.121 -0.49 . . . . 0.0 113.195 -178.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -63.62 106.79 0.64 Allowed 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 122.568 2.179 . . . . 0.0 111.885 -179.662 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.672 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 4.2 p -95.51 15.14 20.52 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-N 115.401 -0.818 . . . . 0.0 112.377 -176.132 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 7.1 p -112.13 126.76 69.56 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.627 -179.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.463 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 80.1 m -88.01 150.2 23.56 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 115.652 -0.704 . . . . 0.0 109.163 177.078 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.14 153.34 43.88 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 177.509 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 24.6 m -55.97 128.43 35.2 Favored 'General case' 0 N--CA 1.435 -1.184 0 CA-C-O 121.336 0.589 . . . . 0.0 110.705 -179.677 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 111.97 -18.12 24.27 Favored Glycine 0 N--CA 1.432 -1.576 0 N-CA-C 110.927 -0.869 . . . . 0.0 110.927 -177.095 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 68.6 p -121.54 146.73 46.65 Favored 'General case' 0 N--CA 1.441 -0.886 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 178.118 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 34.2 p -114.85 144.04 44.16 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.07 179.306 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 52.9 t -78.62 106.3 10.5 Favored 'General case' 0 C--N 1.308 -1.2 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 178.607 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -111.08 130.56 55.57 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.179 -178.35 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 43.2 t -87.71 114.45 26.55 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.831 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 -177.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 86.4 mt -92.94 -72.72 0.59 Allowed 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 179.282 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 84.3 m-20 -93.63 163.23 25.04 Favored Pre-proline 0 C--N 1.305 -1.341 0 N-CA-C 106.322 -1.733 . . . . 0.0 106.322 175.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -58.07 -35.28 98.87 Favored 'Trans proline' 0 CA--C 1.534 0.477 0 C-N-CA 121.626 1.551 . . . . 0.0 111.55 179.63 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 90.3 m-85 -97.69 -25.04 15.23 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.671 -179.47 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 65.9 t80 -105.48 114.43 28.61 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 119.937 -0.705 . . . . 0.0 112.714 -179.579 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.512 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 19.9 m -119.21 143.95 46.98 Favored 'General case' 0 C--N 1.295 -1.791 0 N-CA-C 106.962 -1.496 . . . . 0.0 106.962 174.515 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . 0.407 ' HA ' ' O ' ' A' ' 6' ' ' GLY . 35.2 tt0 -129.96 143.62 50.9 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 111.941 0.349 . . . . 0.0 111.941 -171.478 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.761 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 86.0 m -82.0 111.07 17.83 Favored 'General case' 0 C--O 1.252 1.221 0 CA-C-O 121.169 0.509 . . . . 0.0 109.892 176.345 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 96.1 mt . . . . . 0 C--N 1.298 -1.674 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.646 179.586 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 41.1 tp60 . . . . . 0 N--CA 1.432 -1.374 0 CA-C-O 121.479 0.657 . . . . 0.0 109.733 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 58.3 p -78.11 168.47 19.81 Favored 'General case' 0 C--N 1.293 -1.878 0 CA-C-N 115.316 -0.856 . . . . 0.0 112.161 -175.031 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 50.0 t-80 -57.21 137.51 55.84 Favored 'General case' 0 C--O 1.238 0.465 0 N-CA-C 109.141 -0.688 . . . . 0.0 109.141 176.018 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 72.19 15.48 5.4 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 123.784 0.834 . . . . 0.0 111.407 -179.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -105.98 160.98 14.51 Favored Glycine 0 N--CA 1.432 -1.574 0 N-CA-C 110.26 -1.136 . . . . 0.0 110.26 174.533 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.576 ' HA ' ' O ' ' A' ' 33' ' ' SER . 53.5 tt0 -80.68 109.91 15.67 Favored 'General case' 0 C--O 1.21 -0.988 0 CA-C-N 116.869 0.334 . . . . 0.0 110.331 -178.599 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.778 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 23.5 p -84.62 -15.36 45.81 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -177.188 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.409 ' HA2' ' CD1' ' A' ' 13' ' ' TYR . . . 135.14 100.69 0.65 Allowed Glycine 0 N--CA 1.42 -2.423 0 C-N-CA 117.72 -2.181 . . . . 0.0 115.253 176.119 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -112.23 -171.15 18.53 Favored Glycine 0 N--CA 1.423 -2.221 0 N-CA-C 106.991 -2.444 . . . . 0.0 106.991 172.048 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 77.7 mt -58.39 113.81 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.994 0 CA-C-N 117.946 0.873 . . . . 0.0 110.443 179.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 114.02 -16.87 20.26 Favored Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.964 -0.636 . . . . 0.0 113.028 177.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.409 ' CD1' ' HA2' ' A' ' 9' ' ' GLY . 66.3 t80 -94.36 129.06 41.21 Favored 'General case' 0 C--N 1.312 -1.046 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 -179.159 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 11.4 p -131.58 14.31 4.95 Favored 'General case' 0 C--O 1.248 0.997 0 N-CA-C 112.981 0.734 . . . . 0.0 112.981 -174.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -90.93 -140.73 8.92 Favored Glycine 0 C--N 1.309 -0.967 0 C-N-CA 121.19 -0.529 . . . . 0.0 111.958 178.713 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -66.14 108.97 1.43 Allowed 'Trans proline' 0 N--CA 1.46 -0.484 0 C-N-CA 122.317 2.011 . . . . 0.0 111.659 -179.411 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.461 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 17.5 p -97.06 -3.49 41.26 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-N 115.696 -0.683 . . . . 0.0 111.747 -178.817 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 7.2 p -90.28 125.09 43.16 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.941 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.933 178.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 84.8 m -84.4 161.95 20.16 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 115.699 -0.682 . . . . 0.0 112.055 -179.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.83 160.18 28.85 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 115.098 -0.955 . . . . 0.0 110.79 178.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 31.1 m -54.06 116.29 2.5 Favored 'General case' 0 C--N 1.31 -1.147 0 C-N-CA 124.058 0.943 . . . . 0.0 111.989 -179.062 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 105.86 -19.09 39.13 Favored Glycine 0 N--CA 1.435 -1.425 0 CA-C-N 115.779 -0.646 . . . . 0.0 112.237 178.224 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 74.9 p -106.91 145.15 32.55 Favored 'General case' 0 C--N 1.309 -1.181 0 O-C-N 122.252 -0.558 . . . . 0.0 110.813 -177.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 22.2 p -114.96 152.15 32.86 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 110.079 -0.341 . . . . 0.0 110.079 178.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 50.8 t -77.98 106.02 9.56 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 178.706 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 68.4 mt-30 -108.45 123.88 49.55 Favored 'General case' 0 N--CA 1.429 -1.49 0 CA-C-O 121.11 0.481 . . . . 0.0 109.792 -179.571 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 55.0 t -80.58 111.53 17.42 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.239 -177.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 86.6 mt -91.67 -70.06 0.71 Allowed 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 179.688 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 51.2 m-20 -94.58 163.99 21.14 Favored Pre-proline 0 C--N 1.299 -1.612 0 N-CA-C 105.814 -1.921 . . . . 0.0 105.814 176.109 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_exo -62.39 -26.44 76.79 Favored 'Trans proline' 0 CA--C 1.539 0.744 0 C-N-CA 121.539 1.493 . . . . 0.0 111.798 178.25 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 41.8 m-85 -108.47 -25.26 11.03 Favored 'General case' 0 N--CA 1.444 -0.742 0 C-N-CA 120.216 -0.594 . . . . 0.0 111.11 -177.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 78.6 t80 -105.58 113.96 27.83 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 120.915 0.388 . . . . 0.0 111.888 177.702 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.576 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 24.8 m -116.3 143.43 45.55 Favored 'General case' 0 C--N 1.285 -2.212 0 N-CA-C 106.426 -1.694 . . . . 0.0 106.426 175.753 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -129.4 140.04 51.47 Favored 'General case' 0 C--N 1.303 -1.434 0 CA-C-N 118.269 0.486 . . . . 0.0 111.379 -173.248 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.778 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 74.9 m -74.84 112.56 11.17 Favored 'General case' 0 C--O 1.256 1.4 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.094 175.759 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 92.6 mt . . . . . 0 N--CA 1.429 -1.477 0 C-N-CA 124.401 1.08 . . . . 0.0 108.091 179.965 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . 0.408 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 5.8 tp-100 . . . . . 0 N--CA 1.446 -0.653 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' SER . . . . . 0.426 ' O ' ' HB2' ' A' ' 35' ' ' CYS . 33.0 m -98.64 -177.03 3.54 Favored 'General case' 0 C--N 1.294 -1.826 0 CA-C-N 116.733 -0.212 . . . . 0.0 111.152 -175.717 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 53.4 t-80 -61.99 126.56 27.77 Favored 'General case' 0 CA--C 1.511 -0.549 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 177.203 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 71.24 102.99 0.06 Allowed 'General case' 0 C--O 1.237 0.442 0 O-C-N 124.775 1.297 . . . . 0.0 109.726 -173.394 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . 0.453 ' O ' ' HA ' ' A' ' 34' ' ' GLN . . . 158.86 147.48 4.87 Favored Glycine 0 N--CA 1.418 -2.519 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 -176.277 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.584 ' HA ' ' O ' ' A' ' 33' ' ' SER . 53.8 tt0 -78.51 106.83 10.73 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-O 121.03 0.443 . . . . 0.0 110.333 -179.033 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.662 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 7.9 p -82.11 -41.32 20.67 Favored 'General case' 0 C--N 1.301 -1.519 0 CA-C-N 115.556 -0.747 . . . . 0.0 112.05 -179.118 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 173.47 100.26 0.13 Allowed Glycine 0 N--CA 1.432 -1.628 0 C-N-CA 117.881 -2.104 . . . . 0.0 114.397 -177.552 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -112.0 -167.8 17.98 Favored Glycine 0 C--N 1.289 -2.069 0 N-CA-C 108.252 -1.939 . . . . 0.0 108.252 174.446 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 86.1 mt -59.58 109.25 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.01 0 CA-C-N 117.724 0.762 . . . . 0.0 110.995 179.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 104.82 -10.08 48.27 Favored Glycine 0 N--CA 1.437 -1.243 0 CA-C-N 115.989 -0.55 . . . . 0.0 113.313 176.504 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 34.5 t80 -100.12 111.22 23.5 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 -177.62 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 5.5 p -113.33 10.96 18.49 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 113.466 0.913 . . . . 0.0 113.466 -175.367 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -74.97 -131.74 0.27 Allowed Glycine 0 CA--C 1.53 1.024 0 CA-C-N 116.16 -0.473 . . . . 0.0 113.475 -179.016 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.86 81.06 0.87 Allowed 'Trans proline' 0 N--CA 1.461 -0.439 0 C-N-CA 122.672 2.248 . . . . 0.0 112.792 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.453 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 29.2 p -81.28 -10.41 59.58 Favored 'General case' 0 N--CA 1.437 -1.084 0 CA-C-N 115.338 -0.847 . . . . 0.0 110.606 178.88 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 7.1 p -89.96 132.82 33.65 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.275 0 CA-C-N 114.833 -1.076 . . . . 0.0 108.886 176.601 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.47 ' SG ' ' HB2' ' A' ' 25' ' ' CYS . 76.1 m -101.1 156.67 17.28 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.39 -177.028 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.18 175.29 3.94 Favored 'General case' 0 C--O 1.246 0.877 0 C-N-CA 123.829 0.851 . . . . 0.0 112.065 -178.545 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 5.1 m -51.72 113.05 0.87 Allowed 'General case' 0 N--CA 1.443 -0.815 0 C-N-CA 124.863 1.265 . . . . 0.0 112.275 -177.426 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 89.81 12.63 62.06 Favored Glycine 0 N--CA 1.434 -1.444 0 C-N-CA 120.509 -0.853 . . . . 0.0 113.499 174.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.461 ' OG1' ' HB3' ' A' ' 19' ' ' CYS . 73.6 p -124.96 143.93 50.63 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 117.294 0.547 . . . . 0.0 110.274 177.33 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 40.1 p -118.85 137.03 53.71 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.705 179.609 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.47 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 53.3 t -76.35 109.22 9.87 Favored 'General case' 0 C--N 1.312 -1.024 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 179.523 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 74.6 mt-30 -116.28 125.97 52.92 Favored 'General case' 0 C--N 1.298 -1.664 0 CA-C-O 121.026 0.441 . . . . 0.0 110.542 -179.368 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 69.1 t -70.29 115.72 10.16 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.201 0 CA-C-N 115.016 -0.993 . . . . 0.0 109.045 178.441 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 67.8 mt -98.97 -70.67 0.72 Allowed 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 81.9 m-20 -95.5 168.98 9.93 Favored Pre-proline 0 C--N 1.298 -1.644 0 N-CA-C 106.763 -1.569 . . . . 0.0 106.763 175.539 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_exo -59.54 -36.75 92.17 Favored 'Trans proline' 0 CA--C 1.542 0.924 0 C-N-CA 121.614 1.543 . . . . 0.0 113.085 -179.657 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 66.6 m-85 -104.46 -24.02 13.09 Favored 'General case' 0 C--N 1.312 -1.049 0 O-C-N 121.716 -0.615 . . . . 0.0 110.574 -178.762 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 62.8 t80 -103.32 113.59 27.2 Favored 'General case' 0 N--CA 1.431 -1.4 0 CA-C-O 121.658 0.742 . . . . 0.0 111.422 -178.344 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.584 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 26.0 m -122.67 143.67 49.63 Favored 'General case' 0 C--N 1.288 -2.094 0 N-CA-C 105.536 -2.024 . . . . 0.0 105.536 176.355 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . 0.453 ' HA ' ' O ' ' A' ' 6' ' ' GLY . 27.1 tt0 -135.34 145.72 47.7 Favored 'General case' 0 C--N 1.297 -1.675 0 C-N-CA 120.274 -0.571 . . . . 0.0 112.465 -173.105 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.662 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 66.8 m -76.17 112.16 12.34 Favored 'General case' 0 C--O 1.251 1.165 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.335 176.304 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 94.9 mt . . . . . 0 C--N 1.3 -1.558 0 CA-C-N 115.012 -0.995 . . . . 0.0 108.397 179.081 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . 0.512 ' HA ' ' OE1' ' A' ' 2' ' ' GLN . 3.4 tp60 . . . . . 0 N--CA 1.436 -1.144 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 87.2 p -92.39 -178.15 4.84 Favored 'General case' 0 C--N 1.294 -1.838 0 CA-C-O 121.006 0.432 . . . . 0.0 111.193 -177.508 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 50.5 t-80 -54.43 136.54 44.01 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 123.954 0.902 . . . . 0.0 110.768 178.589 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 75.75 3.5 3.85 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 124.781 1.232 . . . . 0.0 112.713 177.82 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -93.37 154.98 22.03 Favored Glycine 0 N--CA 1.437 -1.257 0 N-CA-C 110.433 -1.067 . . . . 0.0 110.433 175.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.47 ' HA ' ' O ' ' A' ' 33' ' ' SER . 52.3 tt0 -81.36 110.1 16.48 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 177.933 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.7 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 8.7 p -79.18 -43.39 24.0 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 123.333 0.396 . . . . 0.0 111.867 -177.573 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 157.31 115.74 0.47 Allowed Glycine 0 N--CA 1.42 -2.383 0 C-N-CA 117.145 -2.455 . . . . 0.0 114.708 179.492 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -101.81 -149.9 22.87 Favored Glycine 0 N--CA 1.418 -2.559 0 N-CA-C 108.352 -1.899 . . . . 0.0 108.352 174.417 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 84.3 mt -71.92 112.98 8.07 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.715 0 CA-C-N 117.417 0.609 . . . . 0.0 111.008 178.475 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 92.61 30.06 10.17 Favored Glycine 0 N--CA 1.449 -0.492 0 CA-C-N 115.807 -0.633 . . . . 0.0 113.597 174.604 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 36.3 t80 -111.72 117.05 31.8 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-N 117.342 0.571 . . . . 0.0 109.513 -179.104 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 39.0 p -102.78 11.27 37.81 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-O 120.864 0.364 . . . . 0.0 111.742 -177.263 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -80.01 -151.78 7.2 Favored Glycine 0 CA--C 1.529 0.965 0 CA-C-N 116.071 -0.513 . . . . 0.0 112.315 179.638 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -75.35 96.59 1.04 Allowed 'Trans proline' 0 N--CA 1.453 -0.89 0 C-N-CA 122.276 1.984 . . . . 0.0 111.163 179.352 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.575 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 15.2 p -90.52 -8.76 49.5 Favored 'General case' 0 N--CA 1.423 -1.808 0 CA-C-N 115.407 -0.815 . . . . 0.0 112.259 -175.303 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 9.3 p -95.78 130.71 44.1 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.225 0 CA-C-N 116.123 -0.49 . . . . 0.0 109.932 177.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.478 ' HA ' ' O ' ' A' ' 2' ' ' GLN . 73.6 m -91.86 159.19 15.91 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.467 -179.404 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -78.86 170.0 17.36 Favored 'General case' 0 C--O 1.251 1.138 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.261 -179.472 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 46.4 m -58.51 126.65 28.47 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.972 -179.19 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 104.37 -6.24 45.68 Favored Glycine 0 N--CA 1.431 -1.667 0 C-N-CA 120.147 -1.025 . . . . 0.0 112.207 178.786 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 38.8 p -135.07 153.08 52.16 Favored 'General case' 0 C--O 1.241 0.627 0 CA-C-O 120.653 0.263 . . . . 0.0 111.305 -179.389 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 8.8 p -124.01 153.51 41.21 Favored 'General case' 0 N--CA 1.437 -1.093 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 176.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 50.9 t -82.34 99.38 9.33 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 -179.399 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 58.5 mt-30 -99.83 122.36 42.67 Favored 'General case' 0 N--CA 1.438 -1.059 0 CA-C-O 121.123 0.487 . . . . 0.0 110.087 -177.832 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 55.8 t -82.57 107.42 14.41 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.35 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.164 -179.001 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 84.1 mt -88.47 -70.39 0.64 Allowed 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 -179.786 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 55.7 m-80 -94.39 164.41 20.16 Favored Pre-proline 0 C--N 1.303 -1.441 0 N-CA-C 106.343 -1.725 . . . . 0.0 106.343 174.235 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_exo -60.46 -24.58 78.33 Favored 'Trans proline' 0 C--N 1.35 0.624 0 C-N-CA 121.766 1.644 . . . . 0.0 111.963 179.496 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 55.8 m-85 -109.56 -24.26 11.06 Favored 'General case' 0 N--CA 1.432 -1.356 0 C-N-CA 120.276 -0.57 . . . . 0.0 111.502 -179.256 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 57.0 t80 -103.95 113.43 26.95 Favored 'General case' 0 C--N 1.315 -0.934 0 C-N-CA 119.606 -0.838 . . . . 0.0 110.461 -179.474 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.47 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 49.8 m -123.18 137.56 54.86 Favored 'General case' 0 C--N 1.28 -2.447 0 N-CA-C 105.813 -1.921 . . . . 0.0 105.813 177.065 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 29.4 tt0 -131.46 141.04 49.71 Favored 'General case' 0 C--N 1.288 -2.075 0 C-N-CA 121.077 -0.249 . . . . 0.0 111.087 -172.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.7 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 76.8 m -74.56 107.98 7.03 Favored 'General case' 0 C--O 1.255 1.39 0 CA-C-O 121.636 0.731 . . . . 0.0 110.653 177.374 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 96.2 mt . . . . . 0 N--CA 1.428 -1.543 0 N-CA-C 106.304 -1.739 . . . . 0.0 106.304 179.028 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 . . . . . 0 N--CA 1.447 -0.58 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 5.0 m -93.03 169.63 10.27 Favored 'General case' 0 C--N 1.298 -1.667 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.6 -175.417 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 42.9 t-80 -52.92 139.45 27.42 Favored 'General case' 0 C--O 1.242 0.697 0 CA-C-N 115.14 -0.936 . . . . 0.0 109.274 173.159 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 69.0 8.28 6.75 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.753 0.821 . . . . 0.0 112.836 179.141 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -100.17 159.09 19.45 Favored Glycine 0 N--CA 1.436 -1.332 0 C-N-CA 120.68 -0.772 . . . . 0.0 111.501 178.283 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.52 ' HA ' ' O ' ' A' ' 33' ' ' SER . 53.7 tt0 -80.7 112.56 18.18 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 179.033 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.685 ' O ' ' HA ' ' A' ' 17' ' ' THR . 25.4 p -91.33 -38.29 12.72 Favored 'General case' 0 C--N 1.293 -1.856 0 N-CA-C 113.304 0.853 . . . . 0.0 113.304 -174.808 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 177.79 85.1 0.06 OUTLIER Glycine 0 CA--C 1.484 -1.851 0 C-N-CA 117.85 -2.119 . . . . 0.0 113.868 -176.754 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.465 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -112.55 176.28 17.6 Favored Glycine 0 C--N 1.285 -2.29 0 N-CA-C 108.469 -1.852 . . . . 0.0 108.469 174.573 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 78.3 mt -61.62 118.82 4.52 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.042 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 176.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 110.38 -5.77 30.02 Favored Glycine 0 N--CA 1.432 -1.608 0 C-N-CA 120.845 -0.693 . . . . 0.0 111.675 -178.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 65.2 t80 -114.0 108.28 16.81 Favored 'General case' 0 C--N 1.311 -1.089 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 178.232 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 21.9 p -109.61 15.65 22.72 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.658 -177.467 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -88.23 -154.67 28.16 Favored Glycine 0 N--CA 1.45 -0.423 0 CA-C-O 119.597 -0.557 . . . . 0.0 112.32 -179.688 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_endo -62.0 109.79 0.88 Allowed 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 122.882 2.388 . . . . 0.0 111.232 177.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.685 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 7.7 p -95.04 -6.46 42.13 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 114.215 1.191 . . . . 0.0 114.215 -173.267 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 7.6 p -95.71 134.76 32.05 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.371 0 O-C-N 121.973 -0.454 . . . . 0.0 109.98 179.43 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 46.9 m -91.37 168.87 11.25 Favored 'General case' 0 C--N 1.312 -1.051 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 -179.786 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.64 141.61 53.62 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 175.082 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 46.7 m -56.46 133.66 53.36 Favored 'General case' 0 N--CA 1.433 -1.314 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.255 -179.201 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 111.9 -13.17 26.96 Favored Glycine 0 C--N 1.296 -1.69 0 N-CA-C 109.86 -1.296 . . . . 0.0 109.86 -173.733 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 55.2 p -136.28 143.63 44.33 Favored 'General case' 0 C--O 1.248 1.004 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 174.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 21.3 p -111.35 138.08 48.29 Favored 'General case' 0 C--N 1.288 -2.098 0 CA-C-N 116.654 -0.248 . . . . 0.0 110.994 -179.212 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 46.4 t -72.3 99.0 2.3 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 176.458 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 74.8 mt-30 -108.06 129.29 55.15 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-O 121.223 0.535 . . . . 0.0 110.305 -179.234 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 58.3 t -78.05 107.6 10.21 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.371 0 CA-C-N 115.137 -0.938 . . . . 0.0 109.342 -179.77 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 83.6 mt -86.48 -72.33 0.51 Allowed 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 82.2 m-20 -94.84 165.17 17.69 Favored Pre-proline 0 C--N 1.292 -1.892 0 N-CA-C 105.789 -1.93 . . . . 0.0 105.789 174.769 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -60.95 -33.6 92.12 Favored 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 121.617 1.544 . . . . 0.0 111.316 179.087 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.465 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 76.1 m-85 -100.11 -26.3 14.0 Favored 'General case' 0 C--N 1.311 -1.079 0 C-N-CA 120.396 -0.522 . . . . 0.0 111.199 -177.787 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 53.6 t80 -106.28 113.82 27.57 Favored 'General case' 0 C--N 1.311 -1.078 0 C-N-CA 120.723 -0.391 . . . . 0.0 111.946 -179.341 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.52 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 20.0 m -121.69 141.09 51.5 Favored 'General case' 0 C--N 1.288 -2.087 0 N-CA-C 106.545 -1.65 . . . . 0.0 106.545 175.353 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 29.0 tt0 -133.43 145.96 50.75 Favored 'General case' 0 C--N 1.3 -1.579 0 C-N-CA 120.092 -0.643 . . . . 0.0 111.376 -172.215 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.658 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 57.2 m -75.77 110.6 10.32 Favored 'General case' 0 C--O 1.252 1.228 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.014 177.483 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 84.7 mt . . . . . 0 C--N 1.302 -1.462 0 CA-C-N 115.042 -0.981 . . . . 0.0 109.503 -177.442 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 . . . . . 0 N--CA 1.429 -1.519 0 N-CA-C 106.301 -1.74 . . . . 0.0 106.301 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 23.2 t -127.49 -177.61 4.15 Favored 'General case' 0 C--N 1.293 -1.866 0 C-N-CA 119.991 -0.684 . . . . 0.0 110.266 -176.635 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 41.6 t-80 -49.99 132.83 23.07 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 124.113 0.965 . . . . 0.0 110.93 -179.575 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 75.6 6.15 3.98 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 124.824 1.25 . . . . 0.0 112.294 178.652 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -98.8 155.92 20.11 Favored Glycine 0 N--CA 1.433 -1.528 0 N-CA-C 110.441 -1.064 . . . . 0.0 110.441 175.653 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.442 ' HA ' ' O ' ' A' ' 33' ' ' SER . 51.6 tt0 -81.23 116.53 21.15 Favored 'General case' 0 N--CA 1.438 -1.039 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 179.824 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.728 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 10.8 p -91.08 -22.02 20.93 Favored 'General case' 0 C--N 1.292 -1.904 0 N-CA-C 113.261 0.837 . . . . 0.0 113.261 -175.102 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 157.45 90.54 0.08 OUTLIER Glycine 0 CA--C 1.473 -2.592 0 C-N-CA 117.203 -2.427 . . . . 0.0 113.818 -179.108 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.648 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -113.11 179.41 19.08 Favored Glycine 0 C--N 1.275 -2.843 0 N-CA-C 108.076 -2.01 . . . . 0.0 108.076 173.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.431 ' HB ' ' CD1' ' A' ' 31' ' ' TYR . 56.5 mt -64.67 112.22 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 178.623 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 113.41 -4.37 24.96 Favored Glycine 0 N--CA 1.441 -1.027 0 C-N-CA 121.1 -0.572 . . . . 0.0 112.036 -179.399 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 72.9 t80 -101.42 129.29 47.41 Favored 'General case' 0 C--N 1.31 -1.129 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 3.7 p -129.12 5.76 5.35 Favored 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 112.751 0.649 . . . . 0.0 112.751 -177.39 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -81.49 -149.69 7.17 Favored Glycine 0 CA--C 1.533 1.21 0 C-N-CA 121.171 -0.538 . . . . 0.0 112.04 177.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_endo -63.02 111.43 1.39 Allowed 'Trans proline' 0 C--N 1.357 1.007 0 C-N-CA 122.538 2.159 . . . . 0.0 112.225 179.102 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.653 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 3.1 p -93.71 -16.09 24.59 Favored 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 113.166 0.802 . . . . 0.0 113.166 -176.238 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 8.2 p -90.48 128.1 42.57 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 CA-C-O 121.001 0.429 . . . . 0.0 110.402 -179.74 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 69.8 m -86.75 153.24 21.85 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 177.559 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -59.57 127.42 31.93 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 174.566 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 35.3 m -53.67 130.56 36.8 Favored 'General case' 0 C--O 1.246 0.909 0 CA-C-O 121.319 0.581 . . . . 0.0 110.973 -177.717 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 113.18 -21.21 18.1 Favored Glycine 0 N--CA 1.434 -1.464 0 N-CA-C 109.263 -1.535 . . . . 0.0 109.263 -170.591 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 70.6 p -117.57 143.34 46.2 Favored 'General case' 0 N--CA 1.443 -0.783 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 172.405 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 34.1 p -112.55 144.07 42.64 Favored 'General case' 0 C--N 1.295 -1.782 0 CA-C-O 120.71 0.29 . . . . 0.0 111.007 -177.034 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 50.9 t -78.83 98.51 6.35 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 178.54 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 75.3 mt-30 -103.74 127.69 51.19 Favored 'General case' 0 N--CA 1.431 -1.379 0 CA-C-O 120.996 0.427 . . . . 0.0 110.031 -177.713 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 60.0 t -78.37 114.04 18.45 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 179.463 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 74.2 mt -94.16 -70.38 0.71 Allowed 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 -178.692 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 77.6 m-20 -94.94 164.08 20.39 Favored Pre-proline 0 C--N 1.299 -1.612 0 N-CA-C 106.608 -1.627 . . . . 0.0 106.608 175.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -57.1 -35.33 98.88 Favored 'Trans proline' 0 CA--C 1.538 0.679 0 C-N-CA 121.886 1.724 . . . . 0.0 112.586 -179.029 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.648 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 50.5 m-85 -103.89 -21.07 13.7 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.991 -178.849 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 24.1 t80 -104.44 113.3 26.78 Favored 'General case' 0 C--N 1.316 -0.859 0 C-N-CA 119.87 -0.732 . . . . 0.0 111.24 -178.736 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.442 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 16.9 m -116.93 135.71 53.51 Favored 'General case' 0 C--N 1.289 -2.064 0 N-CA-C 106.068 -1.827 . . . . 0.0 106.068 175.648 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 28.7 tt0 -129.92 144.72 51.47 Favored 'General case' 0 C--N 1.299 -1.621 0 CA-C-N 118.111 0.414 . . . . 0.0 110.832 -172.068 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.728 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 61.7 m -76.46 116.84 17.52 Favored 'General case' 0 C--O 1.259 1.592 0 CA-C-O 121.17 0.51 . . . . 0.0 110.154 177.479 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 94.5 mt . . . . . 0 C--N 1.298 -1.666 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 177.582 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 . . . . . 0 N--CA 1.446 -0.65 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' SER . . . . . 0.426 ' O ' ' HB2' ' A' ' 35' ' ' CYS . 19.6 p -95.05 -178.13 4.38 Favored 'General case' 0 C--N 1.29 -2.013 0 C-N-CA 123.134 0.574 . . . . 0.0 111.54 -174.479 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 51.0 t-80 -64.55 123.59 19.65 Favored 'General case' 0 N--CA 1.445 -0.694 0 N-CA-C 108.023 -1.102 . . . . 0.0 108.023 176.718 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 65.03 83.95 0.16 Allowed 'General case' 0 C--N 1.319 -0.727 0 O-C-N 124.446 1.092 . . . . 0.0 111.453 -175.819 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . 0.493 ' O ' ' HA ' ' A' ' 34' ' ' GLN . . . -167.38 159.13 32.36 Favored Glycine 0 N--CA 1.424 -2.138 0 N-CA-C 106.916 -2.474 . . . . 0.0 106.916 179.398 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.596 ' HA ' ' O ' ' A' ' 33' ' ' SER . 53.3 tt0 -82.36 110.36 17.44 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 118.281 1.04 . . . . 0.0 110.049 -179.19 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.712 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 1.8 p -86.1 -47.81 9.18 Favored 'General case' 0 C--N 1.295 -1.793 0 N-CA-C 113.237 0.829 . . . . 0.0 113.237 -177.79 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -174.22 89.16 0.08 OUTLIER Glycine 0 CA--C 1.486 -1.73 0 C-N-CA 117.716 -2.183 . . . . 0.0 114.07 -175.669 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.51 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -112.87 178.38 18.75 Favored Glycine 0 C--N 1.286 -2.213 0 N-CA-C 107.673 -2.171 . . . . 0.0 107.673 173.616 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 67.6 mt -61.58 118.44 4.08 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-N 118.239 1.019 . . . . 0.0 108.83 177.037 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 110.26 -14.85 30.64 Favored Glycine 0 N--CA 1.443 -0.897 0 C-N-CA 120.767 -0.73 . . . . 0.0 111.841 -178.852 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 25.7 t80 -114.09 121.47 43.92 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 -179.574 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 13.7 p -134.96 18.28 3.48 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-O 121.282 0.563 . . . . 0.0 111.545 -179.496 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -78.6 -128.61 0.53 Allowed Glycine 0 CA--C 1.521 0.414 0 CA-C-N 115.311 -0.859 . . . . 0.0 111.065 176.844 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -67.04 88.37 0.3 Allowed 'Trans proline' 0 CA--C 1.536 0.576 0 C-N-CA 122.201 1.934 . . . . 0.0 111.95 176.549 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.623 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 39.2 p -86.73 0.15 55.21 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.651 0.739 . . . . 0.0 110.756 -179.625 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 7.6 p -102.27 129.74 53.23 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.579 0 CA-C-N 114.89 -1.05 . . . . 0.0 108.82 178.663 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.456 ' SG ' ' HB2' ' A' ' 25' ' ' CYS . 71.4 m -92.64 153.64 18.86 Favored 'General case' 0 C--N 1.293 -1.886 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.67 -179.703 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -56.51 133.01 53.05 Favored 'General case' 0 C--O 1.249 1.039 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 174.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 9.2 p -53.97 127.51 26.63 Favored 'General case' 0 C--O 1.249 1.073 0 CA-C-O 121.528 0.68 . . . . 0.0 112.294 -177.149 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 112.43 -9.49 26.38 Favored Glycine 0 N--CA 1.431 -1.687 0 CA-C-N 114.843 -1.071 . . . . 0.0 110.784 -175.493 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 67.1 p -127.39 145.73 50.71 Favored 'General case' 0 C--O 1.246 0.899 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 176.477 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 23.6 p -111.3 140.14 46.12 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-O 120.381 0.134 . . . . 0.0 111.178 -178.337 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.456 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 53.6 t -73.31 103.07 3.87 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 179.094 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 16.7 mm-40 -91.12 113.48 25.76 Favored 'General case' 0 N--CA 1.425 -1.695 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.024 -179.005 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 45.5 t -76.19 101.36 2.59 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.114 0 N-CA-C 107.142 -1.429 . . . . 0.0 107.142 176.698 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 77.3 mt -86.87 -69.93 0.64 Allowed 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 -177.661 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 79.1 m-20 -95.74 165.31 16.82 Favored Pre-proline 0 C--N 1.298 -1.668 0 N-CA-C 107.038 -1.467 . . . . 0.0 107.038 174.727 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_exo -60.91 -29.98 89.11 Favored 'Trans proline' 0 CA--C 1.542 0.884 0 C-N-CA 121.499 1.466 . . . . 0.0 111.658 178.428 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.51 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 87.8 m-85 -101.77 -25.54 13.8 Favored 'General case' 0 N--CA 1.44 -0.969 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.553 -179.839 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 68.2 t80 -106.05 114.8 29.16 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 113.008 0.744 . . . . 0.0 113.008 -178.538 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.596 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 23.8 m -121.18 136.59 54.95 Favored 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 175.711 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . 0.493 ' HA ' ' O ' ' A' ' 6' ' ' GLY . 35.2 tt0 -127.59 133.24 49.73 Favored 'General case' 0 C--N 1.318 -0.762 0 C-N-CA 122.202 0.201 . . . . 0.0 110.763 -173.253 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.712 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 64.1 m -74.01 109.03 7.18 Favored 'General case' 0 C--O 1.243 0.739 0 CA-C-O 120.972 0.415 . . . . 0.0 111.756 177.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 96.6 mt . . . . . 0 C--N 1.299 -1.591 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 178.689 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 . . . . . 0 N--CA 1.416 -2.133 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 61.3 p -91.99 173.9 7.6 Favored 'General case' 0 C--N 1.282 -2.332 0 CA-C-N 114.857 -1.065 . . . . 0.0 110.146 -175.027 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 55.2 t-80 -57.54 134.23 55.94 Favored 'General case' 0 C--N 1.315 -0.905 0 C-N-CA 123.453 0.701 . . . . 0.0 110.107 177.183 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 70.51 10.42 7.16 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.646 1.178 . . . . 0.0 112.908 178.169 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . 0.517 ' O ' ' HA ' ' A' ' 34' ' ' GLN . . . -97.62 155.8 20.56 Favored Glycine 0 N--CA 1.438 -1.2 0 N-CA-C 110.726 -0.95 . . . . 0.0 110.726 176.175 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.628 ' HA ' ' O ' ' A' ' 33' ' ' SER . 64.4 tt0 -70.25 110.51 5.27 Favored 'General case' 0 C--O 1.217 -0.608 0 CA-C-N 117.14 0.47 . . . . 0.0 109.931 -178.958 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.733 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 21.1 p -93.13 -31.68 14.71 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 113.565 0.95 . . . . 0.0 113.565 -175.764 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 179.84 84.36 0.06 OUTLIER Glycine 0 CA--C 1.483 -1.932 0 C-N-CA 117.574 -2.251 . . . . 0.0 113.786 -174.673 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.56 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -112.44 167.2 12.3 Favored Glycine 0 C--N 1.286 -2.24 0 N-CA-C 108.748 -1.741 . . . . 0.0 108.748 174.81 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 79.7 mt -60.78 117.53 2.66 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 177.532 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 105.37 -8.75 44.79 Favored Glycine 0 N--CA 1.442 -0.965 0 C-N-CA 120.373 -0.918 . . . . 0.0 111.804 179.734 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 90.4 t80 -94.74 108.85 20.85 Favored 'General case' 0 N--CA 1.44 -0.932 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 178.06 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 3.3 p -103.87 7.71 36.9 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-N 114.806 -1.088 . . . . 0.0 111.743 -176.741 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -81.05 -163.3 30.08 Favored Glycine 0 N--CA 1.445 -0.737 0 C-N-CA 121.084 -0.579 . . . . 0.0 112.361 -179.28 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_endo -62.16 118.25 5.13 Favored 'Trans proline' 0 C--O 1.235 0.342 0 C-N-CA 122.834 2.356 . . . . 0.0 110.754 177.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.568 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 10.2 p -99.71 -14.89 18.71 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 -174.639 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 13.6 p -79.48 137.66 21.33 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 C-N-CA 120.594 -0.442 . . . . 0.0 110.004 179.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 71.2 m -97.31 153.08 18.28 Favored 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 179.544 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.53 155.67 21.48 Favored 'General case' 0 C--O 1.251 1.159 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.238 178.107 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 4.9 p -58.3 118.55 5.64 Favored 'General case' 0 C--N 1.307 -1.254 0 C-N-CA 123.429 0.692 . . . . 0.0 111.383 -179.328 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 111.92 -11.33 27.26 Favored Glycine 0 N--CA 1.441 -0.982 0 C-N-CA 120.926 -0.654 . . . . 0.0 111.641 -178.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 76.7 p -120.22 151.78 38.65 Favored 'General case' 0 C--O 1.256 1.412 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 178.058 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.407 ' O ' ' HA ' ' A' ' 35' ' ' CYS . 16.9 p -121.87 148.83 44.21 Favored 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 110.278 -0.268 . . . . 0.0 110.278 176.478 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 49.4 t -77.47 103.88 7.66 Favored 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 179.679 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 12.7 mm-40 -98.44 117.83 33.74 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 116.052 -0.522 . . . . 0.0 109.951 -178.382 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 41.2 t -87.06 105.71 15.33 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 -178.715 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 69.1 mt -89.68 -69.46 0.72 Allowed 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 -178.168 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 48.7 m-80 -95.19 170.34 8.02 Favored Pre-proline 0 C--N 1.301 -1.522 0 N-CA-C 107.038 -1.468 . . . . 0.0 107.038 176.148 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_exo -65.97 -30.15 48.49 Favored 'Trans proline' 0 C--N 1.345 0.349 0 CA-C-N 120.57 1.239 . . . . 0.0 111.875 177.072 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.56 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 28.5 m-85 -106.43 -25.59 11.81 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 119.779 -0.768 . . . . 0.0 110.585 -177.875 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 60.4 t80 -104.76 115.3 30.07 Favored 'General case' 0 N--CA 1.443 -0.807 0 C-N-CA 119.893 -0.723 . . . . 0.0 112.563 177.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.628 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 14.5 m -131.65 141.14 49.54 Favored 'General case' 0 C--N 1.293 -1.861 0 N-CA-C 105.993 -1.854 . . . . 0.0 105.993 176.272 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . 0.517 ' HA ' ' O ' ' A' ' 6' ' ' GLY . 4.1 pt20 -132.82 151.1 52.08 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 119.084 0.857 . . . . 0.0 111.882 -178.172 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.733 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 61.2 m -76.55 118.41 19.18 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-O 121.218 0.533 . . . . 0.0 110.517 178.082 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 97.0 mt . . . . . 0 C--N 1.303 -1.453 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 178.525 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 . . . . . 0 N--CA 1.44 -0.97 0 N-CA-C 107.429 -1.323 . . . . 0.0 107.429 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 22.7 t -110.03 -168.52 1.33 Allowed 'General case' 0 C--N 1.29 -1.987 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 -176.409 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 25.2 t-80 -56.18 126.46 26.21 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 123.249 0.62 . . . . 0.0 110.182 -178.587 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 69.57 76.94 0.22 Allowed 'General case' 0 C--N 1.328 -0.339 0 O-C-N 124.604 1.19 . . . . 0.0 111.424 -178.41 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . 0.557 ' O ' ' HA ' ' A' ' 34' ' ' GLN . . . -169.55 155.55 25.75 Favored Glycine 0 N--CA 1.433 -1.527 0 N-CA-C 108.699 -1.761 . . . . 0.0 108.699 179.175 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.675 ' HA ' ' O ' ' A' ' 33' ' ' SER . 53.2 tt0 -77.64 107.24 9.98 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 117.591 0.696 . . . . 0.0 110.329 -178.268 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.786 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 6.1 p -87.82 -41.9 12.94 Favored 'General case' 0 C--N 1.297 -1.709 0 CA-C-N 115.395 -0.82 . . . . 0.0 113.133 -176.613 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -161.96 53.99 0.31 Allowed Glycine 0 CA--C 1.471 -2.687 0 C-N-CA 118.956 -1.592 . . . . 0.0 111.687 -173.685 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.435 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -95.69 149.68 19.41 Favored Glycine 0 N--CA 1.423 -2.202 0 N-CA-C 108.442 -1.863 . . . . 0.0 108.442 175.692 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.428 ' HB ' ' CD1' ' A' ' 31' ' ' TYR . 61.4 mt -57.97 121.03 4.76 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.913 0 CA-C-N 117.315 0.558 . . . . 0.0 110.443 -178.299 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 109.59 4.26 30.3 Favored Glycine 0 N--CA 1.445 -0.713 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.985 -179.114 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.437 ' HB2' ' NE2' ' A' ' 7' ' ' GLN . 70.0 t80 -103.54 119.94 39.88 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 177.929 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 14.3 p -99.64 1.17 43.32 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 112.397 0.517 . . . . 0.0 112.397 -177.157 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -85.68 -175.8 50.2 Favored Glycine 0 N--CA 1.444 -0.822 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.329 -179.266 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -66.16 130.41 24.08 Favored 'Trans proline' 0 CA--C 1.533 0.454 0 C-N-CA 122.759 2.306 . . . . 0.0 111.616 -179.535 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.566 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 37.1 p -88.04 10.29 19.58 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-O 121.626 0.727 . . . . 0.0 111.679 -177.911 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 7.1 p -94.19 123.41 46.29 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.496 0 CA-C-O 121.567 0.699 . . . . 0.0 110.82 -178.372 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 83.7 m -88.56 160.12 17.59 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-N 115.112 -0.949 . . . . 0.0 109.154 177.064 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -72.17 146.15 47.59 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 176.751 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 67.9 m -53.1 130.27 33.59 Favored 'General case' 0 C--O 1.25 1.1 0 CA-C-O 121.092 0.472 . . . . 0.0 110.211 176.763 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 112.18 -16.81 24.75 Favored Glycine 0 N--CA 1.43 -1.722 0 N-CA-C 110.781 -0.928 . . . . 0.0 110.781 -173.593 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 41.4 p -133.2 144.78 50.04 Favored 'General case' 0 N--CA 1.443 -0.818 0 CA-C-O 120.819 0.342 . . . . 0.0 111.327 179.577 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 23.3 p -116.77 152.32 34.62 Favored 'General case' 0 C--N 1.309 -1.161 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 177.778 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 44.8 t -77.53 111.44 13.27 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 -179.422 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 70.3 mt-30 -110.9 127.93 55.63 Favored 'General case' 0 N--CA 1.434 -1.238 0 CA-C-O 121.331 0.586 . . . . 0.0 110.273 -179.656 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 58.8 t -81.01 110.75 16.84 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.723 -178.141 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 75.4 mt -90.02 -72.65 0.55 Allowed 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 107.01 -1.478 . . . . 0.0 107.01 177.314 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 54.8 m-80 -95.79 164.29 19.13 Favored Pre-proline 0 C--N 1.298 -1.66 0 N-CA-C 106.785 -1.561 . . . . 0.0 106.785 170.536 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_exo -63.56 -33.45 67.82 Favored 'Trans proline' 0 C--O 1.241 0.637 0 C-N-CA 121.64 1.56 . . . . 0.0 111.26 176.374 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.435 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 76.8 m-85 -97.17 -26.38 14.97 Favored 'General case' 0 N--CA 1.442 -0.83 0 C-N-CA 119.633 -0.827 . . . . 0.0 110.819 -179.689 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 53.1 t80 -106.21 113.01 26.29 Favored 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 119.436 -0.906 . . . . 0.0 110.956 175.397 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.675 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 20.0 m -123.98 140.92 52.5 Favored 'General case' 0 C--N 1.288 -2.103 0 N-CA-C 106.616 -1.624 . . . . 0.0 106.616 177.393 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . 0.557 ' HA ' ' O ' ' A' ' 6' ' ' GLY . 28.6 tt0 -129.89 140.57 50.94 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 -169.493 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.786 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 73.7 m -71.41 116.85 12.22 Favored 'General case' 0 C--O 1.258 1.522 0 CA-C-O 121.147 0.499 . . . . 0.0 110.544 175.303 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 95.5 mt . . . . . 0 C--N 1.303 -1.424 0 C-N-CA 125.156 1.382 . . . . 0.0 107.949 179.515 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 5.6 tp-100 . . . . . 0 N--CA 1.442 -0.839 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 62.4 m -126.16 -173.22 2.8 Favored 'General case' 0 C--N 1.297 -1.715 0 C-N-CA 120.176 -0.61 . . . . 0.0 111.923 -177.181 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . 0.578 ' HA ' ' O ' ' A' ' 35' ' ' CYS . 57.6 t-80 -54.29 132.27 43.41 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 123.055 0.542 . . . . 0.0 110.326 -178.702 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . 0.49 ' HA ' ' OE1' ' A' ' 34' ' ' GLN . . . 81.16 1.61 1.66 Allowed 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 125.251 1.42 . . . . 0.0 112.195 -178.423 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -98.91 153.22 19.79 Favored Glycine 0 N--CA 1.433 -1.54 0 N-CA-C 110.766 -0.934 . . . . 0.0 110.766 177.061 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.444 ' HA ' ' O ' ' A' ' 33' ' ' SER . 49.7 tt0 -82.17 111.5 18.34 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 179.856 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.757 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 14.6 p -83.45 -14.36 52.69 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.783 -178.025 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 122.94 115.24 2.23 Favored Glycine 0 N--CA 1.416 -2.674 0 C-N-CA 117.574 -2.25 . . . . 0.0 116.279 173.424 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -112.38 -153.59 11.93 Favored Glycine 0 N--CA 1.418 -2.555 0 N-CA-C 107.063 -2.415 . . . . 0.0 107.063 171.503 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 78.9 mt -64.29 124.18 18.57 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.679 0 CA-C-N 117.756 0.778 . . . . 0.0 110.493 177.836 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 95.9 6.87 59.04 Favored Glycine 0 N--CA 1.442 -0.956 0 CA-C-N 115.998 -0.546 . . . . 0.0 113.741 176.438 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 49.4 t80 -109.25 127.55 54.34 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 -179.712 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 6.7 p -128.83 15.7 6.37 Favored 'General case' 0 C--N 1.303 -1.434 0 CA-C-O 121.505 0.669 . . . . 0.0 111.144 -177.397 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -84.42 -143.83 6.16 Favored Glycine 0 C--O 1.248 0.981 0 N-CA-C 111.449 -0.66 . . . . 0.0 111.449 178.216 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -73.01 103.53 1.61 Allowed 'Trans proline' 0 N--CA 1.448 -1.154 0 C-N-CA 122.227 1.951 . . . . 0.0 111.395 177.769 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.51 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 32.8 p -94.46 -7.68 40.73 Favored 'General case' 0 N--CA 1.434 -1.234 0 CA-C-O 121.669 0.747 . . . . 0.0 110.816 -178.474 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 7.4 p -82.31 123.64 38.46 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.805 0 CA-C-N 115.239 -0.891 . . . . 0.0 110.732 178.051 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 78.4 m -90.44 148.88 22.5 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 109.481 -0.562 . . . . 0.0 109.481 176.395 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.53 150.9 17.89 Favored 'General case' 0 C--O 1.251 1.169 0 O-C-N 123.774 0.671 . . . . 0.0 110.449 177.381 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 8.9 t -59.41 115.87 3.56 Favored 'General case' 0 N--CA 1.433 -1.297 0 CA-C-N 115.663 -0.698 . . . . 0.0 109.491 -177.577 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 111.91 -5.69 27.41 Favored Glycine 0 N--CA 1.437 -1.237 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.077 -178.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 60.3 p -121.43 147.02 46.29 Favored 'General case' 0 C--N 1.312 -1.06 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 175.36 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 26.5 p -117.84 141.48 48.37 Favored 'General case' 0 C--N 1.304 -1.41 0 C-N-CA 121.26 -0.176 . . . . 0.0 110.586 -178.836 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 48.4 t -72.66 103.8 3.71 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 85.3 mm-40 -98.26 112.26 24.31 Favored 'General case' 0 N--CA 1.415 -2.186 0 CA-C-O 121.264 0.554 . . . . 0.0 110.24 -179.225 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 41.4 t -80.39 96.51 2.75 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.588 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 179.732 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 87.1 mt -80.9 -69.98 0.56 Allowed 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 -177.828 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 47.7 m-80 -94.27 164.55 19.87 Favored Pre-proline 0 C--N 1.298 -1.649 0 N-CA-C 106.449 -1.685 . . . . 0.0 106.449 175.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -59.77 -33.1 96.38 Favored 'Trans proline' 0 N--CA 1.475 0.42 0 C-N-CA 121.655 1.57 . . . . 0.0 111.669 178.781 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -100.27 -25.36 14.27 Favored 'General case' 0 N--CA 1.441 -0.915 0 C-N-CA 120.077 -0.649 . . . . 0.0 111.206 179.606 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 80.2 t80 -105.05 114.42 28.61 Favored 'General case' 0 C--N 1.309 -1.191 0 C-N-CA 119.798 -0.761 . . . . 0.0 112.673 -176.782 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.444 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 24.0 m -125.58 137.3 53.9 Favored 'General case' 0 C--N 1.284 -2.257 0 N-CA-C 106.858 -1.534 . . . . 0.0 106.858 178.114 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . 0.49 ' OE1' ' HA ' ' A' ' 5' ' ' ALA . 8.0 tt0 -128.53 142.04 51.19 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 109.956 -0.386 . . . . 0.0 109.956 -175.943 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.757 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 75.2 m -75.06 110.74 9.63 Favored 'General case' 0 C--O 1.249 1.037 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 175.806 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 96.6 mt . . . . . 0 N--CA 1.423 -1.801 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 179.08 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 . . . . . 0 N--CA 1.434 -1.269 0 CA-C-O 121.383 0.611 . . . . 0.0 110.255 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 18.3 p -88.01 166.89 14.15 Favored 'General case' 0 C--N 1.285 -2.2 0 CA-C-N 115.243 -0.889 . . . . 0.0 111.575 -174.555 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 56.6 t-80 -57.82 136.75 57.01 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 107.675 -1.232 . . . . 0.0 107.675 172.63 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . 0.408 ' HA ' ' CD ' ' A' ' 34' ' ' GLN . . . 73.2 12.56 4.88 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.396 0.678 . . . . 0.0 112.665 -179.935 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . 0.426 ' O ' ' HA ' ' A' ' 34' ' ' GLN . . . -107.58 164.42 13.0 Favored Glycine 0 C--O 1.243 0.715 0 N-CA-C 110.478 -1.049 . . . . 0.0 110.478 175.364 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.574 ' HA ' ' O ' ' A' ' 33' ' ' SER . 54.1 tt0 -84.55 107.05 16.57 Favored 'General case' 0 C--O 1.224 -0.251 0 CA-C-N 117.395 0.598 . . . . 0.0 110.894 -177.839 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.792 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 12.3 p -84.34 -37.79 21.16 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 113.705 1.002 . . . . 0.0 113.705 -175.565 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -177.43 87.81 0.07 OUTLIER Glycine 0 CA--C 1.481 -2.04 0 C-N-CA 117.96 -2.067 . . . . 0.0 113.24 -176.291 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.549 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -112.42 172.9 14.96 Favored Glycine 0 C--N 1.28 -2.548 0 N-CA-C 107.921 -2.072 . . . . 0.0 107.921 174.867 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 68.8 mt -63.07 118.0 4.64 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.208 0 CA-C-N 117.861 0.83 . . . . 0.0 109.353 178.785 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 105.73 6.21 38.07 Favored Glycine 0 C--N 1.312 -0.799 0 C-N-CA 120.421 -0.895 . . . . 0.0 112.386 178.73 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 85.2 t80 -102.47 118.48 36.97 Favored 'General case' 0 C--N 1.307 -1.262 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 178.532 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 14.3 p -109.36 0.38 19.44 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-O 121.271 0.558 . . . . 0.0 111.513 -177.703 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -77.92 -171.64 37.77 Favored Glycine 0 N--CA 1.443 -0.841 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.918 178.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_endo -64.37 119.24 6.22 Favored 'Trans proline' 0 C--O 1.237 0.454 0 C-N-CA 122.481 2.121 . . . . 0.0 111.291 178.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.566 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 70.1 p -90.71 -8.32 50.17 Favored 'General case' 0 C--O 1.24 0.558 0 CA-C-O 121.41 0.624 . . . . 0.0 111.211 -176.873 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 5.6 p -80.07 126.41 39.36 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.185 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.334 179.411 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 83.9 m -87.78 163.46 16.46 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.253 -179.017 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.29 150.89 45.16 Favored 'General case' 0 C--O 1.254 1.323 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 175.49 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 35.6 t -57.76 126.01 25.51 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-O 121.503 0.668 . . . . 0.0 110.572 -175.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 112.32 -21.11 20.25 Favored Glycine 0 N--CA 1.43 -1.766 0 CA-C-N 115.172 -0.922 . . . . 0.0 111.62 -178.412 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 50.7 p -116.02 147.09 41.6 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 120.765 -0.374 . . . . 0.0 110.384 179.569 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.405 ' O ' ' HA ' ' A' ' 35' ' ' CYS . 21.7 p -120.23 155.39 33.29 Favored 'General case' 0 C--N 1.298 -1.656 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.767 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 48.5 t -80.23 102.95 9.78 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-O 121.143 0.497 . . . . 0.0 110.433 -178.833 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 9.1 mm-40 -100.87 122.29 43.18 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 -179.166 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 57.6 t -79.84 114.8 21.21 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.715 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 -179.083 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 86.4 mt -98.25 -70.04 0.74 Allowed 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 179.192 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 -94.07 166.11 16.3 Favored Pre-proline 0 C--N 1.304 -1.373 0 N-CA-C 105.986 -1.857 . . . . 0.0 105.986 174.225 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -64.49 -26.6 62.41 Favored 'Trans proline' 0 CA--C 1.538 0.691 0 C-N-CA 121.255 1.303 . . . . 0.0 111.341 177.277 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.549 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 70.1 m-85 -107.16 -26.34 11.14 Favored 'General case' 0 N--CA 1.443 -0.777 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.121 -178.935 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 67.6 t80 -105.73 113.84 27.64 Favored 'General case' 0 C--N 1.304 -1.383 0 C-N-CA 119.627 -0.829 . . . . 0.0 110.978 178.418 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.574 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 21.3 m -121.72 140.92 51.7 Favored 'General case' 0 C--N 1.279 -2.494 0 N-CA-C 105.616 -1.994 . . . . 0.0 105.616 175.088 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . 0.449 ' OE1' HD21 ' A' ' 36' ' ' LEU . 35.9 tt0 -125.81 141.36 52.03 Favored 'General case' 0 C--N 1.29 -1.999 0 C-N-CA 120.874 -0.33 . . . . 0.0 110.766 -171.407 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.792 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 85.5 m -74.38 114.21 12.5 Favored 'General case' 0 C--O 1.252 1.187 0 CA-C-O 121.176 0.512 . . . . 0.0 109.982 176.247 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.449 HD21 ' OE1' ' A' ' 34' ' ' GLN . 95.5 mt . . . . . 0 N--CA 1.426 -1.639 0 CA-C-N 115.127 -0.942 . . . . 0.0 108.84 -179.382 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 6.3 m . . . . . 0 N--CA 1.436 -1.167 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -78.74 134.89 37.02 Favored 'General case' 0 N--CA 1.426 -1.639 0 CA-C-O 121.377 0.608 . . . . 0.0 109.774 -175.419 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 22.9 t -97.97 171.82 8.02 Favored 'General case' 0 C--N 1.282 -2.345 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.213 -173.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . 0.546 ' O ' ' H5 ' ' A' ' 101' ' ' MAN . 41.8 t-80 -61.45 132.11 52.37 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 179.078 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.446 ' HA ' ' OE1' ' A' ' 34' ' ' GLN . . . 83.71 0.28 1.04 Allowed 'General case' 0 N--CA 1.48 1.053 0 O-C-N 124.915 1.384 . . . . 0.0 113.011 -177.745 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.408 ' O ' ' HA ' ' A' ' 34' ' ' GLN . . . -96.66 160.25 21.79 Favored Glycine 0 C--O 1.245 0.809 0 C-N-CA 120.474 -0.87 . . . . 0.0 111.914 178.265 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.608 ' HA ' ' O ' ' A' ' 33' ' ' SER . 51.6 tt0 -81.72 104.42 12.1 Favored 'General case' 0 C--O 1.225 -0.235 0 CA-C-O 121.451 0.643 . . . . 0.0 110.851 -179.198 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.769 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 7.7 p -80.8 -41.91 22.56 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 114.384 1.253 . . . . 0.0 114.384 -174.729 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -176.03 81.22 0.07 OUTLIER Glycine 0 CA--C 1.477 -2.324 0 C-N-CA 117.547 -2.263 . . . . 0.0 113.674 -175.432 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.442 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -112.69 175.63 16.98 Favored Glycine 0 C--N 1.283 -2.399 0 N-CA-C 107.989 -2.045 . . . . 0.0 107.989 173.352 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.455 ' HB ' ' CD2' ' A' ' 31' ' ' TYR . 55.1 mt -65.54 133.75 30.39 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 175.853 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 103.86 -16.23 51.12 Favored Glycine 0 C--N 1.311 -0.834 0 N-CA-C 111.251 -0.74 . . . . 0.0 111.251 -177.479 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 67.1 t80 -100.94 109.62 21.58 Favored 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 179.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 11.4 p -101.63 1.31 37.59 Favored 'General case' 0 C--N 1.3 -1.557 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.314 -178.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -79.46 -178.76 51.55 Favored Glycine 0 N--CA 1.441 -1.023 0 CA-C-N 115.887 -0.597 . . . . 0.0 112.317 179.322 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -60.48 122.4 11.24 Favored 'Trans proline' 0 C--O 1.241 0.637 0 C-N-CA 123.194 2.596 . . . . 0.0 111.825 179.536 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.593 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 22.9 p -92.6 9.12 36.05 Favored 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 113.571 0.952 . . . . 0.0 113.571 -173.372 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 7.5 p -91.82 126.79 44.39 Favored 'Isoleucine or valine' 0 C--O 1.248 1.02 0 CA-C-O 121.39 0.614 . . . . 0.0 111.551 -178.117 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 71.2 m -84.26 161.48 20.47 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.847 178.139 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.33 154.46 42.0 Favored 'General case' 0 C--O 1.25 1.088 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.494 176.129 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 3.1 p -60.2 129.13 40.17 Favored 'General case' 0 N--CA 1.433 -1.302 0 CA-C-O 121.263 0.554 . . . . 0.0 111.458 -178.495 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 111.34 -17.67 26.12 Favored Glycine 0 N--CA 1.423 -2.216 0 N-CA-C 110.666 -0.974 . . . . 0.0 110.666 -177.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 77.6 p -123.03 153.29 40.03 Favored 'General case' 0 C--O 1.252 1.215 0 CA-C-O 120.828 0.346 . . . . 0.0 110.983 -178.536 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 34.2 p -119.79 149.56 41.85 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 178.33 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 44.9 t -75.49 105.37 6.49 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 177.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 84.0 mm-40 -100.64 110.82 22.98 Favored 'General case' 0 N--CA 1.415 -2.188 0 CA-C-O 121.718 0.77 . . . . 0.0 110.556 -179.355 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 63.9 t -77.73 121.52 30.57 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.089 0 CA-C-N 114.637 -1.165 . . . . 0.0 108.267 179.493 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 84.6 mt -104.26 -67.72 0.88 Allowed 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 107.324 -1.362 . . . . 0.0 107.324 179.229 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 48.7 m-80 -95.07 163.27 22.34 Favored Pre-proline 0 C--N 1.293 -1.891 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 173.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_exo -63.96 -30.61 67.1 Favored 'Trans proline' 0 CA--C 1.531 0.355 0 C-N-CA 121.204 1.27 . . . . 0.0 111.198 178.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.455 ' CD2' ' HB ' ' A' ' 11' ' ' ILE . 22.3 m-85 -100.31 -25.9 14.08 Favored 'General case' 0 N--CA 1.437 -1.118 0 C-N-CA 120.364 -0.534 . . . . 0.0 110.834 -179.415 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 75.8 t80 -105.96 114.13 28.09 Favored 'General case' 0 C--O 1.243 0.749 0 N-CA-C 112.6 0.592 . . . . 0.0 112.6 178.374 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.608 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 15.1 m -125.55 143.45 51.01 Favored 'General case' 0 C--N 1.293 -1.871 0 N-CA-C 106.631 -1.618 . . . . 0.0 106.631 176.34 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.446 ' OE1' ' HA ' ' A' ' 5' ' ' ALA . 8.4 tt0 -132.08 141.23 49.12 Favored 'General case' 0 C--N 1.298 -1.671 0 CA-C-N 118.02 0.373 . . . . 0.0 110.464 -174.112 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.769 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 77.6 m -74.21 114.75 12.92 Favored 'General case' 0 C--O 1.253 1.245 0 C-N-CA 120.714 -0.394 . . . . 0.0 110.344 175.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 97.2 mt . . . . . 0 N--CA 1.428 -1.566 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 178.602 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' MAN . . . . . 0.546 ' H5 ' ' O ' ' A' ' 4' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 9.1 m . . . . . 0 N--CA 1.438 -1.043 0 N-CA-C 107.678 -1.231 . . . . 0.0 107.678 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 5.9 tp-100 -126.81 135.58 51.21 Favored 'General case' 0 N--CA 1.433 -1.324 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 173.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 53.3 m -107.61 -176.24 3.01 Favored 'General case' 0 C--N 1.302 -1.471 0 C-N-CA 120.505 -0.478 . . . . 0.0 111.266 -177.011 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . 0.437 ' CD2' ' HA ' ' A' ' 36' ' ' LEU . 47.9 t-80 -57.61 132.7 54.02 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 122.846 0.458 . . . . 0.0 109.957 -177.723 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.451 ' HA ' ' NE2' ' A' ' 34' ' ' GLN . . . 80.15 -4.48 1.88 Allowed 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 125.557 1.543 . . . . 0.0 112.63 -179.253 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -85.68 146.54 21.55 Favored Glycine 0 N--CA 1.437 -1.285 0 C-N-CA 120.37 -0.919 . . . . 0.0 110.912 178.172 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.539 ' HA ' ' O ' ' A' ' 33' ' ' SER . 62.1 tt0 -62.95 108.68 1.25 Allowed 'General case' 0 C--O 1.22 -0.473 0 CA-C-O 121.148 0.499 . . . . 0.0 110.382 178.267 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.726 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 23.3 p -86.04 -43.39 13.16 Favored 'General case' 0 C--N 1.297 -1.678 0 CA-C-N 115.73 -0.668 . . . . 0.0 112.678 -174.806 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -179.03 86.34 0.07 OUTLIER Glycine 0 CA--C 1.473 -2.542 0 C-N-CA 118.188 -1.958 . . . . 0.0 113.326 -174.474 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.517 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -104.7 178.46 24.01 Favored Glycine 0 N--CA 1.42 -2.418 0 N-CA-C 108.736 -1.745 . . . . 0.0 108.736 175.033 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 64.9 mt -66.12 128.03 28.4 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.757 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 176.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 99.51 -17.28 57.89 Favored Glycine 0 N--CA 1.44 -1.035 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.043 -179.666 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 67.7 t80 -87.22 109.07 19.23 Favored 'General case' 0 C--N 1.312 -1.042 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 -178.567 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 37.0 p -99.23 2.31 45.54 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.481 -178.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -74.56 -178.31 39.83 Favored Glycine 0 N--CA 1.436 -1.312 0 CA-C-N 115.357 -0.838 . . . . 0.0 112.486 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_endo -62.38 121.46 9.45 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 122.605 2.203 . . . . 0.0 112.133 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.627 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 29.1 p -92.89 0.67 57.45 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.005 -179.703 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 7.8 p -78.64 110.22 14.14 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.11 0 CA-C-O 121.993 0.901 . . . . 0.0 111.664 -179.36 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 70.9 m -83.79 152.9 24.39 Favored 'General case' 0 C--N 1.302 -1.486 0 CA-C-N 115.115 -0.948 . . . . 0.0 109.644 177.732 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.4 145.33 33.06 Favored 'General case' 0 C--O 1.25 1.079 0 O-C-N 123.459 0.475 . . . . 0.0 110.229 176.533 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 19.3 m -52.83 119.36 4.51 Favored 'General case' 0 C--N 1.318 -0.79 0 O-C-N 123.757 0.661 . . . . 0.0 111.464 -178.012 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 111.88 -11.25 27.38 Favored Glycine 0 N--CA 1.439 -1.126 0 CA-C-N 115.832 -0.622 . . . . 0.0 112.255 -179.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 68.2 p -118.42 147.29 43.72 Favored 'General case' 0 C--O 1.244 0.789 0 N-CA-C 109.808 -0.441 . . . . 0.0 109.808 178.239 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 38.9 p -113.35 149.5 33.92 Favored 'General case' 0 C--N 1.309 -1.192 0 C-N-CA 121.223 -0.191 . . . . 0.0 110.751 -178.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 51.5 t -76.42 103.6 6.51 Favored 'General case' 0 C--N 1.312 -1.047 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 178.367 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 68.6 mt-30 -102.78 120.22 40.21 Favored 'General case' 0 N--CA 1.425 -1.679 0 CA-C-O 121.887 0.851 . . . . 0.0 111.363 -178.222 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 95.2 t -83.42 104.94 12.58 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 CA-C-N 114.385 -1.28 . . . . 0.0 109.829 -178.597 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 56.1 mt -85.48 -72.04 0.5 Allowed 'General case' 0 N--CA 1.433 -1.317 0 N-CA-C 107.748 -1.205 . . . . 0.0 107.748 178.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 47.7 m-80 -96.31 166.8 13.52 Favored Pre-proline 0 C--N 1.302 -1.468 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 174.321 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -58.78 -42.23 55.22 Favored 'Trans proline' 0 CA--C 1.538 0.696 0 C-N-CA 121.741 1.628 . . . . 0.0 112.336 177.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.517 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 49.0 m-85 -96.49 -25.96 15.47 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 120.029 -0.669 . . . . 0.0 110.562 -177.333 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 75.3 t80 -104.15 114.03 27.99 Favored 'General case' 0 N--CA 1.435 -1.196 0 C-N-CA 119.691 -0.804 . . . . 0.0 111.312 178.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.539 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 15.9 m -135.84 139.99 43.84 Favored 'General case' 0 C--N 1.283 -2.308 0 N-CA-C 105.501 -2.037 . . . . 0.0 105.501 178.883 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.451 ' NE2' ' HA ' ' A' ' 5' ' ' ALA . 19.8 pt20 -135.82 153.83 51.38 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 118.853 0.751 . . . . 0.0 111.564 -175.789 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.726 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 63.7 m -72.58 117.0 13.72 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.527 178.438 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.437 ' HA ' ' CD2' ' A' ' 4' ' ' HIS . 96.5 mt . . . . . 0 C--N 1.289 -2.028 0 N-CA-C 106.802 -1.555 . . . . 0.0 106.802 177.328 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' MAN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 20.3 m . . . . . 0 N--CA 1.436 -1.129 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -74.12 142.97 45.52 Favored 'General case' 0 N--CA 1.438 -1.059 0 CA-C-O 121.296 0.569 . . . . 0.0 110.369 -175.151 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 30.0 t -100.21 172.15 7.35 Favored 'General case' 0 C--N 1.286 -2.166 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.072 -175.398 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . 0.445 ' O ' ' H5 ' ' A' ' 101' ' ' MAN . 18.8 t-80 -59.77 134.27 56.87 Favored 'General case' 0 C--O 1.238 0.48 0 N-CA-C 109.846 -0.428 . . . . 0.0 109.846 177.848 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 79.21 10.78 1.5 Allowed 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.818 1.247 . . . . 0.0 112.351 179.147 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -105.54 162.3 14.33 Favored Glycine 0 N--CA 1.442 -0.925 0 N-CA-C 110.505 -1.038 . . . . 0.0 110.505 176.182 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.583 ' HA ' ' O ' ' A' ' 33' ' ' SER . 53.4 tt0 -82.26 111.62 18.51 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 -179.66 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.729 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 20.7 p -87.36 -35.08 18.57 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 113.469 0.914 . . . . 0.0 113.469 -175.121 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 173.5 80.51 0.05 OUTLIER Glycine 0 CA--C 1.489 -1.559 0 C-N-CA 117.993 -2.051 . . . . 0.0 113.492 -176.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.417 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -112.48 174.11 15.88 Favored Glycine 0 C--N 1.287 -2.163 0 N-CA-C 107.731 -2.148 . . . . 0.0 107.731 174.232 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 74.5 mt -54.93 111.55 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 117.631 0.716 . . . . 0.0 110.211 178.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 114.34 -8.42 22.64 Favored Glycine 0 N--CA 1.437 -1.251 0 C-N-CA 120.606 -0.807 . . . . 0.0 113.405 179.679 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 70.7 t80 -101.36 110.45 22.46 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 179.03 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 4.8 p -107.72 7.02 28.2 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-N 115.83 -0.623 . . . . 0.0 112.042 -177.258 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -83.0 -165.41 37.56 Favored Glycine 0 N--CA 1.444 -0.809 0 CA-C-N 115.486 -0.779 . . . . 0.0 112.268 178.222 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -60.51 111.02 0.9 Allowed 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 123.12 2.546 . . . . 0.0 112.317 -179.46 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.623 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 6.7 p -87.04 -11.17 51.13 Favored 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 113.205 0.817 . . . . 0.0 113.205 -175.69 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 7.5 p -80.87 130.43 35.9 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.91 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.139 179.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 77.3 m -91.32 169.0 11.17 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-O 120.873 0.368 . . . . 0.0 110.401 179.25 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -59.81 137.67 57.99 Favored 'General case' 0 N--CA 1.438 -1.073 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 174.496 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 54.1 m -59.99 121.08 10.93 Favored 'General case' 0 N--CA 1.432 -1.37 0 CA-C-O 121.14 0.495 . . . . 0.0 110.095 -179.258 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 112.66 -10.0 25.81 Favored Glycine 0 N--CA 1.439 -1.125 0 N-CA-C 111.018 -0.833 . . . . 0.0 111.018 -175.091 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 68.2 p -121.63 142.97 49.6 Favored 'General case' 0 C--O 1.244 0.812 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 174.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 34.2 p -110.83 139.24 46.31 Favored 'General case' 0 C--N 1.295 -1.803 0 C-N-CA 120.819 -0.352 . . . . 0.0 111.652 -176.537 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 41.3 t -77.63 102.96 7.29 Favored 'General case' 0 C--N 1.312 -1.041 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 179.338 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -106.79 126.53 52.41 Favored 'General case' 0 N--CA 1.421 -1.897 0 C-N-CA 120.541 -0.464 . . . . 0.0 110.832 -178.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 51.5 t -79.21 95.18 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.207 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 179.649 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 77.6 mt -75.21 -69.77 0.46 Allowed 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 -178.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 49.0 m-80 -96.31 163.87 19.71 Favored Pre-proline 0 C--N 1.294 -1.842 0 N-CA-C 106.968 -1.493 . . . . 0.0 106.968 174.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -61.7 -33.17 86.53 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 121.374 1.383 . . . . 0.0 112.025 179.517 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.417 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 39.8 m-85 -101.64 -25.18 13.96 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 120.419 -0.512 . . . . 0.0 110.914 -179.18 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 61.5 t80 -106.13 113.78 27.52 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 120.076 -0.65 . . . . 0.0 112.135 178.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.583 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 19.7 m -118.13 143.94 46.08 Favored 'General case' 0 C--N 1.293 -1.855 0 N-CA-C 106.524 -1.658 . . . . 0.0 106.524 174.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 29.7 tt0 -135.93 141.94 44.56 Favored 'General case' 0 C--N 1.3 -1.563 0 C-N-CA 120.768 -0.373 . . . . 0.0 111.613 -173.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.729 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 58.7 m -75.29 116.67 16.26 Favored 'General case' 0 C--O 1.254 1.32 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.02 177.184 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 96.1 mt . . . . . 0 C--N 1.308 -1.204 0 C-N-CA 124.336 1.054 . . . . 0.0 108.686 178.718 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' MAN . . . . . 0.445 ' H5 ' ' O ' ' A' ' 4' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 12.0 m . . . . . 0 N--CA 1.444 -0.755 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -72.91 140.6 47.6 Favored 'General case' 0 N--CA 1.445 -0.688 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 179.472 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 12.8 m -119.57 179.73 4.13 Favored 'General case' 0 C--N 1.293 -1.887 0 C-N-CA 120.731 -0.388 . . . . 0.0 110.994 -172.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 51.1 t-80 -50.19 133.78 23.18 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 123.71 0.804 . . . . 0.0 111.811 -177.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 75.98 -0.69 3.1 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 125.26 1.424 . . . . 0.0 112.106 179.453 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -90.5 153.09 22.42 Favored Glycine 0 N--CA 1.428 -1.877 0 N-CA-C 111.145 -0.782 . . . . 0.0 111.145 178.348 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.504 ' HA ' ' O ' ' A' ' 33' ' ' SER . 54.5 tt0 -75.27 114.82 14.24 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 178.465 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.754 ' O ' ' HA ' ' A' ' 17' ' ' THR . 9.8 p -86.61 -48.73 8.07 Favored 'General case' 0 C--O 1.195 -1.805 0 N-CA-C 112.822 0.675 . . . . 0.0 112.822 -177.456 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -177.45 97.69 0.11 Allowed Glycine 0 CA--C 1.479 -2.169 0 C-N-CA 117.536 -2.268 . . . . 0.0 113.604 -173.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.581 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -113.23 178.34 18.57 Favored Glycine 0 C--N 1.28 -2.545 0 N-CA-C 107.582 -2.207 . . . . 0.0 107.582 174.164 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 68.6 mt -61.64 113.18 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.056 0 CA-C-N 117.749 0.774 . . . . 0.0 109.827 178.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 95.47 29.81 8.57 Favored Glycine 0 N--CA 1.438 -1.193 0 CA-C-N 116.023 -0.535 . . . . 0.0 113.139 178.039 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 77.6 t80 -114.14 112.15 22.72 Favored 'General case' 0 C--N 1.313 -1.017 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 177.316 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 23.4 p -95.92 -4.29 43.71 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 -176.124 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -76.57 -162.46 14.24 Favored Glycine 0 CA--C 1.532 1.138 0 C-N-CA 121.212 -0.518 . . . . 0.0 112.82 -179.415 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -61.8 112.25 1.43 Allowed 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 123.131 2.554 . . . . 0.0 111.152 178.079 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.754 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 16.2 p -93.21 -15.04 26.35 Favored 'General case' 0 N--CA 1.433 -1.295 0 CA-C-N 115.874 -0.603 . . . . 0.0 112.444 -176.42 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 10.0 p -95.57 139.03 19.73 Favored 'Isoleucine or valine' 0 C--O 1.255 1.382 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 178.719 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 81.1 m -91.61 155.74 18.13 Favored 'General case' 0 C--N 1.291 -1.978 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.935 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -58.86 137.92 57.55 Favored 'General case' 0 C--O 1.25 1.13 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 175.409 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 7.1 p -51.03 124.82 12.2 Favored 'General case' 0 C--N 1.311 -1.094 0 O-C-N 123.864 0.728 . . . . 0.0 111.828 -177.255 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 112.22 -21.05 20.58 Favored Glycine 0 N--CA 1.434 -1.441 0 CA-C-N 115.463 -0.789 . . . . 0.0 111.228 -176.405 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 75.8 p -110.86 149.26 30.85 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 176.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 22.8 p -112.06 142.54 44.36 Favored 'General case' 0 C--N 1.297 -1.698 0 CA-C-N 116.818 -0.173 . . . . 0.0 110.651 -178.196 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 44.3 t -78.6 99.19 6.45 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 176.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 75.4 mt-30 -96.26 119.26 34.42 Favored 'General case' 0 N--CA 1.415 -2.217 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.62 -178.015 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 46.5 t -75.37 102.45 2.6 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 177.114 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 56.5 mt -85.16 -74.51 0.4 Allowed 'General case' 0 N--CA 1.428 -1.55 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 -179.34 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 74.9 m-20 -95.56 166.78 13.95 Favored Pre-proline 0 C--N 1.289 -2.032 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 176.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -59.67 -36.95 90.64 Favored 'Trans proline' 0 CA--C 1.543 0.939 0 C-N-CA 121.89 1.727 . . . . 0.0 112.99 179.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.581 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 69.3 m-85 -102.47 -24.34 13.83 Favored 'General case' 0 C--N 1.315 -0.935 0 C-N-CA 120.192 -0.603 . . . . 0.0 110.876 -178.688 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 69.9 t80 -104.71 114.25 28.34 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 112.505 0.557 . . . . 0.0 112.505 179.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.504 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 26.7 m -121.67 146.37 47.07 Favored 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 175.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.501 ' OE1' HD23 ' A' ' 36' ' ' LEU . 35.8 tt0 -134.98 142.43 46.47 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-N 118.242 0.474 . . . . 0.0 111.363 -172.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.745 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 77.4 m -77.26 113.39 14.97 Favored 'General case' 0 C--O 1.247 0.949 0 CA-C-O 121.164 0.507 . . . . 0.0 110.117 176.664 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.501 HD23 ' OE1' ' A' ' 34' ' ' GLN . 97.1 mt . . . . . 0 C--N 1.291 -1.952 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.01 -179.005 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' MAN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 33.3 m . . . . . 0 N--CA 1.449 -0.487 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -76.46 149.69 36.78 Favored 'General case' 0 N--CA 1.445 -0.69 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 -174.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 14.2 m -123.67 179.39 4.8 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 -176.267 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 36.9 t-80 -56.16 143.62 32.59 Favored 'General case' 0 C--O 1.239 0.532 0 C-N-CA 123.213 0.605 . . . . 0.0 110.128 178.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 71.91 10.01 6.17 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 124.586 1.155 . . . . 0.0 111.188 -178.3 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -109.76 147.56 17.15 Favored Glycine 0 N--CA 1.422 -2.267 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.392 178.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.536 ' HA ' ' O ' ' A' ' 33' ' ' SER . 53.3 tt0 -79.22 115.19 18.72 Favored 'General case' 0 C--N 1.31 -1.138 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 178.22 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.646 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 7.0 p -88.16 -45.7 9.9 Favored 'General case' 0 C--N 1.285 -2.219 0 CA-C-N 115.648 -0.706 . . . . 0.0 112.86 -176.159 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -171.89 91.6 0.09 OUTLIER Glycine 0 N--CA 1.428 -1.875 0 C-N-CA 118.152 -1.975 . . . . 0.0 113.968 -174.171 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.425 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -112.74 178.27 18.75 Favored Glycine 0 N--CA 1.427 -1.955 0 N-CA-C 108.341 -1.904 . . . . 0.0 108.341 175.036 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 85.5 mt -60.01 113.33 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.074 0 CA-C-N 117.526 0.663 . . . . 0.0 111.377 179.199 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 94.57 13.04 55.03 Favored Glycine 0 N--CA 1.434 -1.457 0 CA-C-N 115.233 -0.894 . . . . 0.0 112.878 177.475 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 57.1 t80 -96.72 113.15 24.69 Favored 'General case' 0 N--CA 1.442 -0.835 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 179.415 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 11.2 p -107.3 21.26 17.78 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-O 121.681 0.753 . . . . 0.0 111.981 -177.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -94.23 -154.18 30.8 Favored Glycine 0 C--N 1.298 -1.546 0 C-N-CA 120.626 -0.797 . . . . 0.0 111.402 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -70.39 107.11 1.91 Allowed 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 122.329 2.019 . . . . 0.0 111.374 178.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.618 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 9.8 p -87.22 -18.17 30.91 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-N 115.415 -0.811 . . . . 0.0 111.99 -177.855 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 12.0 p -88.15 129.85 38.7 Favored 'Isoleucine or valine' 0 C--O 1.25 1.115 0 CA-C-O 121.177 0.513 . . . . 0.0 110.509 178.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 82.1 m -93.36 148.48 22.01 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.987 -179.638 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -59.74 147.13 38.96 Favored 'General case' 0 C--O 1.247 0.96 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.323 177.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 9.7 t -54.12 126.5 23.02 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.054 -178.033 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 112.44 -18.17 23.13 Favored Glycine 0 N--CA 1.438 -1.167 0 N-CA-C 110.716 -0.953 . . . . 0.0 110.716 -175.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 57.7 p -127.19 146.2 50.49 Favored 'General case' 0 N--CA 1.443 -0.802 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 176.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 16.4 p -120.97 143.11 49.19 Favored 'General case' 0 C--N 1.296 -1.73 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 178.248 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 42.0 t -69.74 105.38 2.72 Favored 'General case' 0 C--N 1.309 -1.163 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 178.153 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 68.5 mt-30 -107.41 119.01 38.24 Favored 'General case' 0 N--CA 1.423 -1.816 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 179.295 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 52.8 t -75.22 119.41 22.87 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 CA-C-N 115.298 -0.864 . . . . 0.0 108.752 -179.241 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 76.6 mt -100.81 -69.48 0.77 Allowed 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 179.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 88.7 m-20 -95.48 166.66 14.22 Favored Pre-proline 0 C--N 1.304 -1.381 0 N-CA-C 106.782 -1.562 . . . . 0.0 106.782 173.104 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -63.6 -27.15 69.31 Favored 'Trans proline' 0 CA--C 1.534 0.476 0 C-N-CA 121.089 1.193 . . . . 0.0 111.858 177.275 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.425 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 55.8 m-85 -105.55 -26.03 12.06 Favored 'General case' 0 N--CA 1.443 -0.795 0 C-N-CA 119.789 -0.765 . . . . 0.0 110.716 -179.242 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 68.2 t80 -105.28 114.24 28.3 Favored 'General case' 0 N--CA 1.439 -1.0 0 C-N-CA 119.748 -0.781 . . . . 0.0 112.061 178.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.536 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 19.3 m -126.65 134.56 50.71 Favored 'General case' 0 C--N 1.283 -2.315 0 N-CA-C 105.766 -1.939 . . . . 0.0 105.766 176.206 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 7.7 tt0 -122.05 146.92 46.72 Favored 'General case' 0 C--N 1.303 -1.422 0 C-N-CA 120.268 -0.573 . . . . 0.0 110.567 -175.055 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.646 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 85.8 m -73.35 104.9 4.52 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 172.798 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 95.8 mt . . . . . 0 C--N 1.296 -1.743 0 C-N-CA 123.993 0.917 . . . . 0.0 108.649 -177.86 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' MAN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 22.7 p . . . . . 0 N--CA 1.442 -0.868 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -82.72 134.9 35.13 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 179.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 39.4 m -81.09 178.33 8.48 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-O 121.145 0.498 . . . . 0.0 110.906 -178.462 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 55.1 t-80 -63.67 133.35 53.47 Favored 'General case' 0 N--CA 1.444 -0.754 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 175.098 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 65.15 75.66 0.36 Allowed 'General case' 0 C--N 1.322 -0.59 0 O-C-N 124.356 1.035 . . . . 0.0 110.76 -177.502 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.469 ' O ' ' HA ' ' A' ' 34' ' ' GLN . . . -165.75 152.36 21.61 Favored Glycine 0 N--CA 1.42 -2.425 0 N-CA-C 108.454 -1.858 . . . . 0.0 108.454 178.557 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.589 ' HA ' ' O ' ' A' ' 33' ' ' SER . 52.7 tt0 -76.97 111.24 12.3 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 117.486 0.643 . . . . 0.0 110.049 -178.286 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.775 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 2.4 p -86.13 -41.58 14.6 Favored 'General case' 0 C--N 1.296 -1.758 0 CA-C-N 115.2 -0.909 . . . . 0.0 112.66 -177.429 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 169.76 101.68 0.15 Allowed Glycine 0 N--CA 1.423 -2.172 0 C-N-CA 117.895 -2.098 . . . . 0.0 113.778 -177.656 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -112.52 -160.51 14.98 Favored Glycine 0 N--CA 1.422 -2.265 0 N-CA-C 108.157 -1.977 . . . . 0.0 108.157 174.527 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 76.8 mt -65.91 109.69 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 CA-C-N 117.706 0.753 . . . . 0.0 110.994 177.547 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 95.13 20.63 27.4 Favored Glycine 0 N--CA 1.441 -1.027 0 C-N-CA 121.022 -0.608 . . . . 0.0 113.853 175.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 53.1 t80 -114.16 112.08 22.6 Favored 'General case' 0 C--N 1.31 -1.129 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 178.476 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 10.3 p -109.68 18.92 19.75 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-O 121.365 0.602 . . . . 0.0 111.662 -177.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -82.18 -150.79 8.73 Favored Glycine 0 N--CA 1.446 -0.688 0 CA-C-O 119.259 -0.745 . . . . 0.0 111.431 179.629 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -66.61 93.9 0.32 Allowed 'Trans proline' 0 CA--C 1.535 0.541 0 C-N-CA 122.158 1.905 . . . . 0.0 111.912 178.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.585 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 17.3 p -83.34 -13.59 54.73 Favored 'General case' 0 C--O 1.251 1.156 0 CA-C-O 121.905 0.86 . . . . 0.0 111.058 -177.533 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 4.7 p -92.9 121.64 43.74 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.56 0 CA-C-N 114.625 -1.17 . . . . 0.0 110.033 177.783 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 65.5 m -86.07 153.2 22.28 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 179.084 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -68.56 163.87 22.6 Favored 'General case' 0 C--O 1.26 1.64 0 CA-C-O 120.712 0.291 . . . . 0.0 111.062 178.599 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 28.1 m -47.49 115.91 1.27 Allowed 'General case' 0 C--O 1.248 1.004 0 C-N-CA 124.667 1.187 . . . . 0.0 113.276 -176.381 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 108.37 -20.83 29.7 Favored Glycine 0 N--CA 1.437 -1.282 0 CA-C-N 115.482 -0.781 . . . . 0.0 113.407 175.236 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 21.2 p -106.7 146.03 31.3 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 122.214 -0.58 . . . . 0.0 111.702 -178.251 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 14.5 p -118.92 147.65 43.79 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.558 -178.327 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 43.4 t -77.88 100.3 6.32 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-O 121.225 0.536 . . . . 0.0 109.644 -179.466 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 85.1 mm-40 -90.72 119.68 31.15 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.844 -179.063 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 46.7 t -83.76 108.71 16.47 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 -179.056 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 81.4 mt -95.03 -68.46 0.8 Allowed 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 -179.668 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.4 ' HB2' ' HB3' ' A' ' 32' ' ' TYR . 45.6 m-80 -95.61 166.82 13.83 Favored Pre-proline 0 C--N 1.296 -1.745 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 175.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -61.28 -37.91 69.62 Favored 'Trans proline' 0 C--N 1.349 0.558 0 C-N-CA 121.204 1.269 . . . . 0.0 111.009 178.624 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 49.4 m-85 -96.63 -25.03 15.73 Favored 'General case' 0 N--CA 1.441 -0.921 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.817 -178.703 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.4 ' HB3' ' HB2' ' A' ' 29' ' ' ASN . 48.9 t80 -104.6 113.43 27.0 Favored 'General case' 0 C--N 1.315 -0.898 0 C-N-CA 118.977 -1.089 . . . . 0.0 111.314 -177.506 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.589 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 26.6 m -124.68 137.91 54.33 Favored 'General case' 0 C--N 1.286 -2.193 0 N-CA-C 105.906 -1.887 . . . . 0.0 105.906 176.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.469 ' HA ' ' O ' ' A' ' 6' ' ' GLY . 30.1 tt0 -131.47 136.21 47.74 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -173.243 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.775 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 85.5 m -70.2 110.56 5.26 Favored 'General case' 0 C--O 1.245 0.831 0 CA-C-O 121.263 0.554 . . . . 0.0 110.937 177.3 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 95.8 mt . . . . . 0 C--N 1.294 -1.817 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 179.059 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' MAN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 28.4 m . . . . . 0 N--CA 1.44 -0.929 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -84.23 134.26 34.55 Favored 'General case' 0 N--CA 1.44 -0.943 0 C-N-CA 119.782 -0.767 . . . . 0.0 109.221 -179.537 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 27.7 t -91.95 -178.08 4.91 Favored 'General case' 0 C--N 1.297 -1.695 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.457 -175.582 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 16.8 t-80 -63.43 118.07 7.59 Favored 'General case' 0 N--CA 1.445 -0.691 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 71.83 91.36 0.09 Allowed 'General case' 0 C--O 1.24 0.576 0 C-N-CA 124.62 1.168 . . . . 0.0 111.141 -174.431 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.57 ' O ' ' HA ' ' A' ' 34' ' ' GLN . . . -177.4 163.68 32.42 Favored Glycine 0 N--CA 1.43 -1.766 0 N-CA-C 107.121 -2.392 . . . . 0.0 107.121 179.801 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.612 ' HA ' ' O ' ' A' ' 33' ' ' SER . 53.3 tt0 -84.31 113.47 21.16 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 118.52 1.16 . . . . 0.0 109.608 -178.745 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.76 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 7.4 p -95.17 -36.6 11.41 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 113.248 0.833 . . . . 0.0 113.248 -176.594 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -164.72 66.02 0.22 Allowed Glycine 0 CA--C 1.478 -2.234 0 C-N-CA 118.523 -1.799 . . . . 0.0 112.345 -176.236 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.527 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -110.15 157.04 15.27 Favored Glycine 0 C--N 1.285 -2.284 0 N-CA-C 108.764 -1.734 . . . . 0.0 108.764 177.324 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 69.0 mt -57.49 115.96 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 CA-C-N 117.32 0.56 . . . . 0.0 110.962 -177.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 114.13 -9.66 22.77 Favored Glycine 0 N--CA 1.451 -0.366 0 CA-C-N 116.022 -0.536 . . . . 0.0 112.027 -179.522 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 91.8 t80 -93.55 120.64 34.07 Favored 'General case' 0 C--N 1.311 -1.072 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 179.008 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 12.4 p -111.5 4.55 18.9 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 112.103 0.409 . . . . 0.0 112.103 -176.088 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -82.73 -160.51 28.52 Favored Glycine 0 CA--C 1.528 0.844 0 C-N-CA 121.127 -0.559 . . . . 0.0 112.525 179.687 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -72.87 126.3 11.19 Favored 'Trans proline' 0 CA--C 1.512 -0.62 0 C-N-CA 122.286 1.991 . . . . 0.0 111.175 179.143 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.573 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 21.7 p -85.1 -14.51 46.92 Favored 'General case' 0 C--N 1.295 -1.804 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.357 -177.155 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 12.3 p -75.42 132.8 32.62 Favored 'Isoleucine or valine' 0 C--O 1.257 1.469 0 CA-C-O 121.794 0.807 . . . . 0.0 111.426 -177.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 80.5 m -93.86 167.78 11.4 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-N 114.886 -1.052 . . . . 0.0 110.182 179.219 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.13 140.89 58.25 Favored 'General case' 0 C--N 1.308 -1.196 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 175.244 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 34.6 t -55.29 125.71 21.86 Favored 'General case' 0 C--N 1.312 -1.04 0 O-C-N 123.504 0.502 . . . . 0.0 109.961 -179.719 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 112.56 -20.68 20.29 Favored Glycine 0 N--CA 1.439 -1.141 0 N-CA-C 110.662 -0.975 . . . . 0.0 110.662 -175.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 72.7 p -114.89 157.54 23.19 Favored 'General case' 0 C--N 1.311 -1.074 0 O-C-N 122.293 -0.534 . . . . 0.0 109.665 177.572 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 16.6 p -126.02 148.98 49.16 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 110.089 -0.338 . . . . 0.0 110.089 177.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 53.2 t -76.63 100.88 5.5 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 62.0 mt-30 -101.0 114.99 29.43 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-O 121.122 0.486 . . . . 0.0 110.384 -178.154 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 48.2 t -71.33 116.51 13.13 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.252 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 178.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 78.6 mt -101.15 -68.69 0.8 Allowed 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 -178.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -95.38 166.07 15.48 Favored Pre-proline 0 C--N 1.301 -1.541 0 N-CA-C 106.915 -1.513 . . . . 0.0 106.915 174.657 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_exo -62.6 -27.41 76.36 Favored 'Trans proline' 0 CA--C 1.536 0.583 0 C-N-CA 121.531 1.487 . . . . 0.0 111.622 176.616 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.527 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 88.1 m-85 -105.31 -25.31 12.46 Favored 'General case' 0 N--CA 1.443 -0.798 0 C-N-CA 120.135 -0.626 . . . . 0.0 111.518 179.254 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 44.7 t80 -105.87 113.73 27.45 Favored 'General case' 0 C--N 1.311 -1.074 0 C-N-CA 119.548 -0.861 . . . . 0.0 112.033 179.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.612 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 16.9 m -120.24 135.01 55.13 Favored 'General case' 0 C--N 1.291 -1.953 0 N-CA-C 105.759 -1.941 . . . . 0.0 105.759 175.134 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.57 ' HA ' ' O ' ' A' ' 6' ' ' GLY . 28.1 tt0 -127.79 138.15 52.64 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 112.694 0.627 . . . . 0.0 112.694 -171.466 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.76 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 68.9 m -71.91 109.9 6.07 Favored 'General case' 0 C--O 1.251 1.158 0 CA-C-O 120.979 0.419 . . . . 0.0 111.073 176.875 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 94.3 mt . . . . . 0 N--CA 1.431 -1.398 0 N-CA-C 107.275 -1.38 . . . . 0.0 107.275 178.762 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' MAN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 23.1 m . . . . . 0 C--O 1.248 1.014 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -77.87 153.21 32.88 Favored 'General case' 0 N--CA 1.446 -0.637 0 C-N-CA 123.268 0.627 . . . . 0.0 109.504 -176.21 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 67.7 m -127.31 -170.45 2.22 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 111.602 0.223 . . . . 0.0 111.602 -177.052 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . 0.431 ' HA ' ' O ' ' A' ' 35' ' ' CYS . 37.0 t-80 -60.13 136.64 58.09 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 122.718 0.407 . . . . 0.0 110.936 -173.363 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.472 ' HA ' ' CD ' ' A' ' 34' ' ' GLN . . . 74.4 8.76 4.47 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 124.143 0.977 . . . . 0.0 111.953 -179.814 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.411 ' O ' ' HA ' ' A' ' 34' ' ' GLN . . . -103.92 151.29 17.62 Favored Glycine 0 N--CA 1.431 -1.65 0 N-CA-C 111.386 -0.686 . . . . 0.0 111.386 178.537 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.607 ' HA ' ' O ' ' A' ' 33' ' ' SER . 54.3 tt0 -77.98 114.43 16.84 Favored 'General case' 0 CA--C 1.502 -0.883 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 178.608 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.698 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 8.0 p -94.27 -43.74 8.29 Favored 'General case' 0 C--N 1.288 -2.077 0 N-CA-C 113.549 0.944 . . . . 0.0 113.549 -175.64 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -159.38 69.75 0.25 Allowed Glycine 0 CA--C 1.481 -2.046 0 C-N-CA 118.541 -1.79 . . . . 0.0 112.765 -172.204 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.559 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -112.42 153.63 17.32 Favored Glycine 0 C--N 1.279 -2.584 0 N-CA-C 109.307 -1.517 . . . . 0.0 109.307 178.217 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.424 ' HB ' ' CD1' ' A' ' 31' ' ' TYR . 72.6 mt -56.24 123.89 8.38 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 O-C-N 123.974 0.455 . . . . 0.0 109.909 179.721 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 108.02 -15.27 36.93 Favored Glycine 0 N--CA 1.442 -0.9 0 N-CA-C 111.074 -0.81 . . . . 0.0 111.074 -179.218 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 80.1 t80 -101.78 109.7 21.53 Favored 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 178.602 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 13.5 p -107.68 7.34 28.44 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 112.381 0.511 . . . . 0.0 112.381 -176.629 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -82.41 -152.9 11.28 Favored Glycine 0 CA--C 1.53 0.978 0 CA-C-N 116.071 -0.513 . . . . 0.0 113.079 -179.547 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -64.49 112.25 1.88 Allowed 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 122.993 2.462 . . . . 0.0 112.294 -179.146 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.599 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 14.1 p -95.28 -4.73 45.1 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 115.375 -0.83 . . . . 0.0 113.022 -176.113 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 9.2 p -89.76 127.59 42.28 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.998 0 CA-C-O 120.896 0.379 . . . . 0.0 110.84 -178.648 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.474 ' SG ' ' HB2' ' A' ' 25' ' ' CYS . 72.9 m -87.91 154.1 20.79 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.167 178.789 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.72 143.4 57.46 Favored 'General case' 0 N--CA 1.438 -1.07 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.25 175.528 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.2 p -62.4 127.82 33.11 Favored 'General case' 0 C--N 1.297 -1.688 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.658 -179.15 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 112.5 -5.07 26.41 Favored Glycine 0 N--CA 1.438 -1.172 0 N-CA-C 110.727 -0.949 . . . . 0.0 110.727 -174.141 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 49.3 p -136.26 145.0 45.1 Favored 'General case' 0 C--O 1.239 0.547 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 174.586 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 46.4 p -112.1 145.01 40.51 Favored 'General case' 0 C--N 1.305 -1.338 0 C-N-CA 120.884 -0.326 . . . . 0.0 110.139 -179.518 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.474 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 43.6 t -79.28 97.63 6.35 Favored 'General case' 0 C--N 1.31 -1.144 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 -179.706 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 72.1 mt-30 -93.74 114.75 27.1 Favored 'General case' 0 N--CA 1.424 -1.767 0 CA-C-O 121.303 0.573 . . . . 0.0 110.716 -177.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 48.1 t -76.76 95.12 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 CA-C-N 114.798 -1.092 . . . . 0.0 108.404 177.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 87.7 mt -78.23 -70.91 0.46 Allowed 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 -179.388 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 75.2 m-20 -95.36 166.72 14.17 Favored Pre-proline 0 C--N 1.296 -1.738 0 N-CA-C 106.644 -1.613 . . . . 0.0 106.644 174.66 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_exo -62.95 -35.66 65.17 Favored 'Trans proline' 0 C--O 1.246 0.915 0 C-N-CA 121.171 1.247 . . . . 0.0 111.441 176.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.559 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 73.2 m-85 -97.41 -26.33 14.9 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 120.411 -0.516 . . . . 0.0 111.056 -178.639 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 68.8 t80 -105.68 114.09 28.04 Favored 'General case' 0 C--N 1.311 -1.09 0 C-N-CA 119.879 -0.728 . . . . 0.0 112.512 177.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.607 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 18.6 m -127.01 135.88 51.45 Favored 'General case' 0 C--N 1.295 -1.79 0 N-CA-C 106.45 -1.685 . . . . 0.0 106.45 175.841 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.472 ' CD ' ' HA ' ' A' ' 5' ' ' ALA . 7.9 tt0 -126.22 141.41 51.93 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-N 117.975 0.352 . . . . 0.0 111.022 -174.476 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.698 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 60.3 m -73.55 109.98 7.48 Favored 'General case' 0 C--O 1.253 1.25 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 174.075 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 87.4 mt . . . . . 0 C--N 1.289 -2.036 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 179.503 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' MAN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 19.6 p . . . . . 0 C--O 1.249 1.051 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -85.65 147.75 26.22 Favored 'General case' 0 N--CA 1.436 -1.144 0 N-CA-C 107.767 -1.198 . . . . 0.0 107.767 178.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 33.4 t -114.82 179.32 3.98 Favored 'General case' 0 C--N 1.288 -2.088 0 C-N-CA 120.642 -0.423 . . . . 0.0 111.425 -173.538 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 57.4 t-80 -58.15 137.04 57.31 Favored 'General case' 0 CA--C 1.519 -0.243 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 -178.642 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 78.21 -3.69 2.29 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 124.858 1.263 . . . . 0.0 112.059 179.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -90.15 141.91 16.19 Favored Glycine 0 N--CA 1.426 -1.997 0 N-CA-C 110.76 -0.936 . . . . 0.0 110.76 178.313 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.575 ' HA ' ' O ' ' A' ' 33' ' ' SER . 54.0 tt0 -69.26 113.55 6.71 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 176.425 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.711 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 10.5 p -86.29 -40.83 15.11 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 112.764 0.654 . . . . 0.0 112.764 -176.178 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 177.4 93.25 0.09 OUTLIER Glycine 0 CA--C 1.488 -1.653 0 C-N-CA 117.788 -2.148 . . . . 0.0 113.847 -176.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.503 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -112.01 174.85 16.74 Favored Glycine 0 C--N 1.286 -2.238 0 N-CA-C 107.519 -2.232 . . . . 0.0 107.519 174.755 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 65.2 mt -60.55 113.25 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.139 0 CA-C-N 117.912 0.856 . . . . 0.0 109.469 178.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 113.8 -20.09 17.89 Favored Glycine 0 N--CA 1.438 -1.229 0 C-N-CA 121.1 -0.571 . . . . 0.0 112.165 179.206 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 71.0 t80 -81.35 118.97 23.1 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-O 121.038 0.447 . . . . 0.0 110.425 -176.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 11.7 p -102.58 5.79 39.45 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 113.055 0.761 . . . . 0.0 113.055 -175.175 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -87.89 -157.04 31.22 Favored Glycine 0 CA--C 1.524 0.628 0 C-N-CA 120.703 -0.761 . . . . 0.0 113.275 -175.262 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -70.7 113.16 3.44 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.637 2.225 . . . . 0.0 111.805 -179.586 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.635 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 18.5 p -89.04 -3.41 58.7 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.847 -177.36 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 4.0 p -98.91 120.82 48.75 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.953 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.859 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 63.1 m -85.74 164.27 17.71 Favored 'General case' 0 C--N 1.299 -1.621 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.48 179.448 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.42 146.0 55.04 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 174.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 46.1 m -61.67 130.74 47.28 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 178.049 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 112.36 -13.12 25.85 Favored Glycine 0 C--N 1.309 -0.962 0 N-CA-C 110.384 -1.086 . . . . 0.0 110.384 -173.482 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 65.0 p -127.57 155.27 44.09 Favored 'General case' 0 C--O 1.248 0.986 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 175.229 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 33.8 p -120.6 143.26 48.74 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 177.331 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 52.7 t -74.53 99.6 3.64 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 176.644 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 -97.82 119.68 36.85 Favored 'General case' 0 N--CA 1.425 -1.717 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 -177.722 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 43.1 t -77.86 93.88 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 178.091 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 82.7 mt -74.96 -70.77 0.39 Allowed 'General case' 0 C--N 1.306 -1.297 0 CA-C-N 115.278 -0.874 . . . . 0.0 109.092 -177.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 52.1 m-80 -95.58 165.91 15.7 Favored Pre-proline 0 C--N 1.295 -1.802 0 N-CA-C 106.206 -1.776 . . . . 0.0 106.206 174.006 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -63.43 -30.46 72.28 Favored 'Trans proline' 0 C--O 1.239 0.543 0 C-N-CA 121.376 1.384 . . . . 0.0 111.287 178.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.503 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 55.4 m-85 -103.15 -25.71 13.28 Favored 'General case' 0 N--CA 1.438 -1.073 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.464 -179.754 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 40.6 t80 -106.03 114.2 28.2 Favored 'General case' 0 C--N 1.317 -0.843 0 C-N-CA 119.413 -0.915 . . . . 0.0 111.562 178.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.575 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 15.4 m -121.03 141.04 51.12 Favored 'General case' 0 C--N 1.294 -1.824 0 N-CA-C 106.485 -1.672 . . . . 0.0 106.485 176.271 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -136.04 140.93 44.21 Favored 'General case' 0 C--N 1.297 -1.699 0 CA-C-N 118.053 0.388 . . . . 0.0 111.047 -172.623 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.711 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 66.7 m -73.17 111.24 8.1 Favored 'General case' 0 C--O 1.257 1.488 0 CA-C-O 121.108 0.48 . . . . 0.0 110.369 177.63 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 82.2 mt . . . . . 0 C--N 1.303 -1.443 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 -179.844 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' MAN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 25.5 m . . . . . 0 C--O 1.225 -0.205 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.442 ' O ' ' HA ' ' A' ' 19' ' ' CYS . 8.2 tp-100 -80.63 134.07 35.83 Favored 'General case' 0 N--CA 1.442 -0.832 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 178.781 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' SER . . . . . 0.406 ' O ' ' HB2' ' A' ' 35' ' ' CYS . 69.7 m -126.06 -165.62 1.46 Allowed 'General case' 0 C--N 1.276 -2.621 0 C-N-CA 120.99 -0.284 . . . . 0.0 111.518 -174.774 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 56.8 t-80 -50.3 130.58 23.35 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 113.647 0.98 . . . . 0.0 113.647 -172.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 71.52 12.06 6.52 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 114.275 -1.33 . . . . 0.0 112.649 175.671 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.407 ' O ' ' HA ' ' A' ' 34' ' ' GLN . . . -100.15 165.57 19.66 Favored Glycine 0 N--CA 1.433 -1.5 0 N-CA-C 110.846 -0.902 . . . . 0.0 110.846 176.225 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.512 ' HA ' ' O ' ' A' ' 33' ' ' SER . 54.0 tt0 -87.82 112.35 22.36 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 110.245 -0.28 . . . . 0.0 110.245 -177.562 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.761 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 14.6 p -83.03 -41.94 18.08 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 112.383 0.512 . . . . 0.0 112.383 -178.226 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 165.14 101.42 0.16 Allowed Glycine 0 CA--C 1.483 -1.923 0 C-N-CA 117.624 -2.227 . . . . 0.0 114.265 -178.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -112.63 -169.98 17.92 Favored Glycine 0 N--CA 1.423 -2.199 0 N-CA-C 107.489 -2.244 . . . . 0.0 107.489 173.4 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 70.3 mt -62.09 122.86 13.73 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.34 0 CA-C-N 117.815 0.807 . . . . 0.0 110.21 179.156 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 99.02 -5.27 59.36 Favored Glycine 0 N--CA 1.444 -0.814 0 C-N-CA 120.834 -0.698 . . . . 0.0 113.24 175.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 69.4 t80 -94.38 113.79 25.72 Favored 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 27.0 p -106.41 -1.18 23.52 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 116.317 -0.402 . . . . 0.0 112.039 -176.736 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -76.02 -156.7 6.54 Favored Glycine 0 CA--C 1.526 0.728 0 CA-C-N 116.121 -0.49 . . . . 0.0 113.195 -178.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -63.62 106.79 0.64 Allowed 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 122.568 2.179 . . . . 0.0 111.885 -179.662 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.672 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 4.2 p -95.51 15.14 20.52 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-N 115.401 -0.818 . . . . 0.0 112.377 -176.132 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 7.1 p -112.13 126.76 69.56 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.627 -179.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.463 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 80.1 m -88.01 150.2 23.56 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 115.652 -0.704 . . . . 0.0 109.163 177.078 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.14 153.34 43.88 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 177.509 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 24.6 m -55.97 128.43 35.2 Favored 'General case' 0 N--CA 1.435 -1.184 0 CA-C-O 121.336 0.589 . . . . 0.0 110.705 -179.677 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 111.97 -18.12 24.27 Favored Glycine 0 N--CA 1.432 -1.576 0 N-CA-C 110.927 -0.869 . . . . 0.0 110.927 -177.095 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 68.6 p -121.54 146.73 46.65 Favored 'General case' 0 N--CA 1.441 -0.886 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 178.118 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 34.2 p -114.85 144.04 44.16 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.07 179.306 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 52.9 t -78.62 106.3 10.5 Favored 'General case' 0 C--N 1.308 -1.2 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 178.607 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -111.08 130.56 55.57 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.179 -178.35 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 43.2 t -87.71 114.45 26.55 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.831 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 -177.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 86.4 mt -92.94 -72.72 0.59 Allowed 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 179.282 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 84.3 m-20 -93.63 163.23 25.04 Favored Pre-proline 0 C--N 1.305 -1.341 0 N-CA-C 106.322 -1.733 . . . . 0.0 106.322 175.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -58.07 -35.28 98.87 Favored 'Trans proline' 0 CA--C 1.534 0.477 0 C-N-CA 121.626 1.551 . . . . 0.0 111.55 179.63 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 90.3 m-85 -97.69 -25.04 15.23 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.671 -179.47 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 65.9 t80 -105.48 114.43 28.61 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 119.937 -0.705 . . . . 0.0 112.714 -179.579 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.512 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 19.9 m -119.21 143.95 46.98 Favored 'General case' 0 C--N 1.295 -1.791 0 N-CA-C 106.962 -1.496 . . . . 0.0 106.962 174.515 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.407 ' HA ' ' O ' ' A' ' 6' ' ' GLY . 35.2 tt0 -129.96 143.62 50.9 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 111.941 0.349 . . . . 0.0 111.941 -171.478 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.761 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 86.0 m -82.0 111.07 17.83 Favored 'General case' 0 C--O 1.252 1.221 0 CA-C-O 121.169 0.509 . . . . 0.0 109.892 176.345 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 96.1 mt . . . . . 0 C--N 1.298 -1.674 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.646 179.586 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' MAN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 7.8 m . . . . . 0 N--CA 1.438 -1.066 0 N-CA-C 108.072 -1.085 . . . . 0.0 108.072 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 41.1 tp60 -83.66 118.09 23.63 Favored 'General case' 0 N--CA 1.432 -1.374 0 CA-C-O 121.479 0.657 . . . . 0.0 109.733 -177.543 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 58.3 p -78.11 168.47 19.81 Favored 'General case' 0 C--N 1.293 -1.878 0 CA-C-N 115.316 -0.856 . . . . 0.0 112.161 -175.031 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 50.0 t-80 -57.21 137.51 55.84 Favored 'General case' 0 C--O 1.238 0.465 0 N-CA-C 109.141 -0.688 . . . . 0.0 109.141 176.018 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 72.19 15.48 5.4 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 123.784 0.834 . . . . 0.0 111.407 -179.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -105.98 160.98 14.51 Favored Glycine 0 N--CA 1.432 -1.574 0 N-CA-C 110.26 -1.136 . . . . 0.0 110.26 174.533 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.576 ' HA ' ' O ' ' A' ' 33' ' ' SER . 53.5 tt0 -80.68 109.91 15.67 Favored 'General case' 0 C--O 1.21 -0.988 0 CA-C-N 116.869 0.334 . . . . 0.0 110.331 -178.599 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.778 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 23.5 p -84.62 -15.36 45.81 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -177.188 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.409 ' HA2' ' CD1' ' A' ' 13' ' ' TYR . . . 135.14 100.69 0.65 Allowed Glycine 0 N--CA 1.42 -2.423 0 C-N-CA 117.72 -2.181 . . . . 0.0 115.253 176.119 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -112.23 -171.15 18.53 Favored Glycine 0 N--CA 1.423 -2.221 0 N-CA-C 106.991 -2.444 . . . . 0.0 106.991 172.048 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 77.7 mt -58.39 113.81 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.994 0 CA-C-N 117.946 0.873 . . . . 0.0 110.443 179.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 114.02 -16.87 20.26 Favored Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.964 -0.636 . . . . 0.0 113.028 177.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.409 ' CD1' ' HA2' ' A' ' 9' ' ' GLY . 66.3 t80 -94.36 129.06 41.21 Favored 'General case' 0 C--N 1.312 -1.046 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 -179.159 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 11.4 p -131.58 14.31 4.95 Favored 'General case' 0 C--O 1.248 0.997 0 N-CA-C 112.981 0.734 . . . . 0.0 112.981 -174.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -90.93 -140.73 8.92 Favored Glycine 0 C--N 1.309 -0.967 0 C-N-CA 121.19 -0.529 . . . . 0.0 111.958 178.713 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -66.14 108.97 1.43 Allowed 'Trans proline' 0 N--CA 1.46 -0.484 0 C-N-CA 122.317 2.011 . . . . 0.0 111.659 -179.411 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.461 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 17.5 p -97.06 -3.49 41.26 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-N 115.696 -0.683 . . . . 0.0 111.747 -178.817 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 7.2 p -90.28 125.09 43.16 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.941 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.933 178.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 84.8 m -84.4 161.95 20.16 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 115.699 -0.682 . . . . 0.0 112.055 -179.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.83 160.18 28.85 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 115.098 -0.955 . . . . 0.0 110.79 178.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 31.1 m -54.06 116.29 2.5 Favored 'General case' 0 C--N 1.31 -1.147 0 C-N-CA 124.058 0.943 . . . . 0.0 111.989 -179.062 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 105.86 -19.09 39.13 Favored Glycine 0 N--CA 1.435 -1.425 0 CA-C-N 115.779 -0.646 . . . . 0.0 112.237 178.224 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 74.9 p -106.91 145.15 32.55 Favored 'General case' 0 C--N 1.309 -1.181 0 O-C-N 122.252 -0.558 . . . . 0.0 110.813 -177.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 22.2 p -114.96 152.15 32.86 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 110.079 -0.341 . . . . 0.0 110.079 178.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 50.8 t -77.98 106.02 9.56 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 178.706 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 68.4 mt-30 -108.45 123.88 49.55 Favored 'General case' 0 N--CA 1.429 -1.49 0 CA-C-O 121.11 0.481 . . . . 0.0 109.792 -179.571 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 55.0 t -80.58 111.53 17.42 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.239 -177.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 86.6 mt -91.67 -70.06 0.71 Allowed 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 179.688 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 51.2 m-20 -94.58 163.99 21.14 Favored Pre-proline 0 C--N 1.299 -1.612 0 N-CA-C 105.814 -1.921 . . . . 0.0 105.814 176.109 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_exo -62.39 -26.44 76.79 Favored 'Trans proline' 0 CA--C 1.539 0.744 0 C-N-CA 121.539 1.493 . . . . 0.0 111.798 178.25 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 41.8 m-85 -108.47 -25.26 11.03 Favored 'General case' 0 N--CA 1.444 -0.742 0 C-N-CA 120.216 -0.594 . . . . 0.0 111.11 -177.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 78.6 t80 -105.58 113.96 27.83 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 120.915 0.388 . . . . 0.0 111.888 177.702 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.576 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 24.8 m -116.3 143.43 45.55 Favored 'General case' 0 C--N 1.285 -2.212 0 N-CA-C 106.426 -1.694 . . . . 0.0 106.426 175.753 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -129.4 140.04 51.47 Favored 'General case' 0 C--N 1.303 -1.434 0 CA-C-N 118.269 0.486 . . . . 0.0 111.379 -173.248 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.778 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 74.9 m -74.84 112.56 11.17 Favored 'General case' 0 C--O 1.256 1.4 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.094 175.759 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 92.6 mt . . . . . 0 N--CA 1.429 -1.477 0 C-N-CA 124.401 1.08 . . . . 0.0 108.091 179.965 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' MAN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 19.3 m . . . . . 0 N--CA 1.438 -1.073 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.408 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 5.8 tp-100 -87.58 138.3 31.59 Favored 'General case' 0 N--CA 1.446 -0.653 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 -177.775 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' SER . . . . . 0.426 ' O ' ' HB2' ' A' ' 35' ' ' CYS . 33.0 m -98.64 -177.03 3.54 Favored 'General case' 0 C--N 1.294 -1.826 0 CA-C-N 116.733 -0.212 . . . . 0.0 111.152 -175.717 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 53.4 t-80 -61.99 126.56 27.77 Favored 'General case' 0 CA--C 1.511 -0.549 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 177.203 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 71.24 102.99 0.06 Allowed 'General case' 0 C--O 1.237 0.442 0 O-C-N 124.775 1.297 . . . . 0.0 109.726 -173.394 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.453 ' O ' ' HA ' ' A' ' 34' ' ' GLN . . . 158.86 147.48 4.87 Favored Glycine 0 N--CA 1.418 -2.519 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 -176.277 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.584 ' HA ' ' O ' ' A' ' 33' ' ' SER . 53.8 tt0 -78.51 106.83 10.73 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-O 121.03 0.443 . . . . 0.0 110.333 -179.033 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.662 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 7.9 p -82.11 -41.32 20.67 Favored 'General case' 0 C--N 1.301 -1.519 0 CA-C-N 115.556 -0.747 . . . . 0.0 112.05 -179.118 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 173.47 100.26 0.13 Allowed Glycine 0 N--CA 1.432 -1.628 0 C-N-CA 117.881 -2.104 . . . . 0.0 114.397 -177.552 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -112.0 -167.8 17.98 Favored Glycine 0 C--N 1.289 -2.069 0 N-CA-C 108.252 -1.939 . . . . 0.0 108.252 174.446 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 86.1 mt -59.58 109.25 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.01 0 CA-C-N 117.724 0.762 . . . . 0.0 110.995 179.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 104.82 -10.08 48.27 Favored Glycine 0 N--CA 1.437 -1.243 0 CA-C-N 115.989 -0.55 . . . . 0.0 113.313 176.504 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 34.5 t80 -100.12 111.22 23.5 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 -177.62 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 5.5 p -113.33 10.96 18.49 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 113.466 0.913 . . . . 0.0 113.466 -175.367 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -74.97 -131.74 0.27 Allowed Glycine 0 CA--C 1.53 1.024 0 CA-C-N 116.16 -0.473 . . . . 0.0 113.475 -179.016 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.86 81.06 0.87 Allowed 'Trans proline' 0 N--CA 1.461 -0.439 0 C-N-CA 122.672 2.248 . . . . 0.0 112.792 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.453 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 29.2 p -81.28 -10.41 59.58 Favored 'General case' 0 N--CA 1.437 -1.084 0 CA-C-N 115.338 -0.847 . . . . 0.0 110.606 178.88 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 7.1 p -89.96 132.82 33.65 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.275 0 CA-C-N 114.833 -1.076 . . . . 0.0 108.886 176.601 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.47 ' SG ' ' HB2' ' A' ' 25' ' ' CYS . 76.1 m -101.1 156.67 17.28 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.39 -177.028 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.18 175.29 3.94 Favored 'General case' 0 C--O 1.246 0.877 0 C-N-CA 123.829 0.851 . . . . 0.0 112.065 -178.545 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 5.1 m -51.72 113.05 0.87 Allowed 'General case' 0 N--CA 1.443 -0.815 0 C-N-CA 124.863 1.265 . . . . 0.0 112.275 -177.426 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 89.81 12.63 62.06 Favored Glycine 0 N--CA 1.434 -1.444 0 C-N-CA 120.509 -0.853 . . . . 0.0 113.499 174.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.461 ' OG1' ' HB3' ' A' ' 19' ' ' CYS . 73.6 p -124.96 143.93 50.63 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 117.294 0.547 . . . . 0.0 110.274 177.33 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 40.1 p -118.85 137.03 53.71 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.705 179.609 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.47 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 53.3 t -76.35 109.22 9.87 Favored 'General case' 0 C--N 1.312 -1.024 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 179.523 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 74.6 mt-30 -116.28 125.97 52.92 Favored 'General case' 0 C--N 1.298 -1.664 0 CA-C-O 121.026 0.441 . . . . 0.0 110.542 -179.368 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 69.1 t -70.29 115.72 10.16 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.201 0 CA-C-N 115.016 -0.993 . . . . 0.0 109.045 178.441 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 67.8 mt -98.97 -70.67 0.72 Allowed 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 81.9 m-20 -95.5 168.98 9.93 Favored Pre-proline 0 C--N 1.298 -1.644 0 N-CA-C 106.763 -1.569 . . . . 0.0 106.763 175.539 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_exo -59.54 -36.75 92.17 Favored 'Trans proline' 0 CA--C 1.542 0.924 0 C-N-CA 121.614 1.543 . . . . 0.0 113.085 -179.657 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 66.6 m-85 -104.46 -24.02 13.09 Favored 'General case' 0 C--N 1.312 -1.049 0 O-C-N 121.716 -0.615 . . . . 0.0 110.574 -178.762 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 62.8 t80 -103.32 113.59 27.2 Favored 'General case' 0 N--CA 1.431 -1.4 0 CA-C-O 121.658 0.742 . . . . 0.0 111.422 -178.344 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.584 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 26.0 m -122.67 143.67 49.63 Favored 'General case' 0 C--N 1.288 -2.094 0 N-CA-C 105.536 -2.024 . . . . 0.0 105.536 176.355 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.453 ' HA ' ' O ' ' A' ' 6' ' ' GLY . 27.1 tt0 -135.34 145.72 47.7 Favored 'General case' 0 C--N 1.297 -1.675 0 C-N-CA 120.274 -0.571 . . . . 0.0 112.465 -173.105 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.662 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 66.8 m -76.17 112.16 12.34 Favored 'General case' 0 C--O 1.251 1.165 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.335 176.304 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 94.9 mt . . . . . 0 C--N 1.3 -1.558 0 CA-C-N 115.012 -0.995 . . . . 0.0 108.397 179.081 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' MAN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 22.9 m . . . . . 0 N--CA 1.438 -1.025 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.512 ' HA ' ' OE1' ' A' ' 2' ' ' GLN . 3.4 tp60 -89.01 125.92 35.2 Favored 'General case' 0 N--CA 1.436 -1.144 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 -174.644 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 87.2 p -92.39 -178.15 4.84 Favored 'General case' 0 C--N 1.294 -1.838 0 CA-C-O 121.006 0.432 . . . . 0.0 111.193 -177.508 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . 0.518 ' O ' ' H3 ' ' A' ' 101' ' ' MAN . 50.5 t-80 -54.43 136.54 44.01 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 123.954 0.902 . . . . 0.0 110.768 178.589 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 75.75 3.5 3.85 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 124.781 1.232 . . . . 0.0 112.713 177.82 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -93.37 154.98 22.03 Favored Glycine 0 N--CA 1.437 -1.257 0 N-CA-C 110.433 -1.067 . . . . 0.0 110.433 175.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.47 ' HA ' ' O ' ' A' ' 33' ' ' SER . 52.3 tt0 -81.36 110.1 16.48 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 177.933 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.7 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 8.7 p -79.18 -43.39 24.0 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 123.333 0.396 . . . . 0.0 111.867 -177.573 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 157.31 115.74 0.47 Allowed Glycine 0 N--CA 1.42 -2.383 0 C-N-CA 117.145 -2.455 . . . . 0.0 114.708 179.492 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -101.81 -149.9 22.87 Favored Glycine 0 N--CA 1.418 -2.559 0 N-CA-C 108.352 -1.899 . . . . 0.0 108.352 174.417 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 84.3 mt -71.92 112.98 8.07 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.715 0 CA-C-N 117.417 0.609 . . . . 0.0 111.008 178.475 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 92.61 30.06 10.17 Favored Glycine 0 N--CA 1.449 -0.492 0 CA-C-N 115.807 -0.633 . . . . 0.0 113.597 174.604 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 36.3 t80 -111.72 117.05 31.8 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-N 117.342 0.571 . . . . 0.0 109.513 -179.104 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 39.0 p -102.78 11.27 37.81 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-O 120.864 0.364 . . . . 0.0 111.742 -177.263 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -80.01 -151.78 7.2 Favored Glycine 0 CA--C 1.529 0.965 0 CA-C-N 116.071 -0.513 . . . . 0.0 112.315 179.638 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -75.35 96.59 1.04 Allowed 'Trans proline' 0 N--CA 1.453 -0.89 0 C-N-CA 122.276 1.984 . . . . 0.0 111.163 179.352 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.575 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 15.2 p -90.52 -8.76 49.5 Favored 'General case' 0 N--CA 1.423 -1.808 0 CA-C-N 115.407 -0.815 . . . . 0.0 112.259 -175.303 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 9.3 p -95.78 130.71 44.1 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.225 0 CA-C-N 116.123 -0.49 . . . . 0.0 109.932 177.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.478 ' HA ' ' O ' ' A' ' 2' ' ' GLN . 73.6 m -91.86 159.19 15.91 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.467 -179.404 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -78.86 170.0 17.36 Favored 'General case' 0 C--O 1.251 1.138 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.261 -179.472 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 46.4 m -58.51 126.65 28.47 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.972 -179.19 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 104.37 -6.24 45.68 Favored Glycine 0 N--CA 1.431 -1.667 0 C-N-CA 120.147 -1.025 . . . . 0.0 112.207 178.786 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 38.8 p -135.07 153.08 52.16 Favored 'General case' 0 C--O 1.241 0.627 0 CA-C-O 120.653 0.263 . . . . 0.0 111.305 -179.389 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 8.8 p -124.01 153.51 41.21 Favored 'General case' 0 N--CA 1.437 -1.093 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 176.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 50.9 t -82.34 99.38 9.33 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 -179.399 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 58.5 mt-30 -99.83 122.36 42.67 Favored 'General case' 0 N--CA 1.438 -1.059 0 CA-C-O 121.123 0.487 . . . . 0.0 110.087 -177.832 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 55.8 t -82.57 107.42 14.41 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.35 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.164 -179.001 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 84.1 mt -88.47 -70.39 0.64 Allowed 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 -179.786 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 55.7 m-80 -94.39 164.41 20.16 Favored Pre-proline 0 C--N 1.303 -1.441 0 N-CA-C 106.343 -1.725 . . . . 0.0 106.343 174.235 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_exo -60.46 -24.58 78.33 Favored 'Trans proline' 0 C--N 1.35 0.624 0 C-N-CA 121.766 1.644 . . . . 0.0 111.963 179.496 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 55.8 m-85 -109.56 -24.26 11.06 Favored 'General case' 0 N--CA 1.432 -1.356 0 C-N-CA 120.276 -0.57 . . . . 0.0 111.502 -179.256 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 57.0 t80 -103.95 113.43 26.95 Favored 'General case' 0 C--N 1.315 -0.934 0 C-N-CA 119.606 -0.838 . . . . 0.0 110.461 -179.474 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.47 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 49.8 m -123.18 137.56 54.86 Favored 'General case' 0 C--N 1.28 -2.447 0 N-CA-C 105.813 -1.921 . . . . 0.0 105.813 177.065 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 29.4 tt0 -131.46 141.04 49.71 Favored 'General case' 0 C--N 1.288 -2.075 0 C-N-CA 121.077 -0.249 . . . . 0.0 111.087 -172.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.7 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 76.8 m -74.56 107.98 7.03 Favored 'General case' 0 C--O 1.255 1.39 0 CA-C-O 121.636 0.731 . . . . 0.0 110.653 177.374 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 96.2 mt . . . . . 0 N--CA 1.428 -1.543 0 N-CA-C 106.304 -1.739 . . . . 0.0 106.304 179.028 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' MAN . . . . . 0.518 ' H3 ' ' O ' ' A' ' 4' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 3.6 p . . . . . 0 C--O 1.241 0.653 0 N-CA-C 110.302 -0.258 . . . . 0.0 110.302 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -79.53 147.43 32.18 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 178.415 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 5.0 m -93.03 169.63 10.27 Favored 'General case' 0 C--N 1.298 -1.667 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.6 -175.417 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 42.9 t-80 -52.92 139.45 27.42 Favored 'General case' 0 C--O 1.242 0.697 0 CA-C-N 115.14 -0.936 . . . . 0.0 109.274 173.159 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 69.0 8.28 6.75 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.753 0.821 . . . . 0.0 112.836 179.141 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -100.17 159.09 19.45 Favored Glycine 0 N--CA 1.436 -1.332 0 C-N-CA 120.68 -0.772 . . . . 0.0 111.501 178.283 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.52 ' HA ' ' O ' ' A' ' 33' ' ' SER . 53.7 tt0 -80.7 112.56 18.18 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 179.033 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.685 ' O ' ' HA ' ' A' ' 17' ' ' THR . 25.4 p -91.33 -38.29 12.72 Favored 'General case' 0 C--N 1.293 -1.856 0 N-CA-C 113.304 0.853 . . . . 0.0 113.304 -174.808 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 177.79 85.1 0.06 OUTLIER Glycine 0 CA--C 1.484 -1.851 0 C-N-CA 117.85 -2.119 . . . . 0.0 113.868 -176.754 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.465 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -112.55 176.28 17.6 Favored Glycine 0 C--N 1.285 -2.29 0 N-CA-C 108.469 -1.852 . . . . 0.0 108.469 174.573 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 78.3 mt -61.62 118.82 4.52 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.042 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 176.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 110.38 -5.77 30.02 Favored Glycine 0 N--CA 1.432 -1.608 0 C-N-CA 120.845 -0.693 . . . . 0.0 111.675 -178.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 65.2 t80 -114.0 108.28 16.81 Favored 'General case' 0 C--N 1.311 -1.089 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 178.232 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 21.9 p -109.61 15.65 22.72 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.658 -177.467 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -88.23 -154.67 28.16 Favored Glycine 0 N--CA 1.45 -0.423 0 CA-C-O 119.597 -0.557 . . . . 0.0 112.32 -179.688 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_endo -62.0 109.79 0.88 Allowed 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 122.882 2.388 . . . . 0.0 111.232 177.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.685 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 7.7 p -95.04 -6.46 42.13 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 114.215 1.191 . . . . 0.0 114.215 -173.267 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 7.6 p -95.71 134.76 32.05 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.371 0 O-C-N 121.973 -0.454 . . . . 0.0 109.98 179.43 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 46.9 m -91.37 168.87 11.25 Favored 'General case' 0 C--N 1.312 -1.051 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 -179.786 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.64 141.61 53.62 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 175.082 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 46.7 m -56.46 133.66 53.36 Favored 'General case' 0 N--CA 1.433 -1.314 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.255 -179.201 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 111.9 -13.17 26.96 Favored Glycine 0 C--N 1.296 -1.69 0 N-CA-C 109.86 -1.296 . . . . 0.0 109.86 -173.733 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 55.2 p -136.28 143.63 44.33 Favored 'General case' 0 C--O 1.248 1.004 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 174.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 21.3 p -111.35 138.08 48.29 Favored 'General case' 0 C--N 1.288 -2.098 0 CA-C-N 116.654 -0.248 . . . . 0.0 110.994 -179.212 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 46.4 t -72.3 99.0 2.3 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 176.458 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 74.8 mt-30 -108.06 129.29 55.15 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-O 121.223 0.535 . . . . 0.0 110.305 -179.234 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 58.3 t -78.05 107.6 10.21 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.371 0 CA-C-N 115.137 -0.938 . . . . 0.0 109.342 -179.77 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 83.6 mt -86.48 -72.33 0.51 Allowed 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 82.2 m-20 -94.84 165.17 17.69 Favored Pre-proline 0 C--N 1.292 -1.892 0 N-CA-C 105.789 -1.93 . . . . 0.0 105.789 174.769 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -60.95 -33.6 92.12 Favored 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 121.617 1.544 . . . . 0.0 111.316 179.087 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.465 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 76.1 m-85 -100.11 -26.3 14.0 Favored 'General case' 0 C--N 1.311 -1.079 0 C-N-CA 120.396 -0.522 . . . . 0.0 111.199 -177.787 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 53.6 t80 -106.28 113.82 27.57 Favored 'General case' 0 C--N 1.311 -1.078 0 C-N-CA 120.723 -0.391 . . . . 0.0 111.946 -179.341 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.52 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 20.0 m -121.69 141.09 51.5 Favored 'General case' 0 C--N 1.288 -2.087 0 N-CA-C 106.545 -1.65 . . . . 0.0 106.545 175.353 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 29.0 tt0 -133.43 145.96 50.75 Favored 'General case' 0 C--N 1.3 -1.579 0 C-N-CA 120.092 -0.643 . . . . 0.0 111.376 -172.215 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.658 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 57.2 m -75.77 110.6 10.32 Favored 'General case' 0 C--O 1.252 1.228 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.014 177.483 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 84.7 mt . . . . . 0 C--N 1.302 -1.462 0 CA-C-N 115.042 -0.981 . . . . 0.0 109.503 -177.442 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' MAN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 3.9 m . . . . . 0 N--CA 1.436 -1.135 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -115.2 152.68 32.22 Favored 'General case' 0 N--CA 1.429 -1.519 0 N-CA-C 106.301 -1.74 . . . . 0.0 106.301 172.512 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 23.2 t -127.49 -177.61 4.15 Favored 'General case' 0 C--N 1.293 -1.866 0 C-N-CA 119.991 -0.684 . . . . 0.0 110.266 -176.635 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 41.6 t-80 -49.99 132.83 23.07 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 124.113 0.965 . . . . 0.0 110.93 -179.575 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 75.6 6.15 3.98 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 124.824 1.25 . . . . 0.0 112.294 178.652 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -98.8 155.92 20.11 Favored Glycine 0 N--CA 1.433 -1.528 0 N-CA-C 110.441 -1.064 . . . . 0.0 110.441 175.653 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.442 ' HA ' ' O ' ' A' ' 33' ' ' SER . 51.6 tt0 -81.23 116.53 21.15 Favored 'General case' 0 N--CA 1.438 -1.039 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 179.824 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.728 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 10.8 p -91.08 -22.02 20.93 Favored 'General case' 0 C--N 1.292 -1.904 0 N-CA-C 113.261 0.837 . . . . 0.0 113.261 -175.102 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 157.45 90.54 0.08 OUTLIER Glycine 0 CA--C 1.473 -2.592 0 C-N-CA 117.203 -2.427 . . . . 0.0 113.818 -179.108 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.648 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -113.11 179.41 19.08 Favored Glycine 0 C--N 1.275 -2.843 0 N-CA-C 108.076 -2.01 . . . . 0.0 108.076 173.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.431 ' HB ' ' CD1' ' A' ' 31' ' ' TYR . 56.5 mt -64.67 112.22 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 178.623 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 113.41 -4.37 24.96 Favored Glycine 0 N--CA 1.441 -1.027 0 C-N-CA 121.1 -0.572 . . . . 0.0 112.036 -179.399 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 72.9 t80 -101.42 129.29 47.41 Favored 'General case' 0 C--N 1.31 -1.129 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 3.7 p -129.12 5.76 5.35 Favored 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 112.751 0.649 . . . . 0.0 112.751 -177.39 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -81.49 -149.69 7.17 Favored Glycine 0 CA--C 1.533 1.21 0 C-N-CA 121.171 -0.538 . . . . 0.0 112.04 177.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_endo -63.02 111.43 1.39 Allowed 'Trans proline' 0 C--N 1.357 1.007 0 C-N-CA 122.538 2.159 . . . . 0.0 112.225 179.102 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.653 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 3.1 p -93.71 -16.09 24.59 Favored 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 113.166 0.802 . . . . 0.0 113.166 -176.238 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 8.2 p -90.48 128.1 42.57 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 CA-C-O 121.001 0.429 . . . . 0.0 110.402 -179.74 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 69.8 m -86.75 153.24 21.85 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 177.559 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -59.57 127.42 31.93 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 174.566 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 35.3 m -53.67 130.56 36.8 Favored 'General case' 0 C--O 1.246 0.909 0 CA-C-O 121.319 0.581 . . . . 0.0 110.973 -177.717 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 113.18 -21.21 18.1 Favored Glycine 0 N--CA 1.434 -1.464 0 N-CA-C 109.263 -1.535 . . . . 0.0 109.263 -170.591 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 70.6 p -117.57 143.34 46.2 Favored 'General case' 0 N--CA 1.443 -0.783 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 172.405 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 34.1 p -112.55 144.07 42.64 Favored 'General case' 0 C--N 1.295 -1.782 0 CA-C-O 120.71 0.29 . . . . 0.0 111.007 -177.034 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 50.9 t -78.83 98.51 6.35 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 178.54 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 75.3 mt-30 -103.74 127.69 51.19 Favored 'General case' 0 N--CA 1.431 -1.379 0 CA-C-O 120.996 0.427 . . . . 0.0 110.031 -177.713 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 60.0 t -78.37 114.04 18.45 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 179.463 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 74.2 mt -94.16 -70.38 0.71 Allowed 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 -178.692 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 77.6 m-20 -94.94 164.08 20.39 Favored Pre-proline 0 C--N 1.299 -1.612 0 N-CA-C 106.608 -1.627 . . . . 0.0 106.608 175.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -57.1 -35.33 98.88 Favored 'Trans proline' 0 CA--C 1.538 0.679 0 C-N-CA 121.886 1.724 . . . . 0.0 112.586 -179.029 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.648 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 50.5 m-85 -103.89 -21.07 13.7 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.991 -178.849 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 24.1 t80 -104.44 113.3 26.78 Favored 'General case' 0 C--N 1.316 -0.859 0 C-N-CA 119.87 -0.732 . . . . 0.0 111.24 -178.736 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.442 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 16.9 m -116.93 135.71 53.51 Favored 'General case' 0 C--N 1.289 -2.064 0 N-CA-C 106.068 -1.827 . . . . 0.0 106.068 175.648 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 28.7 tt0 -129.92 144.72 51.47 Favored 'General case' 0 C--N 1.299 -1.621 0 CA-C-N 118.111 0.414 . . . . 0.0 110.832 -172.068 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.728 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 61.7 m -76.46 116.84 17.52 Favored 'General case' 0 C--O 1.259 1.592 0 CA-C-O 121.17 0.51 . . . . 0.0 110.154 177.479 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 94.5 mt . . . . . 0 C--N 1.298 -1.666 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 177.582 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' MAN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 6.8 m . . . . . 0 N--CA 1.441 -0.899 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -82.26 142.05 32.44 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' SER . . . . . 0.426 ' O ' ' HB2' ' A' ' 35' ' ' CYS . 19.6 p -95.05 -178.13 4.38 Favored 'General case' 0 C--N 1.29 -2.013 0 C-N-CA 123.134 0.574 . . . . 0.0 111.54 -174.479 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 51.0 t-80 -64.55 123.59 19.65 Favored 'General case' 0 N--CA 1.445 -0.694 0 N-CA-C 108.023 -1.102 . . . . 0.0 108.023 176.718 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 65.03 83.95 0.16 Allowed 'General case' 0 C--N 1.319 -0.727 0 O-C-N 124.446 1.092 . . . . 0.0 111.453 -175.819 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.493 ' O ' ' HA ' ' A' ' 34' ' ' GLN . . . -167.38 159.13 32.36 Favored Glycine 0 N--CA 1.424 -2.138 0 N-CA-C 106.916 -2.474 . . . . 0.0 106.916 179.398 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.596 ' HA ' ' O ' ' A' ' 33' ' ' SER . 53.3 tt0 -82.36 110.36 17.44 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 118.281 1.04 . . . . 0.0 110.049 -179.19 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.712 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 1.8 p -86.1 -47.81 9.18 Favored 'General case' 0 C--N 1.295 -1.793 0 N-CA-C 113.237 0.829 . . . . 0.0 113.237 -177.79 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -174.22 89.16 0.08 OUTLIER Glycine 0 CA--C 1.486 -1.73 0 C-N-CA 117.716 -2.183 . . . . 0.0 114.07 -175.669 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.51 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -112.87 178.38 18.75 Favored Glycine 0 C--N 1.286 -2.213 0 N-CA-C 107.673 -2.171 . . . . 0.0 107.673 173.616 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 67.6 mt -61.58 118.44 4.08 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-N 118.239 1.019 . . . . 0.0 108.83 177.037 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 110.26 -14.85 30.64 Favored Glycine 0 N--CA 1.443 -0.897 0 C-N-CA 120.767 -0.73 . . . . 0.0 111.841 -178.852 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 25.7 t80 -114.09 121.47 43.92 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 -179.574 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 13.7 p -134.96 18.28 3.48 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-O 121.282 0.563 . . . . 0.0 111.545 -179.496 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -78.6 -128.61 0.53 Allowed Glycine 0 CA--C 1.521 0.414 0 CA-C-N 115.311 -0.859 . . . . 0.0 111.065 176.844 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -67.04 88.37 0.3 Allowed 'Trans proline' 0 CA--C 1.536 0.576 0 C-N-CA 122.201 1.934 . . . . 0.0 111.95 176.549 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.623 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 39.2 p -86.73 0.15 55.21 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.651 0.739 . . . . 0.0 110.756 -179.625 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 7.6 p -102.27 129.74 53.23 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.579 0 CA-C-N 114.89 -1.05 . . . . 0.0 108.82 178.663 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.456 ' SG ' ' HB2' ' A' ' 25' ' ' CYS . 71.4 m -92.64 153.64 18.86 Favored 'General case' 0 C--N 1.293 -1.886 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.67 -179.703 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -56.51 133.01 53.05 Favored 'General case' 0 C--O 1.249 1.039 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 174.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 9.2 p -53.97 127.51 26.63 Favored 'General case' 0 C--O 1.249 1.073 0 CA-C-O 121.528 0.68 . . . . 0.0 112.294 -177.149 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 112.43 -9.49 26.38 Favored Glycine 0 N--CA 1.431 -1.687 0 CA-C-N 114.843 -1.071 . . . . 0.0 110.784 -175.493 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 67.1 p -127.39 145.73 50.71 Favored 'General case' 0 C--O 1.246 0.899 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 176.477 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 23.6 p -111.3 140.14 46.12 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-O 120.381 0.134 . . . . 0.0 111.178 -178.337 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.456 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 53.6 t -73.31 103.07 3.87 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 179.094 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 16.7 mm-40 -91.12 113.48 25.76 Favored 'General case' 0 N--CA 1.425 -1.695 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.024 -179.005 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 45.5 t -76.19 101.36 2.59 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.114 0 N-CA-C 107.142 -1.429 . . . . 0.0 107.142 176.698 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 77.3 mt -86.87 -69.93 0.64 Allowed 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 -177.661 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 79.1 m-20 -95.74 165.31 16.82 Favored Pre-proline 0 C--N 1.298 -1.668 0 N-CA-C 107.038 -1.467 . . . . 0.0 107.038 174.727 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_exo -60.91 -29.98 89.11 Favored 'Trans proline' 0 CA--C 1.542 0.884 0 C-N-CA 121.499 1.466 . . . . 0.0 111.658 178.428 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.51 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 87.8 m-85 -101.77 -25.54 13.8 Favored 'General case' 0 N--CA 1.44 -0.969 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.553 -179.839 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 68.2 t80 -106.05 114.8 29.16 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 113.008 0.744 . . . . 0.0 113.008 -178.538 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.596 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 23.8 m -121.18 136.59 54.95 Favored 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 175.711 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.493 ' HA ' ' O ' ' A' ' 6' ' ' GLY . 35.2 tt0 -127.59 133.24 49.73 Favored 'General case' 0 C--N 1.318 -0.762 0 C-N-CA 122.202 0.201 . . . . 0.0 110.763 -173.253 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.712 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 64.1 m -74.01 109.03 7.18 Favored 'General case' 0 C--O 1.243 0.739 0 CA-C-O 120.972 0.415 . . . . 0.0 111.756 177.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 96.6 mt . . . . . 0 C--N 1.299 -1.591 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 178.689 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' MAN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 8.1 t . . . . . 0 C--O 1.242 0.665 0 N-CA-C 107.467 -1.308 . . . . 0.0 107.467 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -93.61 135.94 34.38 Favored 'General case' 0 N--CA 1.416 -2.133 0 C-N-CA 119.815 -0.754 . . . . 0.0 109.045 178.217 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 61.3 p -91.99 173.9 7.6 Favored 'General case' 0 C--N 1.282 -2.332 0 CA-C-N 114.857 -1.065 . . . . 0.0 110.146 -175.027 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 55.2 t-80 -57.54 134.23 55.94 Favored 'General case' 0 C--N 1.315 -0.905 0 C-N-CA 123.453 0.701 . . . . 0.0 110.107 177.183 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 70.51 10.42 7.16 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.646 1.178 . . . . 0.0 112.908 178.169 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.517 ' O ' ' HA ' ' A' ' 34' ' ' GLN . . . -97.62 155.8 20.56 Favored Glycine 0 N--CA 1.438 -1.2 0 N-CA-C 110.726 -0.95 . . . . 0.0 110.726 176.175 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.628 ' HA ' ' O ' ' A' ' 33' ' ' SER . 64.4 tt0 -70.25 110.51 5.27 Favored 'General case' 0 C--O 1.217 -0.608 0 CA-C-N 117.14 0.47 . . . . 0.0 109.931 -178.958 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.733 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 21.1 p -93.13 -31.68 14.71 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 113.565 0.95 . . . . 0.0 113.565 -175.764 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 179.84 84.36 0.06 OUTLIER Glycine 0 CA--C 1.483 -1.932 0 C-N-CA 117.574 -2.251 . . . . 0.0 113.786 -174.673 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.56 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -112.44 167.2 12.3 Favored Glycine 0 C--N 1.286 -2.24 0 N-CA-C 108.748 -1.741 . . . . 0.0 108.748 174.81 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 79.7 mt -60.78 117.53 2.66 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 177.532 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 105.37 -8.75 44.79 Favored Glycine 0 N--CA 1.442 -0.965 0 C-N-CA 120.373 -0.918 . . . . 0.0 111.804 179.734 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 90.4 t80 -94.74 108.85 20.85 Favored 'General case' 0 N--CA 1.44 -0.932 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 178.06 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 3.3 p -103.87 7.71 36.9 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-N 114.806 -1.088 . . . . 0.0 111.743 -176.741 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -81.05 -163.3 30.08 Favored Glycine 0 N--CA 1.445 -0.737 0 C-N-CA 121.084 -0.579 . . . . 0.0 112.361 -179.28 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_endo -62.16 118.25 5.13 Favored 'Trans proline' 0 C--O 1.235 0.342 0 C-N-CA 122.834 2.356 . . . . 0.0 110.754 177.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.568 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 10.2 p -99.71 -14.89 18.71 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 -174.639 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 13.6 p -79.48 137.66 21.33 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 C-N-CA 120.594 -0.442 . . . . 0.0 110.004 179.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 71.2 m -97.31 153.08 18.28 Favored 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 179.544 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.53 155.67 21.48 Favored 'General case' 0 C--O 1.251 1.159 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.238 178.107 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 4.9 p -58.3 118.55 5.64 Favored 'General case' 0 C--N 1.307 -1.254 0 C-N-CA 123.429 0.692 . . . . 0.0 111.383 -179.328 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 111.92 -11.33 27.26 Favored Glycine 0 N--CA 1.441 -0.982 0 C-N-CA 120.926 -0.654 . . . . 0.0 111.641 -178.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 76.7 p -120.22 151.78 38.65 Favored 'General case' 0 C--O 1.256 1.412 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 178.058 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.407 ' O ' ' HA ' ' A' ' 35' ' ' CYS . 16.9 p -121.87 148.83 44.21 Favored 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 110.278 -0.268 . . . . 0.0 110.278 176.478 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 49.4 t -77.47 103.88 7.66 Favored 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 179.679 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 12.7 mm-40 -98.44 117.83 33.74 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 116.052 -0.522 . . . . 0.0 109.951 -178.382 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 41.2 t -87.06 105.71 15.33 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 -178.715 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 69.1 mt -89.68 -69.46 0.72 Allowed 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 -178.168 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 48.7 m-80 -95.19 170.34 8.02 Favored Pre-proline 0 C--N 1.301 -1.522 0 N-CA-C 107.038 -1.468 . . . . 0.0 107.038 176.148 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_exo -65.97 -30.15 48.49 Favored 'Trans proline' 0 C--N 1.345 0.349 0 CA-C-N 120.57 1.239 . . . . 0.0 111.875 177.072 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.56 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 28.5 m-85 -106.43 -25.59 11.81 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 119.779 -0.768 . . . . 0.0 110.585 -177.875 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 60.4 t80 -104.76 115.3 30.07 Favored 'General case' 0 N--CA 1.443 -0.807 0 C-N-CA 119.893 -0.723 . . . . 0.0 112.563 177.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.628 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 14.5 m -131.65 141.14 49.54 Favored 'General case' 0 C--N 1.293 -1.861 0 N-CA-C 105.993 -1.854 . . . . 0.0 105.993 176.272 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.517 ' HA ' ' O ' ' A' ' 6' ' ' GLY . 4.1 pt20 -132.82 151.1 52.08 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 119.084 0.857 . . . . 0.0 111.882 -178.172 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.733 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 61.2 m -76.55 118.41 19.18 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-O 121.218 0.533 . . . . 0.0 110.517 178.082 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 97.0 mt . . . . . 0 C--N 1.303 -1.453 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 178.525 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' MAN . . . . . 0.442 ' O6 ' ' H1 ' ' A' ' 101' ' ' MAN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 20.0 m . . . . . 0 N--CA 1.445 -0.676 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -79.92 131.72 35.9 Favored 'General case' 0 N--CA 1.44 -0.97 0 N-CA-C 107.429 -1.323 . . . . 0.0 107.429 178.847 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 22.7 t -110.03 -168.52 1.33 Allowed 'General case' 0 C--N 1.29 -1.987 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 -176.409 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 25.2 t-80 -56.18 126.46 26.21 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 123.249 0.62 . . . . 0.0 110.182 -178.587 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 69.57 76.94 0.22 Allowed 'General case' 0 C--N 1.328 -0.339 0 O-C-N 124.604 1.19 . . . . 0.0 111.424 -178.41 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.557 ' O ' ' HA ' ' A' ' 34' ' ' GLN . . . -169.55 155.55 25.75 Favored Glycine 0 N--CA 1.433 -1.527 0 N-CA-C 108.699 -1.761 . . . . 0.0 108.699 179.175 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.675 ' HA ' ' O ' ' A' ' 33' ' ' SER . 53.2 tt0 -77.64 107.24 9.98 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 117.591 0.696 . . . . 0.0 110.329 -178.268 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.786 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 6.1 p -87.82 -41.9 12.94 Favored 'General case' 0 C--N 1.297 -1.709 0 CA-C-N 115.395 -0.82 . . . . 0.0 113.133 -176.613 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -161.96 53.99 0.31 Allowed Glycine 0 CA--C 1.471 -2.687 0 C-N-CA 118.956 -1.592 . . . . 0.0 111.687 -173.685 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.435 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -95.69 149.68 19.41 Favored Glycine 0 N--CA 1.423 -2.202 0 N-CA-C 108.442 -1.863 . . . . 0.0 108.442 175.692 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.428 ' HB ' ' CD1' ' A' ' 31' ' ' TYR . 61.4 mt -57.97 121.03 4.76 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.913 0 CA-C-N 117.315 0.558 . . . . 0.0 110.443 -178.299 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 109.59 4.26 30.3 Favored Glycine 0 N--CA 1.445 -0.713 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.985 -179.114 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.437 ' HB2' ' NE2' ' A' ' 7' ' ' GLN . 70.0 t80 -103.54 119.94 39.88 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 177.929 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 14.3 p -99.64 1.17 43.32 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 112.397 0.517 . . . . 0.0 112.397 -177.157 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -85.68 -175.8 50.2 Favored Glycine 0 N--CA 1.444 -0.822 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.329 -179.266 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -66.16 130.41 24.08 Favored 'Trans proline' 0 CA--C 1.533 0.454 0 C-N-CA 122.759 2.306 . . . . 0.0 111.616 -179.535 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.566 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 37.1 p -88.04 10.29 19.58 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-O 121.626 0.727 . . . . 0.0 111.679 -177.911 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 7.1 p -94.19 123.41 46.29 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.496 0 CA-C-O 121.567 0.699 . . . . 0.0 110.82 -178.372 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 83.7 m -88.56 160.12 17.59 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-N 115.112 -0.949 . . . . 0.0 109.154 177.064 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -72.17 146.15 47.59 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 176.751 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 67.9 m -53.1 130.27 33.59 Favored 'General case' 0 C--O 1.25 1.1 0 CA-C-O 121.092 0.472 . . . . 0.0 110.211 176.763 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 112.18 -16.81 24.75 Favored Glycine 0 N--CA 1.43 -1.722 0 N-CA-C 110.781 -0.928 . . . . 0.0 110.781 -173.593 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 41.4 p -133.2 144.78 50.04 Favored 'General case' 0 N--CA 1.443 -0.818 0 CA-C-O 120.819 0.342 . . . . 0.0 111.327 179.577 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 23.3 p -116.77 152.32 34.62 Favored 'General case' 0 C--N 1.309 -1.161 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 177.778 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 44.8 t -77.53 111.44 13.27 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 -179.422 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 70.3 mt-30 -110.9 127.93 55.63 Favored 'General case' 0 N--CA 1.434 -1.238 0 CA-C-O 121.331 0.586 . . . . 0.0 110.273 -179.656 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 58.8 t -81.01 110.75 16.84 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.723 -178.141 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 75.4 mt -90.02 -72.65 0.55 Allowed 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 107.01 -1.478 . . . . 0.0 107.01 177.314 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 54.8 m-80 -95.79 164.29 19.13 Favored Pre-proline 0 C--N 1.298 -1.66 0 N-CA-C 106.785 -1.561 . . . . 0.0 106.785 170.536 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_exo -63.56 -33.45 67.82 Favored 'Trans proline' 0 C--O 1.241 0.637 0 C-N-CA 121.64 1.56 . . . . 0.0 111.26 176.374 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.435 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 76.8 m-85 -97.17 -26.38 14.97 Favored 'General case' 0 N--CA 1.442 -0.83 0 C-N-CA 119.633 -0.827 . . . . 0.0 110.819 -179.689 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 53.1 t80 -106.21 113.01 26.29 Favored 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 119.436 -0.906 . . . . 0.0 110.956 175.397 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.675 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 20.0 m -123.98 140.92 52.5 Favored 'General case' 0 C--N 1.288 -2.103 0 N-CA-C 106.616 -1.624 . . . . 0.0 106.616 177.393 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.557 ' HA ' ' O ' ' A' ' 6' ' ' GLY . 28.6 tt0 -129.89 140.57 50.94 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 -169.493 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.786 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 73.7 m -71.41 116.85 12.22 Favored 'General case' 0 C--O 1.258 1.522 0 CA-C-O 121.147 0.499 . . . . 0.0 110.544 175.303 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 95.5 mt . . . . . 0 C--N 1.303 -1.424 0 C-N-CA 125.156 1.382 . . . . 0.0 107.949 179.515 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' MAN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 28.9 m . . . . . 0 N--CA 1.444 -0.749 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 5.6 tp-100 -80.37 144.15 32.94 Favored 'General case' 0 N--CA 1.442 -0.839 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 -177.31 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 62.4 m -126.16 -173.22 2.8 Favored 'General case' 0 C--N 1.297 -1.715 0 C-N-CA 120.176 -0.61 . . . . 0.0 111.923 -177.181 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . 0.578 ' HA ' ' O ' ' A' ' 35' ' ' CYS . 57.6 t-80 -54.29 132.27 43.41 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 123.055 0.542 . . . . 0.0 110.326 -178.702 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.49 ' HA ' ' OE1' ' A' ' 34' ' ' GLN . . . 81.16 1.61 1.66 Allowed 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 125.251 1.42 . . . . 0.0 112.195 -178.423 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -98.91 153.22 19.79 Favored Glycine 0 N--CA 1.433 -1.54 0 N-CA-C 110.766 -0.934 . . . . 0.0 110.766 177.061 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.444 ' HA ' ' O ' ' A' ' 33' ' ' SER . 49.7 tt0 -82.17 111.5 18.34 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 179.856 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.757 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 14.6 p -83.45 -14.36 52.69 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.783 -178.025 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 122.94 115.24 2.23 Favored Glycine 0 N--CA 1.416 -2.674 0 C-N-CA 117.574 -2.25 . . . . 0.0 116.279 173.424 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -112.38 -153.59 11.93 Favored Glycine 0 N--CA 1.418 -2.555 0 N-CA-C 107.063 -2.415 . . . . 0.0 107.063 171.503 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 78.9 mt -64.29 124.18 18.57 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.679 0 CA-C-N 117.756 0.778 . . . . 0.0 110.493 177.836 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 95.9 6.87 59.04 Favored Glycine 0 N--CA 1.442 -0.956 0 CA-C-N 115.998 -0.546 . . . . 0.0 113.741 176.438 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 49.4 t80 -109.25 127.55 54.34 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 -179.712 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 6.7 p -128.83 15.7 6.37 Favored 'General case' 0 C--N 1.303 -1.434 0 CA-C-O 121.505 0.669 . . . . 0.0 111.144 -177.397 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -84.42 -143.83 6.16 Favored Glycine 0 C--O 1.248 0.981 0 N-CA-C 111.449 -0.66 . . . . 0.0 111.449 178.216 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -73.01 103.53 1.61 Allowed 'Trans proline' 0 N--CA 1.448 -1.154 0 C-N-CA 122.227 1.951 . . . . 0.0 111.395 177.769 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.51 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 32.8 p -94.46 -7.68 40.73 Favored 'General case' 0 N--CA 1.434 -1.234 0 CA-C-O 121.669 0.747 . . . . 0.0 110.816 -178.474 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 7.4 p -82.31 123.64 38.46 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.805 0 CA-C-N 115.239 -0.891 . . . . 0.0 110.732 178.051 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 78.4 m -90.44 148.88 22.5 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 109.481 -0.562 . . . . 0.0 109.481 176.395 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.53 150.9 17.89 Favored 'General case' 0 C--O 1.251 1.169 0 O-C-N 123.774 0.671 . . . . 0.0 110.449 177.381 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 8.9 t -59.41 115.87 3.56 Favored 'General case' 0 N--CA 1.433 -1.297 0 CA-C-N 115.663 -0.698 . . . . 0.0 109.491 -177.577 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 111.91 -5.69 27.41 Favored Glycine 0 N--CA 1.437 -1.237 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.077 -178.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 60.3 p -121.43 147.02 46.29 Favored 'General case' 0 C--N 1.312 -1.06 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 175.36 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 26.5 p -117.84 141.48 48.37 Favored 'General case' 0 C--N 1.304 -1.41 0 C-N-CA 121.26 -0.176 . . . . 0.0 110.586 -178.836 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 48.4 t -72.66 103.8 3.71 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 85.3 mm-40 -98.26 112.26 24.31 Favored 'General case' 0 N--CA 1.415 -2.186 0 CA-C-O 121.264 0.554 . . . . 0.0 110.24 -179.225 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 41.4 t -80.39 96.51 2.75 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.588 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 179.732 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 87.1 mt -80.9 -69.98 0.56 Allowed 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 -177.828 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 47.7 m-80 -94.27 164.55 19.87 Favored Pre-proline 0 C--N 1.298 -1.649 0 N-CA-C 106.449 -1.685 . . . . 0.0 106.449 175.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -59.77 -33.1 96.38 Favored 'Trans proline' 0 N--CA 1.475 0.42 0 C-N-CA 121.655 1.57 . . . . 0.0 111.669 178.781 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -100.27 -25.36 14.27 Favored 'General case' 0 N--CA 1.441 -0.915 0 C-N-CA 120.077 -0.649 . . . . 0.0 111.206 179.606 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 80.2 t80 -105.05 114.42 28.61 Favored 'General case' 0 C--N 1.309 -1.191 0 C-N-CA 119.798 -0.761 . . . . 0.0 112.673 -176.782 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.444 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 24.0 m -125.58 137.3 53.9 Favored 'General case' 0 C--N 1.284 -2.257 0 N-CA-C 106.858 -1.534 . . . . 0.0 106.858 178.114 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.49 ' OE1' ' HA ' ' A' ' 5' ' ' ALA . 8.0 tt0 -128.53 142.04 51.19 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 109.956 -0.386 . . . . 0.0 109.956 -175.943 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.757 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 75.2 m -75.06 110.74 9.63 Favored 'General case' 0 C--O 1.249 1.037 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 175.806 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 96.6 mt . . . . . 0 N--CA 1.423 -1.801 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 179.08 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' MAN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 15.9 p . . . . . 0 N--CA 1.442 -0.849 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.744 ' OE1' ' H3 ' ' A' ' 101' ' ' MAN . 6.3 tp-100 -79.7 135.85 36.64 Favored 'General case' 0 N--CA 1.434 -1.269 0 C-N-CA 119.804 -0.759 . . . . 0.0 110.255 -178.425 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 18.3 p -88.01 166.89 14.15 Favored 'General case' 0 C--N 1.285 -2.2 0 CA-C-N 115.243 -0.889 . . . . 0.0 111.575 -174.555 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 56.6 t-80 -57.82 136.75 57.01 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 107.675 -1.232 . . . . 0.0 107.675 172.63 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.408 ' HA ' ' CD ' ' A' ' 34' ' ' GLN . . . 73.2 12.56 4.88 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.396 0.678 . . . . 0.0 112.665 -179.935 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.426 ' O ' ' HA ' ' A' ' 34' ' ' GLN . . . -107.58 164.42 13.0 Favored Glycine 0 C--O 1.243 0.715 0 N-CA-C 110.478 -1.049 . . . . 0.0 110.478 175.364 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.574 ' HA ' ' O ' ' A' ' 33' ' ' SER . 54.1 tt0 -84.55 107.05 16.57 Favored 'General case' 0 C--O 1.224 -0.251 0 CA-C-N 117.395 0.598 . . . . 0.0 110.894 -177.839 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.792 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 12.3 p -84.34 -37.79 21.16 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 113.705 1.002 . . . . 0.0 113.705 -175.565 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -177.43 87.81 0.07 OUTLIER Glycine 0 CA--C 1.481 -2.04 0 C-N-CA 117.96 -2.067 . . . . 0.0 113.24 -176.291 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.549 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -112.42 172.9 14.96 Favored Glycine 0 C--N 1.28 -2.548 0 N-CA-C 107.921 -2.072 . . . . 0.0 107.921 174.867 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 68.8 mt -63.07 118.0 4.64 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.208 0 CA-C-N 117.861 0.83 . . . . 0.0 109.353 178.785 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 105.73 6.21 38.07 Favored Glycine 0 C--N 1.312 -0.799 0 C-N-CA 120.421 -0.895 . . . . 0.0 112.386 178.73 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 85.2 t80 -102.47 118.48 36.97 Favored 'General case' 0 C--N 1.307 -1.262 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 178.532 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 14.3 p -109.36 0.38 19.44 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-O 121.271 0.558 . . . . 0.0 111.513 -177.703 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -77.92 -171.64 37.77 Favored Glycine 0 N--CA 1.443 -0.841 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.918 178.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_endo -64.37 119.24 6.22 Favored 'Trans proline' 0 C--O 1.237 0.454 0 C-N-CA 122.481 2.121 . . . . 0.0 111.291 178.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.566 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 70.1 p -90.71 -8.32 50.17 Favored 'General case' 0 C--O 1.24 0.558 0 CA-C-O 121.41 0.624 . . . . 0.0 111.211 -176.873 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 5.6 p -80.07 126.41 39.36 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.185 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.334 179.411 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 83.9 m -87.78 163.46 16.46 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.253 -179.017 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.29 150.89 45.16 Favored 'General case' 0 C--O 1.254 1.323 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 175.49 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 35.6 t -57.76 126.01 25.51 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-O 121.503 0.668 . . . . 0.0 110.572 -175.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 112.32 -21.11 20.25 Favored Glycine 0 N--CA 1.43 -1.766 0 CA-C-N 115.172 -0.922 . . . . 0.0 111.62 -178.412 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 50.7 p -116.02 147.09 41.6 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 120.765 -0.374 . . . . 0.0 110.384 179.569 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.405 ' O ' ' HA ' ' A' ' 35' ' ' CYS . 21.7 p -120.23 155.39 33.29 Favored 'General case' 0 C--N 1.298 -1.656 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.767 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 48.5 t -80.23 102.95 9.78 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-O 121.143 0.497 . . . . 0.0 110.433 -178.833 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 9.1 mm-40 -100.87 122.29 43.18 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 -179.166 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 57.6 t -79.84 114.8 21.21 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.715 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 -179.083 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 86.4 mt -98.25 -70.04 0.74 Allowed 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 179.192 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 -94.07 166.11 16.3 Favored Pre-proline 0 C--N 1.304 -1.373 0 N-CA-C 105.986 -1.857 . . . . 0.0 105.986 174.225 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -64.49 -26.6 62.41 Favored 'Trans proline' 0 CA--C 1.538 0.691 0 C-N-CA 121.255 1.303 . . . . 0.0 111.341 177.277 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.549 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 70.1 m-85 -107.16 -26.34 11.14 Favored 'General case' 0 N--CA 1.443 -0.777 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.121 -178.935 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 67.6 t80 -105.73 113.84 27.64 Favored 'General case' 0 C--N 1.304 -1.383 0 C-N-CA 119.627 -0.829 . . . . 0.0 110.978 178.418 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.574 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 21.3 m -121.72 140.92 51.7 Favored 'General case' 0 C--N 1.279 -2.494 0 N-CA-C 105.616 -1.994 . . . . 0.0 105.616 175.088 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.449 ' OE1' HD21 ' A' ' 36' ' ' LEU . 35.9 tt0 -125.81 141.36 52.03 Favored 'General case' 0 C--N 1.29 -1.999 0 C-N-CA 120.874 -0.33 . . . . 0.0 110.766 -171.407 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.792 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 85.5 m -74.38 114.21 12.5 Favored 'General case' 0 C--O 1.252 1.187 0 CA-C-O 121.176 0.512 . . . . 0.0 109.982 176.247 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.449 HD21 ' OE1' ' A' ' 34' ' ' GLN . 95.5 mt . . . . . 0 N--CA 1.426 -1.639 0 CA-C-N 115.127 -0.942 . . . . 0.0 108.84 -179.382 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' MAN . . . . . 0.744 ' H3 ' ' OE1' ' A' ' 2' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 . . . . . 0 N--CA 1.426 -1.639 0 CA-C-O 121.377 0.608 . . . . 0.0 109.774 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 22.9 t -97.97 171.82 8.02 Favored 'General case' 0 C--N 1.282 -2.345 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.213 -173.885 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 41.8 t-80 -61.45 132.11 52.37 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 179.078 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' ALA . . . . . 0.47 ' HA ' ' OE1' ' A' ' 34' ' ' GLN . . . 83.71 0.28 1.04 Allowed 'General case' 0 N--CA 1.48 1.053 0 O-C-N 124.915 1.384 . . . . 0.0 113.011 -177.745 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.427 ' O ' ' HA ' ' A' ' 34' ' ' GLN . . . -96.66 160.25 21.79 Favored Glycine 0 C--O 1.245 0.809 0 C-N-CA 120.474 -0.87 . . . . 0.0 111.914 178.265 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.618 ' HA ' ' O ' ' A' ' 33' ' ' SER . 7.6 tt0 -81.72 104.42 12.1 Favored 'General case' 0 C--O 1.225 -0.235 0 CA-C-O 121.451 0.643 . . . . 0.0 110.851 -179.198 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.777 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 7.7 p -80.8 -41.91 22.56 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 114.384 1.253 . . . . 0.0 114.384 -174.729 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.43 ' H ' ' HB2' ' A' ' 33' ' ' SER . . . -176.03 81.22 0.07 OUTLIER Glycine 0 CA--C 1.477 -2.324 0 C-N-CA 117.547 -2.263 . . . . 0.0 113.674 -175.432 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.437 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -112.69 175.63 16.98 Favored Glycine 0 C--N 1.283 -2.399 0 N-CA-C 107.989 -2.045 . . . . 0.0 107.989 173.352 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.46 ' HB ' ' CD2' ' A' ' 31' ' ' TYR . 55.1 mt -65.54 133.75 30.39 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 175.853 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 103.86 -16.23 51.12 Favored Glycine 0 C--N 1.311 -0.834 0 N-CA-C 111.251 -0.74 . . . . 0.0 111.251 -177.479 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 67.1 t80 -100.94 109.62 21.58 Favored 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 179.747 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 11.4 p -101.63 1.31 37.59 Favored 'General case' 0 C--N 1.3 -1.557 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.314 -178.986 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -79.46 -178.76 51.55 Favored Glycine 0 N--CA 1.441 -1.023 0 CA-C-N 115.887 -0.597 . . . . 0.0 112.317 179.322 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -60.48 122.4 11.24 Favored 'Trans proline' 0 C--O 1.241 0.637 0 C-N-CA 123.194 2.596 . . . . 0.0 111.825 179.536 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.562 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 22.9 p -92.6 9.12 36.05 Favored 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 113.571 0.952 . . . . 0.0 113.571 -173.372 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 7.5 p -91.82 126.79 44.39 Favored 'Isoleucine or valine' 0 C--O 1.248 1.02 0 CA-C-O 121.39 0.614 . . . . 0.0 111.551 -178.117 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 71.2 m -84.26 161.48 20.47 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.847 178.139 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.33 154.46 42.0 Favored 'General case' 0 C--O 1.25 1.088 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.494 176.129 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 3.1 p -60.2 129.13 40.17 Favored 'General case' 0 N--CA 1.433 -1.302 0 CA-C-O 121.263 0.554 . . . . 0.0 111.458 -178.495 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 111.34 -17.67 26.12 Favored Glycine 0 N--CA 1.423 -2.216 0 N-CA-C 110.666 -0.974 . . . . 0.0 110.666 -177.659 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 77.6 p -123.03 153.29 40.03 Favored 'General case' 0 C--O 1.252 1.215 0 CA-C-O 120.828 0.346 . . . . 0.0 110.983 -178.536 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 34.2 p -119.79 149.56 41.85 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 178.33 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 44.9 t -75.49 105.37 6.49 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 177.828 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 84.0 mm-40 -100.64 110.82 22.98 Favored 'General case' 0 N--CA 1.415 -2.188 0 CA-C-O 121.718 0.77 . . . . 0.0 110.556 -179.355 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 63.9 t -77.73 121.52 30.57 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.089 0 CA-C-N 114.637 -1.165 . . . . 0.0 108.267 179.493 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 84.6 mt -104.26 -67.72 0.88 Allowed 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 107.324 -1.362 . . . . 0.0 107.324 179.229 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 48.7 m-80 -95.07 163.27 22.34 Favored Pre-proline 0 C--N 1.293 -1.891 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 173.893 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_exo -63.96 -30.61 67.1 Favored 'Trans proline' 0 CA--C 1.531 0.355 0 C-N-CA 121.204 1.27 . . . . 0.0 111.198 178.759 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.46 ' CD2' ' HB ' ' A' ' 11' ' ' ILE . 22.3 m-85 -100.31 -25.9 14.08 Favored 'General case' 0 N--CA 1.437 -1.118 0 C-N-CA 120.364 -0.534 . . . . 0.0 110.834 -179.415 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 75.8 t80 -105.96 114.13 28.09 Favored 'General case' 0 C--O 1.243 0.749 0 N-CA-C 112.6 0.592 . . . . 0.0 112.6 178.374 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.618 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 15.1 m -125.55 143.45 51.01 Favored 'General case' 0 C--N 1.293 -1.871 0 N-CA-C 106.631 -1.618 . . . . 0.0 106.631 176.34 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' GLN . . . . . 0.47 ' OE1' ' HA ' ' A' ' 5' ' ' ALA . 8.4 tt0 -132.08 141.23 49.12 Favored 'General case' 0 C--N 1.298 -1.671 0 CA-C-N 118.02 0.373 . . . . 0.0 110.464 -174.112 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.777 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 77.6 m -74.21 114.75 12.92 Favored 'General case' 0 C--O 1.253 1.245 0 C-N-CA 120.714 -0.394 . . . . 0.0 110.344 175.921 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 97.2 mt . . . . . 0 N--CA 1.428 -1.566 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 178.602 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 5.9 tp-100 . . . . . 0 N--CA 1.433 -1.324 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 53.3 m -107.61 -176.24 3.01 Favored 'General case' 0 C--N 1.302 -1.471 0 C-N-CA 120.505 -0.478 . . . . 0.0 111.266 -177.011 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 54.0 t60 -57.61 132.7 54.02 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 122.846 0.458 . . . . 0.0 109.957 -177.723 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' ALA . . . . . 0.467 ' HA ' ' NE2' ' A' ' 34' ' ' GLN . . . 80.15 -4.48 1.88 Allowed 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 125.557 1.543 . . . . 0.0 112.63 -179.253 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -85.68 146.54 21.55 Favored Glycine 0 N--CA 1.437 -1.285 0 C-N-CA 120.37 -0.919 . . . . 0.0 110.912 178.172 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.552 ' HA ' ' O ' ' A' ' 33' ' ' SER . 62.1 tt0 -62.95 108.68 1.25 Allowed 'General case' 0 C--O 1.22 -0.473 0 CA-C-O 121.148 0.499 . . . . 0.0 110.382 178.267 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.744 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 23.3 p -86.04 -43.39 13.16 Favored 'General case' 0 C--N 1.297 -1.678 0 CA-C-N 115.73 -0.668 . . . . 0.0 112.678 -174.806 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -179.03 86.34 0.07 OUTLIER Glycine 0 CA--C 1.473 -2.542 0 C-N-CA 118.188 -1.958 . . . . 0.0 113.326 -174.474 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.523 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -104.7 178.46 24.01 Favored Glycine 0 N--CA 1.42 -2.418 0 N-CA-C 108.736 -1.745 . . . . 0.0 108.736 175.033 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 64.9 mt -66.12 128.03 28.4 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.757 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 176.725 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 99.51 -17.28 57.89 Favored Glycine 0 N--CA 1.44 -1.035 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.043 -179.666 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 67.7 t80 -87.22 109.07 19.23 Favored 'General case' 0 C--N 1.312 -1.042 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 -178.567 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 37.0 p -99.23 2.31 45.54 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.481 -178.67 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -74.56 -178.31 39.83 Favored Glycine 0 N--CA 1.436 -1.312 0 CA-C-N 115.357 -0.838 . . . . 0.0 112.486 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_endo -62.38 121.46 9.45 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 122.605 2.203 . . . . 0.0 112.133 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.634 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 29.1 p -92.89 0.67 57.45 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.005 -179.703 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 7.8 p -78.64 110.22 14.14 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.11 0 CA-C-O 121.993 0.901 . . . . 0.0 111.664 -179.36 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 70.9 m -83.79 152.9 24.39 Favored 'General case' 0 C--N 1.302 -1.486 0 CA-C-N 115.115 -0.948 . . . . 0.0 109.644 177.732 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.4 145.33 33.06 Favored 'General case' 0 C--O 1.25 1.079 0 O-C-N 123.459 0.475 . . . . 0.0 110.229 176.533 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 19.3 m -52.83 119.36 4.51 Favored 'General case' 0 C--N 1.318 -0.79 0 O-C-N 123.757 0.661 . . . . 0.0 111.464 -178.012 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 111.88 -11.25 27.38 Favored Glycine 0 N--CA 1.439 -1.126 0 CA-C-N 115.832 -0.622 . . . . 0.0 112.255 -179.737 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 68.2 p -118.42 147.29 43.72 Favored 'General case' 0 C--O 1.244 0.789 0 N-CA-C 109.808 -0.441 . . . . 0.0 109.808 178.239 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 38.9 p -113.35 149.5 33.92 Favored 'General case' 0 C--N 1.309 -1.192 0 C-N-CA 121.223 -0.191 . . . . 0.0 110.751 -178.977 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 51.5 t -76.42 103.6 6.51 Favored 'General case' 0 C--N 1.312 -1.047 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 178.367 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 68.6 mt-30 -102.78 120.22 40.21 Favored 'General case' 0 N--CA 1.425 -1.679 0 CA-C-O 121.887 0.851 . . . . 0.0 111.363 -178.222 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 95.2 t -83.42 104.94 12.58 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 CA-C-N 114.385 -1.28 . . . . 0.0 109.829 -178.597 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 56.1 mt -85.48 -72.04 0.5 Allowed 'General case' 0 N--CA 1.433 -1.317 0 N-CA-C 107.748 -1.205 . . . . 0.0 107.748 178.599 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 47.7 m-80 -96.31 166.8 13.52 Favored Pre-proline 0 C--N 1.302 -1.468 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 174.321 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -58.78 -42.23 55.22 Favored 'Trans proline' 0 CA--C 1.538 0.696 0 C-N-CA 121.741 1.628 . . . . 0.0 112.336 177.835 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.523 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 49.0 m-85 -96.49 -25.96 15.47 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 120.029 -0.669 . . . . 0.0 110.562 -177.333 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 75.3 t80 -104.15 114.03 27.99 Favored 'General case' 0 N--CA 1.435 -1.196 0 C-N-CA 119.691 -0.804 . . . . 0.0 111.312 178.784 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.552 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 15.9 m -135.84 139.99 43.84 Favored 'General case' 0 C--N 1.283 -2.308 0 N-CA-C 105.501 -2.037 . . . . 0.0 105.501 178.883 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' GLN . . . . . 0.467 ' NE2' ' HA ' ' A' ' 5' ' ' ALA . 19.8 pt20 -135.82 153.83 51.38 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 118.853 0.751 . . . . 0.0 111.564 -175.789 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.744 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 63.7 m -72.58 117.0 13.72 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.527 178.438 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 96.5 mt . . . . . 0 C--N 1.289 -2.028 0 N-CA-C 106.802 -1.555 . . . . 0.0 106.802 177.328 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 . . . . . 0 N--CA 1.438 -1.059 0 CA-C-O 121.296 0.569 . . . . 0.0 110.369 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 30.0 t -100.21 172.15 7.35 Favored 'General case' 0 C--N 1.286 -2.166 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.072 -175.398 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 59.2 t60 -59.77 134.27 56.87 Favored 'General case' 0 C--O 1.238 0.48 0 N-CA-C 109.846 -0.428 . . . . 0.0 109.846 177.848 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 79.21 10.78 1.5 Allowed 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.818 1.247 . . . . 0.0 112.351 179.147 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -105.54 162.3 14.33 Favored Glycine 0 N--CA 1.442 -0.925 0 N-CA-C 110.505 -1.038 . . . . 0.0 110.505 176.182 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.601 ' HA ' ' O ' ' A' ' 33' ' ' SER . 53.4 tt0 -82.26 111.62 18.51 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 -179.66 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.74 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 20.7 p -87.36 -35.08 18.57 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 113.469 0.914 . . . . 0.0 113.469 -175.121 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 173.5 80.51 0.05 OUTLIER Glycine 0 CA--C 1.489 -1.559 0 C-N-CA 117.993 -2.051 . . . . 0.0 113.492 -176.837 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.408 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -112.48 174.11 15.88 Favored Glycine 0 C--N 1.287 -2.163 0 N-CA-C 107.731 -2.148 . . . . 0.0 107.731 174.232 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 74.5 mt -54.93 111.55 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 117.631 0.716 . . . . 0.0 110.211 178.927 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 114.34 -8.42 22.64 Favored Glycine 0 N--CA 1.437 -1.251 0 C-N-CA 120.606 -0.807 . . . . 0.0 113.405 179.679 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.422 ' HB2' HE21 ' A' ' 7' ' ' GLN . 70.7 t80 -101.36 110.45 22.46 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 179.03 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 4.8 p -107.72 7.02 28.2 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-N 115.83 -0.623 . . . . 0.0 112.042 -177.258 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -83.0 -165.41 37.56 Favored Glycine 0 N--CA 1.444 -0.809 0 CA-C-N 115.486 -0.779 . . . . 0.0 112.268 178.222 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -60.51 111.02 0.9 Allowed 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 123.12 2.546 . . . . 0.0 112.317 -179.46 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.616 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 6.7 p -87.04 -11.17 51.13 Favored 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 113.205 0.817 . . . . 0.0 113.205 -175.69 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 7.5 p -80.87 130.43 35.9 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.91 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.139 179.533 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 77.3 m -91.32 169.0 11.17 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-O 120.873 0.368 . . . . 0.0 110.401 179.25 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -59.81 137.67 57.99 Favored 'General case' 0 N--CA 1.438 -1.073 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 174.496 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 54.1 m -59.99 121.08 10.93 Favored 'General case' 0 N--CA 1.432 -1.37 0 CA-C-O 121.14 0.495 . . . . 0.0 110.095 -179.258 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 112.66 -10.0 25.81 Favored Glycine 0 N--CA 1.439 -1.125 0 N-CA-C 111.018 -0.833 . . . . 0.0 111.018 -175.091 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 68.2 p -121.63 142.97 49.6 Favored 'General case' 0 C--O 1.244 0.812 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 174.821 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 34.2 p -110.83 139.24 46.31 Favored 'General case' 0 C--N 1.295 -1.803 0 C-N-CA 120.819 -0.352 . . . . 0.0 111.652 -176.537 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 41.3 t -77.63 102.96 7.29 Favored 'General case' 0 C--N 1.312 -1.041 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 179.338 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -106.79 126.53 52.41 Favored 'General case' 0 N--CA 1.421 -1.897 0 C-N-CA 120.541 -0.464 . . . . 0.0 110.832 -178.695 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 51.5 t -79.21 95.18 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.207 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 179.649 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 77.6 mt -75.21 -69.77 0.46 Allowed 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 -178.893 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 49.0 m-80 -96.31 163.87 19.71 Favored Pre-proline 0 C--N 1.294 -1.842 0 N-CA-C 106.968 -1.493 . . . . 0.0 106.968 174.676 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -61.7 -33.17 86.53 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 121.374 1.383 . . . . 0.0 112.025 179.517 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.408 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 39.8 m-85 -101.64 -25.18 13.96 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 120.419 -0.512 . . . . 0.0 110.914 -179.18 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 61.5 t80 -106.13 113.78 27.52 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 120.076 -0.65 . . . . 0.0 112.135 178.935 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.601 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 19.7 m -118.13 143.94 46.08 Favored 'General case' 0 C--N 1.293 -1.855 0 N-CA-C 106.524 -1.658 . . . . 0.0 106.524 174.984 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' GLN . . . . . 0.478 HE21 HD21 ' A' ' 36' ' ' LEU . 29.7 tt0 -135.93 141.94 44.56 Favored 'General case' 0 C--N 1.3 -1.563 0 C-N-CA 120.768 -0.373 . . . . 0.0 111.613 -173.769 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.74 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 58.7 m -75.29 116.67 16.26 Favored 'General case' 0 C--O 1.254 1.32 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.02 177.184 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.478 HD21 HE21 ' A' ' 34' ' ' GLN . 96.1 mt . . . . . 0 C--N 1.308 -1.204 0 C-N-CA 124.336 1.054 . . . . 0.0 108.686 178.718 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 . . . . . 0 N--CA 1.445 -0.688 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 12.8 m -119.57 179.73 4.13 Favored 'General case' 0 C--N 1.293 -1.887 0 C-N-CA 120.731 -0.388 . . . . 0.0 110.994 -172.888 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' HIS . . . . . 0.4 ' HA ' ' O ' ' A' ' 35' ' ' CYS . 76.7 t60 -50.19 133.78 23.18 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 123.71 0.804 . . . . 0.0 111.811 -177.94 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 75.98 -0.69 3.1 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 125.26 1.424 . . . . 0.0 112.106 179.453 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -90.5 153.09 22.42 Favored Glycine 0 N--CA 1.428 -1.877 0 N-CA-C 111.145 -0.782 . . . . 0.0 111.145 178.348 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.514 ' HA ' ' O ' ' A' ' 33' ' ' SER . 54.5 tt0 -75.27 114.82 14.24 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 178.465 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.76 ' O ' ' HA ' ' A' ' 17' ' ' THR . 9.8 p -86.61 -48.73 8.07 Favored 'General case' 0 C--O 1.195 -1.805 0 N-CA-C 112.822 0.675 . . . . 0.0 112.822 -177.456 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -177.45 97.69 0.11 Allowed Glycine 0 CA--C 1.479 -2.169 0 C-N-CA 117.536 -2.268 . . . . 0.0 113.604 -173.949 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.585 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -113.23 178.34 18.57 Favored Glycine 0 C--N 1.28 -2.545 0 N-CA-C 107.582 -2.207 . . . . 0.0 107.582 174.164 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 68.6 mt -61.64 113.18 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.056 0 CA-C-N 117.749 0.774 . . . . 0.0 109.827 178.694 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 95.47 29.81 8.57 Favored Glycine 0 N--CA 1.438 -1.193 0 CA-C-N 116.023 -0.535 . . . . 0.0 113.139 178.039 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 77.6 t80 -114.14 112.15 22.72 Favored 'General case' 0 C--N 1.313 -1.017 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 177.316 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 23.4 p -95.92 -4.29 43.71 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 -176.124 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -76.57 -162.46 14.24 Favored Glycine 0 CA--C 1.532 1.138 0 C-N-CA 121.212 -0.518 . . . . 0.0 112.82 -179.415 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -61.8 112.25 1.43 Allowed 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 123.131 2.554 . . . . 0.0 111.152 178.079 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.76 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 16.2 p -93.21 -15.04 26.35 Favored 'General case' 0 N--CA 1.433 -1.295 0 CA-C-N 115.874 -0.603 . . . . 0.0 112.444 -176.42 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 10.0 p -95.57 139.03 19.73 Favored 'Isoleucine or valine' 0 C--O 1.255 1.382 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 178.719 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 81.1 m -91.61 155.74 18.13 Favored 'General case' 0 C--N 1.291 -1.978 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.935 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -58.86 137.92 57.55 Favored 'General case' 0 C--O 1.25 1.13 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 175.409 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 7.1 p -51.03 124.82 12.2 Favored 'General case' 0 C--N 1.311 -1.094 0 O-C-N 123.864 0.728 . . . . 0.0 111.828 -177.255 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 112.22 -21.05 20.58 Favored Glycine 0 N--CA 1.434 -1.441 0 CA-C-N 115.463 -0.789 . . . . 0.0 111.228 -176.405 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 75.8 p -110.86 149.26 30.85 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 176.604 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 22.8 p -112.06 142.54 44.36 Favored 'General case' 0 C--N 1.297 -1.698 0 CA-C-N 116.818 -0.173 . . . . 0.0 110.651 -178.196 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 44.3 t -78.6 99.19 6.45 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 176.974 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 75.4 mt-30 -96.26 119.26 34.42 Favored 'General case' 0 N--CA 1.415 -2.217 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.62 -178.015 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 46.5 t -75.37 102.45 2.6 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 177.114 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 56.5 mt -85.16 -74.51 0.4 Allowed 'General case' 0 N--CA 1.428 -1.55 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 -179.34 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 74.9 m-20 -95.56 166.78 13.95 Favored Pre-proline 0 C--N 1.289 -2.032 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 176.955 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -59.67 -36.95 90.64 Favored 'Trans proline' 0 CA--C 1.543 0.939 0 C-N-CA 121.89 1.727 . . . . 0.0 112.99 179.723 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.585 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 69.3 m-85 -102.47 -24.34 13.83 Favored 'General case' 0 C--N 1.315 -0.935 0 C-N-CA 120.192 -0.603 . . . . 0.0 110.876 -178.688 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 69.9 t80 -104.71 114.25 28.34 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 112.505 0.557 . . . . 0.0 112.505 179.626 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.514 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 26.7 m -121.67 146.37 47.07 Favored 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 175.988 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' GLN . . . . . 0.515 ' OE1' HD21 ' A' ' 36' ' ' LEU . 35.8 tt0 -134.98 142.43 46.47 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-N 118.242 0.474 . . . . 0.0 111.363 -172.934 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.755 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 77.4 m -77.26 113.39 14.97 Favored 'General case' 0 C--O 1.247 0.949 0 CA-C-O 121.164 0.507 . . . . 0.0 110.117 176.664 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.515 HD21 ' OE1' ' A' ' 34' ' ' GLN . 97.1 mt . . . . . 0 C--N 1.291 -1.952 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.01 -179.005 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 . . . . . 0 N--CA 1.445 -0.69 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 14.2 m -123.67 179.39 4.8 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 -176.267 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 36.9 t-80 -56.16 143.62 32.59 Favored 'General case' 0 C--O 1.239 0.532 0 C-N-CA 123.213 0.605 . . . . 0.0 110.128 178.956 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 71.91 10.01 6.17 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 124.586 1.155 . . . . 0.0 111.188 -178.3 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -109.76 147.56 17.15 Favored Glycine 0 N--CA 1.422 -2.267 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.392 178.704 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.551 ' HA ' ' O ' ' A' ' 33' ' ' SER . 53.3 tt0 -79.22 115.19 18.72 Favored 'General case' 0 C--N 1.31 -1.138 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 178.22 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.656 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 7.0 p -88.16 -45.7 9.9 Favored 'General case' 0 C--N 1.285 -2.219 0 CA-C-N 115.648 -0.706 . . . . 0.0 112.86 -176.159 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -171.89 91.6 0.09 OUTLIER Glycine 0 N--CA 1.428 -1.875 0 C-N-CA 118.152 -1.975 . . . . 0.0 113.968 -174.171 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.436 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -112.74 178.27 18.75 Favored Glycine 0 N--CA 1.427 -1.955 0 N-CA-C 108.341 -1.904 . . . . 0.0 108.341 175.036 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 85.5 mt -60.01 113.33 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.074 0 CA-C-N 117.526 0.663 . . . . 0.0 111.377 179.199 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 94.57 13.04 55.03 Favored Glycine 0 N--CA 1.434 -1.457 0 CA-C-N 115.233 -0.894 . . . . 0.0 112.878 177.475 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 57.1 t80 -96.72 113.15 24.69 Favored 'General case' 0 N--CA 1.442 -0.835 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 179.415 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 11.2 p -107.3 21.26 17.78 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-O 121.681 0.753 . . . . 0.0 111.981 -177.906 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -94.23 -154.18 30.8 Favored Glycine 0 C--N 1.298 -1.546 0 C-N-CA 120.626 -0.797 . . . . 0.0 111.402 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -70.39 107.11 1.91 Allowed 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 122.329 2.019 . . . . 0.0 111.374 178.76 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.622 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 9.8 p -87.22 -18.17 30.91 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-N 115.415 -0.811 . . . . 0.0 111.99 -177.855 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 12.0 p -88.15 129.85 38.7 Favored 'Isoleucine or valine' 0 C--O 1.25 1.115 0 CA-C-O 121.177 0.513 . . . . 0.0 110.509 178.797 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 82.1 m -93.36 148.48 22.01 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.987 -179.638 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -59.74 147.13 38.96 Favored 'General case' 0 C--O 1.247 0.96 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.323 177.732 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 9.7 t -54.12 126.5 23.02 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.054 -178.033 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 112.44 -18.17 23.13 Favored Glycine 0 N--CA 1.438 -1.167 0 N-CA-C 110.716 -0.953 . . . . 0.0 110.716 -175.957 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 57.7 p -127.19 146.2 50.49 Favored 'General case' 0 N--CA 1.443 -0.802 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 176.948 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 16.4 p -120.97 143.11 49.19 Favored 'General case' 0 C--N 1.296 -1.73 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 178.248 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 42.0 t -69.74 105.38 2.72 Favored 'General case' 0 C--N 1.309 -1.163 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 178.153 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 68.5 mt-30 -107.41 119.01 38.24 Favored 'General case' 0 N--CA 1.423 -1.816 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 179.295 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 52.8 t -75.22 119.41 22.87 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 CA-C-N 115.298 -0.864 . . . . 0.0 108.752 -179.241 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 76.6 mt -100.81 -69.48 0.77 Allowed 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 179.782 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 88.7 m-20 -95.48 166.66 14.22 Favored Pre-proline 0 C--N 1.304 -1.381 0 N-CA-C 106.782 -1.562 . . . . 0.0 106.782 173.104 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -63.6 -27.15 69.31 Favored 'Trans proline' 0 CA--C 1.534 0.476 0 C-N-CA 121.089 1.193 . . . . 0.0 111.858 177.275 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.436 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 55.8 m-85 -105.55 -26.03 12.06 Favored 'General case' 0 N--CA 1.443 -0.795 0 C-N-CA 119.789 -0.765 . . . . 0.0 110.716 -179.242 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 68.2 t80 -105.28 114.24 28.3 Favored 'General case' 0 N--CA 1.439 -1.0 0 C-N-CA 119.748 -0.781 . . . . 0.0 112.061 178.726 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.551 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 19.3 m -126.65 134.56 50.71 Favored 'General case' 0 C--N 1.283 -2.315 0 N-CA-C 105.766 -1.939 . . . . 0.0 105.766 176.206 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 7.7 tt0 -122.05 146.92 46.72 Favored 'General case' 0 C--N 1.303 -1.422 0 C-N-CA 120.268 -0.573 . . . . 0.0 110.567 -175.055 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.656 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 85.8 m -73.35 104.9 4.52 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 172.798 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 95.8 mt . . . . . 0 C--N 1.296 -1.743 0 C-N-CA 123.993 0.917 . . . . 0.0 108.649 -177.86 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 . . . . . 0 C--O 1.244 0.795 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 39.4 m -81.09 178.33 8.48 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-O 121.145 0.498 . . . . 0.0 110.906 -178.462 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 55.1 t-80 -63.67 133.35 53.47 Favored 'General case' 0 N--CA 1.444 -0.754 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 175.098 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 65.15 75.66 0.36 Allowed 'General case' 0 C--N 1.322 -0.59 0 O-C-N 124.356 1.035 . . . . 0.0 110.76 -177.502 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.493 ' O ' ' HA ' ' A' ' 34' ' ' GLN . . . -165.75 152.36 21.61 Favored Glycine 0 N--CA 1.42 -2.425 0 N-CA-C 108.454 -1.858 . . . . 0.0 108.454 178.557 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.604 ' HA ' ' O ' ' A' ' 33' ' ' SER . 52.7 tt0 -76.97 111.24 12.3 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 117.486 0.643 . . . . 0.0 110.049 -178.286 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.783 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 2.4 p -86.13 -41.58 14.6 Favored 'General case' 0 C--N 1.296 -1.758 0 CA-C-N 115.2 -0.909 . . . . 0.0 112.66 -177.429 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.402 ' HA2' ' HB3' ' A' ' 13' ' ' TYR . . . 169.76 101.68 0.15 Allowed Glycine 0 N--CA 1.423 -2.172 0 C-N-CA 117.895 -2.098 . . . . 0.0 113.778 -177.656 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -112.52 -160.51 14.98 Favored Glycine 0 N--CA 1.422 -2.265 0 N-CA-C 108.157 -1.977 . . . . 0.0 108.157 174.527 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 76.8 mt -65.91 109.69 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 CA-C-N 117.706 0.753 . . . . 0.0 110.994 177.547 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 95.13 20.63 27.4 Favored Glycine 0 N--CA 1.441 -1.027 0 C-N-CA 121.022 -0.608 . . . . 0.0 113.853 175.858 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.402 ' HB3' ' HA2' ' A' ' 9' ' ' GLY . 53.1 t80 -114.16 112.08 22.6 Favored 'General case' 0 C--N 1.31 -1.129 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 178.476 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 10.3 p -109.68 18.92 19.75 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-O 121.365 0.602 . . . . 0.0 111.662 -177.965 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -82.18 -150.79 8.73 Favored Glycine 0 N--CA 1.446 -0.688 0 CA-C-O 119.259 -0.745 . . . . 0.0 111.431 179.629 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -66.61 93.9 0.32 Allowed 'Trans proline' 0 CA--C 1.535 0.541 0 C-N-CA 122.158 1.905 . . . . 0.0 111.912 178.827 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.578 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 17.3 p -83.34 -13.59 54.73 Favored 'General case' 0 C--O 1.251 1.156 0 CA-C-O 121.905 0.86 . . . . 0.0 111.058 -177.533 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 4.7 p -92.9 121.64 43.74 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.56 0 CA-C-N 114.625 -1.17 . . . . 0.0 110.033 177.783 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 65.5 m -86.07 153.2 22.28 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 179.084 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -68.56 163.87 22.6 Favored 'General case' 0 C--O 1.26 1.64 0 CA-C-O 120.712 0.291 . . . . 0.0 111.062 178.599 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 28.1 m -47.49 115.91 1.27 Allowed 'General case' 0 C--O 1.248 1.004 0 C-N-CA 124.667 1.187 . . . . 0.0 113.276 -176.381 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 108.37 -20.83 29.7 Favored Glycine 0 N--CA 1.437 -1.282 0 CA-C-N 115.482 -0.781 . . . . 0.0 113.407 175.236 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 21.2 p -106.7 146.03 31.3 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 122.214 -0.58 . . . . 0.0 111.702 -178.251 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 14.5 p -118.92 147.65 43.79 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.558 -178.327 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 43.4 t -77.88 100.3 6.32 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-O 121.225 0.536 . . . . 0.0 109.644 -179.466 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 85.1 mm-40 -90.72 119.68 31.15 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.844 -179.063 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 46.7 t -83.76 108.71 16.47 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 -179.056 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 81.4 mt -95.03 -68.46 0.8 Allowed 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 -179.668 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.441 ' HB2' ' HB3' ' A' ' 32' ' ' TYR . 45.6 m-80 -95.61 166.82 13.83 Favored Pre-proline 0 C--N 1.296 -1.745 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 175.933 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -61.28 -37.91 69.62 Favored 'Trans proline' 0 C--N 1.349 0.558 0 C-N-CA 121.204 1.269 . . . . 0.0 111.009 178.624 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 49.4 m-85 -96.63 -25.03 15.73 Favored 'General case' 0 N--CA 1.441 -0.921 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.817 -178.703 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.441 ' HB3' ' HB2' ' A' ' 29' ' ' ASN . 48.9 t80 -104.6 113.43 27.0 Favored 'General case' 0 C--N 1.315 -0.898 0 C-N-CA 118.977 -1.089 . . . . 0.0 111.314 -177.506 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.604 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 26.6 m -124.68 137.91 54.33 Favored 'General case' 0 C--N 1.286 -2.193 0 N-CA-C 105.906 -1.887 . . . . 0.0 105.906 176.958 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' GLN . . . . . 0.493 ' HA ' ' O ' ' A' ' 6' ' ' GLY . 30.1 tt0 -131.47 136.21 47.74 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -173.243 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.783 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 85.5 m -70.2 110.56 5.26 Favored 'General case' 0 C--O 1.245 0.831 0 CA-C-O 121.263 0.554 . . . . 0.0 110.937 177.3 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 95.8 mt . . . . . 0 C--N 1.294 -1.817 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 179.059 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 . . . . . 0 N--CA 1.44 -0.943 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 27.7 t -91.95 -178.08 4.91 Favored 'General case' 0 C--N 1.297 -1.695 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.457 -175.582 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 16.8 t-80 -63.43 118.07 7.59 Favored 'General case' 0 N--CA 1.445 -0.691 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 71.83 91.36 0.09 Allowed 'General case' 0 C--O 1.24 0.576 0 C-N-CA 124.62 1.168 . . . . 0.0 111.141 -174.431 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.583 ' O ' ' HA ' ' A' ' 34' ' ' GLN . . . -177.4 163.68 32.42 Favored Glycine 0 N--CA 1.43 -1.766 0 N-CA-C 107.121 -2.392 . . . . 0.0 107.121 179.801 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.625 ' HA ' ' O ' ' A' ' 33' ' ' SER . 53.3 tt0 -84.31 113.47 21.16 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 118.52 1.16 . . . . 0.0 109.608 -178.745 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.766 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 7.4 p -95.17 -36.6 11.41 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 113.248 0.833 . . . . 0.0 113.248 -176.594 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -164.72 66.02 0.22 Allowed Glycine 0 CA--C 1.478 -2.234 0 C-N-CA 118.523 -1.799 . . . . 0.0 112.345 -176.236 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.538 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -110.15 157.04 15.27 Favored Glycine 0 C--N 1.285 -2.284 0 N-CA-C 108.764 -1.734 . . . . 0.0 108.764 177.324 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 69.0 mt -57.49 115.96 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 CA-C-N 117.32 0.56 . . . . 0.0 110.962 -177.781 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 114.13 -9.66 22.77 Favored Glycine 0 N--CA 1.451 -0.366 0 CA-C-N 116.022 -0.536 . . . . 0.0 112.027 -179.522 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 91.8 t80 -93.55 120.64 34.07 Favored 'General case' 0 C--N 1.311 -1.072 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 179.008 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 12.4 p -111.5 4.55 18.9 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 112.103 0.409 . . . . 0.0 112.103 -176.088 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -82.73 -160.51 28.52 Favored Glycine 0 CA--C 1.528 0.844 0 C-N-CA 121.127 -0.559 . . . . 0.0 112.525 179.687 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -72.87 126.3 11.19 Favored 'Trans proline' 0 CA--C 1.512 -0.62 0 C-N-CA 122.286 1.991 . . . . 0.0 111.175 179.143 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.569 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 21.7 p -85.1 -14.51 46.92 Favored 'General case' 0 C--N 1.295 -1.804 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.357 -177.155 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 12.3 p -75.42 132.8 32.62 Favored 'Isoleucine or valine' 0 C--O 1.257 1.469 0 CA-C-O 121.794 0.807 . . . . 0.0 111.426 -177.951 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 80.5 m -93.86 167.78 11.4 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-N 114.886 -1.052 . . . . 0.0 110.182 179.219 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.13 140.89 58.25 Favored 'General case' 0 C--N 1.308 -1.196 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 175.244 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 34.6 t -55.29 125.71 21.86 Favored 'General case' 0 C--N 1.312 -1.04 0 O-C-N 123.504 0.502 . . . . 0.0 109.961 -179.719 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 112.56 -20.68 20.29 Favored Glycine 0 N--CA 1.439 -1.141 0 N-CA-C 110.662 -0.975 . . . . 0.0 110.662 -175.934 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 72.7 p -114.89 157.54 23.19 Favored 'General case' 0 C--N 1.311 -1.074 0 O-C-N 122.293 -0.534 . . . . 0.0 109.665 177.572 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 16.6 p -126.02 148.98 49.16 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 110.089 -0.338 . . . . 0.0 110.089 177.845 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 53.2 t -76.63 100.88 5.5 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 62.0 mt-30 -101.0 114.99 29.43 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-O 121.122 0.486 . . . . 0.0 110.384 -178.154 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 48.2 t -71.33 116.51 13.13 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.252 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 178.833 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 78.6 mt -101.15 -68.69 0.8 Allowed 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 -178.72 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.454 ' HB2' ' H ' ' A' ' 32' ' ' TYR . 80.7 m-20 -95.38 166.07 15.48 Favored Pre-proline 0 C--N 1.301 -1.541 0 N-CA-C 106.915 -1.513 . . . . 0.0 106.915 174.657 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_exo -62.6 -27.41 76.36 Favored 'Trans proline' 0 CA--C 1.536 0.583 0 C-N-CA 121.531 1.487 . . . . 0.0 111.622 176.616 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.538 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 88.1 m-85 -105.31 -25.31 12.46 Favored 'General case' 0 N--CA 1.443 -0.798 0 C-N-CA 120.135 -0.626 . . . . 0.0 111.518 179.254 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.454 ' H ' ' HB2' ' A' ' 29' ' ' ASN . 44.7 t80 -105.87 113.73 27.45 Favored 'General case' 0 C--N 1.311 -1.074 0 C-N-CA 119.548 -0.861 . . . . 0.0 112.033 179.8 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.625 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 16.9 m -120.24 135.01 55.13 Favored 'General case' 0 C--N 1.291 -1.953 0 N-CA-C 105.759 -1.941 . . . . 0.0 105.759 175.134 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' GLN . . . . . 0.583 ' HA ' ' O ' ' A' ' 6' ' ' GLY . 28.1 tt0 -127.79 138.15 52.64 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 112.694 0.627 . . . . 0.0 112.694 -171.466 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.766 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 68.9 m -71.91 109.9 6.07 Favored 'General case' 0 C--O 1.251 1.158 0 CA-C-O 120.979 0.419 . . . . 0.0 111.073 176.875 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 94.3 mt . . . . . 0 N--CA 1.431 -1.398 0 N-CA-C 107.275 -1.38 . . . . 0.0 107.275 178.762 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 . . . . . 0 N--CA 1.446 -0.637 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 67.7 m -127.31 -170.45 2.22 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 111.602 0.223 . . . . 0.0 111.602 -177.052 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' HIS . . . . . 0.448 ' HA ' ' O ' ' A' ' 35' ' ' CYS . 37.0 t-80 -60.13 136.64 58.09 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 122.718 0.407 . . . . 0.0 110.936 -173.363 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' ALA . . . . . 0.589 ' HA ' ' NE2' ' A' ' 34' ' ' GLN . . . 74.4 8.76 4.47 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 124.143 0.977 . . . . 0.0 111.953 -179.814 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.426 ' O ' ' HA ' ' A' ' 34' ' ' GLN . . . -103.92 151.29 17.62 Favored Glycine 0 N--CA 1.431 -1.65 0 N-CA-C 111.386 -0.686 . . . . 0.0 111.386 178.537 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.612 ' HA ' ' O ' ' A' ' 33' ' ' SER . 54.3 tt0 -77.98 114.43 16.84 Favored 'General case' 0 CA--C 1.502 -0.883 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 178.608 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.705 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 8.0 p -94.27 -43.74 8.29 Favored 'General case' 0 C--N 1.288 -2.077 0 N-CA-C 113.549 0.944 . . . . 0.0 113.549 -175.64 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.449 ' H ' ' HB2' ' A' ' 33' ' ' SER . . . -159.38 69.75 0.25 Allowed Glycine 0 CA--C 1.481 -2.046 0 C-N-CA 118.541 -1.79 . . . . 0.0 112.765 -172.204 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.571 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -112.42 153.63 17.32 Favored Glycine 0 C--N 1.279 -2.584 0 N-CA-C 109.307 -1.517 . . . . 0.0 109.307 178.217 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.429 ' HB ' ' CD1' ' A' ' 31' ' ' TYR . 72.6 mt -56.24 123.89 8.38 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 O-C-N 123.974 0.455 . . . . 0.0 109.909 179.721 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 108.02 -15.27 36.93 Favored Glycine 0 N--CA 1.442 -0.9 0 N-CA-C 111.074 -0.81 . . . . 0.0 111.074 -179.218 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 80.1 t80 -101.78 109.7 21.53 Favored 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 178.602 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 13.5 p -107.68 7.34 28.44 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 112.381 0.511 . . . . 0.0 112.381 -176.629 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -82.41 -152.9 11.28 Favored Glycine 0 CA--C 1.53 0.978 0 CA-C-N 116.071 -0.513 . . . . 0.0 113.079 -179.547 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -64.49 112.25 1.88 Allowed 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 122.993 2.462 . . . . 0.0 112.294 -179.146 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.581 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 14.1 p -95.28 -4.73 45.1 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 115.375 -0.83 . . . . 0.0 113.022 -176.113 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 9.2 p -89.76 127.59 42.28 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.998 0 CA-C-O 120.896 0.379 . . . . 0.0 110.84 -178.648 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.471 ' SG ' ' HB2' ' A' ' 25' ' ' CYS . 72.9 m -87.91 154.1 20.79 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.167 178.789 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.72 143.4 57.46 Favored 'General case' 0 N--CA 1.438 -1.07 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.25 175.528 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.2 p -62.4 127.82 33.11 Favored 'General case' 0 C--N 1.297 -1.688 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.658 -179.15 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 112.5 -5.07 26.41 Favored Glycine 0 N--CA 1.438 -1.172 0 N-CA-C 110.727 -0.949 . . . . 0.0 110.727 -174.141 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 49.3 p -136.26 145.0 45.1 Favored 'General case' 0 C--O 1.239 0.547 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 174.586 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 46.4 p -112.1 145.01 40.51 Favored 'General case' 0 C--N 1.305 -1.338 0 C-N-CA 120.884 -0.326 . . . . 0.0 110.139 -179.518 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.471 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 43.6 t -79.28 97.63 6.35 Favored 'General case' 0 C--N 1.31 -1.144 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 -179.706 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 72.1 mt-30 -93.74 114.75 27.1 Favored 'General case' 0 N--CA 1.424 -1.767 0 CA-C-O 121.303 0.573 . . . . 0.0 110.716 -177.738 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 48.1 t -76.76 95.12 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 CA-C-N 114.798 -1.092 . . . . 0.0 108.404 177.92 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 87.7 mt -78.23 -70.91 0.46 Allowed 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 -179.388 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 75.2 m-20 -95.36 166.72 14.17 Favored Pre-proline 0 C--N 1.296 -1.738 0 N-CA-C 106.644 -1.613 . . . . 0.0 106.644 174.66 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_exo -62.95 -35.66 65.17 Favored 'Trans proline' 0 C--O 1.246 0.915 0 C-N-CA 121.171 1.247 . . . . 0.0 111.441 176.909 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.571 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 73.2 m-85 -97.41 -26.33 14.9 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 120.411 -0.516 . . . . 0.0 111.056 -178.639 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 68.8 t80 -105.68 114.09 28.04 Favored 'General case' 0 C--N 1.311 -1.09 0 C-N-CA 119.879 -0.728 . . . . 0.0 112.512 177.954 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.612 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 18.6 m -127.01 135.88 51.45 Favored 'General case' 0 C--N 1.295 -1.79 0 N-CA-C 106.45 -1.685 . . . . 0.0 106.45 175.841 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' GLN . . . . . 0.589 ' NE2' ' HA ' ' A' ' 5' ' ' ALA . 47.3 tt0 -126.22 141.41 51.93 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-N 117.975 0.352 . . . . 0.0 111.022 -174.476 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.705 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 60.3 m -73.55 109.98 7.48 Favored 'General case' 0 C--O 1.253 1.25 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 174.075 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 87.4 mt . . . . . 0 C--N 1.289 -2.036 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 179.503 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 . . . . . 0 N--CA 1.436 -1.144 0 N-CA-C 107.767 -1.198 . . . . 0.0 107.767 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 33.4 t -114.82 179.32 3.98 Favored 'General case' 0 C--N 1.288 -2.088 0 C-N-CA 120.642 -0.423 . . . . 0.0 111.425 -173.538 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 57.4 t-80 -58.15 137.04 57.31 Favored 'General case' 0 CA--C 1.519 -0.243 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 -178.642 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 78.21 -3.69 2.29 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 124.858 1.263 . . . . 0.0 112.059 179.0 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -90.15 141.91 16.19 Favored Glycine 0 N--CA 1.426 -1.997 0 N-CA-C 110.76 -0.936 . . . . 0.0 110.76 178.313 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.599 ' HA ' ' O ' ' A' ' 33' ' ' SER . 54.0 tt0 -69.26 113.55 6.71 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 176.425 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.719 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 10.5 p -86.29 -40.83 15.11 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 112.764 0.654 . . . . 0.0 112.764 -176.178 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 177.4 93.25 0.09 OUTLIER Glycine 0 CA--C 1.488 -1.653 0 C-N-CA 117.788 -2.148 . . . . 0.0 113.847 -176.81 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.509 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -112.01 174.85 16.74 Favored Glycine 0 C--N 1.286 -2.238 0 N-CA-C 107.519 -2.232 . . . . 0.0 107.519 174.755 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 65.2 mt -60.55 113.25 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.139 0 CA-C-N 117.912 0.856 . . . . 0.0 109.469 178.976 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 113.8 -20.09 17.89 Favored Glycine 0 N--CA 1.438 -1.229 0 C-N-CA 121.1 -0.571 . . . . 0.0 112.165 179.206 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 71.0 t80 -81.35 118.97 23.1 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-O 121.038 0.447 . . . . 0.0 110.425 -176.891 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 11.7 p -102.58 5.79 39.45 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 113.055 0.761 . . . . 0.0 113.055 -175.175 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -87.89 -157.04 31.22 Favored Glycine 0 CA--C 1.524 0.628 0 C-N-CA 120.703 -0.761 . . . . 0.0 113.275 -175.262 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -70.7 113.16 3.44 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.637 2.225 . . . . 0.0 111.805 -179.586 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.628 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 18.5 p -89.04 -3.41 58.7 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.847 -177.36 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 4.0 p -98.91 120.82 48.75 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.953 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.859 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 63.1 m -85.74 164.27 17.71 Favored 'General case' 0 C--N 1.299 -1.621 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.48 179.448 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.42 146.0 55.04 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 174.84 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 46.1 m -61.67 130.74 47.28 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 178.049 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 112.36 -13.12 25.85 Favored Glycine 0 C--N 1.309 -0.962 0 N-CA-C 110.384 -1.086 . . . . 0.0 110.384 -173.482 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 65.0 p -127.57 155.27 44.09 Favored 'General case' 0 C--O 1.248 0.986 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 175.229 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 33.8 p -120.6 143.26 48.74 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 177.331 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 52.7 t -74.53 99.6 3.64 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 176.644 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 -97.82 119.68 36.85 Favored 'General case' 0 N--CA 1.425 -1.717 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 -177.722 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 43.1 t -77.86 93.88 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 178.091 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 82.7 mt -74.96 -70.77 0.39 Allowed 'General case' 0 C--N 1.306 -1.297 0 CA-C-N 115.278 -0.874 . . . . 0.0 109.092 -177.828 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 24.2 m120 -95.58 165.91 15.7 Favored Pre-proline 0 C--N 1.295 -1.802 0 N-CA-C 106.206 -1.776 . . . . 0.0 106.206 174.006 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -63.43 -30.46 72.28 Favored 'Trans proline' 0 C--O 1.239 0.543 0 C-N-CA 121.376 1.384 . . . . 0.0 111.287 178.796 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.509 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 55.4 m-85 -103.15 -25.71 13.28 Favored 'General case' 0 N--CA 1.438 -1.073 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.464 -179.754 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 40.6 t80 -106.03 114.2 28.2 Favored 'General case' 0 C--N 1.317 -0.843 0 C-N-CA 119.413 -0.915 . . . . 0.0 111.562 178.786 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.599 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 15.4 m -121.03 141.04 51.12 Favored 'General case' 0 C--N 1.294 -1.824 0 N-CA-C 106.485 -1.672 . . . . 0.0 106.485 176.271 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -136.04 140.93 44.21 Favored 'General case' 0 C--N 1.297 -1.699 0 CA-C-N 118.053 0.388 . . . . 0.0 111.047 -172.623 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.719 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 66.7 m -73.17 111.24 8.1 Favored 'General case' 0 C--O 1.257 1.488 0 CA-C-O 121.108 0.48 . . . . 0.0 110.369 177.63 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 82.2 mt . . . . . 0 C--N 1.303 -1.443 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 -179.844 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' GLN . . . . . 0.438 ' O ' ' HA ' ' A' ' 19' ' ' CYS . 8.2 tp-100 . . . . . 0 N--CA 1.442 -0.832 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' SER . . . . . 0.413 ' O ' ' HB2' ' A' ' 35' ' ' CYS . 69.7 m -126.06 -165.62 1.46 Allowed 'General case' 0 C--N 1.276 -2.621 0 C-N-CA 120.99 -0.284 . . . . 0.0 111.518 -174.774 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 56.8 t-80 -50.3 130.58 23.35 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 113.647 0.98 . . . . 0.0 113.647 -172.822 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 71.52 12.06 6.52 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 114.275 -1.33 . . . . 0.0 112.649 175.671 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.442 ' O ' ' HA ' ' A' ' 34' ' ' GLN . . . -100.15 165.57 19.66 Favored Glycine 0 N--CA 1.433 -1.5 0 N-CA-C 110.846 -0.902 . . . . 0.0 110.846 176.225 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.525 ' HA ' ' O ' ' A' ' 33' ' ' SER . 54.0 tt0 -87.82 112.35 22.36 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 110.245 -0.28 . . . . 0.0 110.245 -177.562 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.772 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 14.6 p -83.03 -41.94 18.08 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 112.383 0.512 . . . . 0.0 112.383 -178.226 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 165.14 101.42 0.16 Allowed Glycine 0 CA--C 1.483 -1.923 0 C-N-CA 117.624 -2.227 . . . . 0.0 114.265 -178.795 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -112.63 -169.98 17.92 Favored Glycine 0 N--CA 1.423 -2.199 0 N-CA-C 107.489 -2.244 . . . . 0.0 107.489 173.4 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 70.3 mt -62.09 122.86 13.73 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.34 0 CA-C-N 117.815 0.807 . . . . 0.0 110.21 179.156 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 99.02 -5.27 59.36 Favored Glycine 0 N--CA 1.444 -0.814 0 C-N-CA 120.834 -0.698 . . . . 0.0 113.24 175.753 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 69.4 t80 -94.38 113.79 25.72 Favored 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 27.0 p -106.41 -1.18 23.52 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 116.317 -0.402 . . . . 0.0 112.039 -176.736 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -76.02 -156.7 6.54 Favored Glycine 0 CA--C 1.526 0.728 0 CA-C-N 116.121 -0.49 . . . . 0.0 113.195 -178.903 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -63.62 106.79 0.64 Allowed 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 122.568 2.179 . . . . 0.0 111.885 -179.662 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.676 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 4.2 p -95.51 15.14 20.52 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-N 115.401 -0.818 . . . . 0.0 112.377 -176.132 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 7.1 p -112.13 126.76 69.56 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.627 -179.764 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.467 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 80.1 m -88.01 150.2 23.56 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 115.652 -0.704 . . . . 0.0 109.163 177.078 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.14 153.34 43.88 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 177.509 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 24.6 m -55.97 128.43 35.2 Favored 'General case' 0 N--CA 1.435 -1.184 0 CA-C-O 121.336 0.589 . . . . 0.0 110.705 -179.677 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 111.97 -18.12 24.27 Favored Glycine 0 N--CA 1.432 -1.576 0 N-CA-C 110.927 -0.869 . . . . 0.0 110.927 -177.095 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 68.6 p -121.54 146.73 46.65 Favored 'General case' 0 N--CA 1.441 -0.886 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 178.118 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 34.2 p -114.85 144.04 44.16 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.07 179.306 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 52.9 t -78.62 106.3 10.5 Favored 'General case' 0 C--N 1.308 -1.2 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 178.607 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -111.08 130.56 55.57 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.179 -178.35 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 43.2 t -87.71 114.45 26.55 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.831 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 -177.802 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 86.4 mt -92.94 -72.72 0.59 Allowed 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 179.282 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 84.3 m-20 -93.63 163.23 25.04 Favored Pre-proline 0 C--N 1.305 -1.341 0 N-CA-C 106.322 -1.733 . . . . 0.0 106.322 175.896 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -58.07 -35.28 98.87 Favored 'Trans proline' 0 CA--C 1.534 0.477 0 C-N-CA 121.626 1.551 . . . . 0.0 111.55 179.63 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 90.3 m-85 -97.69 -25.04 15.23 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.671 -179.47 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 65.9 t80 -105.48 114.43 28.61 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 119.937 -0.705 . . . . 0.0 112.714 -179.579 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.525 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 19.9 m -119.21 143.95 46.98 Favored 'General case' 0 C--N 1.295 -1.791 0 N-CA-C 106.962 -1.496 . . . . 0.0 106.962 174.515 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' GLN . . . . . 0.442 ' HA ' ' O ' ' A' ' 6' ' ' GLY . 35.2 tt0 -129.96 143.62 50.9 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 111.941 0.349 . . . . 0.0 111.941 -171.478 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.772 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 86.0 m -82.0 111.07 17.83 Favored 'General case' 0 C--O 1.252 1.221 0 CA-C-O 121.169 0.509 . . . . 0.0 109.892 176.345 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 96.1 mt . . . . . 0 C--N 1.298 -1.674 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.646 179.586 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 41.1 tp60 . . . . . 0 N--CA 1.432 -1.374 0 CA-C-O 121.479 0.657 . . . . 0.0 109.733 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 58.3 p -78.11 168.47 19.81 Favored 'General case' 0 C--N 1.293 -1.878 0 CA-C-N 115.316 -0.856 . . . . 0.0 112.161 -175.031 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 50.0 t-80 -57.21 137.51 55.84 Favored 'General case' 0 C--O 1.238 0.465 0 N-CA-C 109.141 -0.688 . . . . 0.0 109.141 176.018 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 72.19 15.48 5.4 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 123.784 0.834 . . . . 0.0 111.407 -179.837 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -105.98 160.98 14.51 Favored Glycine 0 N--CA 1.432 -1.574 0 N-CA-C 110.26 -1.136 . . . . 0.0 110.26 174.533 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.59 ' HA ' ' O ' ' A' ' 33' ' ' SER . 53.5 tt0 -80.68 109.91 15.67 Favored 'General case' 0 C--O 1.21 -0.988 0 CA-C-N 116.869 0.334 . . . . 0.0 110.331 -178.599 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.791 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 23.5 p -84.62 -15.36 45.81 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -177.188 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.426 ' HA2' ' CD1' ' A' ' 13' ' ' TYR . . . 135.14 100.69 0.65 Allowed Glycine 0 N--CA 1.42 -2.423 0 C-N-CA 117.72 -2.181 . . . . 0.0 115.253 176.119 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -112.23 -171.15 18.53 Favored Glycine 0 N--CA 1.423 -2.221 0 N-CA-C 106.991 -2.444 . . . . 0.0 106.991 172.048 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 77.7 mt -58.39 113.81 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.994 0 CA-C-N 117.946 0.873 . . . . 0.0 110.443 179.893 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 114.02 -16.87 20.26 Favored Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.964 -0.636 . . . . 0.0 113.028 177.967 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.426 ' CD1' ' HA2' ' A' ' 9' ' ' GLY . 66.3 t80 -94.36 129.06 41.21 Favored 'General case' 0 C--N 1.312 -1.046 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 -179.159 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 11.4 p -131.58 14.31 4.95 Favored 'General case' 0 C--O 1.248 0.997 0 N-CA-C 112.981 0.734 . . . . 0.0 112.981 -174.858 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -90.93 -140.73 8.92 Favored Glycine 0 C--N 1.309 -0.967 0 C-N-CA 121.19 -0.529 . . . . 0.0 111.958 178.713 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -66.14 108.97 1.43 Allowed 'Trans proline' 0 N--CA 1.46 -0.484 0 C-N-CA 122.317 2.011 . . . . 0.0 111.659 -179.411 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.474 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 17.5 p -97.06 -3.49 41.26 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-N 115.696 -0.683 . . . . 0.0 111.747 -178.817 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 7.2 p -90.28 125.09 43.16 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.941 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.933 178.938 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 84.8 m -84.4 161.95 20.16 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 115.699 -0.682 . . . . 0.0 112.055 -179.858 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.83 160.18 28.85 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 115.098 -0.955 . . . . 0.0 110.79 178.874 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 31.1 m -54.06 116.29 2.5 Favored 'General case' 0 C--N 1.31 -1.147 0 C-N-CA 124.058 0.943 . . . . 0.0 111.989 -179.062 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 105.86 -19.09 39.13 Favored Glycine 0 N--CA 1.435 -1.425 0 CA-C-N 115.779 -0.646 . . . . 0.0 112.237 178.224 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 74.9 p -106.91 145.15 32.55 Favored 'General case' 0 C--N 1.309 -1.181 0 O-C-N 122.252 -0.558 . . . . 0.0 110.813 -177.95 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 22.2 p -114.96 152.15 32.86 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 110.079 -0.341 . . . . 0.0 110.079 178.999 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 50.8 t -77.98 106.02 9.56 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 178.706 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 68.4 mt-30 -108.45 123.88 49.55 Favored 'General case' 0 N--CA 1.429 -1.49 0 CA-C-O 121.11 0.481 . . . . 0.0 109.792 -179.571 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 55.0 t -80.58 111.53 17.42 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.239 -177.875 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 86.6 mt -91.67 -70.06 0.71 Allowed 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 179.688 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.456 ' HB2' ' H ' ' A' ' 32' ' ' TYR . 51.2 m-20 -94.58 163.99 21.14 Favored Pre-proline 0 C--N 1.299 -1.612 0 N-CA-C 105.814 -1.921 . . . . 0.0 105.814 176.109 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_exo -62.39 -26.44 76.79 Favored 'Trans proline' 0 CA--C 1.539 0.744 0 C-N-CA 121.539 1.493 . . . . 0.0 111.798 178.25 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 41.8 m-85 -108.47 -25.26 11.03 Favored 'General case' 0 N--CA 1.444 -0.742 0 C-N-CA 120.216 -0.594 . . . . 0.0 111.11 -177.983 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.456 ' H ' ' HB2' ' A' ' 29' ' ' ASN . 78.6 t80 -105.58 113.96 27.83 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 120.915 0.388 . . . . 0.0 111.888 177.702 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.59 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 24.8 m -116.3 143.43 45.55 Favored 'General case' 0 C--N 1.285 -2.212 0 N-CA-C 106.426 -1.694 . . . . 0.0 106.426 175.753 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -129.4 140.04 51.47 Favored 'General case' 0 C--N 1.303 -1.434 0 CA-C-N 118.269 0.486 . . . . 0.0 111.379 -173.248 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.791 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 74.9 m -74.84 112.56 11.17 Favored 'General case' 0 C--O 1.256 1.4 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.094 175.759 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 92.6 mt . . . . . 0 N--CA 1.429 -1.477 0 C-N-CA 124.401 1.08 . . . . 0.0 108.091 179.965 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 2' ' ' GLN . . . . . 0.405 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 5.8 tp-100 . . . . . 0 N--CA 1.446 -0.653 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 3' ' ' SER . . . . . 0.431 ' O ' ' HB2' ' A' ' 35' ' ' CYS . 33.0 m -98.64 -177.03 3.54 Favored 'General case' 0 C--N 1.294 -1.826 0 CA-C-N 116.733 -0.212 . . . . 0.0 111.152 -175.717 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 53.4 t-80 -61.99 126.56 27.77 Favored 'General case' 0 CA--C 1.511 -0.549 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 177.203 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 71.24 102.99 0.06 Allowed 'General case' 0 C--O 1.237 0.442 0 O-C-N 124.775 1.297 . . . . 0.0 109.726 -173.394 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.464 ' O ' ' HA ' ' A' ' 34' ' ' GLN . . . 158.86 147.48 4.87 Favored Glycine 0 N--CA 1.418 -2.519 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 -176.277 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.603 ' HA ' ' O ' ' A' ' 33' ' ' SER . 53.8 tt0 -78.51 106.83 10.73 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-O 121.03 0.443 . . . . 0.0 110.333 -179.033 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.67 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 7.9 p -82.11 -41.32 20.67 Favored 'General case' 0 C--N 1.301 -1.519 0 CA-C-N 115.556 -0.747 . . . . 0.0 112.05 -179.118 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 173.47 100.26 0.13 Allowed Glycine 0 N--CA 1.432 -1.628 0 C-N-CA 117.881 -2.104 . . . . 0.0 114.397 -177.552 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -112.0 -167.8 17.98 Favored Glycine 0 C--N 1.289 -2.069 0 N-CA-C 108.252 -1.939 . . . . 0.0 108.252 174.446 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 86.1 mt -59.58 109.25 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.01 0 CA-C-N 117.724 0.762 . . . . 0.0 110.995 179.885 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 104.82 -10.08 48.27 Favored Glycine 0 N--CA 1.437 -1.243 0 CA-C-N 115.989 -0.55 . . . . 0.0 113.313 176.504 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 34.5 t80 -100.12 111.22 23.5 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 -177.62 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 5.5 p -113.33 10.96 18.49 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 113.466 0.913 . . . . 0.0 113.466 -175.367 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -74.97 -131.74 0.27 Allowed Glycine 0 CA--C 1.53 1.024 0 CA-C-N 116.16 -0.473 . . . . 0.0 113.475 -179.016 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.86 81.06 0.87 Allowed 'Trans proline' 0 N--CA 1.461 -0.439 0 C-N-CA 122.672 2.248 . . . . 0.0 112.792 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.446 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 29.2 p -81.28 -10.41 59.58 Favored 'General case' 0 N--CA 1.437 -1.084 0 CA-C-N 115.338 -0.847 . . . . 0.0 110.606 178.88 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 7.1 p -89.96 132.82 33.65 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.275 0 CA-C-N 114.833 -1.076 . . . . 0.0 108.886 176.601 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.482 ' HB3' ' OG1' ' A' ' 23' ' ' THR . 76.1 m -101.1 156.67 17.28 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.39 -177.028 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.18 175.29 3.94 Favored 'General case' 0 C--O 1.246 0.877 0 C-N-CA 123.829 0.851 . . . . 0.0 112.065 -178.545 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 5.1 m -51.72 113.05 0.87 Allowed 'General case' 0 N--CA 1.443 -0.815 0 C-N-CA 124.863 1.265 . . . . 0.0 112.275 -177.426 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 89.81 12.63 62.06 Favored Glycine 0 N--CA 1.434 -1.444 0 C-N-CA 120.509 -0.853 . . . . 0.0 113.499 174.832 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.482 ' OG1' ' HB3' ' A' ' 19' ' ' CYS . 73.6 p -124.96 143.93 50.63 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 117.294 0.547 . . . . 0.0 110.274 177.33 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 40.1 p -118.85 137.03 53.71 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.705 179.609 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.481 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 53.3 t -76.35 109.22 9.87 Favored 'General case' 0 C--N 1.312 -1.024 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 179.523 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 74.6 mt-30 -116.28 125.97 52.92 Favored 'General case' 0 C--N 1.298 -1.664 0 CA-C-O 121.026 0.441 . . . . 0.0 110.542 -179.368 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 69.1 t -70.29 115.72 10.16 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.201 0 CA-C-N 115.016 -0.993 . . . . 0.0 109.045 178.441 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 67.8 mt -98.97 -70.67 0.72 Allowed 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 81.9 m-20 -95.5 168.98 9.93 Favored Pre-proline 0 C--N 1.298 -1.644 0 N-CA-C 106.763 -1.569 . . . . 0.0 106.763 175.539 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_exo -59.54 -36.75 92.17 Favored 'Trans proline' 0 CA--C 1.542 0.924 0 C-N-CA 121.614 1.543 . . . . 0.0 113.085 -179.657 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 66.6 m-85 -104.46 -24.02 13.09 Favored 'General case' 0 C--N 1.312 -1.049 0 O-C-N 121.716 -0.615 . . . . 0.0 110.574 -178.762 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 62.8 t80 -103.32 113.59 27.2 Favored 'General case' 0 N--CA 1.431 -1.4 0 CA-C-O 121.658 0.742 . . . . 0.0 111.422 -178.344 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.603 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 26.0 m -122.67 143.67 49.63 Favored 'General case' 0 C--N 1.288 -2.094 0 N-CA-C 105.536 -2.024 . . . . 0.0 105.536 176.355 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' GLN . . . . . 0.464 ' HA ' ' O ' ' A' ' 6' ' ' GLY . 27.1 tt0 -135.34 145.72 47.7 Favored 'General case' 0 C--N 1.297 -1.675 0 C-N-CA 120.274 -0.571 . . . . 0.0 112.465 -173.105 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.67 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 66.8 m -76.17 112.16 12.34 Favored 'General case' 0 C--O 1.251 1.165 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.335 176.304 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.436 HD21 HE21 ' A' ' 34' ' ' GLN . 94.9 mt . . . . . 0 C--N 1.3 -1.558 0 CA-C-N 115.012 -0.995 . . . . 0.0 108.397 179.081 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 2' ' ' GLN . . . . . 0.524 ' HA ' ' OE1' ' A' ' 2' ' ' GLN . 3.4 tp60 . . . . . 0 N--CA 1.436 -1.144 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 87.2 p -92.39 -178.15 4.84 Favored 'General case' 0 C--N 1.294 -1.838 0 CA-C-O 121.006 0.432 . . . . 0.0 111.193 -177.508 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 50.5 t-80 -54.43 136.54 44.01 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 123.954 0.902 . . . . 0.0 110.768 178.589 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 75.75 3.5 3.85 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 124.781 1.232 . . . . 0.0 112.713 177.82 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -93.37 154.98 22.03 Favored Glycine 0 N--CA 1.437 -1.257 0 N-CA-C 110.433 -1.067 . . . . 0.0 110.433 175.958 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.484 ' HA ' ' O ' ' A' ' 33' ' ' SER . 52.3 tt0 -81.36 110.1 16.48 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 177.933 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.707 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 8.7 p -79.18 -43.39 24.0 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 123.333 0.396 . . . . 0.0 111.867 -177.573 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.442 ' H ' ' HB2' ' A' ' 33' ' ' SER . . . 157.31 115.74 0.47 Allowed Glycine 0 N--CA 1.42 -2.383 0 C-N-CA 117.145 -2.455 . . . . 0.0 114.708 179.492 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -101.81 -149.9 22.87 Favored Glycine 0 N--CA 1.418 -2.559 0 N-CA-C 108.352 -1.899 . . . . 0.0 108.352 174.417 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 84.3 mt -71.92 112.98 8.07 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.715 0 CA-C-N 117.417 0.609 . . . . 0.0 111.008 178.475 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 92.61 30.06 10.17 Favored Glycine 0 N--CA 1.449 -0.492 0 CA-C-N 115.807 -0.633 . . . . 0.0 113.597 174.604 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 36.3 t80 -111.72 117.05 31.8 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-N 117.342 0.571 . . . . 0.0 109.513 -179.104 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 39.0 p -102.78 11.27 37.81 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-O 120.864 0.364 . . . . 0.0 111.742 -177.263 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -80.01 -151.78 7.2 Favored Glycine 0 CA--C 1.529 0.965 0 CA-C-N 116.071 -0.513 . . . . 0.0 112.315 179.638 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -75.35 96.59 1.04 Allowed 'Trans proline' 0 N--CA 1.453 -0.89 0 C-N-CA 122.276 1.984 . . . . 0.0 111.163 179.352 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.568 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 15.2 p -90.52 -8.76 49.5 Favored 'General case' 0 N--CA 1.423 -1.808 0 CA-C-N 115.407 -0.815 . . . . 0.0 112.259 -175.303 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 9.3 p -95.78 130.71 44.1 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.225 0 CA-C-N 116.123 -0.49 . . . . 0.0 109.932 177.932 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.492 ' HA ' ' O ' ' A' ' 2' ' ' GLN . 73.6 m -91.86 159.19 15.91 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.467 -179.404 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -78.86 170.0 17.36 Favored 'General case' 0 C--O 1.251 1.138 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.261 -179.472 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 46.4 m -58.51 126.65 28.47 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.972 -179.19 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 104.37 -6.24 45.68 Favored Glycine 0 N--CA 1.431 -1.667 0 C-N-CA 120.147 -1.025 . . . . 0.0 112.207 178.786 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 38.8 p -135.07 153.08 52.16 Favored 'General case' 0 C--O 1.241 0.627 0 CA-C-O 120.653 0.263 . . . . 0.0 111.305 -179.389 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 8.8 p -124.01 153.51 41.21 Favored 'General case' 0 N--CA 1.437 -1.093 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 176.893 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 50.9 t -82.34 99.38 9.33 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 -179.399 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 58.5 mt-30 -99.83 122.36 42.67 Favored 'General case' 0 N--CA 1.438 -1.059 0 CA-C-O 121.123 0.487 . . . . 0.0 110.087 -177.832 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 55.8 t -82.57 107.42 14.41 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.35 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.164 -179.001 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 84.1 mt -88.47 -70.39 0.64 Allowed 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 -179.786 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 55.7 m-80 -94.39 164.41 20.16 Favored Pre-proline 0 C--N 1.303 -1.441 0 N-CA-C 106.343 -1.725 . . . . 0.0 106.343 174.235 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_exo -60.46 -24.58 78.33 Favored 'Trans proline' 0 C--N 1.35 0.624 0 C-N-CA 121.766 1.644 . . . . 0.0 111.963 179.496 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 55.8 m-85 -109.56 -24.26 11.06 Favored 'General case' 0 N--CA 1.432 -1.356 0 C-N-CA 120.276 -0.57 . . . . 0.0 111.502 -179.256 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 57.0 t80 -103.95 113.43 26.95 Favored 'General case' 0 C--N 1.315 -0.934 0 C-N-CA 119.606 -0.838 . . . . 0.0 110.461 -179.474 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.484 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 49.8 m -123.18 137.56 54.86 Favored 'General case' 0 C--N 1.28 -2.447 0 N-CA-C 105.813 -1.921 . . . . 0.0 105.813 177.065 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 29.4 tt0 -131.46 141.04 49.71 Favored 'General case' 0 C--N 1.288 -2.075 0 C-N-CA 121.077 -0.249 . . . . 0.0 111.087 -172.972 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.707 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 76.8 m -74.56 107.98 7.03 Favored 'General case' 0 C--O 1.255 1.39 0 CA-C-O 121.636 0.731 . . . . 0.0 110.653 177.374 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 96.2 mt . . . . . 0 N--CA 1.428 -1.543 0 N-CA-C 106.304 -1.739 . . . . 0.0 106.304 179.028 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 . . . . . 0 N--CA 1.447 -0.58 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 5.0 m -93.03 169.63 10.27 Favored 'General case' 0 C--N 1.298 -1.667 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.6 -175.417 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 42.9 t-80 -52.92 139.45 27.42 Favored 'General case' 0 C--O 1.242 0.697 0 CA-C-N 115.14 -0.936 . . . . 0.0 109.274 173.159 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 69.0 8.28 6.75 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.753 0.821 . . . . 0.0 112.836 179.141 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -100.17 159.09 19.45 Favored Glycine 0 N--CA 1.436 -1.332 0 C-N-CA 120.68 -0.772 . . . . 0.0 111.501 178.283 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.534 ' HA ' ' O ' ' A' ' 33' ' ' SER . 53.7 tt0 -80.7 112.56 18.18 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 179.033 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.688 ' O ' ' HA ' ' A' ' 17' ' ' THR . 25.4 p -91.33 -38.29 12.72 Favored 'General case' 0 C--N 1.293 -1.856 0 N-CA-C 113.304 0.853 . . . . 0.0 113.304 -174.808 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 177.79 85.1 0.06 OUTLIER Glycine 0 CA--C 1.484 -1.851 0 C-N-CA 117.85 -2.119 . . . . 0.0 113.868 -176.754 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.461 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -112.55 176.28 17.6 Favored Glycine 0 C--N 1.285 -2.29 0 N-CA-C 108.469 -1.852 . . . . 0.0 108.469 174.573 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 78.3 mt -61.62 118.82 4.52 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.042 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 176.907 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 110.38 -5.77 30.02 Favored Glycine 0 N--CA 1.432 -1.608 0 C-N-CA 120.845 -0.693 . . . . 0.0 111.675 -178.988 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 65.2 t80 -114.0 108.28 16.81 Favored 'General case' 0 C--N 1.311 -1.089 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 178.232 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 21.9 p -109.61 15.65 22.72 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.658 -177.467 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -88.23 -154.67 28.16 Favored Glycine 0 N--CA 1.45 -0.423 0 CA-C-O 119.597 -0.557 . . . . 0.0 112.32 -179.688 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_endo -62.0 109.79 0.88 Allowed 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 122.882 2.388 . . . . 0.0 111.232 177.883 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.688 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 7.7 p -95.04 -6.46 42.13 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 114.215 1.191 . . . . 0.0 114.215 -173.267 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 7.6 p -95.71 134.76 32.05 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.371 0 O-C-N 121.973 -0.454 . . . . 0.0 109.98 179.43 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 46.9 m -91.37 168.87 11.25 Favored 'General case' 0 C--N 1.312 -1.051 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 -179.786 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.64 141.61 53.62 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 175.082 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 46.7 m -56.46 133.66 53.36 Favored 'General case' 0 N--CA 1.433 -1.314 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.255 -179.201 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 111.9 -13.17 26.96 Favored Glycine 0 C--N 1.296 -1.69 0 N-CA-C 109.86 -1.296 . . . . 0.0 109.86 -173.733 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 55.2 p -136.28 143.63 44.33 Favored 'General case' 0 C--O 1.248 1.004 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 174.93 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 21.3 p -111.35 138.08 48.29 Favored 'General case' 0 C--N 1.288 -2.098 0 CA-C-N 116.654 -0.248 . . . . 0.0 110.994 -179.212 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 46.4 t -72.3 99.0 2.3 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 176.458 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 74.8 mt-30 -108.06 129.29 55.15 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-O 121.223 0.535 . . . . 0.0 110.305 -179.234 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 58.3 t -78.05 107.6 10.21 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.371 0 CA-C-N 115.137 -0.938 . . . . 0.0 109.342 -179.77 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 83.6 mt -86.48 -72.33 0.51 Allowed 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 82.2 m-20 -94.84 165.17 17.69 Favored Pre-proline 0 C--N 1.292 -1.892 0 N-CA-C 105.789 -1.93 . . . . 0.0 105.789 174.769 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -60.95 -33.6 92.12 Favored 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 121.617 1.544 . . . . 0.0 111.316 179.087 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.461 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 76.1 m-85 -100.11 -26.3 14.0 Favored 'General case' 0 C--N 1.311 -1.079 0 C-N-CA 120.396 -0.522 . . . . 0.0 111.199 -177.787 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 53.6 t80 -106.28 113.82 27.57 Favored 'General case' 0 C--N 1.311 -1.078 0 C-N-CA 120.723 -0.391 . . . . 0.0 111.946 -179.341 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.534 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 20.0 m -121.69 141.09 51.5 Favored 'General case' 0 C--N 1.288 -2.087 0 N-CA-C 106.545 -1.65 . . . . 0.0 106.545 175.353 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 34.8 tt0 -133.43 145.96 50.75 Favored 'General case' 0 C--N 1.3 -1.579 0 C-N-CA 120.092 -0.643 . . . . 0.0 111.376 -172.215 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.667 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 57.2 m -75.77 110.6 10.32 Favored 'General case' 0 C--O 1.252 1.228 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.014 177.483 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 84.7 mt . . . . . 0 C--N 1.302 -1.462 0 CA-C-N 115.042 -0.981 . . . . 0.0 109.503 -177.442 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 . . . . . 0 N--CA 1.429 -1.519 0 N-CA-C 106.301 -1.74 . . . . 0.0 106.301 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 23.2 t -127.49 -177.61 4.15 Favored 'General case' 0 C--N 1.293 -1.866 0 C-N-CA 119.991 -0.684 . . . . 0.0 110.266 -176.635 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 41.6 t-80 -49.99 132.83 23.07 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 124.113 0.965 . . . . 0.0 110.93 -179.575 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 75.6 6.15 3.98 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 124.824 1.25 . . . . 0.0 112.294 178.652 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -98.8 155.92 20.11 Favored Glycine 0 N--CA 1.433 -1.528 0 N-CA-C 110.441 -1.064 . . . . 0.0 110.441 175.653 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.459 ' HA ' ' O ' ' A' ' 33' ' ' SER . 51.6 tt0 -81.23 116.53 21.15 Favored 'General case' 0 N--CA 1.438 -1.039 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 179.824 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.738 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 10.8 p -91.08 -22.02 20.93 Favored 'General case' 0 C--N 1.292 -1.904 0 N-CA-C 113.261 0.837 . . . . 0.0 113.261 -175.102 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 157.45 90.54 0.08 OUTLIER Glycine 0 CA--C 1.473 -2.592 0 C-N-CA 117.203 -2.427 . . . . 0.0 113.818 -179.108 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.649 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -113.11 179.41 19.08 Favored Glycine 0 C--N 1.275 -2.843 0 N-CA-C 108.076 -2.01 . . . . 0.0 108.076 173.999 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.44 ' HB ' ' CD1' ' A' ' 31' ' ' TYR . 56.5 mt -64.67 112.22 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 178.623 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 113.41 -4.37 24.96 Favored Glycine 0 N--CA 1.441 -1.027 0 C-N-CA 121.1 -0.572 . . . . 0.0 112.036 -179.399 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 72.9 t80 -101.42 129.29 47.41 Favored 'General case' 0 C--N 1.31 -1.129 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 3.7 p -129.12 5.76 5.35 Favored 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 112.751 0.649 . . . . 0.0 112.751 -177.39 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -81.49 -149.69 7.17 Favored Glycine 0 CA--C 1.533 1.21 0 C-N-CA 121.171 -0.538 . . . . 0.0 112.04 177.881 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_endo -63.02 111.43 1.39 Allowed 'Trans proline' 0 C--N 1.357 1.007 0 C-N-CA 122.538 2.159 . . . . 0.0 112.225 179.102 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.645 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 3.1 p -93.71 -16.09 24.59 Favored 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 113.166 0.802 . . . . 0.0 113.166 -176.238 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 8.2 p -90.48 128.1 42.57 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 CA-C-O 121.001 0.429 . . . . 0.0 110.402 -179.74 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 69.8 m -86.75 153.24 21.85 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 177.559 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -59.57 127.42 31.93 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 174.566 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 35.3 m -53.67 130.56 36.8 Favored 'General case' 0 C--O 1.246 0.909 0 CA-C-O 121.319 0.581 . . . . 0.0 110.973 -177.717 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 113.18 -21.21 18.1 Favored Glycine 0 N--CA 1.434 -1.464 0 N-CA-C 109.263 -1.535 . . . . 0.0 109.263 -170.591 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 70.6 p -117.57 143.34 46.2 Favored 'General case' 0 N--CA 1.443 -0.783 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 172.405 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 34.1 p -112.55 144.07 42.64 Favored 'General case' 0 C--N 1.295 -1.782 0 CA-C-O 120.71 0.29 . . . . 0.0 111.007 -177.034 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 50.9 t -78.83 98.51 6.35 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 178.54 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 75.3 mt-30 -103.74 127.69 51.19 Favored 'General case' 0 N--CA 1.431 -1.379 0 CA-C-O 120.996 0.427 . . . . 0.0 110.031 -177.713 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 60.0 t -78.37 114.04 18.45 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 179.463 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 74.2 mt -94.16 -70.38 0.71 Allowed 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 -178.692 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 77.6 m-20 -94.94 164.08 20.39 Favored Pre-proline 0 C--N 1.299 -1.612 0 N-CA-C 106.608 -1.627 . . . . 0.0 106.608 175.964 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -57.1 -35.33 98.88 Favored 'Trans proline' 0 CA--C 1.538 0.679 0 C-N-CA 121.886 1.724 . . . . 0.0 112.586 -179.029 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.649 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 50.5 m-85 -103.89 -21.07 13.7 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.991 -178.849 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 24.1 t80 -104.44 113.3 26.78 Favored 'General case' 0 C--N 1.316 -0.859 0 C-N-CA 119.87 -0.732 . . . . 0.0 111.24 -178.736 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.459 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 16.9 m -116.93 135.71 53.51 Favored 'General case' 0 C--N 1.289 -2.064 0 N-CA-C 106.068 -1.827 . . . . 0.0 106.068 175.648 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -129.92 144.72 51.47 Favored 'General case' 0 C--N 1.299 -1.621 0 CA-C-N 118.111 0.414 . . . . 0.0 110.832 -172.068 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.738 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 61.7 m -76.46 116.84 17.52 Favored 'General case' 0 C--O 1.259 1.592 0 CA-C-O 121.17 0.51 . . . . 0.0 110.154 177.479 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 94.5 mt . . . . . 0 C--N 1.298 -1.666 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 177.582 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 . . . . . 0 N--CA 1.446 -0.65 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 3' ' ' SER . . . . . 0.434 ' O ' ' HB2' ' A' ' 35' ' ' CYS . 19.6 p -95.05 -178.13 4.38 Favored 'General case' 0 C--N 1.29 -2.013 0 C-N-CA 123.134 0.574 . . . . 0.0 111.54 -174.479 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 51.0 t-80 -64.55 123.59 19.65 Favored 'General case' 0 N--CA 1.445 -0.694 0 N-CA-C 108.023 -1.102 . . . . 0.0 108.023 176.718 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 65.03 83.95 0.16 Allowed 'General case' 0 C--N 1.319 -0.727 0 O-C-N 124.446 1.092 . . . . 0.0 111.453 -175.819 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.511 ' O ' ' HA ' ' A' ' 34' ' ' GLN . . . -167.38 159.13 32.36 Favored Glycine 0 N--CA 1.424 -2.138 0 N-CA-C 106.916 -2.474 . . . . 0.0 106.916 179.398 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.603 ' HA ' ' O ' ' A' ' 33' ' ' SER . 53.3 tt0 -82.36 110.36 17.44 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 118.281 1.04 . . . . 0.0 110.049 -179.19 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.709 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 1.8 p -86.1 -47.81 9.18 Favored 'General case' 0 C--N 1.295 -1.793 0 N-CA-C 113.237 0.829 . . . . 0.0 113.237 -177.79 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.422 ' H ' ' HB2' ' A' ' 33' ' ' SER . . . -174.22 89.16 0.08 OUTLIER Glycine 0 CA--C 1.486 -1.73 0 C-N-CA 117.716 -2.183 . . . . 0.0 114.07 -175.669 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.509 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -112.87 178.38 18.75 Favored Glycine 0 C--N 1.286 -2.213 0 N-CA-C 107.673 -2.171 . . . . 0.0 107.673 173.616 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 67.6 mt -61.58 118.44 4.08 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-N 118.239 1.019 . . . . 0.0 108.83 177.037 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 110.26 -14.85 30.64 Favored Glycine 0 N--CA 1.443 -0.897 0 C-N-CA 120.767 -0.73 . . . . 0.0 111.841 -178.852 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 25.7 t80 -114.09 121.47 43.92 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 -179.574 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 13.7 p -134.96 18.28 3.48 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-O 121.282 0.563 . . . . 0.0 111.545 -179.496 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -78.6 -128.61 0.53 Allowed Glycine 0 CA--C 1.521 0.414 0 CA-C-N 115.311 -0.859 . . . . 0.0 111.065 176.844 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -67.04 88.37 0.3 Allowed 'Trans proline' 0 CA--C 1.536 0.576 0 C-N-CA 122.201 1.934 . . . . 0.0 111.95 176.549 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.633 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 39.2 p -86.73 0.15 55.21 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.651 0.739 . . . . 0.0 110.756 -179.625 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 7.6 p -102.27 129.74 53.23 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.579 0 CA-C-N 114.89 -1.05 . . . . 0.0 108.82 178.663 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.461 ' SG ' ' HB2' ' A' ' 25' ' ' CYS . 71.4 m -92.64 153.64 18.86 Favored 'General case' 0 C--N 1.293 -1.886 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.67 -179.703 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -56.51 133.01 53.05 Favored 'General case' 0 C--O 1.249 1.039 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 174.899 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 9.2 p -53.97 127.51 26.63 Favored 'General case' 0 C--O 1.249 1.073 0 CA-C-O 121.528 0.68 . . . . 0.0 112.294 -177.149 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 112.43 -9.49 26.38 Favored Glycine 0 N--CA 1.431 -1.687 0 CA-C-N 114.843 -1.071 . . . . 0.0 110.784 -175.493 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 67.1 p -127.39 145.73 50.71 Favored 'General case' 0 C--O 1.246 0.899 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 176.477 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 23.6 p -111.3 140.14 46.12 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-O 120.381 0.134 . . . . 0.0 111.178 -178.337 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.461 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 53.6 t -73.31 103.07 3.87 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 179.094 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 16.7 mm-40 -91.12 113.48 25.76 Favored 'General case' 0 N--CA 1.425 -1.695 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.024 -179.005 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 45.5 t -76.19 101.36 2.59 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.114 0 N-CA-C 107.142 -1.429 . . . . 0.0 107.142 176.698 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 77.3 mt -86.87 -69.93 0.64 Allowed 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 -177.661 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 79.1 m-20 -95.74 165.31 16.82 Favored Pre-proline 0 C--N 1.298 -1.668 0 N-CA-C 107.038 -1.467 . . . . 0.0 107.038 174.727 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_exo -60.91 -29.98 89.11 Favored 'Trans proline' 0 CA--C 1.542 0.884 0 C-N-CA 121.499 1.466 . . . . 0.0 111.658 178.428 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.509 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 87.8 m-85 -101.77 -25.54 13.8 Favored 'General case' 0 N--CA 1.44 -0.969 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.553 -179.839 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 68.2 t80 -106.05 114.8 29.16 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 113.008 0.744 . . . . 0.0 113.008 -178.538 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.603 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 23.8 m -121.18 136.59 54.95 Favored 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 175.711 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' GLN . . . . . 0.511 ' HA ' ' O ' ' A' ' 6' ' ' GLY . 35.2 tt0 -127.59 133.24 49.73 Favored 'General case' 0 C--N 1.318 -0.762 0 C-N-CA 122.202 0.201 . . . . 0.0 110.763 -173.253 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.709 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 64.1 m -74.01 109.03 7.18 Favored 'General case' 0 C--O 1.243 0.739 0 CA-C-O 120.972 0.415 . . . . 0.0 111.756 177.996 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 96.6 mt . . . . . 0 C--N 1.299 -1.591 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 178.689 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 . . . . . 0 N--CA 1.416 -2.133 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 61.3 p -91.99 173.9 7.6 Favored 'General case' 0 C--N 1.282 -2.332 0 CA-C-N 114.857 -1.065 . . . . 0.0 110.146 -175.027 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 55.2 t-80 -57.54 134.23 55.94 Favored 'General case' 0 C--N 1.315 -0.905 0 C-N-CA 123.453 0.701 . . . . 0.0 110.107 177.183 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 70.51 10.42 7.16 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.646 1.178 . . . . 0.0 112.908 178.169 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.526 ' O ' ' HA ' ' A' ' 34' ' ' GLN . . . -97.62 155.8 20.56 Favored Glycine 0 N--CA 1.438 -1.2 0 N-CA-C 110.726 -0.95 . . . . 0.0 110.726 176.175 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.634 ' HA ' ' O ' ' A' ' 33' ' ' SER . 64.4 tt0 -70.25 110.51 5.27 Favored 'General case' 0 C--O 1.217 -0.608 0 CA-C-N 117.14 0.47 . . . . 0.0 109.931 -178.958 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.742 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 21.1 p -93.13 -31.68 14.71 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 113.565 0.95 . . . . 0.0 113.565 -175.764 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 179.84 84.36 0.06 OUTLIER Glycine 0 CA--C 1.483 -1.932 0 C-N-CA 117.574 -2.251 . . . . 0.0 113.786 -174.673 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.567 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -112.44 167.2 12.3 Favored Glycine 0 C--N 1.286 -2.24 0 N-CA-C 108.748 -1.741 . . . . 0.0 108.748 174.81 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 79.7 mt -60.78 117.53 2.66 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 177.532 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 105.37 -8.75 44.79 Favored Glycine 0 N--CA 1.442 -0.965 0 C-N-CA 120.373 -0.918 . . . . 0.0 111.804 179.734 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 90.4 t80 -94.74 108.85 20.85 Favored 'General case' 0 N--CA 1.44 -0.932 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 178.06 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 3.3 p -103.87 7.71 36.9 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-N 114.806 -1.088 . . . . 0.0 111.743 -176.741 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -81.05 -163.3 30.08 Favored Glycine 0 N--CA 1.445 -0.737 0 C-N-CA 121.084 -0.579 . . . . 0.0 112.361 -179.28 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_endo -62.16 118.25 5.13 Favored 'Trans proline' 0 C--O 1.235 0.342 0 C-N-CA 122.834 2.356 . . . . 0.0 110.754 177.905 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.551 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 10.2 p -99.71 -14.89 18.71 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 -174.639 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 13.6 p -79.48 137.66 21.33 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 C-N-CA 120.594 -0.442 . . . . 0.0 110.004 179.882 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.405 ' HB3' ' OG1' ' A' ' 23' ' ' THR . 71.2 m -97.31 153.08 18.28 Favored 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 179.544 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.53 155.67 21.48 Favored 'General case' 0 C--O 1.251 1.159 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.238 178.107 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 4.9 p -58.3 118.55 5.64 Favored 'General case' 0 C--N 1.307 -1.254 0 C-N-CA 123.429 0.692 . . . . 0.0 111.383 -179.328 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 111.92 -11.33 27.26 Favored Glycine 0 N--CA 1.441 -0.982 0 C-N-CA 120.926 -0.654 . . . . 0.0 111.641 -178.926 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.405 ' OG1' ' HB3' ' A' ' 19' ' ' CYS . 76.7 p -120.22 151.78 38.65 Favored 'General case' 0 C--O 1.256 1.412 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 178.058 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.411 ' O ' ' HA ' ' A' ' 35' ' ' CYS . 16.9 p -121.87 148.83 44.21 Favored 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 110.278 -0.268 . . . . 0.0 110.278 176.478 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 49.4 t -77.47 103.88 7.66 Favored 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 179.679 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 12.7 mm-40 -98.44 117.83 33.74 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 116.052 -0.522 . . . . 0.0 109.951 -178.382 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 41.2 t -87.06 105.71 15.33 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 -178.715 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 69.1 mt -89.68 -69.46 0.72 Allowed 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 -178.168 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 48.7 m-80 -95.19 170.34 8.02 Favored Pre-proline 0 C--N 1.301 -1.522 0 N-CA-C 107.038 -1.468 . . . . 0.0 107.038 176.148 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_exo -65.97 -30.15 48.49 Favored 'Trans proline' 0 C--N 1.345 0.349 0 CA-C-N 120.57 1.239 . . . . 0.0 111.875 177.072 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.567 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 28.5 m-85 -106.43 -25.59 11.81 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 119.779 -0.768 . . . . 0.0 110.585 -177.875 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 60.4 t80 -104.76 115.3 30.07 Favored 'General case' 0 N--CA 1.443 -0.807 0 C-N-CA 119.893 -0.723 . . . . 0.0 112.563 177.883 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.634 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 14.5 m -131.65 141.14 49.54 Favored 'General case' 0 C--N 1.293 -1.861 0 N-CA-C 105.993 -1.854 . . . . 0.0 105.993 176.272 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' GLN . . . . . 0.526 ' HA ' ' O ' ' A' ' 6' ' ' GLY . 4.1 pt20 -132.82 151.1 52.08 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 119.084 0.857 . . . . 0.0 111.882 -178.172 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.742 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 61.2 m -76.55 118.41 19.18 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-O 121.218 0.533 . . . . 0.0 110.517 178.082 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 97.0 mt . . . . . 0 C--N 1.303 -1.453 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 178.525 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 . . . . . 0 N--CA 1.44 -0.97 0 N-CA-C 107.429 -1.323 . . . . 0.0 107.429 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 22.7 t -110.03 -168.52 1.33 Allowed 'General case' 0 C--N 1.29 -1.987 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 -176.409 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 25.2 t-80 -56.18 126.46 26.21 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 123.249 0.62 . . . . 0.0 110.182 -178.587 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 69.57 76.94 0.22 Allowed 'General case' 0 C--N 1.328 -0.339 0 O-C-N 124.604 1.19 . . . . 0.0 111.424 -178.41 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.574 ' O ' ' HA ' ' A' ' 34' ' ' GLN . . . -169.55 155.55 25.75 Favored Glycine 0 N--CA 1.433 -1.527 0 N-CA-C 108.699 -1.761 . . . . 0.0 108.699 179.175 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.689 ' HA ' ' O ' ' A' ' 33' ' ' SER . 53.2 tt0 -77.64 107.24 9.98 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 117.591 0.696 . . . . 0.0 110.329 -178.268 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.796 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 6.1 p -87.82 -41.9 12.94 Favored 'General case' 0 C--N 1.297 -1.709 0 CA-C-N 115.395 -0.82 . . . . 0.0 113.133 -176.613 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -161.96 53.99 0.31 Allowed Glycine 0 CA--C 1.471 -2.687 0 C-N-CA 118.956 -1.592 . . . . 0.0 111.687 -173.685 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.439 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -95.69 149.68 19.41 Favored Glycine 0 N--CA 1.423 -2.202 0 N-CA-C 108.442 -1.863 . . . . 0.0 108.442 175.692 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.437 ' HB ' ' CD1' ' A' ' 31' ' ' TYR . 61.4 mt -57.97 121.03 4.76 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.913 0 CA-C-N 117.315 0.558 . . . . 0.0 110.443 -178.299 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 109.59 4.26 30.3 Favored Glycine 0 N--CA 1.445 -0.713 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.985 -179.114 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.458 ' HB2' ' NE2' ' A' ' 7' ' ' GLN . 70.0 t80 -103.54 119.94 39.88 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 177.929 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 14.3 p -99.64 1.17 43.32 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 112.397 0.517 . . . . 0.0 112.397 -177.157 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -85.68 -175.8 50.2 Favored Glycine 0 N--CA 1.444 -0.822 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.329 -179.266 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -66.16 130.41 24.08 Favored 'Trans proline' 0 CA--C 1.533 0.454 0 C-N-CA 122.759 2.306 . . . . 0.0 111.616 -179.535 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.564 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 37.1 p -88.04 10.29 19.58 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-O 121.626 0.727 . . . . 0.0 111.679 -177.911 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 7.1 p -94.19 123.41 46.29 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.496 0 CA-C-O 121.567 0.699 . . . . 0.0 110.82 -178.372 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 83.7 m -88.56 160.12 17.59 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-N 115.112 -0.949 . . . . 0.0 109.154 177.064 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -72.17 146.15 47.59 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 176.751 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 67.9 m -53.1 130.27 33.59 Favored 'General case' 0 C--O 1.25 1.1 0 CA-C-O 121.092 0.472 . . . . 0.0 110.211 176.763 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 112.18 -16.81 24.75 Favored Glycine 0 N--CA 1.43 -1.722 0 N-CA-C 110.781 -0.928 . . . . 0.0 110.781 -173.593 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 41.4 p -133.2 144.78 50.04 Favored 'General case' 0 N--CA 1.443 -0.818 0 CA-C-O 120.819 0.342 . . . . 0.0 111.327 179.577 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 23.3 p -116.77 152.32 34.62 Favored 'General case' 0 C--N 1.309 -1.161 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 177.778 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 44.8 t -77.53 111.44 13.27 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 -179.422 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 70.3 mt-30 -110.9 127.93 55.63 Favored 'General case' 0 N--CA 1.434 -1.238 0 CA-C-O 121.331 0.586 . . . . 0.0 110.273 -179.656 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 58.8 t -81.01 110.75 16.84 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.723 -178.141 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 75.4 mt -90.02 -72.65 0.55 Allowed 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 107.01 -1.478 . . . . 0.0 107.01 177.314 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 54.8 m-80 -95.79 164.29 19.13 Favored Pre-proline 0 C--N 1.298 -1.66 0 N-CA-C 106.785 -1.561 . . . . 0.0 106.785 170.536 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_exo -63.56 -33.45 67.82 Favored 'Trans proline' 0 C--O 1.241 0.637 0 C-N-CA 121.64 1.56 . . . . 0.0 111.26 176.374 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.439 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 76.8 m-85 -97.17 -26.38 14.97 Favored 'General case' 0 N--CA 1.442 -0.83 0 C-N-CA 119.633 -0.827 . . . . 0.0 110.819 -179.689 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 53.1 t80 -106.21 113.01 26.29 Favored 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 119.436 -0.906 . . . . 0.0 110.956 175.397 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.689 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 20.0 m -123.98 140.92 52.5 Favored 'General case' 0 C--N 1.288 -2.103 0 N-CA-C 106.616 -1.624 . . . . 0.0 106.616 177.393 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' GLN . . . . . 0.574 ' HA ' ' O ' ' A' ' 6' ' ' GLY . 37.1 tt0 -129.89 140.57 50.94 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 -169.493 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.796 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 73.7 m -71.41 116.85 12.22 Favored 'General case' 0 C--O 1.258 1.522 0 CA-C-O 121.147 0.499 . . . . 0.0 110.544 175.303 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 95.5 mt . . . . . 0 C--N 1.303 -1.424 0 C-N-CA 125.156 1.382 . . . . 0.0 107.949 179.515 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 5.6 tp-100 . . . . . 0 N--CA 1.442 -0.839 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 62.4 m -126.16 -173.22 2.8 Favored 'General case' 0 C--N 1.297 -1.715 0 C-N-CA 120.176 -0.61 . . . . 0.0 111.923 -177.181 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' HIS . . . . . 0.59 ' HA ' ' O ' ' A' ' 35' ' ' CYS . 57.6 t-80 -54.29 132.27 43.41 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 123.055 0.542 . . . . 0.0 110.326 -178.702 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 5' ' ' ALA . . . . . 0.493 ' HA ' ' OE1' ' A' ' 34' ' ' GLN . . . 81.16 1.61 1.66 Allowed 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 125.251 1.42 . . . . 0.0 112.195 -178.423 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -98.91 153.22 19.79 Favored Glycine 0 N--CA 1.433 -1.54 0 N-CA-C 110.766 -0.934 . . . . 0.0 110.766 177.061 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.465 ' HA ' ' O ' ' A' ' 33' ' ' SER . 49.7 tt0 -82.17 111.5 18.34 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 179.856 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.77 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 14.6 p -83.45 -14.36 52.69 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.783 -178.025 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 122.94 115.24 2.23 Favored Glycine 0 N--CA 1.416 -2.674 0 C-N-CA 117.574 -2.25 . . . . 0.0 116.279 173.424 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -112.38 -153.59 11.93 Favored Glycine 0 N--CA 1.418 -2.555 0 N-CA-C 107.063 -2.415 . . . . 0.0 107.063 171.503 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 78.9 mt -64.29 124.18 18.57 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.679 0 CA-C-N 117.756 0.778 . . . . 0.0 110.493 177.836 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 95.9 6.87 59.04 Favored Glycine 0 N--CA 1.442 -0.956 0 CA-C-N 115.998 -0.546 . . . . 0.0 113.741 176.438 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 49.4 t80 -109.25 127.55 54.34 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 -179.712 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 6.7 p -128.83 15.7 6.37 Favored 'General case' 0 C--N 1.303 -1.434 0 CA-C-O 121.505 0.669 . . . . 0.0 111.144 -177.397 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -84.42 -143.83 6.16 Favored Glycine 0 C--O 1.248 0.981 0 N-CA-C 111.449 -0.66 . . . . 0.0 111.449 178.216 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -73.01 103.53 1.61 Allowed 'Trans proline' 0 N--CA 1.448 -1.154 0 C-N-CA 122.227 1.951 . . . . 0.0 111.395 177.769 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.524 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 32.8 p -94.46 -7.68 40.73 Favored 'General case' 0 N--CA 1.434 -1.234 0 CA-C-O 121.669 0.747 . . . . 0.0 110.816 -178.474 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 7.4 p -82.31 123.64 38.46 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.805 0 CA-C-N 115.239 -0.891 . . . . 0.0 110.732 178.051 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 78.4 m -90.44 148.88 22.5 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 109.481 -0.562 . . . . 0.0 109.481 176.395 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.53 150.9 17.89 Favored 'General case' 0 C--O 1.251 1.169 0 O-C-N 123.774 0.671 . . . . 0.0 110.449 177.381 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 8.9 t -59.41 115.87 3.56 Favored 'General case' 0 N--CA 1.433 -1.297 0 CA-C-N 115.663 -0.698 . . . . 0.0 109.491 -177.577 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 111.91 -5.69 27.41 Favored Glycine 0 N--CA 1.437 -1.237 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.077 -178.882 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 60.3 p -121.43 147.02 46.29 Favored 'General case' 0 C--N 1.312 -1.06 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 175.36 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 26.5 p -117.84 141.48 48.37 Favored 'General case' 0 C--N 1.304 -1.41 0 C-N-CA 121.26 -0.176 . . . . 0.0 110.586 -178.836 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 48.4 t -72.66 103.8 3.71 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 85.3 mm-40 -98.26 112.26 24.31 Favored 'General case' 0 N--CA 1.415 -2.186 0 CA-C-O 121.264 0.554 . . . . 0.0 110.24 -179.225 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 41.4 t -80.39 96.51 2.75 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.588 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 179.732 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 87.1 mt -80.9 -69.98 0.56 Allowed 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 -177.828 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 23.9 m120 -94.27 164.55 19.87 Favored Pre-proline 0 C--N 1.298 -1.649 0 N-CA-C 106.449 -1.685 . . . . 0.0 106.449 175.949 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -59.77 -33.1 96.38 Favored 'Trans proline' 0 N--CA 1.475 0.42 0 C-N-CA 121.655 1.57 . . . . 0.0 111.669 178.781 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -100.27 -25.36 14.27 Favored 'General case' 0 N--CA 1.441 -0.915 0 C-N-CA 120.077 -0.649 . . . . 0.0 111.206 179.606 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 80.2 t80 -105.05 114.42 28.61 Favored 'General case' 0 C--N 1.309 -1.191 0 C-N-CA 119.798 -0.761 . . . . 0.0 112.673 -176.782 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.465 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 24.0 m -125.58 137.3 53.9 Favored 'General case' 0 C--N 1.284 -2.257 0 N-CA-C 106.858 -1.534 . . . . 0.0 106.858 178.114 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' GLN . . . . . 0.493 ' OE1' ' HA ' ' A' ' 5' ' ' ALA . 8.0 tt0 -128.53 142.04 51.19 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 109.956 -0.386 . . . . 0.0 109.956 -175.943 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.77 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 75.2 m -75.06 110.74 9.63 Favored 'General case' 0 C--O 1.249 1.037 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 175.806 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 96.6 mt . . . . . 0 N--CA 1.423 -1.801 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 179.08 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 . . . . . 0 N--CA 1.434 -1.269 0 CA-C-O 121.383 0.611 . . . . 0.0 110.255 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 18.3 p -88.01 166.89 14.15 Favored 'General case' 0 C--N 1.285 -2.2 0 CA-C-N 115.243 -0.889 . . . . 0.0 111.575 -174.555 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 56.6 t-80 -57.82 136.75 57.01 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 107.675 -1.232 . . . . 0.0 107.675 172.63 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' ALA . . . . . 0.416 ' HA ' ' CD ' ' A' ' 34' ' ' GLN . . . 73.2 12.56 4.88 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.396 0.678 . . . . 0.0 112.665 -179.935 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.454 ' O ' ' HA ' ' A' ' 34' ' ' GLN . . . -107.58 164.42 13.0 Favored Glycine 0 C--O 1.243 0.715 0 N-CA-C 110.478 -1.049 . . . . 0.0 110.478 175.364 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.587 ' HA ' ' O ' ' A' ' 33' ' ' SER . 54.1 tt0 -84.55 107.05 16.57 Favored 'General case' 0 C--O 1.224 -0.251 0 CA-C-N 117.395 0.598 . . . . 0.0 110.894 -177.839 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.805 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 12.3 p -84.34 -37.79 21.16 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 113.705 1.002 . . . . 0.0 113.705 -175.565 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -177.43 87.81 0.07 OUTLIER Glycine 0 CA--C 1.481 -2.04 0 C-N-CA 117.96 -2.067 . . . . 0.0 113.24 -176.291 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.559 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -112.42 172.9 14.96 Favored Glycine 0 C--N 1.28 -2.548 0 N-CA-C 107.921 -2.072 . . . . 0.0 107.921 174.867 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 68.8 mt -63.07 118.0 4.64 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.208 0 CA-C-N 117.861 0.83 . . . . 0.0 109.353 178.785 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 105.73 6.21 38.07 Favored Glycine 0 C--N 1.312 -0.799 0 C-N-CA 120.421 -0.895 . . . . 0.0 112.386 178.73 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 85.2 t80 -102.47 118.48 36.97 Favored 'General case' 0 C--N 1.307 -1.262 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 178.532 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 14.3 p -109.36 0.38 19.44 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-O 121.271 0.558 . . . . 0.0 111.513 -177.703 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -77.92 -171.64 37.77 Favored Glycine 0 N--CA 1.443 -0.841 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.918 178.99 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_endo -64.37 119.24 6.22 Favored 'Trans proline' 0 C--O 1.237 0.454 0 C-N-CA 122.481 2.121 . . . . 0.0 111.291 178.983 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.564 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 70.1 p -90.71 -8.32 50.17 Favored 'General case' 0 C--O 1.24 0.558 0 CA-C-O 121.41 0.624 . . . . 0.0 111.211 -176.873 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 5.6 p -80.07 126.41 39.36 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.185 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.334 179.411 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 83.9 m -87.78 163.46 16.46 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.253 -179.017 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.29 150.89 45.16 Favored 'General case' 0 C--O 1.254 1.323 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 175.49 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 35.6 t -57.76 126.01 25.51 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-O 121.503 0.668 . . . . 0.0 110.572 -175.965 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 112.32 -21.11 20.25 Favored Glycine 0 N--CA 1.43 -1.766 0 CA-C-N 115.172 -0.922 . . . . 0.0 111.62 -178.412 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 50.7 p -116.02 147.09 41.6 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 120.765 -0.374 . . . . 0.0 110.384 179.569 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.405 ' O ' ' HA ' ' A' ' 35' ' ' CYS . 21.7 p -120.23 155.39 33.29 Favored 'General case' 0 C--N 1.298 -1.656 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.767 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 48.5 t -80.23 102.95 9.78 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-O 121.143 0.497 . . . . 0.0 110.433 -178.833 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.451 ' HG3' ' HB2' ' A' ' 36' ' ' LEU . 9.1 mm-40 -100.87 122.29 43.18 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 -179.166 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 57.6 t -79.84 114.8 21.21 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.715 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 -179.083 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 86.4 mt -98.25 -70.04 0.74 Allowed 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 179.192 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.465 ' HB2' ' H ' ' A' ' 32' ' ' TYR . 88.2 m-20 -94.07 166.11 16.3 Favored Pre-proline 0 C--N 1.304 -1.373 0 N-CA-C 105.986 -1.857 . . . . 0.0 105.986 174.225 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -64.49 -26.6 62.41 Favored 'Trans proline' 0 CA--C 1.538 0.691 0 C-N-CA 121.255 1.303 . . . . 0.0 111.341 177.277 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.559 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 70.1 m-85 -107.16 -26.34 11.14 Favored 'General case' 0 N--CA 1.443 -0.777 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.121 -178.935 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.465 ' H ' ' HB2' ' A' ' 29' ' ' ASN . 67.6 t80 -105.73 113.84 27.64 Favored 'General case' 0 C--N 1.304 -1.383 0 C-N-CA 119.627 -0.829 . . . . 0.0 110.978 178.418 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.587 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 21.3 m -121.72 140.92 51.7 Favored 'General case' 0 C--N 1.279 -2.494 0 N-CA-C 105.616 -1.994 . . . . 0.0 105.616 175.088 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' GLN . . . . . 0.464 ' OE1' HD21 ' A' ' 36' ' ' LEU . 35.9 tt0 -125.81 141.36 52.03 Favored 'General case' 0 C--N 1.29 -1.999 0 C-N-CA 120.874 -0.33 . . . . 0.0 110.766 -171.407 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.805 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 85.5 m -74.38 114.21 12.5 Favored 'General case' 0 C--O 1.252 1.187 0 CA-C-O 121.176 0.512 . . . . 0.0 109.982 176.247 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.464 HD21 ' OE1' ' A' ' 34' ' ' GLN . 95.5 mt . . . . . 0 N--CA 1.426 -1.639 0 CA-C-N 115.127 -0.942 . . . . 0.0 108.84 -179.382 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 6.3 m . . . . . 0 N--CA 1.436 -1.167 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -78.74 134.89 37.02 Favored 'General case' 0 N--CA 1.426 -1.639 0 CA-C-O 121.377 0.608 . . . . 0.0 109.774 -175.419 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 22.9 t -97.97 171.82 8.02 Favored 'General case' 0 C--N 1.282 -2.345 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.213 -173.885 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' HIS . . . . . 0.569 ' O ' ' H5 ' ' A' ' 101' ' ' MAN . 41.8 t-80 -61.45 132.11 52.37 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 179.078 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.47 ' HA ' ' OE1' ' A' ' 34' ' ' GLN . . . 83.71 0.28 1.04 Allowed 'General case' 0 N--CA 1.48 1.053 0 O-C-N 124.915 1.384 . . . . 0.0 113.011 -177.745 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.427 ' O ' ' HA ' ' A' ' 34' ' ' GLN . . . -96.66 160.25 21.79 Favored Glycine 0 C--O 1.245 0.809 0 C-N-CA 120.474 -0.87 . . . . 0.0 111.914 178.265 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.618 ' HA ' ' O ' ' A' ' 33' ' ' SER . 7.6 tt0 -81.72 104.42 12.1 Favored 'General case' 0 C--O 1.225 -0.235 0 CA-C-O 121.451 0.643 . . . . 0.0 110.851 -179.198 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.777 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 7.7 p -80.8 -41.91 22.56 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 114.384 1.253 . . . . 0.0 114.384 -174.729 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.43 ' H ' ' HB2' ' A' ' 33' ' ' SER . . . -176.03 81.22 0.07 OUTLIER Glycine 0 CA--C 1.477 -2.324 0 C-N-CA 117.547 -2.263 . . . . 0.0 113.674 -175.432 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.437 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -112.69 175.63 16.98 Favored Glycine 0 C--N 1.283 -2.399 0 N-CA-C 107.989 -2.045 . . . . 0.0 107.989 173.352 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.46 ' HB ' ' CD2' ' A' ' 31' ' ' TYR . 55.1 mt -65.54 133.75 30.39 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 175.853 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 103.86 -16.23 51.12 Favored Glycine 0 C--N 1.311 -0.834 0 N-CA-C 111.251 -0.74 . . . . 0.0 111.251 -177.479 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 67.1 t80 -100.94 109.62 21.58 Favored 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 179.747 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 11.4 p -101.63 1.31 37.59 Favored 'General case' 0 C--N 1.3 -1.557 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.314 -178.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -79.46 -178.76 51.55 Favored Glycine 0 N--CA 1.441 -1.023 0 CA-C-N 115.887 -0.597 . . . . 0.0 112.317 179.322 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -60.48 122.4 11.24 Favored 'Trans proline' 0 C--O 1.241 0.637 0 C-N-CA 123.194 2.596 . . . . 0.0 111.825 179.536 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.562 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 22.9 p -92.6 9.12 36.05 Favored 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 113.571 0.952 . . . . 0.0 113.571 -173.372 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 7.5 p -91.82 126.79 44.39 Favored 'Isoleucine or valine' 0 C--O 1.248 1.02 0 CA-C-O 121.39 0.614 . . . . 0.0 111.551 -178.117 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 71.2 m -84.26 161.48 20.47 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.847 178.139 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.33 154.46 42.0 Favored 'General case' 0 C--O 1.25 1.088 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.494 176.129 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 3.1 p -60.2 129.13 40.17 Favored 'General case' 0 N--CA 1.433 -1.302 0 CA-C-O 121.263 0.554 . . . . 0.0 111.458 -178.495 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 111.34 -17.67 26.12 Favored Glycine 0 N--CA 1.423 -2.216 0 N-CA-C 110.666 -0.974 . . . . 0.0 110.666 -177.659 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 77.6 p -123.03 153.29 40.03 Favored 'General case' 0 C--O 1.252 1.215 0 CA-C-O 120.828 0.346 . . . . 0.0 110.983 -178.536 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 34.2 p -119.79 149.56 41.85 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 178.33 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 44.9 t -75.49 105.37 6.49 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 177.828 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 84.0 mm-40 -100.64 110.82 22.98 Favored 'General case' 0 N--CA 1.415 -2.188 0 CA-C-O 121.718 0.77 . . . . 0.0 110.556 -179.355 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 63.9 t -77.73 121.52 30.57 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.089 0 CA-C-N 114.637 -1.165 . . . . 0.0 108.267 179.493 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 84.6 mt -104.26 -67.72 0.88 Allowed 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 107.324 -1.362 . . . . 0.0 107.324 179.229 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 48.7 m-80 -95.07 163.27 22.34 Favored Pre-proline 0 C--N 1.293 -1.891 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 173.893 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_exo -63.96 -30.61 67.1 Favored 'Trans proline' 0 CA--C 1.531 0.355 0 C-N-CA 121.204 1.27 . . . . 0.0 111.198 178.759 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.46 ' CD2' ' HB ' ' A' ' 11' ' ' ILE . 22.3 m-85 -100.31 -25.9 14.08 Favored 'General case' 0 N--CA 1.437 -1.118 0 C-N-CA 120.364 -0.534 . . . . 0.0 110.834 -179.415 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 75.8 t80 -105.96 114.13 28.09 Favored 'General case' 0 C--O 1.243 0.749 0 N-CA-C 112.6 0.592 . . . . 0.0 112.6 178.374 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.618 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 15.1 m -125.55 143.45 51.01 Favored 'General case' 0 C--N 1.293 -1.871 0 N-CA-C 106.631 -1.618 . . . . 0.0 106.631 176.34 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.47 ' OE1' ' HA ' ' A' ' 5' ' ' ALA . 8.4 tt0 -132.08 141.23 49.12 Favored 'General case' 0 C--N 1.298 -1.671 0 CA-C-N 118.02 0.373 . . . . 0.0 110.464 -174.112 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.777 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 77.6 m -74.21 114.75 12.92 Favored 'General case' 0 C--O 1.253 1.245 0 C-N-CA 120.714 -0.394 . . . . 0.0 110.344 175.921 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 97.2 mt . . . . . 0 N--CA 1.428 -1.566 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 178.602 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 101' ' ' MAN . . . . . 0.569 ' H5 ' ' O ' ' A' ' 4' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 9.1 m . . . . . 0 N--CA 1.438 -1.043 0 N-CA-C 107.678 -1.231 . . . . 0.0 107.678 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 5.9 tp-100 -126.81 135.58 51.21 Favored 'General case' 0 N--CA 1.433 -1.324 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 173.915 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 53.3 m -107.61 -176.24 3.01 Favored 'General case' 0 C--N 1.302 -1.471 0 C-N-CA 120.505 -0.478 . . . . 0.0 111.266 -177.011 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 54.0 t60 -57.61 132.7 54.02 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 122.846 0.458 . . . . 0.0 109.957 -177.723 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.467 ' HA ' ' NE2' ' A' ' 34' ' ' GLN . . . 80.15 -4.48 1.88 Allowed 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 125.557 1.543 . . . . 0.0 112.63 -179.253 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -85.68 146.54 21.55 Favored Glycine 0 N--CA 1.437 -1.285 0 C-N-CA 120.37 -0.919 . . . . 0.0 110.912 178.172 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.552 ' HA ' ' O ' ' A' ' 33' ' ' SER . 62.1 tt0 -62.95 108.68 1.25 Allowed 'General case' 0 C--O 1.22 -0.473 0 CA-C-O 121.148 0.499 . . . . 0.0 110.382 178.267 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.744 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 23.3 p -86.04 -43.39 13.16 Favored 'General case' 0 C--N 1.297 -1.678 0 CA-C-N 115.73 -0.668 . . . . 0.0 112.678 -174.806 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -179.03 86.34 0.07 OUTLIER Glycine 0 CA--C 1.473 -2.542 0 C-N-CA 118.188 -1.958 . . . . 0.0 113.326 -174.474 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.523 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -104.7 178.46 24.01 Favored Glycine 0 N--CA 1.42 -2.418 0 N-CA-C 108.736 -1.745 . . . . 0.0 108.736 175.033 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 64.9 mt -66.12 128.03 28.4 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.757 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 176.725 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 99.51 -17.28 57.89 Favored Glycine 0 N--CA 1.44 -1.035 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.043 -179.666 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 67.7 t80 -87.22 109.07 19.23 Favored 'General case' 0 C--N 1.312 -1.042 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 -178.567 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 37.0 p -99.23 2.31 45.54 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.481 -178.67 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -74.56 -178.31 39.83 Favored Glycine 0 N--CA 1.436 -1.312 0 CA-C-N 115.357 -0.838 . . . . 0.0 112.486 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_endo -62.38 121.46 9.45 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 122.605 2.203 . . . . 0.0 112.133 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.634 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 29.1 p -92.89 0.67 57.45 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.005 -179.703 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 7.8 p -78.64 110.22 14.14 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.11 0 CA-C-O 121.993 0.901 . . . . 0.0 111.664 -179.36 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 70.9 m -83.79 152.9 24.39 Favored 'General case' 0 C--N 1.302 -1.486 0 CA-C-N 115.115 -0.948 . . . . 0.0 109.644 177.732 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.4 145.33 33.06 Favored 'General case' 0 C--O 1.25 1.079 0 O-C-N 123.459 0.475 . . . . 0.0 110.229 176.533 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 19.3 m -52.83 119.36 4.51 Favored 'General case' 0 C--N 1.318 -0.79 0 O-C-N 123.757 0.661 . . . . 0.0 111.464 -178.012 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 111.88 -11.25 27.38 Favored Glycine 0 N--CA 1.439 -1.126 0 CA-C-N 115.832 -0.622 . . . . 0.0 112.255 -179.737 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 68.2 p -118.42 147.29 43.72 Favored 'General case' 0 C--O 1.244 0.789 0 N-CA-C 109.808 -0.441 . . . . 0.0 109.808 178.239 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 38.9 p -113.35 149.5 33.92 Favored 'General case' 0 C--N 1.309 -1.192 0 C-N-CA 121.223 -0.191 . . . . 0.0 110.751 -178.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 51.5 t -76.42 103.6 6.51 Favored 'General case' 0 C--N 1.312 -1.047 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 178.367 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 68.6 mt-30 -102.78 120.22 40.21 Favored 'General case' 0 N--CA 1.425 -1.679 0 CA-C-O 121.887 0.851 . . . . 0.0 111.363 -178.222 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 95.2 t -83.42 104.94 12.58 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 CA-C-N 114.385 -1.28 . . . . 0.0 109.829 -178.597 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 56.1 mt -85.48 -72.04 0.5 Allowed 'General case' 0 N--CA 1.433 -1.317 0 N-CA-C 107.748 -1.205 . . . . 0.0 107.748 178.599 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 47.7 m-80 -96.31 166.8 13.52 Favored Pre-proline 0 C--N 1.302 -1.468 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 174.321 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -58.78 -42.23 55.22 Favored 'Trans proline' 0 CA--C 1.538 0.696 0 C-N-CA 121.741 1.628 . . . . 0.0 112.336 177.835 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.523 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 49.0 m-85 -96.49 -25.96 15.47 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 120.029 -0.669 . . . . 0.0 110.562 -177.333 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 75.3 t80 -104.15 114.03 27.99 Favored 'General case' 0 N--CA 1.435 -1.196 0 C-N-CA 119.691 -0.804 . . . . 0.0 111.312 178.784 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.552 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 15.9 m -135.84 139.99 43.84 Favored 'General case' 0 C--N 1.283 -2.308 0 N-CA-C 105.501 -2.037 . . . . 0.0 105.501 178.883 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.467 ' NE2' ' HA ' ' A' ' 5' ' ' ALA . 19.8 pt20 -135.82 153.83 51.38 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 118.853 0.751 . . . . 0.0 111.564 -175.789 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.744 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 63.7 m -72.58 117.0 13.72 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.527 178.438 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 96.5 mt . . . . . 0 C--N 1.289 -2.028 0 N-CA-C 106.802 -1.555 . . . . 0.0 106.802 177.328 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 101' ' ' MAN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 20.3 m . . . . . 0 N--CA 1.436 -1.129 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -74.12 142.97 45.52 Favored 'General case' 0 N--CA 1.438 -1.059 0 CA-C-O 121.296 0.569 . . . . 0.0 110.369 -175.151 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 30.0 t -100.21 172.15 7.35 Favored 'General case' 0 C--N 1.286 -2.166 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.072 -175.398 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' HIS . . . . . 0.514 ' O ' ' H5 ' ' A' ' 101' ' ' MAN . 59.2 t60 -59.77 134.27 56.87 Favored 'General case' 0 C--O 1.238 0.48 0 N-CA-C 109.846 -0.428 . . . . 0.0 109.846 177.848 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 79.21 10.78 1.5 Allowed 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.818 1.247 . . . . 0.0 112.351 179.147 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -105.54 162.3 14.33 Favored Glycine 0 N--CA 1.442 -0.925 0 N-CA-C 110.505 -1.038 . . . . 0.0 110.505 176.182 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.601 ' HA ' ' O ' ' A' ' 33' ' ' SER . 53.4 tt0 -82.26 111.62 18.51 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 -179.66 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.74 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 20.7 p -87.36 -35.08 18.57 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 113.469 0.914 . . . . 0.0 113.469 -175.121 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 173.5 80.51 0.05 OUTLIER Glycine 0 CA--C 1.489 -1.559 0 C-N-CA 117.993 -2.051 . . . . 0.0 113.492 -176.837 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.408 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -112.48 174.11 15.88 Favored Glycine 0 C--N 1.287 -2.163 0 N-CA-C 107.731 -2.148 . . . . 0.0 107.731 174.232 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 74.5 mt -54.93 111.55 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 117.631 0.716 . . . . 0.0 110.211 178.927 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 114.34 -8.42 22.64 Favored Glycine 0 N--CA 1.437 -1.251 0 C-N-CA 120.606 -0.807 . . . . 0.0 113.405 179.679 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.422 ' HB2' HE21 ' A' ' 7' ' ' GLN . 70.7 t80 -101.36 110.45 22.46 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 179.03 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 4.8 p -107.72 7.02 28.2 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-N 115.83 -0.623 . . . . 0.0 112.042 -177.258 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -83.0 -165.41 37.56 Favored Glycine 0 N--CA 1.444 -0.809 0 CA-C-N 115.486 -0.779 . . . . 0.0 112.268 178.222 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -60.51 111.02 0.9 Allowed 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 123.12 2.546 . . . . 0.0 112.317 -179.46 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.616 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 6.7 p -87.04 -11.17 51.13 Favored 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 113.205 0.817 . . . . 0.0 113.205 -175.69 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 7.5 p -80.87 130.43 35.9 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.91 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.139 179.533 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 77.3 m -91.32 169.0 11.17 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-O 120.873 0.368 . . . . 0.0 110.401 179.25 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -59.81 137.67 57.99 Favored 'General case' 0 N--CA 1.438 -1.073 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 174.496 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 54.1 m -59.99 121.08 10.93 Favored 'General case' 0 N--CA 1.432 -1.37 0 CA-C-O 121.14 0.495 . . . . 0.0 110.095 -179.258 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 112.66 -10.0 25.81 Favored Glycine 0 N--CA 1.439 -1.125 0 N-CA-C 111.018 -0.833 . . . . 0.0 111.018 -175.091 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 68.2 p -121.63 142.97 49.6 Favored 'General case' 0 C--O 1.244 0.812 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 174.821 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 34.2 p -110.83 139.24 46.31 Favored 'General case' 0 C--N 1.295 -1.803 0 C-N-CA 120.819 -0.352 . . . . 0.0 111.652 -176.537 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 41.3 t -77.63 102.96 7.29 Favored 'General case' 0 C--N 1.312 -1.041 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 179.338 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -106.79 126.53 52.41 Favored 'General case' 0 N--CA 1.421 -1.897 0 C-N-CA 120.541 -0.464 . . . . 0.0 110.832 -178.695 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 51.5 t -79.21 95.18 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.207 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 179.649 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 77.6 mt -75.21 -69.77 0.46 Allowed 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 -178.893 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 49.0 m-80 -96.31 163.87 19.71 Favored Pre-proline 0 C--N 1.294 -1.842 0 N-CA-C 106.968 -1.493 . . . . 0.0 106.968 174.676 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -61.7 -33.17 86.53 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 121.374 1.383 . . . . 0.0 112.025 179.517 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.408 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 39.8 m-85 -101.64 -25.18 13.96 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 120.419 -0.512 . . . . 0.0 110.914 -179.18 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 61.5 t80 -106.13 113.78 27.52 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 120.076 -0.65 . . . . 0.0 112.135 178.935 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.601 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 19.7 m -118.13 143.94 46.08 Favored 'General case' 0 C--N 1.293 -1.855 0 N-CA-C 106.524 -1.658 . . . . 0.0 106.524 174.984 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.478 HE21 HD21 ' A' ' 36' ' ' LEU . 29.7 tt0 -135.93 141.94 44.56 Favored 'General case' 0 C--N 1.3 -1.563 0 C-N-CA 120.768 -0.373 . . . . 0.0 111.613 -173.769 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.74 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 58.7 m -75.29 116.67 16.26 Favored 'General case' 0 C--O 1.254 1.32 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.02 177.184 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.478 HD21 HE21 ' A' ' 34' ' ' GLN . 96.1 mt . . . . . 0 C--N 1.308 -1.204 0 C-N-CA 124.336 1.054 . . . . 0.0 108.686 178.718 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' MAN . . . . . 0.514 ' H5 ' ' O ' ' A' ' 4' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 12.0 m . . . . . 0 N--CA 1.444 -0.755 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -72.91 140.6 47.6 Favored 'General case' 0 N--CA 1.445 -0.688 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 179.472 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 12.8 m -119.57 179.73 4.13 Favored 'General case' 0 C--N 1.293 -1.887 0 C-N-CA 120.731 -0.388 . . . . 0.0 110.994 -172.888 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' HIS . . . . . 0.4 ' HA ' ' O ' ' A' ' 35' ' ' CYS . 76.7 t60 -50.19 133.78 23.18 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 123.71 0.804 . . . . 0.0 111.811 -177.94 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 75.98 -0.69 3.1 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 125.26 1.424 . . . . 0.0 112.106 179.453 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -90.5 153.09 22.42 Favored Glycine 0 N--CA 1.428 -1.877 0 N-CA-C 111.145 -0.782 . . . . 0.0 111.145 178.348 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.514 ' HA ' ' O ' ' A' ' 33' ' ' SER . 54.5 tt0 -75.27 114.82 14.24 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 178.465 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.76 ' O ' ' HA ' ' A' ' 17' ' ' THR . 9.8 p -86.61 -48.73 8.07 Favored 'General case' 0 C--O 1.195 -1.805 0 N-CA-C 112.822 0.675 . . . . 0.0 112.822 -177.456 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -177.45 97.69 0.11 Allowed Glycine 0 CA--C 1.479 -2.169 0 C-N-CA 117.536 -2.268 . . . . 0.0 113.604 -173.949 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.585 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -113.23 178.34 18.57 Favored Glycine 0 C--N 1.28 -2.545 0 N-CA-C 107.582 -2.207 . . . . 0.0 107.582 174.164 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 68.6 mt -61.64 113.18 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.056 0 CA-C-N 117.749 0.774 . . . . 0.0 109.827 178.694 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 95.47 29.81 8.57 Favored Glycine 0 N--CA 1.438 -1.193 0 CA-C-N 116.023 -0.535 . . . . 0.0 113.139 178.039 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 77.6 t80 -114.14 112.15 22.72 Favored 'General case' 0 C--N 1.313 -1.017 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 177.316 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 23.4 p -95.92 -4.29 43.71 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 -176.124 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -76.57 -162.46 14.24 Favored Glycine 0 CA--C 1.532 1.138 0 C-N-CA 121.212 -0.518 . . . . 0.0 112.82 -179.415 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -61.8 112.25 1.43 Allowed 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 123.131 2.554 . . . . 0.0 111.152 178.079 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.76 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 16.2 p -93.21 -15.04 26.35 Favored 'General case' 0 N--CA 1.433 -1.295 0 CA-C-N 115.874 -0.603 . . . . 0.0 112.444 -176.42 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 10.0 p -95.57 139.03 19.73 Favored 'Isoleucine or valine' 0 C--O 1.255 1.382 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 178.719 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 81.1 m -91.61 155.74 18.13 Favored 'General case' 0 C--N 1.291 -1.978 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.935 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -58.86 137.92 57.55 Favored 'General case' 0 C--O 1.25 1.13 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 175.409 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 7.1 p -51.03 124.82 12.2 Favored 'General case' 0 C--N 1.311 -1.094 0 O-C-N 123.864 0.728 . . . . 0.0 111.828 -177.255 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 112.22 -21.05 20.58 Favored Glycine 0 N--CA 1.434 -1.441 0 CA-C-N 115.463 -0.789 . . . . 0.0 111.228 -176.405 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 75.8 p -110.86 149.26 30.85 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 176.604 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 22.8 p -112.06 142.54 44.36 Favored 'General case' 0 C--N 1.297 -1.698 0 CA-C-N 116.818 -0.173 . . . . 0.0 110.651 -178.196 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 44.3 t -78.6 99.19 6.45 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 176.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 75.4 mt-30 -96.26 119.26 34.42 Favored 'General case' 0 N--CA 1.415 -2.217 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.62 -178.015 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 46.5 t -75.37 102.45 2.6 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 177.114 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 56.5 mt -85.16 -74.51 0.4 Allowed 'General case' 0 N--CA 1.428 -1.55 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 -179.34 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 74.9 m-20 -95.56 166.78 13.95 Favored Pre-proline 0 C--N 1.289 -2.032 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 176.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -59.67 -36.95 90.64 Favored 'Trans proline' 0 CA--C 1.543 0.939 0 C-N-CA 121.89 1.727 . . . . 0.0 112.99 179.723 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.585 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 69.3 m-85 -102.47 -24.34 13.83 Favored 'General case' 0 C--N 1.315 -0.935 0 C-N-CA 120.192 -0.603 . . . . 0.0 110.876 -178.688 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 69.9 t80 -104.71 114.25 28.34 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 112.505 0.557 . . . . 0.0 112.505 179.626 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.514 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 26.7 m -121.67 146.37 47.07 Favored 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 175.988 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.515 ' OE1' HD21 ' A' ' 36' ' ' LEU . 35.8 tt0 -134.98 142.43 46.47 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-N 118.242 0.474 . . . . 0.0 111.363 -172.934 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.755 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 77.4 m -77.26 113.39 14.97 Favored 'General case' 0 C--O 1.247 0.949 0 CA-C-O 121.164 0.507 . . . . 0.0 110.117 176.664 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.515 HD21 ' OE1' ' A' ' 34' ' ' GLN . 97.1 mt . . . . . 0 C--N 1.291 -1.952 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.01 -179.005 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' MAN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 33.3 m . . . . . 0 N--CA 1.449 -0.487 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -76.46 149.69 36.78 Favored 'General case' 0 N--CA 1.445 -0.69 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 -174.886 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 14.2 m -123.67 179.39 4.8 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 -176.267 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 36.9 t-80 -56.16 143.62 32.59 Favored 'General case' 0 C--O 1.239 0.532 0 C-N-CA 123.213 0.605 . . . . 0.0 110.128 178.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 71.91 10.01 6.17 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 124.586 1.155 . . . . 0.0 111.188 -178.3 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -109.76 147.56 17.15 Favored Glycine 0 N--CA 1.422 -2.267 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.392 178.704 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.551 ' HA ' ' O ' ' A' ' 33' ' ' SER . 53.3 tt0 -79.22 115.19 18.72 Favored 'General case' 0 C--N 1.31 -1.138 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 178.22 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.656 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 7.0 p -88.16 -45.7 9.9 Favored 'General case' 0 C--N 1.285 -2.219 0 CA-C-N 115.648 -0.706 . . . . 0.0 112.86 -176.159 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -171.89 91.6 0.09 OUTLIER Glycine 0 N--CA 1.428 -1.875 0 C-N-CA 118.152 -1.975 . . . . 0.0 113.968 -174.171 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.436 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -112.74 178.27 18.75 Favored Glycine 0 N--CA 1.427 -1.955 0 N-CA-C 108.341 -1.904 . . . . 0.0 108.341 175.036 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 85.5 mt -60.01 113.33 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.074 0 CA-C-N 117.526 0.663 . . . . 0.0 111.377 179.199 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 94.57 13.04 55.03 Favored Glycine 0 N--CA 1.434 -1.457 0 CA-C-N 115.233 -0.894 . . . . 0.0 112.878 177.475 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 57.1 t80 -96.72 113.15 24.69 Favored 'General case' 0 N--CA 1.442 -0.835 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 179.415 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 11.2 p -107.3 21.26 17.78 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-O 121.681 0.753 . . . . 0.0 111.981 -177.906 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -94.23 -154.18 30.8 Favored Glycine 0 C--N 1.298 -1.546 0 C-N-CA 120.626 -0.797 . . . . 0.0 111.402 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -70.39 107.11 1.91 Allowed 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 122.329 2.019 . . . . 0.0 111.374 178.76 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.622 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 9.8 p -87.22 -18.17 30.91 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-N 115.415 -0.811 . . . . 0.0 111.99 -177.855 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 12.0 p -88.15 129.85 38.7 Favored 'Isoleucine or valine' 0 C--O 1.25 1.115 0 CA-C-O 121.177 0.513 . . . . 0.0 110.509 178.797 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 82.1 m -93.36 148.48 22.01 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.987 -179.638 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -59.74 147.13 38.96 Favored 'General case' 0 C--O 1.247 0.96 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.323 177.732 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 9.7 t -54.12 126.5 23.02 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.054 -178.033 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 112.44 -18.17 23.13 Favored Glycine 0 N--CA 1.438 -1.167 0 N-CA-C 110.716 -0.953 . . . . 0.0 110.716 -175.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 57.7 p -127.19 146.2 50.49 Favored 'General case' 0 N--CA 1.443 -0.802 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 176.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 16.4 p -120.97 143.11 49.19 Favored 'General case' 0 C--N 1.296 -1.73 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 178.248 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 42.0 t -69.74 105.38 2.72 Favored 'General case' 0 C--N 1.309 -1.163 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 178.153 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 68.5 mt-30 -107.41 119.01 38.24 Favored 'General case' 0 N--CA 1.423 -1.816 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 179.295 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 52.8 t -75.22 119.41 22.87 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 CA-C-N 115.298 -0.864 . . . . 0.0 108.752 -179.241 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 76.6 mt -100.81 -69.48 0.77 Allowed 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 179.782 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 88.7 m-20 -95.48 166.66 14.22 Favored Pre-proline 0 C--N 1.304 -1.381 0 N-CA-C 106.782 -1.562 . . . . 0.0 106.782 173.104 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -63.6 -27.15 69.31 Favored 'Trans proline' 0 CA--C 1.534 0.476 0 C-N-CA 121.089 1.193 . . . . 0.0 111.858 177.275 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.436 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 55.8 m-85 -105.55 -26.03 12.06 Favored 'General case' 0 N--CA 1.443 -0.795 0 C-N-CA 119.789 -0.765 . . . . 0.0 110.716 -179.242 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 68.2 t80 -105.28 114.24 28.3 Favored 'General case' 0 N--CA 1.439 -1.0 0 C-N-CA 119.748 -0.781 . . . . 0.0 112.061 178.726 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.551 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 19.3 m -126.65 134.56 50.71 Favored 'General case' 0 C--N 1.283 -2.315 0 N-CA-C 105.766 -1.939 . . . . 0.0 105.766 176.206 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 7.7 tt0 -122.05 146.92 46.72 Favored 'General case' 0 C--N 1.303 -1.422 0 C-N-CA 120.268 -0.573 . . . . 0.0 110.567 -175.055 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.656 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 85.8 m -73.35 104.9 4.52 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 172.798 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 95.8 mt . . . . . 0 C--N 1.296 -1.743 0 C-N-CA 123.993 0.917 . . . . 0.0 108.649 -177.86 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 101' ' ' MAN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 22.7 p . . . . . 0 N--CA 1.442 -0.868 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -82.72 134.9 35.13 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 179.738 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 39.4 m -81.09 178.33 8.48 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-O 121.145 0.498 . . . . 0.0 110.906 -178.462 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 55.1 t-80 -63.67 133.35 53.47 Favored 'General case' 0 N--CA 1.444 -0.754 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 175.098 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 65.15 75.66 0.36 Allowed 'General case' 0 C--N 1.322 -0.59 0 O-C-N 124.356 1.035 . . . . 0.0 110.76 -177.502 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.493 ' O ' ' HA ' ' A' ' 34' ' ' GLN . . . -165.75 152.36 21.61 Favored Glycine 0 N--CA 1.42 -2.425 0 N-CA-C 108.454 -1.858 . . . . 0.0 108.454 178.557 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.604 ' HA ' ' O ' ' A' ' 33' ' ' SER . 52.7 tt0 -76.97 111.24 12.3 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 117.486 0.643 . . . . 0.0 110.049 -178.286 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.783 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 2.4 p -86.13 -41.58 14.6 Favored 'General case' 0 C--N 1.296 -1.758 0 CA-C-N 115.2 -0.909 . . . . 0.0 112.66 -177.429 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.402 ' HA2' ' HB3' ' A' ' 13' ' ' TYR . . . 169.76 101.68 0.15 Allowed Glycine 0 N--CA 1.423 -2.172 0 C-N-CA 117.895 -2.098 . . . . 0.0 113.778 -177.656 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -112.52 -160.51 14.98 Favored Glycine 0 N--CA 1.422 -2.265 0 N-CA-C 108.157 -1.977 . . . . 0.0 108.157 174.527 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 76.8 mt -65.91 109.69 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 CA-C-N 117.706 0.753 . . . . 0.0 110.994 177.547 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 95.13 20.63 27.4 Favored Glycine 0 N--CA 1.441 -1.027 0 C-N-CA 121.022 -0.608 . . . . 0.0 113.853 175.858 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.402 ' HB3' ' HA2' ' A' ' 9' ' ' GLY . 53.1 t80 -114.16 112.08 22.6 Favored 'General case' 0 C--N 1.31 -1.129 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 178.476 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 10.3 p -109.68 18.92 19.75 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-O 121.365 0.602 . . . . 0.0 111.662 -177.965 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -82.18 -150.79 8.73 Favored Glycine 0 N--CA 1.446 -0.688 0 CA-C-O 119.259 -0.745 . . . . 0.0 111.431 179.629 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -66.61 93.9 0.32 Allowed 'Trans proline' 0 CA--C 1.535 0.541 0 C-N-CA 122.158 1.905 . . . . 0.0 111.912 178.827 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.578 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 17.3 p -83.34 -13.59 54.73 Favored 'General case' 0 C--O 1.251 1.156 0 CA-C-O 121.905 0.86 . . . . 0.0 111.058 -177.533 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 4.7 p -92.9 121.64 43.74 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.56 0 CA-C-N 114.625 -1.17 . . . . 0.0 110.033 177.783 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 65.5 m -86.07 153.2 22.28 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 179.084 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -68.56 163.87 22.6 Favored 'General case' 0 C--O 1.26 1.64 0 CA-C-O 120.712 0.291 . . . . 0.0 111.062 178.599 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 28.1 m -47.49 115.91 1.27 Allowed 'General case' 0 C--O 1.248 1.004 0 C-N-CA 124.667 1.187 . . . . 0.0 113.276 -176.381 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 108.37 -20.83 29.7 Favored Glycine 0 N--CA 1.437 -1.282 0 CA-C-N 115.482 -0.781 . . . . 0.0 113.407 175.236 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 21.2 p -106.7 146.03 31.3 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 122.214 -0.58 . . . . 0.0 111.702 -178.251 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 14.5 p -118.92 147.65 43.79 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.558 -178.327 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 43.4 t -77.88 100.3 6.32 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-O 121.225 0.536 . . . . 0.0 109.644 -179.466 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 85.1 mm-40 -90.72 119.68 31.15 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.844 -179.063 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 46.7 t -83.76 108.71 16.47 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 -179.056 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 81.4 mt -95.03 -68.46 0.8 Allowed 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 -179.668 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.441 ' HB2' ' HB3' ' A' ' 32' ' ' TYR . 45.6 m-80 -95.61 166.82 13.83 Favored Pre-proline 0 C--N 1.296 -1.745 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 175.933 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -61.28 -37.91 69.62 Favored 'Trans proline' 0 C--N 1.349 0.558 0 C-N-CA 121.204 1.269 . . . . 0.0 111.009 178.624 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 49.4 m-85 -96.63 -25.03 15.73 Favored 'General case' 0 N--CA 1.441 -0.921 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.817 -178.703 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.441 ' HB3' ' HB2' ' A' ' 29' ' ' ASN . 48.9 t80 -104.6 113.43 27.0 Favored 'General case' 0 C--N 1.315 -0.898 0 C-N-CA 118.977 -1.089 . . . . 0.0 111.314 -177.506 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.604 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 26.6 m -124.68 137.91 54.33 Favored 'General case' 0 C--N 1.286 -2.193 0 N-CA-C 105.906 -1.887 . . . . 0.0 105.906 176.958 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.493 ' HA ' ' O ' ' A' ' 6' ' ' GLY . 30.1 tt0 -131.47 136.21 47.74 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -173.243 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.783 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 85.5 m -70.2 110.56 5.26 Favored 'General case' 0 C--O 1.245 0.831 0 CA-C-O 121.263 0.554 . . . . 0.0 110.937 177.3 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 95.8 mt . . . . . 0 C--N 1.294 -1.817 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 179.059 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 101' ' ' MAN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 28.4 m . . . . . 0 N--CA 1.44 -0.929 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -84.23 134.26 34.55 Favored 'General case' 0 N--CA 1.44 -0.943 0 C-N-CA 119.782 -0.767 . . . . 0.0 109.221 -179.537 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.411 ' HB2' ' H2 ' ' A' ' 101' ' ' MAN . 27.7 t -91.95 -178.08 4.91 Favored 'General case' 0 C--N 1.297 -1.695 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.457 -175.582 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 16.8 t-80 -63.43 118.07 7.59 Favored 'General case' 0 N--CA 1.445 -0.691 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 71.83 91.36 0.09 Allowed 'General case' 0 C--O 1.24 0.576 0 C-N-CA 124.62 1.168 . . . . 0.0 111.141 -174.431 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.583 ' O ' ' HA ' ' A' ' 34' ' ' GLN . . . -177.4 163.68 32.42 Favored Glycine 0 N--CA 1.43 -1.766 0 N-CA-C 107.121 -2.392 . . . . 0.0 107.121 179.801 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.625 ' HA ' ' O ' ' A' ' 33' ' ' SER . 53.3 tt0 -84.31 113.47 21.16 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 118.52 1.16 . . . . 0.0 109.608 -178.745 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.766 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 7.4 p -95.17 -36.6 11.41 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 113.248 0.833 . . . . 0.0 113.248 -176.594 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -164.72 66.02 0.22 Allowed Glycine 0 CA--C 1.478 -2.234 0 C-N-CA 118.523 -1.799 . . . . 0.0 112.345 -176.236 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.538 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -110.15 157.04 15.27 Favored Glycine 0 C--N 1.285 -2.284 0 N-CA-C 108.764 -1.734 . . . . 0.0 108.764 177.324 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 69.0 mt -57.49 115.96 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 CA-C-N 117.32 0.56 . . . . 0.0 110.962 -177.781 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 114.13 -9.66 22.77 Favored Glycine 0 N--CA 1.451 -0.366 0 CA-C-N 116.022 -0.536 . . . . 0.0 112.027 -179.522 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 91.8 t80 -93.55 120.64 34.07 Favored 'General case' 0 C--N 1.311 -1.072 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 179.008 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 12.4 p -111.5 4.55 18.9 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 112.103 0.409 . . . . 0.0 112.103 -176.088 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -82.73 -160.51 28.52 Favored Glycine 0 CA--C 1.528 0.844 0 C-N-CA 121.127 -0.559 . . . . 0.0 112.525 179.687 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -72.87 126.3 11.19 Favored 'Trans proline' 0 CA--C 1.512 -0.62 0 C-N-CA 122.286 1.991 . . . . 0.0 111.175 179.143 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.569 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 21.7 p -85.1 -14.51 46.92 Favored 'General case' 0 C--N 1.295 -1.804 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.357 -177.155 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 12.3 p -75.42 132.8 32.62 Favored 'Isoleucine or valine' 0 C--O 1.257 1.469 0 CA-C-O 121.794 0.807 . . . . 0.0 111.426 -177.951 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 80.5 m -93.86 167.78 11.4 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-N 114.886 -1.052 . . . . 0.0 110.182 179.219 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.13 140.89 58.25 Favored 'General case' 0 C--N 1.308 -1.196 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 175.244 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 34.6 t -55.29 125.71 21.86 Favored 'General case' 0 C--N 1.312 -1.04 0 O-C-N 123.504 0.502 . . . . 0.0 109.961 -179.719 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 112.56 -20.68 20.29 Favored Glycine 0 N--CA 1.439 -1.141 0 N-CA-C 110.662 -0.975 . . . . 0.0 110.662 -175.934 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 72.7 p -114.89 157.54 23.19 Favored 'General case' 0 C--N 1.311 -1.074 0 O-C-N 122.293 -0.534 . . . . 0.0 109.665 177.572 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 16.6 p -126.02 148.98 49.16 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 110.089 -0.338 . . . . 0.0 110.089 177.845 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 53.2 t -76.63 100.88 5.5 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 62.0 mt-30 -101.0 114.99 29.43 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-O 121.122 0.486 . . . . 0.0 110.384 -178.154 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 48.2 t -71.33 116.51 13.13 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.252 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 178.833 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 78.6 mt -101.15 -68.69 0.8 Allowed 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 -178.72 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.454 ' HB2' ' H ' ' A' ' 32' ' ' TYR . 80.7 m-20 -95.38 166.07 15.48 Favored Pre-proline 0 C--N 1.301 -1.541 0 N-CA-C 106.915 -1.513 . . . . 0.0 106.915 174.657 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_exo -62.6 -27.41 76.36 Favored 'Trans proline' 0 CA--C 1.536 0.583 0 C-N-CA 121.531 1.487 . . . . 0.0 111.622 176.616 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.538 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 88.1 m-85 -105.31 -25.31 12.46 Favored 'General case' 0 N--CA 1.443 -0.798 0 C-N-CA 120.135 -0.626 . . . . 0.0 111.518 179.254 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.454 ' H ' ' HB2' ' A' ' 29' ' ' ASN . 44.7 t80 -105.87 113.73 27.45 Favored 'General case' 0 C--N 1.311 -1.074 0 C-N-CA 119.548 -0.861 . . . . 0.0 112.033 179.8 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.625 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 16.9 m -120.24 135.01 55.13 Favored 'General case' 0 C--N 1.291 -1.953 0 N-CA-C 105.759 -1.941 . . . . 0.0 105.759 175.134 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.583 ' HA ' ' O ' ' A' ' 6' ' ' GLY . 28.1 tt0 -127.79 138.15 52.64 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 112.694 0.627 . . . . 0.0 112.694 -171.466 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.766 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 68.9 m -71.91 109.9 6.07 Favored 'General case' 0 C--O 1.251 1.158 0 CA-C-O 120.979 0.419 . . . . 0.0 111.073 176.875 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 94.3 mt . . . . . 0 N--CA 1.431 -1.398 0 N-CA-C 107.275 -1.38 . . . . 0.0 107.275 178.762 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 101' ' ' MAN . . . . . 0.411 ' H2 ' ' HB2' ' A' ' 3' ' ' SER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 23.1 m . . . . . 0 C--O 1.248 1.014 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -77.87 153.21 32.88 Favored 'General case' 0 N--CA 1.446 -0.637 0 C-N-CA 123.268 0.627 . . . . 0.0 109.504 -176.21 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 67.7 m -127.31 -170.45 2.22 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 111.602 0.223 . . . . 0.0 111.602 -177.052 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' HIS . . . . . 0.448 ' HA ' ' O ' ' A' ' 35' ' ' CYS . 37.0 t-80 -60.13 136.64 58.09 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 122.718 0.407 . . . . 0.0 110.936 -173.363 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.589 ' HA ' ' NE2' ' A' ' 34' ' ' GLN . . . 74.4 8.76 4.47 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 124.143 0.977 . . . . 0.0 111.953 -179.814 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.426 ' O ' ' HA ' ' A' ' 34' ' ' GLN . . . -103.92 151.29 17.62 Favored Glycine 0 N--CA 1.431 -1.65 0 N-CA-C 111.386 -0.686 . . . . 0.0 111.386 178.537 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.612 ' HA ' ' O ' ' A' ' 33' ' ' SER . 54.3 tt0 -77.98 114.43 16.84 Favored 'General case' 0 CA--C 1.502 -0.883 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 178.608 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.705 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 8.0 p -94.27 -43.74 8.29 Favored 'General case' 0 C--N 1.288 -2.077 0 N-CA-C 113.549 0.944 . . . . 0.0 113.549 -175.64 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.449 ' H ' ' HB2' ' A' ' 33' ' ' SER . . . -159.38 69.75 0.25 Allowed Glycine 0 CA--C 1.481 -2.046 0 C-N-CA 118.541 -1.79 . . . . 0.0 112.765 -172.204 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.571 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -112.42 153.63 17.32 Favored Glycine 0 C--N 1.279 -2.584 0 N-CA-C 109.307 -1.517 . . . . 0.0 109.307 178.217 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.429 ' HB ' ' CD1' ' A' ' 31' ' ' TYR . 72.6 mt -56.24 123.89 8.38 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 O-C-N 123.974 0.455 . . . . 0.0 109.909 179.721 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 108.02 -15.27 36.93 Favored Glycine 0 N--CA 1.442 -0.9 0 N-CA-C 111.074 -0.81 . . . . 0.0 111.074 -179.218 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 80.1 t80 -101.78 109.7 21.53 Favored 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 178.602 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 13.5 p -107.68 7.34 28.44 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 112.381 0.511 . . . . 0.0 112.381 -176.629 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -82.41 -152.9 11.28 Favored Glycine 0 CA--C 1.53 0.978 0 CA-C-N 116.071 -0.513 . . . . 0.0 113.079 -179.547 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -64.49 112.25 1.88 Allowed 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 122.993 2.462 . . . . 0.0 112.294 -179.146 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.581 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 14.1 p -95.28 -4.73 45.1 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 115.375 -0.83 . . . . 0.0 113.022 -176.113 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 9.2 p -89.76 127.59 42.28 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.998 0 CA-C-O 120.896 0.379 . . . . 0.0 110.84 -178.648 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.471 ' SG ' ' HB2' ' A' ' 25' ' ' CYS . 72.9 m -87.91 154.1 20.79 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.167 178.789 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.72 143.4 57.46 Favored 'General case' 0 N--CA 1.438 -1.07 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.25 175.528 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.2 p -62.4 127.82 33.11 Favored 'General case' 0 C--N 1.297 -1.688 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.658 -179.15 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 112.5 -5.07 26.41 Favored Glycine 0 N--CA 1.438 -1.172 0 N-CA-C 110.727 -0.949 . . . . 0.0 110.727 -174.141 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 49.3 p -136.26 145.0 45.1 Favored 'General case' 0 C--O 1.239 0.547 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 174.586 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 46.4 p -112.1 145.01 40.51 Favored 'General case' 0 C--N 1.305 -1.338 0 C-N-CA 120.884 -0.326 . . . . 0.0 110.139 -179.518 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.471 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 43.6 t -79.28 97.63 6.35 Favored 'General case' 0 C--N 1.31 -1.144 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 -179.706 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 72.1 mt-30 -93.74 114.75 27.1 Favored 'General case' 0 N--CA 1.424 -1.767 0 CA-C-O 121.303 0.573 . . . . 0.0 110.716 -177.738 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 48.1 t -76.76 95.12 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 CA-C-N 114.798 -1.092 . . . . 0.0 108.404 177.92 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 87.7 mt -78.23 -70.91 0.46 Allowed 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 -179.388 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 75.2 m-20 -95.36 166.72 14.17 Favored Pre-proline 0 C--N 1.296 -1.738 0 N-CA-C 106.644 -1.613 . . . . 0.0 106.644 174.66 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_exo -62.95 -35.66 65.17 Favored 'Trans proline' 0 C--O 1.246 0.915 0 C-N-CA 121.171 1.247 . . . . 0.0 111.441 176.909 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.571 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 73.2 m-85 -97.41 -26.33 14.9 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 120.411 -0.516 . . . . 0.0 111.056 -178.639 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 68.8 t80 -105.68 114.09 28.04 Favored 'General case' 0 C--N 1.311 -1.09 0 C-N-CA 119.879 -0.728 . . . . 0.0 112.512 177.954 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.612 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 18.6 m -127.01 135.88 51.45 Favored 'General case' 0 C--N 1.295 -1.79 0 N-CA-C 106.45 -1.685 . . . . 0.0 106.45 175.841 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.589 ' NE2' ' HA ' ' A' ' 5' ' ' ALA . 47.3 tt0 -126.22 141.41 51.93 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-N 117.975 0.352 . . . . 0.0 111.022 -174.476 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.705 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 60.3 m -73.55 109.98 7.48 Favored 'General case' 0 C--O 1.253 1.25 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 174.075 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 87.4 mt . . . . . 0 C--N 1.289 -2.036 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 179.503 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 101' ' ' MAN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 19.6 p . . . . . 0 C--O 1.249 1.051 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -85.65 147.75 26.22 Favored 'General case' 0 N--CA 1.436 -1.144 0 N-CA-C 107.767 -1.198 . . . . 0.0 107.767 178.592 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 33.4 t -114.82 179.32 3.98 Favored 'General case' 0 C--N 1.288 -2.088 0 C-N-CA 120.642 -0.423 . . . . 0.0 111.425 -173.538 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 57.4 t-80 -58.15 137.04 57.31 Favored 'General case' 0 CA--C 1.519 -0.243 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 -178.642 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 78.21 -3.69 2.29 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 124.858 1.263 . . . . 0.0 112.059 179.0 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -90.15 141.91 16.19 Favored Glycine 0 N--CA 1.426 -1.997 0 N-CA-C 110.76 -0.936 . . . . 0.0 110.76 178.313 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.599 ' HA ' ' O ' ' A' ' 33' ' ' SER . 54.0 tt0 -69.26 113.55 6.71 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 176.425 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.719 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 10.5 p -86.29 -40.83 15.11 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 112.764 0.654 . . . . 0.0 112.764 -176.178 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 177.4 93.25 0.09 OUTLIER Glycine 0 CA--C 1.488 -1.653 0 C-N-CA 117.788 -2.148 . . . . 0.0 113.847 -176.81 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.509 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -112.01 174.85 16.74 Favored Glycine 0 C--N 1.286 -2.238 0 N-CA-C 107.519 -2.232 . . . . 0.0 107.519 174.755 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 65.2 mt -60.55 113.25 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.139 0 CA-C-N 117.912 0.856 . . . . 0.0 109.469 178.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 113.8 -20.09 17.89 Favored Glycine 0 N--CA 1.438 -1.229 0 C-N-CA 121.1 -0.571 . . . . 0.0 112.165 179.206 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 71.0 t80 -81.35 118.97 23.1 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-O 121.038 0.447 . . . . 0.0 110.425 -176.891 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 11.7 p -102.58 5.79 39.45 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 113.055 0.761 . . . . 0.0 113.055 -175.175 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -87.89 -157.04 31.22 Favored Glycine 0 CA--C 1.524 0.628 0 C-N-CA 120.703 -0.761 . . . . 0.0 113.275 -175.262 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -70.7 113.16 3.44 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.637 2.225 . . . . 0.0 111.805 -179.586 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.628 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 18.5 p -89.04 -3.41 58.7 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.847 -177.36 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 4.0 p -98.91 120.82 48.75 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.953 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.859 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 63.1 m -85.74 164.27 17.71 Favored 'General case' 0 C--N 1.299 -1.621 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.48 179.448 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.42 146.0 55.04 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 174.84 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 46.1 m -61.67 130.74 47.28 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 178.049 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 112.36 -13.12 25.85 Favored Glycine 0 C--N 1.309 -0.962 0 N-CA-C 110.384 -1.086 . . . . 0.0 110.384 -173.482 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 65.0 p -127.57 155.27 44.09 Favored 'General case' 0 C--O 1.248 0.986 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 175.229 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 33.8 p -120.6 143.26 48.74 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 177.331 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 52.7 t -74.53 99.6 3.64 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 176.644 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 -97.82 119.68 36.85 Favored 'General case' 0 N--CA 1.425 -1.717 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 -177.722 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 43.1 t -77.86 93.88 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 178.091 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 82.7 mt -74.96 -70.77 0.39 Allowed 'General case' 0 C--N 1.306 -1.297 0 CA-C-N 115.278 -0.874 . . . . 0.0 109.092 -177.828 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 24.2 m120 -95.58 165.91 15.7 Favored Pre-proline 0 C--N 1.295 -1.802 0 N-CA-C 106.206 -1.776 . . . . 0.0 106.206 174.006 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -63.43 -30.46 72.28 Favored 'Trans proline' 0 C--O 1.239 0.543 0 C-N-CA 121.376 1.384 . . . . 0.0 111.287 178.796 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.509 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 55.4 m-85 -103.15 -25.71 13.28 Favored 'General case' 0 N--CA 1.438 -1.073 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.464 -179.754 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 40.6 t80 -106.03 114.2 28.2 Favored 'General case' 0 C--N 1.317 -0.843 0 C-N-CA 119.413 -0.915 . . . . 0.0 111.562 178.786 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.599 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 15.4 m -121.03 141.04 51.12 Favored 'General case' 0 C--N 1.294 -1.824 0 N-CA-C 106.485 -1.672 . . . . 0.0 106.485 176.271 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -136.04 140.93 44.21 Favored 'General case' 0 C--N 1.297 -1.699 0 CA-C-N 118.053 0.388 . . . . 0.0 111.047 -172.623 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.719 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 66.7 m -73.17 111.24 8.1 Favored 'General case' 0 C--O 1.257 1.488 0 CA-C-O 121.108 0.48 . . . . 0.0 110.369 177.63 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 82.2 mt . . . . . 0 C--N 1.303 -1.443 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 -179.844 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 101' ' ' MAN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 25.5 m . . . . . 0 C--O 1.225 -0.205 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.438 ' O ' ' HA ' ' A' ' 19' ' ' CYS . 8.2 tp-100 -80.63 134.07 35.83 Favored 'General case' 0 N--CA 1.442 -0.832 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 178.781 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.413 ' O ' ' HB2' ' A' ' 35' ' ' CYS . 69.7 m -126.06 -165.62 1.46 Allowed 'General case' 0 C--N 1.276 -2.621 0 C-N-CA 120.99 -0.284 . . . . 0.0 111.518 -174.774 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 56.8 t-80 -50.3 130.58 23.35 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 113.647 0.98 . . . . 0.0 113.647 -172.822 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 71.52 12.06 6.52 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 114.275 -1.33 . . . . 0.0 112.649 175.671 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.442 ' O ' ' HA ' ' A' ' 34' ' ' GLN . . . -100.15 165.57 19.66 Favored Glycine 0 N--CA 1.433 -1.5 0 N-CA-C 110.846 -0.902 . . . . 0.0 110.846 176.225 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.525 ' HA ' ' O ' ' A' ' 33' ' ' SER . 54.0 tt0 -87.82 112.35 22.36 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 110.245 -0.28 . . . . 0.0 110.245 -177.562 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.772 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 14.6 p -83.03 -41.94 18.08 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 112.383 0.512 . . . . 0.0 112.383 -178.226 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 165.14 101.42 0.16 Allowed Glycine 0 CA--C 1.483 -1.923 0 C-N-CA 117.624 -2.227 . . . . 0.0 114.265 -178.795 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -112.63 -169.98 17.92 Favored Glycine 0 N--CA 1.423 -2.199 0 N-CA-C 107.489 -2.244 . . . . 0.0 107.489 173.4 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 70.3 mt -62.09 122.86 13.73 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.34 0 CA-C-N 117.815 0.807 . . . . 0.0 110.21 179.156 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 99.02 -5.27 59.36 Favored Glycine 0 N--CA 1.444 -0.814 0 C-N-CA 120.834 -0.698 . . . . 0.0 113.24 175.753 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 69.4 t80 -94.38 113.79 25.72 Favored 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 27.0 p -106.41 -1.18 23.52 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 116.317 -0.402 . . . . 0.0 112.039 -176.736 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -76.02 -156.7 6.54 Favored Glycine 0 CA--C 1.526 0.728 0 CA-C-N 116.121 -0.49 . . . . 0.0 113.195 -178.903 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -63.62 106.79 0.64 Allowed 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 122.568 2.179 . . . . 0.0 111.885 -179.662 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.676 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 4.2 p -95.51 15.14 20.52 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-N 115.401 -0.818 . . . . 0.0 112.377 -176.132 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 7.1 p -112.13 126.76 69.56 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.627 -179.764 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.467 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 80.1 m -88.01 150.2 23.56 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 115.652 -0.704 . . . . 0.0 109.163 177.078 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.449 ' HB2' ' H2 ' ' A' ' 101' ' ' MAN . . . -69.14 153.34 43.88 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 177.509 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 24.6 m -55.97 128.43 35.2 Favored 'General case' 0 N--CA 1.435 -1.184 0 CA-C-O 121.336 0.589 . . . . 0.0 110.705 -179.677 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 111.97 -18.12 24.27 Favored Glycine 0 N--CA 1.432 -1.576 0 N-CA-C 110.927 -0.869 . . . . 0.0 110.927 -177.095 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 68.6 p -121.54 146.73 46.65 Favored 'General case' 0 N--CA 1.441 -0.886 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 178.118 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 34.2 p -114.85 144.04 44.16 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.07 179.306 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 52.9 t -78.62 106.3 10.5 Favored 'General case' 0 C--N 1.308 -1.2 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 178.607 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -111.08 130.56 55.57 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.179 -178.35 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 43.2 t -87.71 114.45 26.55 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.831 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 -177.802 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 86.4 mt -92.94 -72.72 0.59 Allowed 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 179.282 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 84.3 m-20 -93.63 163.23 25.04 Favored Pre-proline 0 C--N 1.305 -1.341 0 N-CA-C 106.322 -1.733 . . . . 0.0 106.322 175.896 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -58.07 -35.28 98.87 Favored 'Trans proline' 0 CA--C 1.534 0.477 0 C-N-CA 121.626 1.551 . . . . 0.0 111.55 179.63 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 90.3 m-85 -97.69 -25.04 15.23 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.671 -179.47 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 65.9 t80 -105.48 114.43 28.61 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 119.937 -0.705 . . . . 0.0 112.714 -179.579 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.525 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 19.9 m -119.21 143.95 46.98 Favored 'General case' 0 C--N 1.295 -1.791 0 N-CA-C 106.962 -1.496 . . . . 0.0 106.962 174.515 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.442 ' HA ' ' O ' ' A' ' 6' ' ' GLY . 35.2 tt0 -129.96 143.62 50.9 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 111.941 0.349 . . . . 0.0 111.941 -171.478 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.772 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 86.0 m -82.0 111.07 17.83 Favored 'General case' 0 C--O 1.252 1.221 0 CA-C-O 121.169 0.509 . . . . 0.0 109.892 176.345 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 96.1 mt . . . . . 0 C--N 1.298 -1.674 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.646 179.586 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 101' ' ' MAN . . . . . 0.449 ' H2 ' ' HB2' ' A' ' 20' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 7.8 m . . . . . 0 N--CA 1.438 -1.066 0 N-CA-C 108.072 -1.085 . . . . 0.0 108.072 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 41.1 tp60 -83.66 118.09 23.63 Favored 'General case' 0 N--CA 1.432 -1.374 0 CA-C-O 121.479 0.657 . . . . 0.0 109.733 -177.543 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 58.3 p -78.11 168.47 19.81 Favored 'General case' 0 C--N 1.293 -1.878 0 CA-C-N 115.316 -0.856 . . . . 0.0 112.161 -175.031 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 50.0 t-80 -57.21 137.51 55.84 Favored 'General case' 0 C--O 1.238 0.465 0 N-CA-C 109.141 -0.688 . . . . 0.0 109.141 176.018 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 72.19 15.48 5.4 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 123.784 0.834 . . . . 0.0 111.407 -179.837 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -105.98 160.98 14.51 Favored Glycine 0 N--CA 1.432 -1.574 0 N-CA-C 110.26 -1.136 . . . . 0.0 110.26 174.533 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.59 ' HA ' ' O ' ' A' ' 33' ' ' SER . 53.5 tt0 -80.68 109.91 15.67 Favored 'General case' 0 C--O 1.21 -0.988 0 CA-C-N 116.869 0.334 . . . . 0.0 110.331 -178.599 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.791 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 23.5 p -84.62 -15.36 45.81 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -177.188 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.426 ' HA2' ' CD1' ' A' ' 13' ' ' TYR . . . 135.14 100.69 0.65 Allowed Glycine 0 N--CA 1.42 -2.423 0 C-N-CA 117.72 -2.181 . . . . 0.0 115.253 176.119 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -112.23 -171.15 18.53 Favored Glycine 0 N--CA 1.423 -2.221 0 N-CA-C 106.991 -2.444 . . . . 0.0 106.991 172.048 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 77.7 mt -58.39 113.81 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.994 0 CA-C-N 117.946 0.873 . . . . 0.0 110.443 179.893 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 114.02 -16.87 20.26 Favored Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.964 -0.636 . . . . 0.0 113.028 177.967 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.426 ' CD1' ' HA2' ' A' ' 9' ' ' GLY . 66.3 t80 -94.36 129.06 41.21 Favored 'General case' 0 C--N 1.312 -1.046 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 -179.159 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 11.4 p -131.58 14.31 4.95 Favored 'General case' 0 C--O 1.248 0.997 0 N-CA-C 112.981 0.734 . . . . 0.0 112.981 -174.858 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -90.93 -140.73 8.92 Favored Glycine 0 C--N 1.309 -0.967 0 C-N-CA 121.19 -0.529 . . . . 0.0 111.958 178.713 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -66.14 108.97 1.43 Allowed 'Trans proline' 0 N--CA 1.46 -0.484 0 C-N-CA 122.317 2.011 . . . . 0.0 111.659 -179.411 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.474 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 17.5 p -97.06 -3.49 41.26 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-N 115.696 -0.683 . . . . 0.0 111.747 -178.817 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 7.2 p -90.28 125.09 43.16 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.941 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.933 178.938 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 84.8 m -84.4 161.95 20.16 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 115.699 -0.682 . . . . 0.0 112.055 -179.858 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.83 160.18 28.85 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 115.098 -0.955 . . . . 0.0 110.79 178.874 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 31.1 m -54.06 116.29 2.5 Favored 'General case' 0 C--N 1.31 -1.147 0 C-N-CA 124.058 0.943 . . . . 0.0 111.989 -179.062 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 105.86 -19.09 39.13 Favored Glycine 0 N--CA 1.435 -1.425 0 CA-C-N 115.779 -0.646 . . . . 0.0 112.237 178.224 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 74.9 p -106.91 145.15 32.55 Favored 'General case' 0 C--N 1.309 -1.181 0 O-C-N 122.252 -0.558 . . . . 0.0 110.813 -177.95 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 22.2 p -114.96 152.15 32.86 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 110.079 -0.341 . . . . 0.0 110.079 178.999 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 50.8 t -77.98 106.02 9.56 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 178.706 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 68.4 mt-30 -108.45 123.88 49.55 Favored 'General case' 0 N--CA 1.429 -1.49 0 CA-C-O 121.11 0.481 . . . . 0.0 109.792 -179.571 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 55.0 t -80.58 111.53 17.42 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.239 -177.875 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 86.6 mt -91.67 -70.06 0.71 Allowed 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 179.688 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.456 ' HB2' ' H ' ' A' ' 32' ' ' TYR . 51.2 m-20 -94.58 163.99 21.14 Favored Pre-proline 0 C--N 1.299 -1.612 0 N-CA-C 105.814 -1.921 . . . . 0.0 105.814 176.109 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_exo -62.39 -26.44 76.79 Favored 'Trans proline' 0 CA--C 1.539 0.744 0 C-N-CA 121.539 1.493 . . . . 0.0 111.798 178.25 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 41.8 m-85 -108.47 -25.26 11.03 Favored 'General case' 0 N--CA 1.444 -0.742 0 C-N-CA 120.216 -0.594 . . . . 0.0 111.11 -177.983 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.456 ' H ' ' HB2' ' A' ' 29' ' ' ASN . 78.6 t80 -105.58 113.96 27.83 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 120.915 0.388 . . . . 0.0 111.888 177.702 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.59 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 24.8 m -116.3 143.43 45.55 Favored 'General case' 0 C--N 1.285 -2.212 0 N-CA-C 106.426 -1.694 . . . . 0.0 106.426 175.753 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -129.4 140.04 51.47 Favored 'General case' 0 C--N 1.303 -1.434 0 CA-C-N 118.269 0.486 . . . . 0.0 111.379 -173.248 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.791 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 74.9 m -74.84 112.56 11.17 Favored 'General case' 0 C--O 1.256 1.4 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.094 175.759 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 92.6 mt . . . . . 0 N--CA 1.429 -1.477 0 C-N-CA 124.401 1.08 . . . . 0.0 108.091 179.965 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 101' ' ' MAN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 19.3 m . . . . . 0 N--CA 1.438 -1.073 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.405 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 5.8 tp-100 -87.58 138.3 31.59 Favored 'General case' 0 N--CA 1.446 -0.653 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 -177.775 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.431 ' O ' ' HB2' ' A' ' 35' ' ' CYS . 33.0 m -98.64 -177.03 3.54 Favored 'General case' 0 C--N 1.294 -1.826 0 CA-C-N 116.733 -0.212 . . . . 0.0 111.152 -175.717 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 53.4 t-80 -61.99 126.56 27.77 Favored 'General case' 0 CA--C 1.511 -0.549 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 177.203 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 71.24 102.99 0.06 Allowed 'General case' 0 C--O 1.237 0.442 0 O-C-N 124.775 1.297 . . . . 0.0 109.726 -173.394 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.464 ' O ' ' HA ' ' A' ' 34' ' ' GLN . . . 158.86 147.48 4.87 Favored Glycine 0 N--CA 1.418 -2.519 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 -176.277 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.603 ' HA ' ' O ' ' A' ' 33' ' ' SER . 53.8 tt0 -78.51 106.83 10.73 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-O 121.03 0.443 . . . . 0.0 110.333 -179.033 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.67 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 7.9 p -82.11 -41.32 20.67 Favored 'General case' 0 C--N 1.301 -1.519 0 CA-C-N 115.556 -0.747 . . . . 0.0 112.05 -179.118 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 173.47 100.26 0.13 Allowed Glycine 0 N--CA 1.432 -1.628 0 C-N-CA 117.881 -2.104 . . . . 0.0 114.397 -177.552 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -112.0 -167.8 17.98 Favored Glycine 0 C--N 1.289 -2.069 0 N-CA-C 108.252 -1.939 . . . . 0.0 108.252 174.446 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 86.1 mt -59.58 109.25 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.01 0 CA-C-N 117.724 0.762 . . . . 0.0 110.995 179.885 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 104.82 -10.08 48.27 Favored Glycine 0 N--CA 1.437 -1.243 0 CA-C-N 115.989 -0.55 . . . . 0.0 113.313 176.504 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 34.5 t80 -100.12 111.22 23.5 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 -177.62 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 5.5 p -113.33 10.96 18.49 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 113.466 0.913 . . . . 0.0 113.466 -175.367 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -74.97 -131.74 0.27 Allowed Glycine 0 CA--C 1.53 1.024 0 CA-C-N 116.16 -0.473 . . . . 0.0 113.475 -179.016 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.86 81.06 0.87 Allowed 'Trans proline' 0 N--CA 1.461 -0.439 0 C-N-CA 122.672 2.248 . . . . 0.0 112.792 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.446 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 29.2 p -81.28 -10.41 59.58 Favored 'General case' 0 N--CA 1.437 -1.084 0 CA-C-N 115.338 -0.847 . . . . 0.0 110.606 178.88 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 7.1 p -89.96 132.82 33.65 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.275 0 CA-C-N 114.833 -1.076 . . . . 0.0 108.886 176.601 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.482 ' HB3' ' OG1' ' A' ' 23' ' ' THR . 76.1 m -101.1 156.67 17.28 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.39 -177.028 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.18 175.29 3.94 Favored 'General case' 0 C--O 1.246 0.877 0 C-N-CA 123.829 0.851 . . . . 0.0 112.065 -178.545 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 5.1 m -51.72 113.05 0.87 Allowed 'General case' 0 N--CA 1.443 -0.815 0 C-N-CA 124.863 1.265 . . . . 0.0 112.275 -177.426 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 89.81 12.63 62.06 Favored Glycine 0 N--CA 1.434 -1.444 0 C-N-CA 120.509 -0.853 . . . . 0.0 113.499 174.832 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.482 ' OG1' ' HB3' ' A' ' 19' ' ' CYS . 73.6 p -124.96 143.93 50.63 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 117.294 0.547 . . . . 0.0 110.274 177.33 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 40.1 p -118.85 137.03 53.71 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.705 179.609 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.481 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 53.3 t -76.35 109.22 9.87 Favored 'General case' 0 C--N 1.312 -1.024 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 179.523 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 74.6 mt-30 -116.28 125.97 52.92 Favored 'General case' 0 C--N 1.298 -1.664 0 CA-C-O 121.026 0.441 . . . . 0.0 110.542 -179.368 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 69.1 t -70.29 115.72 10.16 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.201 0 CA-C-N 115.016 -0.993 . . . . 0.0 109.045 178.441 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 67.8 mt -98.97 -70.67 0.72 Allowed 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 81.9 m-20 -95.5 168.98 9.93 Favored Pre-proline 0 C--N 1.298 -1.644 0 N-CA-C 106.763 -1.569 . . . . 0.0 106.763 175.539 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_exo -59.54 -36.75 92.17 Favored 'Trans proline' 0 CA--C 1.542 0.924 0 C-N-CA 121.614 1.543 . . . . 0.0 113.085 -179.657 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 66.6 m-85 -104.46 -24.02 13.09 Favored 'General case' 0 C--N 1.312 -1.049 0 O-C-N 121.716 -0.615 . . . . 0.0 110.574 -178.762 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 62.8 t80 -103.32 113.59 27.2 Favored 'General case' 0 N--CA 1.431 -1.4 0 CA-C-O 121.658 0.742 . . . . 0.0 111.422 -178.344 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.603 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 26.0 m -122.67 143.67 49.63 Favored 'General case' 0 C--N 1.288 -2.094 0 N-CA-C 105.536 -2.024 . . . . 0.0 105.536 176.355 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.464 ' HA ' ' O ' ' A' ' 6' ' ' GLY . 27.1 tt0 -135.34 145.72 47.7 Favored 'General case' 0 C--N 1.297 -1.675 0 C-N-CA 120.274 -0.571 . . . . 0.0 112.465 -173.105 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.67 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 66.8 m -76.17 112.16 12.34 Favored 'General case' 0 C--O 1.251 1.165 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.335 176.304 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.436 HD21 HE21 ' A' ' 34' ' ' GLN . 94.9 mt . . . . . 0 C--N 1.3 -1.558 0 CA-C-N 115.012 -0.995 . . . . 0.0 108.397 179.081 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' MAN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 22.9 m . . . . . 0 N--CA 1.438 -1.025 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.524 ' HA ' ' OE1' ' A' ' 2' ' ' GLN . 3.4 tp60 -89.01 125.92 35.2 Favored 'General case' 0 N--CA 1.436 -1.144 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 -174.644 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 87.2 p -92.39 -178.15 4.84 Favored 'General case' 0 C--N 1.294 -1.838 0 CA-C-O 121.006 0.432 . . . . 0.0 111.193 -177.508 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' HIS . . . . . 0.495 ' O ' ' H3 ' ' A' ' 101' ' ' MAN . 50.5 t-80 -54.43 136.54 44.01 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 123.954 0.902 . . . . 0.0 110.768 178.589 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 75.75 3.5 3.85 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 124.781 1.232 . . . . 0.0 112.713 177.82 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -93.37 154.98 22.03 Favored Glycine 0 N--CA 1.437 -1.257 0 N-CA-C 110.433 -1.067 . . . . 0.0 110.433 175.958 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.484 ' HA ' ' O ' ' A' ' 33' ' ' SER . 52.3 tt0 -81.36 110.1 16.48 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 177.933 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.707 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 8.7 p -79.18 -43.39 24.0 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 123.333 0.396 . . . . 0.0 111.867 -177.573 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.442 ' H ' ' HB2' ' A' ' 33' ' ' SER . . . 157.31 115.74 0.47 Allowed Glycine 0 N--CA 1.42 -2.383 0 C-N-CA 117.145 -2.455 . . . . 0.0 114.708 179.492 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -101.81 -149.9 22.87 Favored Glycine 0 N--CA 1.418 -2.559 0 N-CA-C 108.352 -1.899 . . . . 0.0 108.352 174.417 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 84.3 mt -71.92 112.98 8.07 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.715 0 CA-C-N 117.417 0.609 . . . . 0.0 111.008 178.475 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 92.61 30.06 10.17 Favored Glycine 0 N--CA 1.449 -0.492 0 CA-C-N 115.807 -0.633 . . . . 0.0 113.597 174.604 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 36.3 t80 -111.72 117.05 31.8 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-N 117.342 0.571 . . . . 0.0 109.513 -179.104 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 39.0 p -102.78 11.27 37.81 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-O 120.864 0.364 . . . . 0.0 111.742 -177.263 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -80.01 -151.78 7.2 Favored Glycine 0 CA--C 1.529 0.965 0 CA-C-N 116.071 -0.513 . . . . 0.0 112.315 179.638 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -75.35 96.59 1.04 Allowed 'Trans proline' 0 N--CA 1.453 -0.89 0 C-N-CA 122.276 1.984 . . . . 0.0 111.163 179.352 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.568 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 15.2 p -90.52 -8.76 49.5 Favored 'General case' 0 N--CA 1.423 -1.808 0 CA-C-N 115.407 -0.815 . . . . 0.0 112.259 -175.303 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 9.3 p -95.78 130.71 44.1 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.225 0 CA-C-N 116.123 -0.49 . . . . 0.0 109.932 177.932 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.492 ' HA ' ' O ' ' A' ' 2' ' ' GLN . 73.6 m -91.86 159.19 15.91 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.467 -179.404 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -78.86 170.0 17.36 Favored 'General case' 0 C--O 1.251 1.138 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.261 -179.472 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 46.4 m -58.51 126.65 28.47 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.972 -179.19 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 104.37 -6.24 45.68 Favored Glycine 0 N--CA 1.431 -1.667 0 C-N-CA 120.147 -1.025 . . . . 0.0 112.207 178.786 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 38.8 p -135.07 153.08 52.16 Favored 'General case' 0 C--O 1.241 0.627 0 CA-C-O 120.653 0.263 . . . . 0.0 111.305 -179.389 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 8.8 p -124.01 153.51 41.21 Favored 'General case' 0 N--CA 1.437 -1.093 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 176.893 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 50.9 t -82.34 99.38 9.33 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 -179.399 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 58.5 mt-30 -99.83 122.36 42.67 Favored 'General case' 0 N--CA 1.438 -1.059 0 CA-C-O 121.123 0.487 . . . . 0.0 110.087 -177.832 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 55.8 t -82.57 107.42 14.41 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.35 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.164 -179.001 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 84.1 mt -88.47 -70.39 0.64 Allowed 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 -179.786 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 55.7 m-80 -94.39 164.41 20.16 Favored Pre-proline 0 C--N 1.303 -1.441 0 N-CA-C 106.343 -1.725 . . . . 0.0 106.343 174.235 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_exo -60.46 -24.58 78.33 Favored 'Trans proline' 0 C--N 1.35 0.624 0 C-N-CA 121.766 1.644 . . . . 0.0 111.963 179.496 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 55.8 m-85 -109.56 -24.26 11.06 Favored 'General case' 0 N--CA 1.432 -1.356 0 C-N-CA 120.276 -0.57 . . . . 0.0 111.502 -179.256 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 57.0 t80 -103.95 113.43 26.95 Favored 'General case' 0 C--N 1.315 -0.934 0 C-N-CA 119.606 -0.838 . . . . 0.0 110.461 -179.474 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.484 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 49.8 m -123.18 137.56 54.86 Favored 'General case' 0 C--N 1.28 -2.447 0 N-CA-C 105.813 -1.921 . . . . 0.0 105.813 177.065 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 29.4 tt0 -131.46 141.04 49.71 Favored 'General case' 0 C--N 1.288 -2.075 0 C-N-CA 121.077 -0.249 . . . . 0.0 111.087 -172.972 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.707 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 76.8 m -74.56 107.98 7.03 Favored 'General case' 0 C--O 1.255 1.39 0 CA-C-O 121.636 0.731 . . . . 0.0 110.653 177.374 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 96.2 mt . . . . . 0 N--CA 1.428 -1.543 0 N-CA-C 106.304 -1.739 . . . . 0.0 106.304 179.028 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 101' ' ' MAN . . . . . 0.495 ' H3 ' ' O ' ' A' ' 4' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 3.6 p . . . . . 0 C--O 1.241 0.653 0 N-CA-C 110.302 -0.258 . . . . 0.0 110.302 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -79.53 147.43 32.18 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 178.415 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 5.0 m -93.03 169.63 10.27 Favored 'General case' 0 C--N 1.298 -1.667 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.6 -175.417 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 42.9 t-80 -52.92 139.45 27.42 Favored 'General case' 0 C--O 1.242 0.697 0 CA-C-N 115.14 -0.936 . . . . 0.0 109.274 173.159 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 69.0 8.28 6.75 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.753 0.821 . . . . 0.0 112.836 179.141 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -100.17 159.09 19.45 Favored Glycine 0 N--CA 1.436 -1.332 0 C-N-CA 120.68 -0.772 . . . . 0.0 111.501 178.283 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.534 ' HA ' ' O ' ' A' ' 33' ' ' SER . 53.7 tt0 -80.7 112.56 18.18 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 179.033 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.688 ' O ' ' HA ' ' A' ' 17' ' ' THR . 25.4 p -91.33 -38.29 12.72 Favored 'General case' 0 C--N 1.293 -1.856 0 N-CA-C 113.304 0.853 . . . . 0.0 113.304 -174.808 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 177.79 85.1 0.06 OUTLIER Glycine 0 CA--C 1.484 -1.851 0 C-N-CA 117.85 -2.119 . . . . 0.0 113.868 -176.754 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.461 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -112.55 176.28 17.6 Favored Glycine 0 C--N 1.285 -2.29 0 N-CA-C 108.469 -1.852 . . . . 0.0 108.469 174.573 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 78.3 mt -61.62 118.82 4.52 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.042 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 176.907 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 110.38 -5.77 30.02 Favored Glycine 0 N--CA 1.432 -1.608 0 C-N-CA 120.845 -0.693 . . . . 0.0 111.675 -178.988 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 65.2 t80 -114.0 108.28 16.81 Favored 'General case' 0 C--N 1.311 -1.089 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 178.232 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 21.9 p -109.61 15.65 22.72 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.658 -177.467 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -88.23 -154.67 28.16 Favored Glycine 0 N--CA 1.45 -0.423 0 CA-C-O 119.597 -0.557 . . . . 0.0 112.32 -179.688 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_endo -62.0 109.79 0.88 Allowed 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 122.882 2.388 . . . . 0.0 111.232 177.883 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.688 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 7.7 p -95.04 -6.46 42.13 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 114.215 1.191 . . . . 0.0 114.215 -173.267 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 7.6 p -95.71 134.76 32.05 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.371 0 O-C-N 121.973 -0.454 . . . . 0.0 109.98 179.43 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 46.9 m -91.37 168.87 11.25 Favored 'General case' 0 C--N 1.312 -1.051 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 -179.786 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.64 141.61 53.62 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 175.082 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 46.7 m -56.46 133.66 53.36 Favored 'General case' 0 N--CA 1.433 -1.314 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.255 -179.201 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 111.9 -13.17 26.96 Favored Glycine 0 C--N 1.296 -1.69 0 N-CA-C 109.86 -1.296 . . . . 0.0 109.86 -173.733 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 55.2 p -136.28 143.63 44.33 Favored 'General case' 0 C--O 1.248 1.004 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 174.93 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 21.3 p -111.35 138.08 48.29 Favored 'General case' 0 C--N 1.288 -2.098 0 CA-C-N 116.654 -0.248 . . . . 0.0 110.994 -179.212 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 46.4 t -72.3 99.0 2.3 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 176.458 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 74.8 mt-30 -108.06 129.29 55.15 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-O 121.223 0.535 . . . . 0.0 110.305 -179.234 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 58.3 t -78.05 107.6 10.21 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.371 0 CA-C-N 115.137 -0.938 . . . . 0.0 109.342 -179.77 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 83.6 mt -86.48 -72.33 0.51 Allowed 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 82.2 m-20 -94.84 165.17 17.69 Favored Pre-proline 0 C--N 1.292 -1.892 0 N-CA-C 105.789 -1.93 . . . . 0.0 105.789 174.769 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -60.95 -33.6 92.12 Favored 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 121.617 1.544 . . . . 0.0 111.316 179.087 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.461 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 76.1 m-85 -100.11 -26.3 14.0 Favored 'General case' 0 C--N 1.311 -1.079 0 C-N-CA 120.396 -0.522 . . . . 0.0 111.199 -177.787 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 53.6 t80 -106.28 113.82 27.57 Favored 'General case' 0 C--N 1.311 -1.078 0 C-N-CA 120.723 -0.391 . . . . 0.0 111.946 -179.341 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.534 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 20.0 m -121.69 141.09 51.5 Favored 'General case' 0 C--N 1.288 -2.087 0 N-CA-C 106.545 -1.65 . . . . 0.0 106.545 175.353 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 34.8 tt0 -133.43 145.96 50.75 Favored 'General case' 0 C--N 1.3 -1.579 0 C-N-CA 120.092 -0.643 . . . . 0.0 111.376 -172.215 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.667 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 57.2 m -75.77 110.6 10.32 Favored 'General case' 0 C--O 1.252 1.228 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.014 177.483 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 84.7 mt . . . . . 0 C--N 1.302 -1.462 0 CA-C-N 115.042 -0.981 . . . . 0.0 109.503 -177.442 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 101' ' ' MAN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 3.9 m . . . . . 0 N--CA 1.436 -1.135 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -115.2 152.68 32.22 Favored 'General case' 0 N--CA 1.429 -1.519 0 N-CA-C 106.301 -1.74 . . . . 0.0 106.301 172.512 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 23.2 t -127.49 -177.61 4.15 Favored 'General case' 0 C--N 1.293 -1.866 0 C-N-CA 119.991 -0.684 . . . . 0.0 110.266 -176.635 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 41.6 t-80 -49.99 132.83 23.07 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 124.113 0.965 . . . . 0.0 110.93 -179.575 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 75.6 6.15 3.98 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 124.824 1.25 . . . . 0.0 112.294 178.652 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -98.8 155.92 20.11 Favored Glycine 0 N--CA 1.433 -1.528 0 N-CA-C 110.441 -1.064 . . . . 0.0 110.441 175.653 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.459 ' HA ' ' O ' ' A' ' 33' ' ' SER . 51.6 tt0 -81.23 116.53 21.15 Favored 'General case' 0 N--CA 1.438 -1.039 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 179.824 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.738 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 10.8 p -91.08 -22.02 20.93 Favored 'General case' 0 C--N 1.292 -1.904 0 N-CA-C 113.261 0.837 . . . . 0.0 113.261 -175.102 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 157.45 90.54 0.08 OUTLIER Glycine 0 CA--C 1.473 -2.592 0 C-N-CA 117.203 -2.427 . . . . 0.0 113.818 -179.108 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.649 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -113.11 179.41 19.08 Favored Glycine 0 C--N 1.275 -2.843 0 N-CA-C 108.076 -2.01 . . . . 0.0 108.076 173.999 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.44 ' HB ' ' CD1' ' A' ' 31' ' ' TYR . 56.5 mt -64.67 112.22 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 178.623 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 113.41 -4.37 24.96 Favored Glycine 0 N--CA 1.441 -1.027 0 C-N-CA 121.1 -0.572 . . . . 0.0 112.036 -179.399 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 72.9 t80 -101.42 129.29 47.41 Favored 'General case' 0 C--N 1.31 -1.129 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 3.7 p -129.12 5.76 5.35 Favored 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 112.751 0.649 . . . . 0.0 112.751 -177.39 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -81.49 -149.69 7.17 Favored Glycine 0 CA--C 1.533 1.21 0 C-N-CA 121.171 -0.538 . . . . 0.0 112.04 177.881 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_endo -63.02 111.43 1.39 Allowed 'Trans proline' 0 C--N 1.357 1.007 0 C-N-CA 122.538 2.159 . . . . 0.0 112.225 179.102 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.645 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 3.1 p -93.71 -16.09 24.59 Favored 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 113.166 0.802 . . . . 0.0 113.166 -176.238 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 8.2 p -90.48 128.1 42.57 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 CA-C-O 121.001 0.429 . . . . 0.0 110.402 -179.74 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 69.8 m -86.75 153.24 21.85 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 177.559 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -59.57 127.42 31.93 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 174.566 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 35.3 m -53.67 130.56 36.8 Favored 'General case' 0 C--O 1.246 0.909 0 CA-C-O 121.319 0.581 . . . . 0.0 110.973 -177.717 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 113.18 -21.21 18.1 Favored Glycine 0 N--CA 1.434 -1.464 0 N-CA-C 109.263 -1.535 . . . . 0.0 109.263 -170.591 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 70.6 p -117.57 143.34 46.2 Favored 'General case' 0 N--CA 1.443 -0.783 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 172.405 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 34.1 p -112.55 144.07 42.64 Favored 'General case' 0 C--N 1.295 -1.782 0 CA-C-O 120.71 0.29 . . . . 0.0 111.007 -177.034 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 50.9 t -78.83 98.51 6.35 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 178.54 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 75.3 mt-30 -103.74 127.69 51.19 Favored 'General case' 0 N--CA 1.431 -1.379 0 CA-C-O 120.996 0.427 . . . . 0.0 110.031 -177.713 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 60.0 t -78.37 114.04 18.45 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 179.463 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 74.2 mt -94.16 -70.38 0.71 Allowed 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 -178.692 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 77.6 m-20 -94.94 164.08 20.39 Favored Pre-proline 0 C--N 1.299 -1.612 0 N-CA-C 106.608 -1.627 . . . . 0.0 106.608 175.964 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -57.1 -35.33 98.88 Favored 'Trans proline' 0 CA--C 1.538 0.679 0 C-N-CA 121.886 1.724 . . . . 0.0 112.586 -179.029 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.649 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 50.5 m-85 -103.89 -21.07 13.7 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.991 -178.849 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 24.1 t80 -104.44 113.3 26.78 Favored 'General case' 0 C--N 1.316 -0.859 0 C-N-CA 119.87 -0.732 . . . . 0.0 111.24 -178.736 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.459 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 16.9 m -116.93 135.71 53.51 Favored 'General case' 0 C--N 1.289 -2.064 0 N-CA-C 106.068 -1.827 . . . . 0.0 106.068 175.648 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -129.92 144.72 51.47 Favored 'General case' 0 C--N 1.299 -1.621 0 CA-C-N 118.111 0.414 . . . . 0.0 110.832 -172.068 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.738 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 61.7 m -76.46 116.84 17.52 Favored 'General case' 0 C--O 1.259 1.592 0 CA-C-O 121.17 0.51 . . . . 0.0 110.154 177.479 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 94.5 mt . . . . . 0 C--N 1.298 -1.666 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 177.582 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 101' ' ' MAN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 6.8 m . . . . . 0 N--CA 1.441 -0.899 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -82.26 142.05 32.44 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.434 ' O ' ' HB2' ' A' ' 35' ' ' CYS . 19.6 p -95.05 -178.13 4.38 Favored 'General case' 0 C--N 1.29 -2.013 0 C-N-CA 123.134 0.574 . . . . 0.0 111.54 -174.479 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 51.0 t-80 -64.55 123.59 19.65 Favored 'General case' 0 N--CA 1.445 -0.694 0 N-CA-C 108.023 -1.102 . . . . 0.0 108.023 176.718 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 65.03 83.95 0.16 Allowed 'General case' 0 C--N 1.319 -0.727 0 O-C-N 124.446 1.092 . . . . 0.0 111.453 -175.819 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.511 ' O ' ' HA ' ' A' ' 34' ' ' GLN . . . -167.38 159.13 32.36 Favored Glycine 0 N--CA 1.424 -2.138 0 N-CA-C 106.916 -2.474 . . . . 0.0 106.916 179.398 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.603 ' HA ' ' O ' ' A' ' 33' ' ' SER . 53.3 tt0 -82.36 110.36 17.44 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 118.281 1.04 . . . . 0.0 110.049 -179.19 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.709 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 1.8 p -86.1 -47.81 9.18 Favored 'General case' 0 C--N 1.295 -1.793 0 N-CA-C 113.237 0.829 . . . . 0.0 113.237 -177.79 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.422 ' H ' ' HB2' ' A' ' 33' ' ' SER . . . -174.22 89.16 0.08 OUTLIER Glycine 0 CA--C 1.486 -1.73 0 C-N-CA 117.716 -2.183 . . . . 0.0 114.07 -175.669 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.509 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -112.87 178.38 18.75 Favored Glycine 0 C--N 1.286 -2.213 0 N-CA-C 107.673 -2.171 . . . . 0.0 107.673 173.616 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 67.6 mt -61.58 118.44 4.08 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-N 118.239 1.019 . . . . 0.0 108.83 177.037 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 110.26 -14.85 30.64 Favored Glycine 0 N--CA 1.443 -0.897 0 C-N-CA 120.767 -0.73 . . . . 0.0 111.841 -178.852 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 25.7 t80 -114.09 121.47 43.92 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 -179.574 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 13.7 p -134.96 18.28 3.48 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-O 121.282 0.563 . . . . 0.0 111.545 -179.496 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -78.6 -128.61 0.53 Allowed Glycine 0 CA--C 1.521 0.414 0 CA-C-N 115.311 -0.859 . . . . 0.0 111.065 176.844 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -67.04 88.37 0.3 Allowed 'Trans proline' 0 CA--C 1.536 0.576 0 C-N-CA 122.201 1.934 . . . . 0.0 111.95 176.549 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.633 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 39.2 p -86.73 0.15 55.21 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.651 0.739 . . . . 0.0 110.756 -179.625 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 7.6 p -102.27 129.74 53.23 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.579 0 CA-C-N 114.89 -1.05 . . . . 0.0 108.82 178.663 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.461 ' SG ' ' HB2' ' A' ' 25' ' ' CYS . 71.4 m -92.64 153.64 18.86 Favored 'General case' 0 C--N 1.293 -1.886 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.67 -179.703 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -56.51 133.01 53.05 Favored 'General case' 0 C--O 1.249 1.039 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 174.899 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 9.2 p -53.97 127.51 26.63 Favored 'General case' 0 C--O 1.249 1.073 0 CA-C-O 121.528 0.68 . . . . 0.0 112.294 -177.149 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 112.43 -9.49 26.38 Favored Glycine 0 N--CA 1.431 -1.687 0 CA-C-N 114.843 -1.071 . . . . 0.0 110.784 -175.493 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 67.1 p -127.39 145.73 50.71 Favored 'General case' 0 C--O 1.246 0.899 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 176.477 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 23.6 p -111.3 140.14 46.12 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-O 120.381 0.134 . . . . 0.0 111.178 -178.337 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.461 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 53.6 t -73.31 103.07 3.87 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 179.094 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 16.7 mm-40 -91.12 113.48 25.76 Favored 'General case' 0 N--CA 1.425 -1.695 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.024 -179.005 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 45.5 t -76.19 101.36 2.59 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.114 0 N-CA-C 107.142 -1.429 . . . . 0.0 107.142 176.698 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 77.3 mt -86.87 -69.93 0.64 Allowed 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 -177.661 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 79.1 m-20 -95.74 165.31 16.82 Favored Pre-proline 0 C--N 1.298 -1.668 0 N-CA-C 107.038 -1.467 . . . . 0.0 107.038 174.727 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_exo -60.91 -29.98 89.11 Favored 'Trans proline' 0 CA--C 1.542 0.884 0 C-N-CA 121.499 1.466 . . . . 0.0 111.658 178.428 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.509 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 87.8 m-85 -101.77 -25.54 13.8 Favored 'General case' 0 N--CA 1.44 -0.969 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.553 -179.839 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 68.2 t80 -106.05 114.8 29.16 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 113.008 0.744 . . . . 0.0 113.008 -178.538 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.603 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 23.8 m -121.18 136.59 54.95 Favored 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 175.711 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.511 ' HA ' ' O ' ' A' ' 6' ' ' GLY . 35.2 tt0 -127.59 133.24 49.73 Favored 'General case' 0 C--N 1.318 -0.762 0 C-N-CA 122.202 0.201 . . . . 0.0 110.763 -173.253 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.709 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 64.1 m -74.01 109.03 7.18 Favored 'General case' 0 C--O 1.243 0.739 0 CA-C-O 120.972 0.415 . . . . 0.0 111.756 177.996 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 96.6 mt . . . . . 0 C--N 1.299 -1.591 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 178.689 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 101' ' ' MAN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 8.1 t . . . . . 0 C--O 1.242 0.665 0 N-CA-C 107.467 -1.308 . . . . 0.0 107.467 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -93.61 135.94 34.38 Favored 'General case' 0 N--CA 1.416 -2.133 0 C-N-CA 119.815 -0.754 . . . . 0.0 109.045 178.217 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 61.3 p -91.99 173.9 7.6 Favored 'General case' 0 C--N 1.282 -2.332 0 CA-C-N 114.857 -1.065 . . . . 0.0 110.146 -175.027 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 55.2 t-80 -57.54 134.23 55.94 Favored 'General case' 0 C--N 1.315 -0.905 0 C-N-CA 123.453 0.701 . . . . 0.0 110.107 177.183 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 70.51 10.42 7.16 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.646 1.178 . . . . 0.0 112.908 178.169 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.526 ' O ' ' HA ' ' A' ' 34' ' ' GLN . . . -97.62 155.8 20.56 Favored Glycine 0 N--CA 1.438 -1.2 0 N-CA-C 110.726 -0.95 . . . . 0.0 110.726 176.175 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.634 ' HA ' ' O ' ' A' ' 33' ' ' SER . 64.4 tt0 -70.25 110.51 5.27 Favored 'General case' 0 C--O 1.217 -0.608 0 CA-C-N 117.14 0.47 . . . . 0.0 109.931 -178.958 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.742 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 21.1 p -93.13 -31.68 14.71 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 113.565 0.95 . . . . 0.0 113.565 -175.764 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 179.84 84.36 0.06 OUTLIER Glycine 0 CA--C 1.483 -1.932 0 C-N-CA 117.574 -2.251 . . . . 0.0 113.786 -174.673 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.567 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -112.44 167.2 12.3 Favored Glycine 0 C--N 1.286 -2.24 0 N-CA-C 108.748 -1.741 . . . . 0.0 108.748 174.81 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 79.7 mt -60.78 117.53 2.66 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 177.532 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 105.37 -8.75 44.79 Favored Glycine 0 N--CA 1.442 -0.965 0 C-N-CA 120.373 -0.918 . . . . 0.0 111.804 179.734 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 90.4 t80 -94.74 108.85 20.85 Favored 'General case' 0 N--CA 1.44 -0.932 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 178.06 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 3.3 p -103.87 7.71 36.9 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-N 114.806 -1.088 . . . . 0.0 111.743 -176.741 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -81.05 -163.3 30.08 Favored Glycine 0 N--CA 1.445 -0.737 0 C-N-CA 121.084 -0.579 . . . . 0.0 112.361 -179.28 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_endo -62.16 118.25 5.13 Favored 'Trans proline' 0 C--O 1.235 0.342 0 C-N-CA 122.834 2.356 . . . . 0.0 110.754 177.905 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.551 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 10.2 p -99.71 -14.89 18.71 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 -174.639 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 13.6 p -79.48 137.66 21.33 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 C-N-CA 120.594 -0.442 . . . . 0.0 110.004 179.882 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.405 ' HB3' ' OG1' ' A' ' 23' ' ' THR . 71.2 m -97.31 153.08 18.28 Favored 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 179.544 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.53 155.67 21.48 Favored 'General case' 0 C--O 1.251 1.159 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.238 178.107 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 4.9 p -58.3 118.55 5.64 Favored 'General case' 0 C--N 1.307 -1.254 0 C-N-CA 123.429 0.692 . . . . 0.0 111.383 -179.328 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 111.92 -11.33 27.26 Favored Glycine 0 N--CA 1.441 -0.982 0 C-N-CA 120.926 -0.654 . . . . 0.0 111.641 -178.926 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.405 ' OG1' ' HB3' ' A' ' 19' ' ' CYS . 76.7 p -120.22 151.78 38.65 Favored 'General case' 0 C--O 1.256 1.412 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 178.058 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.411 ' O ' ' HA ' ' A' ' 35' ' ' CYS . 16.9 p -121.87 148.83 44.21 Favored 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 110.278 -0.268 . . . . 0.0 110.278 176.478 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 49.4 t -77.47 103.88 7.66 Favored 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 179.679 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 12.7 mm-40 -98.44 117.83 33.74 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 116.052 -0.522 . . . . 0.0 109.951 -178.382 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 41.2 t -87.06 105.71 15.33 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 -178.715 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 69.1 mt -89.68 -69.46 0.72 Allowed 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 -178.168 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 48.7 m-80 -95.19 170.34 8.02 Favored Pre-proline 0 C--N 1.301 -1.522 0 N-CA-C 107.038 -1.468 . . . . 0.0 107.038 176.148 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_exo -65.97 -30.15 48.49 Favored 'Trans proline' 0 C--N 1.345 0.349 0 CA-C-N 120.57 1.239 . . . . 0.0 111.875 177.072 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.567 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 28.5 m-85 -106.43 -25.59 11.81 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 119.779 -0.768 . . . . 0.0 110.585 -177.875 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 60.4 t80 -104.76 115.3 30.07 Favored 'General case' 0 N--CA 1.443 -0.807 0 C-N-CA 119.893 -0.723 . . . . 0.0 112.563 177.883 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.634 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 14.5 m -131.65 141.14 49.54 Favored 'General case' 0 C--N 1.293 -1.861 0 N-CA-C 105.993 -1.854 . . . . 0.0 105.993 176.272 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.526 ' HA ' ' O ' ' A' ' 6' ' ' GLY . 4.1 pt20 -132.82 151.1 52.08 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 119.084 0.857 . . . . 0.0 111.882 -178.172 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.742 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 61.2 m -76.55 118.41 19.18 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-O 121.218 0.533 . . . . 0.0 110.517 178.082 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 97.0 mt . . . . . 0 C--N 1.303 -1.453 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 178.525 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 101' ' ' MAN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 20.0 m . . . . . 0 N--CA 1.445 -0.676 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -79.92 131.72 35.9 Favored 'General case' 0 N--CA 1.44 -0.97 0 N-CA-C 107.429 -1.323 . . . . 0.0 107.429 178.847 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.413 ' HB2' ' H2 ' ' A' ' 101' ' ' MAN . 22.7 t -110.03 -168.52 1.33 Allowed 'General case' 0 C--N 1.29 -1.987 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 -176.409 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 25.2 t-80 -56.18 126.46 26.21 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 123.249 0.62 . . . . 0.0 110.182 -178.587 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 69.57 76.94 0.22 Allowed 'General case' 0 C--N 1.328 -0.339 0 O-C-N 124.604 1.19 . . . . 0.0 111.424 -178.41 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.574 ' O ' ' HA ' ' A' ' 34' ' ' GLN . . . -169.55 155.55 25.75 Favored Glycine 0 N--CA 1.433 -1.527 0 N-CA-C 108.699 -1.761 . . . . 0.0 108.699 179.175 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.689 ' HA ' ' O ' ' A' ' 33' ' ' SER . 53.2 tt0 -77.64 107.24 9.98 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 117.591 0.696 . . . . 0.0 110.329 -178.268 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.796 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 6.1 p -87.82 -41.9 12.94 Favored 'General case' 0 C--N 1.297 -1.709 0 CA-C-N 115.395 -0.82 . . . . 0.0 113.133 -176.613 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -161.96 53.99 0.31 Allowed Glycine 0 CA--C 1.471 -2.687 0 C-N-CA 118.956 -1.592 . . . . 0.0 111.687 -173.685 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.439 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -95.69 149.68 19.41 Favored Glycine 0 N--CA 1.423 -2.202 0 N-CA-C 108.442 -1.863 . . . . 0.0 108.442 175.692 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.437 ' HB ' ' CD1' ' A' ' 31' ' ' TYR . 61.4 mt -57.97 121.03 4.76 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.913 0 CA-C-N 117.315 0.558 . . . . 0.0 110.443 -178.299 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 109.59 4.26 30.3 Favored Glycine 0 N--CA 1.445 -0.713 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.985 -179.114 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.458 ' HB2' ' NE2' ' A' ' 7' ' ' GLN . 70.0 t80 -103.54 119.94 39.88 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 177.929 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 14.3 p -99.64 1.17 43.32 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 112.397 0.517 . . . . 0.0 112.397 -177.157 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -85.68 -175.8 50.2 Favored Glycine 0 N--CA 1.444 -0.822 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.329 -179.266 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -66.16 130.41 24.08 Favored 'Trans proline' 0 CA--C 1.533 0.454 0 C-N-CA 122.759 2.306 . . . . 0.0 111.616 -179.535 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.564 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 37.1 p -88.04 10.29 19.58 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-O 121.626 0.727 . . . . 0.0 111.679 -177.911 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 7.1 p -94.19 123.41 46.29 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.496 0 CA-C-O 121.567 0.699 . . . . 0.0 110.82 -178.372 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 83.7 m -88.56 160.12 17.59 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-N 115.112 -0.949 . . . . 0.0 109.154 177.064 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -72.17 146.15 47.59 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 176.751 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 67.9 m -53.1 130.27 33.59 Favored 'General case' 0 C--O 1.25 1.1 0 CA-C-O 121.092 0.472 . . . . 0.0 110.211 176.763 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 112.18 -16.81 24.75 Favored Glycine 0 N--CA 1.43 -1.722 0 N-CA-C 110.781 -0.928 . . . . 0.0 110.781 -173.593 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 41.4 p -133.2 144.78 50.04 Favored 'General case' 0 N--CA 1.443 -0.818 0 CA-C-O 120.819 0.342 . . . . 0.0 111.327 179.577 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 23.3 p -116.77 152.32 34.62 Favored 'General case' 0 C--N 1.309 -1.161 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 177.778 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 44.8 t -77.53 111.44 13.27 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 -179.422 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 70.3 mt-30 -110.9 127.93 55.63 Favored 'General case' 0 N--CA 1.434 -1.238 0 CA-C-O 121.331 0.586 . . . . 0.0 110.273 -179.656 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 58.8 t -81.01 110.75 16.84 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.723 -178.141 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 75.4 mt -90.02 -72.65 0.55 Allowed 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 107.01 -1.478 . . . . 0.0 107.01 177.314 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 54.8 m-80 -95.79 164.29 19.13 Favored Pre-proline 0 C--N 1.298 -1.66 0 N-CA-C 106.785 -1.561 . . . . 0.0 106.785 170.536 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_exo -63.56 -33.45 67.82 Favored 'Trans proline' 0 C--O 1.241 0.637 0 C-N-CA 121.64 1.56 . . . . 0.0 111.26 176.374 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.439 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 76.8 m-85 -97.17 -26.38 14.97 Favored 'General case' 0 N--CA 1.442 -0.83 0 C-N-CA 119.633 -0.827 . . . . 0.0 110.819 -179.689 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 53.1 t80 -106.21 113.01 26.29 Favored 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 119.436 -0.906 . . . . 0.0 110.956 175.397 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.689 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 20.0 m -123.98 140.92 52.5 Favored 'General case' 0 C--N 1.288 -2.103 0 N-CA-C 106.616 -1.624 . . . . 0.0 106.616 177.393 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.574 ' HA ' ' O ' ' A' ' 6' ' ' GLY . 37.1 tt0 -129.89 140.57 50.94 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 -169.493 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.796 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 73.7 m -71.41 116.85 12.22 Favored 'General case' 0 C--O 1.258 1.522 0 CA-C-O 121.147 0.499 . . . . 0.0 110.544 175.303 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 95.5 mt . . . . . 0 C--N 1.303 -1.424 0 C-N-CA 125.156 1.382 . . . . 0.0 107.949 179.515 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 101' ' ' MAN . . . . . 0.413 ' H2 ' ' HB2' ' A' ' 3' ' ' SER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 28.9 m . . . . . 0 N--CA 1.444 -0.749 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 5.6 tp-100 -80.37 144.15 32.94 Favored 'General case' 0 N--CA 1.442 -0.839 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 -177.31 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 62.4 m -126.16 -173.22 2.8 Favored 'General case' 0 C--N 1.297 -1.715 0 C-N-CA 120.176 -0.61 . . . . 0.0 111.923 -177.181 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' HIS . . . . . 0.59 ' HA ' ' O ' ' A' ' 35' ' ' CYS . 57.6 t-80 -54.29 132.27 43.41 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 123.055 0.542 . . . . 0.0 110.326 -178.702 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.493 ' HA ' ' OE1' ' A' ' 34' ' ' GLN . . . 81.16 1.61 1.66 Allowed 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 125.251 1.42 . . . . 0.0 112.195 -178.423 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -98.91 153.22 19.79 Favored Glycine 0 N--CA 1.433 -1.54 0 N-CA-C 110.766 -0.934 . . . . 0.0 110.766 177.061 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.465 ' HA ' ' O ' ' A' ' 33' ' ' SER . 49.7 tt0 -82.17 111.5 18.34 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 179.856 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.77 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 14.6 p -83.45 -14.36 52.69 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.783 -178.025 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 122.94 115.24 2.23 Favored Glycine 0 N--CA 1.416 -2.674 0 C-N-CA 117.574 -2.25 . . . . 0.0 116.279 173.424 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -112.38 -153.59 11.93 Favored Glycine 0 N--CA 1.418 -2.555 0 N-CA-C 107.063 -2.415 . . . . 0.0 107.063 171.503 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 78.9 mt -64.29 124.18 18.57 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.679 0 CA-C-N 117.756 0.778 . . . . 0.0 110.493 177.836 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 95.9 6.87 59.04 Favored Glycine 0 N--CA 1.442 -0.956 0 CA-C-N 115.998 -0.546 . . . . 0.0 113.741 176.438 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 49.4 t80 -109.25 127.55 54.34 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 -179.712 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 6.7 p -128.83 15.7 6.37 Favored 'General case' 0 C--N 1.303 -1.434 0 CA-C-O 121.505 0.669 . . . . 0.0 111.144 -177.397 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -84.42 -143.83 6.16 Favored Glycine 0 C--O 1.248 0.981 0 N-CA-C 111.449 -0.66 . . . . 0.0 111.449 178.216 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -73.01 103.53 1.61 Allowed 'Trans proline' 0 N--CA 1.448 -1.154 0 C-N-CA 122.227 1.951 . . . . 0.0 111.395 177.769 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.524 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 32.8 p -94.46 -7.68 40.73 Favored 'General case' 0 N--CA 1.434 -1.234 0 CA-C-O 121.669 0.747 . . . . 0.0 110.816 -178.474 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 7.4 p -82.31 123.64 38.46 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.805 0 CA-C-N 115.239 -0.891 . . . . 0.0 110.732 178.051 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 78.4 m -90.44 148.88 22.5 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 109.481 -0.562 . . . . 0.0 109.481 176.395 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.53 150.9 17.89 Favored 'General case' 0 C--O 1.251 1.169 0 O-C-N 123.774 0.671 . . . . 0.0 110.449 177.381 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 8.9 t -59.41 115.87 3.56 Favored 'General case' 0 N--CA 1.433 -1.297 0 CA-C-N 115.663 -0.698 . . . . 0.0 109.491 -177.577 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 111.91 -5.69 27.41 Favored Glycine 0 N--CA 1.437 -1.237 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.077 -178.882 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 60.3 p -121.43 147.02 46.29 Favored 'General case' 0 C--N 1.312 -1.06 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 175.36 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 26.5 p -117.84 141.48 48.37 Favored 'General case' 0 C--N 1.304 -1.41 0 C-N-CA 121.26 -0.176 . . . . 0.0 110.586 -178.836 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 48.4 t -72.66 103.8 3.71 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 85.3 mm-40 -98.26 112.26 24.31 Favored 'General case' 0 N--CA 1.415 -2.186 0 CA-C-O 121.264 0.554 . . . . 0.0 110.24 -179.225 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 41.4 t -80.39 96.51 2.75 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.588 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 179.732 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 87.1 mt -80.9 -69.98 0.56 Allowed 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 -177.828 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 23.9 m120 -94.27 164.55 19.87 Favored Pre-proline 0 C--N 1.298 -1.649 0 N-CA-C 106.449 -1.685 . . . . 0.0 106.449 175.949 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -59.77 -33.1 96.38 Favored 'Trans proline' 0 N--CA 1.475 0.42 0 C-N-CA 121.655 1.57 . . . . 0.0 111.669 178.781 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -100.27 -25.36 14.27 Favored 'General case' 0 N--CA 1.441 -0.915 0 C-N-CA 120.077 -0.649 . . . . 0.0 111.206 179.606 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 80.2 t80 -105.05 114.42 28.61 Favored 'General case' 0 C--N 1.309 -1.191 0 C-N-CA 119.798 -0.761 . . . . 0.0 112.673 -176.782 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.465 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 24.0 m -125.58 137.3 53.9 Favored 'General case' 0 C--N 1.284 -2.257 0 N-CA-C 106.858 -1.534 . . . . 0.0 106.858 178.114 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.493 ' OE1' ' HA ' ' A' ' 5' ' ' ALA . 8.0 tt0 -128.53 142.04 51.19 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 109.956 -0.386 . . . . 0.0 109.956 -175.943 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.77 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 75.2 m -75.06 110.74 9.63 Favored 'General case' 0 C--O 1.249 1.037 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 175.806 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 96.6 mt . . . . . 0 N--CA 1.423 -1.801 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 179.08 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 101' ' ' MAN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' THR . . . . . 0.448 HG22 HG13 ' A' ' 18' ' ' VAL . 15.9 p . . . . . 0 N--CA 1.442 -0.849 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.735 ' OE1' ' H3 ' ' A' ' 101' ' ' MAN . 6.3 tp-100 -79.7 135.85 36.64 Favored 'General case' 0 N--CA 1.434 -1.269 0 C-N-CA 119.804 -0.759 . . . . 0.0 110.255 -178.425 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 18.3 p -88.01 166.89 14.15 Favored 'General case' 0 C--N 1.285 -2.2 0 CA-C-N 115.243 -0.889 . . . . 0.0 111.575 -174.555 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 56.6 t-80 -57.82 136.75 57.01 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 107.675 -1.232 . . . . 0.0 107.675 172.63 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.416 ' HA ' ' CD ' ' A' ' 34' ' ' GLN . . . 73.2 12.56 4.88 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.396 0.678 . . . . 0.0 112.665 -179.935 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.454 ' O ' ' HA ' ' A' ' 34' ' ' GLN . . . -107.58 164.42 13.0 Favored Glycine 0 C--O 1.243 0.715 0 N-CA-C 110.478 -1.049 . . . . 0.0 110.478 175.364 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.587 ' HA ' ' O ' ' A' ' 33' ' ' SER . 54.1 tt0 -84.55 107.05 16.57 Favored 'General case' 0 C--O 1.224 -0.251 0 CA-C-N 117.395 0.598 . . . . 0.0 110.894 -177.839 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.805 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 12.3 p -84.34 -37.79 21.16 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 113.705 1.002 . . . . 0.0 113.705 -175.565 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -177.43 87.81 0.07 OUTLIER Glycine 0 CA--C 1.481 -2.04 0 C-N-CA 117.96 -2.067 . . . . 0.0 113.24 -176.291 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.559 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -112.42 172.9 14.96 Favored Glycine 0 C--N 1.28 -2.548 0 N-CA-C 107.921 -2.072 . . . . 0.0 107.921 174.867 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 68.8 mt -63.07 118.0 4.64 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.208 0 CA-C-N 117.861 0.83 . . . . 0.0 109.353 178.785 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 105.73 6.21 38.07 Favored Glycine 0 C--N 1.312 -0.799 0 C-N-CA 120.421 -0.895 . . . . 0.0 112.386 178.73 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 85.2 t80 -102.47 118.48 36.97 Favored 'General case' 0 C--N 1.307 -1.262 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 178.532 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 14.3 p -109.36 0.38 19.44 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-O 121.271 0.558 . . . . 0.0 111.513 -177.703 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -77.92 -171.64 37.77 Favored Glycine 0 N--CA 1.443 -0.841 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.918 178.99 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_endo -64.37 119.24 6.22 Favored 'Trans proline' 0 C--O 1.237 0.454 0 C-N-CA 122.481 2.121 . . . . 0.0 111.291 178.983 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.564 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 70.1 p -90.71 -8.32 50.17 Favored 'General case' 0 C--O 1.24 0.558 0 CA-C-O 121.41 0.624 . . . . 0.0 111.211 -176.873 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.448 HG13 HG22 ' A' ' 1' ' ' THR . 5.6 p -80.07 126.41 39.36 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.185 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.334 179.411 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 83.9 m -87.78 163.46 16.46 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.253 -179.017 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.29 150.89 45.16 Favored 'General case' 0 C--O 1.254 1.323 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 175.49 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 35.6 t -57.76 126.01 25.51 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-O 121.503 0.668 . . . . 0.0 110.572 -175.965 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 112.32 -21.11 20.25 Favored Glycine 0 N--CA 1.43 -1.766 0 CA-C-N 115.172 -0.922 . . . . 0.0 111.62 -178.412 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 50.7 p -116.02 147.09 41.6 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 120.765 -0.374 . . . . 0.0 110.384 179.569 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.405 ' O ' ' HA ' ' A' ' 35' ' ' CYS . 21.7 p -120.23 155.39 33.29 Favored 'General case' 0 C--N 1.298 -1.656 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.767 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 48.5 t -80.23 102.95 9.78 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-O 121.143 0.497 . . . . 0.0 110.433 -178.833 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.451 ' HG3' ' HB2' ' A' ' 36' ' ' LEU . 9.1 mm-40 -100.87 122.29 43.18 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 -179.166 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 57.6 t -79.84 114.8 21.21 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.715 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 -179.083 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 86.4 mt -98.25 -70.04 0.74 Allowed 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 179.192 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.465 ' HB2' ' H ' ' A' ' 32' ' ' TYR . 88.2 m-20 -94.07 166.11 16.3 Favored Pre-proline 0 C--N 1.304 -1.373 0 N-CA-C 105.986 -1.857 . . . . 0.0 105.986 174.225 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -64.49 -26.6 62.41 Favored 'Trans proline' 0 CA--C 1.538 0.691 0 C-N-CA 121.255 1.303 . . . . 0.0 111.341 177.277 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.559 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 70.1 m-85 -107.16 -26.34 11.14 Favored 'General case' 0 N--CA 1.443 -0.777 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.121 -178.935 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.465 ' H ' ' HB2' ' A' ' 29' ' ' ASN . 67.6 t80 -105.73 113.84 27.64 Favored 'General case' 0 C--N 1.304 -1.383 0 C-N-CA 119.627 -0.829 . . . . 0.0 110.978 178.418 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.587 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 21.3 m -121.72 140.92 51.7 Favored 'General case' 0 C--N 1.279 -2.494 0 N-CA-C 105.616 -1.994 . . . . 0.0 105.616 175.088 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.464 ' OE1' HD21 ' A' ' 36' ' ' LEU . 35.9 tt0 -125.81 141.36 52.03 Favored 'General case' 0 C--N 1.29 -1.999 0 C-N-CA 120.874 -0.33 . . . . 0.0 110.766 -171.407 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.805 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 85.5 m -74.38 114.21 12.5 Favored 'General case' 0 C--O 1.252 1.187 0 CA-C-O 121.176 0.512 . . . . 0.0 109.982 176.247 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.464 HD21 ' OE1' ' A' ' 34' ' ' GLN . 95.5 mt . . . . . 0 N--CA 1.426 -1.639 0 CA-C-N 115.127 -0.942 . . . . 0.0 108.84 -179.382 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' MAN . . . . . 0.735 ' H3 ' ' OE1' ' A' ' 2' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 . . . . . 0 N--CA 1.426 -1.639 0 CA-C-O 121.377 0.608 . . . . 0.0 109.774 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 22.9 t -97.97 171.82 8.02 Favored 'General case' 0 C--N 1.282 -2.345 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.213 -173.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 41.8 t-80 -61.45 132.11 52.37 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 179.078 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . 0.47 ' HA ' ' OE1' ' A' ' 34' ' ' GLN . . . 83.71 0.28 1.04 Allowed 'General case' 0 N--CA 1.48 1.053 0 O-C-N 124.915 1.384 . . . . 0.0 113.011 -177.745 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.427 ' O ' ' HA ' ' A' ' 34' ' ' GLN . . . -96.66 160.25 21.79 Favored Glycine 0 C--O 1.245 0.809 0 C-N-CA 120.474 -0.87 . . . . 0.0 111.914 178.265 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.618 ' HA ' ' O ' ' A' ' 33' ' ' SER . 51.6 tt0 -81.72 104.42 12.1 Favored 'General case' 0 C--O 1.225 -0.235 0 CA-C-O 121.451 0.643 . . . . 0.0 110.851 -179.198 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.777 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 7.7 p -80.8 -41.91 22.56 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 114.384 1.253 . . . . 0.0 114.384 -174.729 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.43 ' H ' ' HB2' ' A' ' 33' ' ' SER . . . -176.03 81.22 0.07 OUTLIER Glycine 0 CA--C 1.477 -2.324 0 C-N-CA 117.547 -2.263 . . . . 0.0 113.674 -175.432 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.437 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -112.69 175.63 16.98 Favored Glycine 0 C--N 1.283 -2.399 0 N-CA-C 107.989 -2.045 . . . . 0.0 107.989 173.352 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.46 ' HB ' ' CD2' ' A' ' 31' ' ' TYR . 55.1 mt -65.54 133.75 30.39 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 175.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 103.86 -16.23 51.12 Favored Glycine 0 C--N 1.311 -0.834 0 N-CA-C 111.251 -0.74 . . . . 0.0 111.251 -177.479 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.427 ' HB2' HE21 ' A' ' 7' ' ' GLN . 67.1 t80 -100.94 109.62 21.58 Favored 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 179.747 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 11.4 p -101.63 1.31 37.59 Favored 'General case' 0 C--N 1.3 -1.557 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.314 -178.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -79.46 -178.76 51.55 Favored Glycine 0 N--CA 1.441 -1.023 0 CA-C-N 115.887 -0.597 . . . . 0.0 112.317 179.322 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -60.48 122.4 11.24 Favored 'Trans proline' 0 C--O 1.241 0.637 0 C-N-CA 123.194 2.596 . . . . 0.0 111.825 179.536 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.562 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 22.9 p -92.6 9.12 36.05 Favored 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 113.571 0.952 . . . . 0.0 113.571 -173.372 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 7.5 p -91.82 126.79 44.39 Favored 'Isoleucine or valine' 0 C--O 1.248 1.02 0 CA-C-O 121.39 0.614 . . . . 0.0 111.551 -178.117 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 71.2 m -84.26 161.48 20.47 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.847 178.139 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.33 154.46 42.0 Favored 'General case' 0 C--O 1.25 1.088 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.494 176.129 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 3.1 p -60.2 129.13 40.17 Favored 'General case' 0 N--CA 1.433 -1.302 0 CA-C-O 121.263 0.554 . . . . 0.0 111.458 -178.495 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 111.34 -17.67 26.12 Favored Glycine 0 N--CA 1.423 -2.216 0 N-CA-C 110.666 -0.974 . . . . 0.0 110.666 -177.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 77.6 p -123.03 153.29 40.03 Favored 'General case' 0 C--O 1.252 1.215 0 CA-C-O 120.828 0.346 . . . . 0.0 110.983 -178.536 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 34.2 p -119.79 149.56 41.85 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 178.33 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 44.9 t -75.49 105.37 6.49 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 177.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 84.0 mm-40 -100.64 110.82 22.98 Favored 'General case' 0 N--CA 1.415 -2.188 0 CA-C-O 121.718 0.77 . . . . 0.0 110.556 -179.355 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 63.9 t -77.73 121.52 30.57 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.089 0 CA-C-N 114.637 -1.165 . . . . 0.0 108.267 179.493 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 84.6 mt -104.26 -67.72 0.88 Allowed 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 107.324 -1.362 . . . . 0.0 107.324 179.229 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 48.7 m-80 -95.07 163.27 22.34 Favored Pre-proline 0 C--N 1.293 -1.891 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 173.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_exo -63.96 -30.61 67.1 Favored 'Trans proline' 0 CA--C 1.531 0.355 0 C-N-CA 121.204 1.27 . . . . 0.0 111.198 178.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.46 ' CD2' ' HB ' ' A' ' 11' ' ' ILE . 22.3 m-85 -100.31 -25.9 14.08 Favored 'General case' 0 N--CA 1.437 -1.118 0 C-N-CA 120.364 -0.534 . . . . 0.0 110.834 -179.415 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 75.8 t80 -105.96 114.13 28.09 Favored 'General case' 0 C--O 1.243 0.749 0 N-CA-C 112.6 0.592 . . . . 0.0 112.6 178.374 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.618 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 15.1 m -125.55 143.45 51.01 Favored 'General case' 0 C--N 1.293 -1.871 0 N-CA-C 106.631 -1.618 . . . . 0.0 106.631 176.34 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.47 ' OE1' ' HA ' ' A' ' 5' ' ' ALA . 8.4 tt0 -132.08 141.23 49.12 Favored 'General case' 0 C--N 1.298 -1.671 0 CA-C-N 118.02 0.373 . . . . 0.0 110.464 -174.112 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.777 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 77.6 m -74.21 114.75 12.92 Favored 'General case' 0 C--O 1.253 1.245 0 C-N-CA 120.714 -0.394 . . . . 0.0 110.344 175.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 97.2 mt . . . . . 0 N--CA 1.428 -1.566 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 178.602 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 5.9 tp-100 . . . . . 0 N--CA 1.433 -1.324 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 53.3 m -107.61 -176.24 3.01 Favored 'General case' 0 C--N 1.302 -1.471 0 C-N-CA 120.505 -0.478 . . . . 0.0 111.266 -177.011 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . 0.419 ' CD2' ' HA ' ' A' ' 36' ' ' LEU . 47.9 t-80 -57.61 132.7 54.02 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 122.846 0.458 . . . . 0.0 109.957 -177.723 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . 0.467 ' HA ' ' NE2' ' A' ' 34' ' ' GLN . . . 80.15 -4.48 1.88 Allowed 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 125.557 1.543 . . . . 0.0 112.63 -179.253 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -85.68 146.54 21.55 Favored Glycine 0 N--CA 1.437 -1.285 0 C-N-CA 120.37 -0.919 . . . . 0.0 110.912 178.172 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.552 ' HA ' ' O ' ' A' ' 33' ' ' SER . 62.1 tt0 -62.95 108.68 1.25 Allowed 'General case' 0 C--O 1.22 -0.473 0 CA-C-O 121.148 0.499 . . . . 0.0 110.382 178.267 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.744 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 23.3 p -86.04 -43.39 13.16 Favored 'General case' 0 C--N 1.297 -1.678 0 CA-C-N 115.73 -0.668 . . . . 0.0 112.678 -174.806 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -179.03 86.34 0.07 OUTLIER Glycine 0 CA--C 1.473 -2.542 0 C-N-CA 118.188 -1.958 . . . . 0.0 113.326 -174.474 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.523 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -104.7 178.46 24.01 Favored Glycine 0 N--CA 1.42 -2.418 0 N-CA-C 108.736 -1.745 . . . . 0.0 108.736 175.033 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 64.9 mt -66.12 128.03 28.4 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.757 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 176.725 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 99.51 -17.28 57.89 Favored Glycine 0 N--CA 1.44 -1.035 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.043 -179.666 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 67.7 t80 -87.22 109.07 19.23 Favored 'General case' 0 C--N 1.312 -1.042 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 -178.567 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 37.0 p -99.23 2.31 45.54 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.481 -178.67 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -74.56 -178.31 39.83 Favored Glycine 0 N--CA 1.436 -1.312 0 CA-C-N 115.357 -0.838 . . . . 0.0 112.486 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_endo -62.38 121.46 9.45 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 122.605 2.203 . . . . 0.0 112.133 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.634 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 29.1 p -92.89 0.67 57.45 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.005 -179.703 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 7.8 p -78.64 110.22 14.14 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.11 0 CA-C-O 121.993 0.901 . . . . 0.0 111.664 -179.36 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 70.9 m -83.79 152.9 24.39 Favored 'General case' 0 C--N 1.302 -1.486 0 CA-C-N 115.115 -0.948 . . . . 0.0 109.644 177.732 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.4 145.33 33.06 Favored 'General case' 0 C--O 1.25 1.079 0 O-C-N 123.459 0.475 . . . . 0.0 110.229 176.533 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 19.3 m -52.83 119.36 4.51 Favored 'General case' 0 C--N 1.318 -0.79 0 O-C-N 123.757 0.661 . . . . 0.0 111.464 -178.012 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 111.88 -11.25 27.38 Favored Glycine 0 N--CA 1.439 -1.126 0 CA-C-N 115.832 -0.622 . . . . 0.0 112.255 -179.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 68.2 p -118.42 147.29 43.72 Favored 'General case' 0 C--O 1.244 0.789 0 N-CA-C 109.808 -0.441 . . . . 0.0 109.808 178.239 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 38.9 p -113.35 149.5 33.92 Favored 'General case' 0 C--N 1.309 -1.192 0 C-N-CA 121.223 -0.191 . . . . 0.0 110.751 -178.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 51.5 t -76.42 103.6 6.51 Favored 'General case' 0 C--N 1.312 -1.047 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 178.367 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 68.6 mt-30 -102.78 120.22 40.21 Favored 'General case' 0 N--CA 1.425 -1.679 0 CA-C-O 121.887 0.851 . . . . 0.0 111.363 -178.222 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 95.2 t -83.42 104.94 12.58 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 CA-C-N 114.385 -1.28 . . . . 0.0 109.829 -178.597 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 56.1 mt -85.48 -72.04 0.5 Allowed 'General case' 0 N--CA 1.433 -1.317 0 N-CA-C 107.748 -1.205 . . . . 0.0 107.748 178.599 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 47.7 m-80 -96.31 166.8 13.52 Favored Pre-proline 0 C--N 1.302 -1.468 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 174.321 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -58.78 -42.23 55.22 Favored 'Trans proline' 0 CA--C 1.538 0.696 0 C-N-CA 121.741 1.628 . . . . 0.0 112.336 177.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.523 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 49.0 m-85 -96.49 -25.96 15.47 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 120.029 -0.669 . . . . 0.0 110.562 -177.333 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 75.3 t80 -104.15 114.03 27.99 Favored 'General case' 0 N--CA 1.435 -1.196 0 C-N-CA 119.691 -0.804 . . . . 0.0 111.312 178.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.552 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 15.9 m -135.84 139.99 43.84 Favored 'General case' 0 C--N 1.283 -2.308 0 N-CA-C 105.501 -2.037 . . . . 0.0 105.501 178.883 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.467 ' NE2' ' HA ' ' A' ' 5' ' ' ALA . 19.8 pt20 -135.82 153.83 51.38 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 118.853 0.751 . . . . 0.0 111.564 -175.789 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.744 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 63.7 m -72.58 117.0 13.72 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.527 178.438 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.419 ' HA ' ' CD2' ' A' ' 4' ' ' HIS . 96.5 mt . . . . . 0 C--N 1.289 -2.028 0 N-CA-C 106.802 -1.555 . . . . 0.0 106.802 177.328 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 . . . . . 0 N--CA 1.438 -1.059 0 CA-C-O 121.296 0.569 . . . . 0.0 110.369 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 30.0 t -100.21 172.15 7.35 Favored 'General case' 0 C--N 1.286 -2.166 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.072 -175.398 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 18.8 t-80 -59.77 134.27 56.87 Favored 'General case' 0 C--O 1.238 0.48 0 N-CA-C 109.846 -0.428 . . . . 0.0 109.846 177.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 79.21 10.78 1.5 Allowed 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.818 1.247 . . . . 0.0 112.351 179.147 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -105.54 162.3 14.33 Favored Glycine 0 N--CA 1.442 -0.925 0 N-CA-C 110.505 -1.038 . . . . 0.0 110.505 176.182 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.601 ' HA ' ' O ' ' A' ' 33' ' ' SER . 53.4 tt0 -82.26 111.62 18.51 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 -179.66 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.74 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 20.7 p -87.36 -35.08 18.57 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 113.469 0.914 . . . . 0.0 113.469 -175.121 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 173.5 80.51 0.05 OUTLIER Glycine 0 CA--C 1.489 -1.559 0 C-N-CA 117.993 -2.051 . . . . 0.0 113.492 -176.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.408 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -112.48 174.11 15.88 Favored Glycine 0 C--N 1.287 -2.163 0 N-CA-C 107.731 -2.148 . . . . 0.0 107.731 174.232 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 74.5 mt -54.93 111.55 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 117.631 0.716 . . . . 0.0 110.211 178.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 114.34 -8.42 22.64 Favored Glycine 0 N--CA 1.437 -1.251 0 C-N-CA 120.606 -0.807 . . . . 0.0 113.405 179.679 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.422 ' HB2' HE21 ' A' ' 7' ' ' GLN . 70.7 t80 -101.36 110.45 22.46 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 179.03 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 4.8 p -107.72 7.02 28.2 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-N 115.83 -0.623 . . . . 0.0 112.042 -177.258 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -83.0 -165.41 37.56 Favored Glycine 0 N--CA 1.444 -0.809 0 CA-C-N 115.486 -0.779 . . . . 0.0 112.268 178.222 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -60.51 111.02 0.9 Allowed 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 123.12 2.546 . . . . 0.0 112.317 -179.46 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.616 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 6.7 p -87.04 -11.17 51.13 Favored 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 113.205 0.817 . . . . 0.0 113.205 -175.69 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 7.5 p -80.87 130.43 35.9 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.91 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.139 179.533 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 77.3 m -91.32 169.0 11.17 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-O 120.873 0.368 . . . . 0.0 110.401 179.25 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -59.81 137.67 57.99 Favored 'General case' 0 N--CA 1.438 -1.073 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 174.496 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 54.1 m -59.99 121.08 10.93 Favored 'General case' 0 N--CA 1.432 -1.37 0 CA-C-O 121.14 0.495 . . . . 0.0 110.095 -179.258 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 112.66 -10.0 25.81 Favored Glycine 0 N--CA 1.439 -1.125 0 N-CA-C 111.018 -0.833 . . . . 0.0 111.018 -175.091 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 68.2 p -121.63 142.97 49.6 Favored 'General case' 0 C--O 1.244 0.812 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 174.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 34.2 p -110.83 139.24 46.31 Favored 'General case' 0 C--N 1.295 -1.803 0 C-N-CA 120.819 -0.352 . . . . 0.0 111.652 -176.537 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 41.3 t -77.63 102.96 7.29 Favored 'General case' 0 C--N 1.312 -1.041 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 179.338 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -106.79 126.53 52.41 Favored 'General case' 0 N--CA 1.421 -1.897 0 C-N-CA 120.541 -0.464 . . . . 0.0 110.832 -178.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 51.5 t -79.21 95.18 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.207 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 179.649 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 77.6 mt -75.21 -69.77 0.46 Allowed 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 -178.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 49.0 m-80 -96.31 163.87 19.71 Favored Pre-proline 0 C--N 1.294 -1.842 0 N-CA-C 106.968 -1.493 . . . . 0.0 106.968 174.676 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -61.7 -33.17 86.53 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 121.374 1.383 . . . . 0.0 112.025 179.517 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.408 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 39.8 m-85 -101.64 -25.18 13.96 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 120.419 -0.512 . . . . 0.0 110.914 -179.18 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 61.5 t80 -106.13 113.78 27.52 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 120.076 -0.65 . . . . 0.0 112.135 178.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.601 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 19.7 m -118.13 143.94 46.08 Favored 'General case' 0 C--N 1.293 -1.855 0 N-CA-C 106.524 -1.658 . . . . 0.0 106.524 174.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.478 HE21 HD21 ' A' ' 36' ' ' LEU . 29.7 tt0 -135.93 141.94 44.56 Favored 'General case' 0 C--N 1.3 -1.563 0 C-N-CA 120.768 -0.373 . . . . 0.0 111.613 -173.769 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.74 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 58.7 m -75.29 116.67 16.26 Favored 'General case' 0 C--O 1.254 1.32 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.02 177.184 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.478 HD21 HE21 ' A' ' 34' ' ' GLN . 96.1 mt . . . . . 0 C--N 1.308 -1.204 0 C-N-CA 124.336 1.054 . . . . 0.0 108.686 178.718 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 . . . . . 0 N--CA 1.445 -0.688 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 12.8 m -119.57 179.73 4.13 Favored 'General case' 0 C--N 1.293 -1.887 0 C-N-CA 120.731 -0.388 . . . . 0.0 110.994 -172.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . 0.4 ' HA ' ' O ' ' A' ' 35' ' ' CYS . 51.1 t-80 -50.19 133.78 23.18 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 123.71 0.804 . . . . 0.0 111.811 -177.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 75.98 -0.69 3.1 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 125.26 1.424 . . . . 0.0 112.106 179.453 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -90.5 153.09 22.42 Favored Glycine 0 N--CA 1.428 -1.877 0 N-CA-C 111.145 -0.782 . . . . 0.0 111.145 178.348 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.514 ' HA ' ' O ' ' A' ' 33' ' ' SER . 54.5 tt0 -75.27 114.82 14.24 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 178.465 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.76 ' O ' ' HA ' ' A' ' 17' ' ' THR . 9.8 p -86.61 -48.73 8.07 Favored 'General case' 0 C--O 1.195 -1.805 0 N-CA-C 112.822 0.675 . . . . 0.0 112.822 -177.456 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -177.45 97.69 0.11 Allowed Glycine 0 CA--C 1.479 -2.169 0 C-N-CA 117.536 -2.268 . . . . 0.0 113.604 -173.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.585 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -113.23 178.34 18.57 Favored Glycine 0 C--N 1.28 -2.545 0 N-CA-C 107.582 -2.207 . . . . 0.0 107.582 174.164 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 68.6 mt -61.64 113.18 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.056 0 CA-C-N 117.749 0.774 . . . . 0.0 109.827 178.694 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 95.47 29.81 8.57 Favored Glycine 0 N--CA 1.438 -1.193 0 CA-C-N 116.023 -0.535 . . . . 0.0 113.139 178.039 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 77.6 t80 -114.14 112.15 22.72 Favored 'General case' 0 C--N 1.313 -1.017 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 177.316 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 23.4 p -95.92 -4.29 43.71 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 -176.124 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -76.57 -162.46 14.24 Favored Glycine 0 CA--C 1.532 1.138 0 C-N-CA 121.212 -0.518 . . . . 0.0 112.82 -179.415 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -61.8 112.25 1.43 Allowed 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 123.131 2.554 . . . . 0.0 111.152 178.079 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.76 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 16.2 p -93.21 -15.04 26.35 Favored 'General case' 0 N--CA 1.433 -1.295 0 CA-C-N 115.874 -0.603 . . . . 0.0 112.444 -176.42 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 10.0 p -95.57 139.03 19.73 Favored 'Isoleucine or valine' 0 C--O 1.255 1.382 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 178.719 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 81.1 m -91.61 155.74 18.13 Favored 'General case' 0 C--N 1.291 -1.978 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.935 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -58.86 137.92 57.55 Favored 'General case' 0 C--O 1.25 1.13 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 175.409 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 7.1 p -51.03 124.82 12.2 Favored 'General case' 0 C--N 1.311 -1.094 0 O-C-N 123.864 0.728 . . . . 0.0 111.828 -177.255 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 112.22 -21.05 20.58 Favored Glycine 0 N--CA 1.434 -1.441 0 CA-C-N 115.463 -0.789 . . . . 0.0 111.228 -176.405 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 75.8 p -110.86 149.26 30.85 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 176.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 22.8 p -112.06 142.54 44.36 Favored 'General case' 0 C--N 1.297 -1.698 0 CA-C-N 116.818 -0.173 . . . . 0.0 110.651 -178.196 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 44.3 t -78.6 99.19 6.45 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 176.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 75.4 mt-30 -96.26 119.26 34.42 Favored 'General case' 0 N--CA 1.415 -2.217 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.62 -178.015 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 46.5 t -75.37 102.45 2.6 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 177.114 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 56.5 mt -85.16 -74.51 0.4 Allowed 'General case' 0 N--CA 1.428 -1.55 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 -179.34 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 74.9 m-20 -95.56 166.78 13.95 Favored Pre-proline 0 C--N 1.289 -2.032 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 176.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -59.67 -36.95 90.64 Favored 'Trans proline' 0 CA--C 1.543 0.939 0 C-N-CA 121.89 1.727 . . . . 0.0 112.99 179.723 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.585 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 69.3 m-85 -102.47 -24.34 13.83 Favored 'General case' 0 C--N 1.315 -0.935 0 C-N-CA 120.192 -0.603 . . . . 0.0 110.876 -178.688 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 69.9 t80 -104.71 114.25 28.34 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 112.505 0.557 . . . . 0.0 112.505 179.626 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.514 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 26.7 m -121.67 146.37 47.07 Favored 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 175.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.515 ' OE1' HD21 ' A' ' 36' ' ' LEU . 35.8 tt0 -134.98 142.43 46.47 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-N 118.242 0.474 . . . . 0.0 111.363 -172.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.755 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 77.4 m -77.26 113.39 14.97 Favored 'General case' 0 C--O 1.247 0.949 0 CA-C-O 121.164 0.507 . . . . 0.0 110.117 176.664 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.515 HD21 ' OE1' ' A' ' 34' ' ' GLN . 97.1 mt . . . . . 0 C--N 1.291 -1.952 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.01 -179.005 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 . . . . . 0 N--CA 1.445 -0.69 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 14.2 m -123.67 179.39 4.8 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 -176.267 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 36.9 t-80 -56.16 143.62 32.59 Favored 'General case' 0 C--O 1.239 0.532 0 C-N-CA 123.213 0.605 . . . . 0.0 110.128 178.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 71.91 10.01 6.17 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 124.586 1.155 . . . . 0.0 111.188 -178.3 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -109.76 147.56 17.15 Favored Glycine 0 N--CA 1.422 -2.267 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.392 178.704 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.551 ' HA ' ' O ' ' A' ' 33' ' ' SER . 53.3 tt0 -79.22 115.19 18.72 Favored 'General case' 0 C--N 1.31 -1.138 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 178.22 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.656 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 7.0 p -88.16 -45.7 9.9 Favored 'General case' 0 C--N 1.285 -2.219 0 CA-C-N 115.648 -0.706 . . . . 0.0 112.86 -176.159 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -171.89 91.6 0.09 OUTLIER Glycine 0 N--CA 1.428 -1.875 0 C-N-CA 118.152 -1.975 . . . . 0.0 113.968 -174.171 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.436 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -112.74 178.27 18.75 Favored Glycine 0 N--CA 1.427 -1.955 0 N-CA-C 108.341 -1.904 . . . . 0.0 108.341 175.036 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 85.5 mt -60.01 113.33 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.074 0 CA-C-N 117.526 0.663 . . . . 0.0 111.377 179.199 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 94.57 13.04 55.03 Favored Glycine 0 N--CA 1.434 -1.457 0 CA-C-N 115.233 -0.894 . . . . 0.0 112.878 177.475 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 57.1 t80 -96.72 113.15 24.69 Favored 'General case' 0 N--CA 1.442 -0.835 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 179.415 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 11.2 p -107.3 21.26 17.78 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-O 121.681 0.753 . . . . 0.0 111.981 -177.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -94.23 -154.18 30.8 Favored Glycine 0 C--N 1.298 -1.546 0 C-N-CA 120.626 -0.797 . . . . 0.0 111.402 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -70.39 107.11 1.91 Allowed 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 122.329 2.019 . . . . 0.0 111.374 178.76 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.622 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 9.8 p -87.22 -18.17 30.91 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-N 115.415 -0.811 . . . . 0.0 111.99 -177.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 12.0 p -88.15 129.85 38.7 Favored 'Isoleucine or valine' 0 C--O 1.25 1.115 0 CA-C-O 121.177 0.513 . . . . 0.0 110.509 178.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 82.1 m -93.36 148.48 22.01 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.987 -179.638 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -59.74 147.13 38.96 Favored 'General case' 0 C--O 1.247 0.96 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.323 177.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 9.7 t -54.12 126.5 23.02 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.054 -178.033 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 112.44 -18.17 23.13 Favored Glycine 0 N--CA 1.438 -1.167 0 N-CA-C 110.716 -0.953 . . . . 0.0 110.716 -175.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 57.7 p -127.19 146.2 50.49 Favored 'General case' 0 N--CA 1.443 -0.802 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 176.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 16.4 p -120.97 143.11 49.19 Favored 'General case' 0 C--N 1.296 -1.73 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 178.248 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 42.0 t -69.74 105.38 2.72 Favored 'General case' 0 C--N 1.309 -1.163 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 178.153 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 68.5 mt-30 -107.41 119.01 38.24 Favored 'General case' 0 N--CA 1.423 -1.816 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 179.295 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 52.8 t -75.22 119.41 22.87 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 CA-C-N 115.298 -0.864 . . . . 0.0 108.752 -179.241 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 76.6 mt -100.81 -69.48 0.77 Allowed 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 179.782 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 88.7 m-20 -95.48 166.66 14.22 Favored Pre-proline 0 C--N 1.304 -1.381 0 N-CA-C 106.782 -1.562 . . . . 0.0 106.782 173.104 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -63.6 -27.15 69.31 Favored 'Trans proline' 0 CA--C 1.534 0.476 0 C-N-CA 121.089 1.193 . . . . 0.0 111.858 177.275 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.436 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 55.8 m-85 -105.55 -26.03 12.06 Favored 'General case' 0 N--CA 1.443 -0.795 0 C-N-CA 119.789 -0.765 . . . . 0.0 110.716 -179.242 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 68.2 t80 -105.28 114.24 28.3 Favored 'General case' 0 N--CA 1.439 -1.0 0 C-N-CA 119.748 -0.781 . . . . 0.0 112.061 178.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.551 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 19.3 m -126.65 134.56 50.71 Favored 'General case' 0 C--N 1.283 -2.315 0 N-CA-C 105.766 -1.939 . . . . 0.0 105.766 176.206 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 7.7 tt0 -122.05 146.92 46.72 Favored 'General case' 0 C--N 1.303 -1.422 0 C-N-CA 120.268 -0.573 . . . . 0.0 110.567 -175.055 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.656 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 85.8 m -73.35 104.9 4.52 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 172.798 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 95.8 mt . . . . . 0 C--N 1.296 -1.743 0 C-N-CA 123.993 0.917 . . . . 0.0 108.649 -177.86 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 . . . . . 0 C--O 1.244 0.795 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 39.4 m -81.09 178.33 8.48 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-O 121.145 0.498 . . . . 0.0 110.906 -178.462 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 55.1 t-80 -63.67 133.35 53.47 Favored 'General case' 0 N--CA 1.444 -0.754 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 175.098 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 65.15 75.66 0.36 Allowed 'General case' 0 C--N 1.322 -0.59 0 O-C-N 124.356 1.035 . . . . 0.0 110.76 -177.502 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.493 ' O ' ' HA ' ' A' ' 34' ' ' GLN . . . -165.75 152.36 21.61 Favored Glycine 0 N--CA 1.42 -2.425 0 N-CA-C 108.454 -1.858 . . . . 0.0 108.454 178.557 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.604 ' HA ' ' O ' ' A' ' 33' ' ' SER . 52.7 tt0 -76.97 111.24 12.3 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 117.486 0.643 . . . . 0.0 110.049 -178.286 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.783 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 2.4 p -86.13 -41.58 14.6 Favored 'General case' 0 C--N 1.296 -1.758 0 CA-C-N 115.2 -0.909 . . . . 0.0 112.66 -177.429 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.402 ' HA2' ' HB3' ' A' ' 13' ' ' TYR . . . 169.76 101.68 0.15 Allowed Glycine 0 N--CA 1.423 -2.172 0 C-N-CA 117.895 -2.098 . . . . 0.0 113.778 -177.656 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -112.52 -160.51 14.98 Favored Glycine 0 N--CA 1.422 -2.265 0 N-CA-C 108.157 -1.977 . . . . 0.0 108.157 174.527 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 76.8 mt -65.91 109.69 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 CA-C-N 117.706 0.753 . . . . 0.0 110.994 177.547 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 95.13 20.63 27.4 Favored Glycine 0 N--CA 1.441 -1.027 0 C-N-CA 121.022 -0.608 . . . . 0.0 113.853 175.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.402 ' HB3' ' HA2' ' A' ' 9' ' ' GLY . 53.1 t80 -114.16 112.08 22.6 Favored 'General case' 0 C--N 1.31 -1.129 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 178.476 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 10.3 p -109.68 18.92 19.75 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-O 121.365 0.602 . . . . 0.0 111.662 -177.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -82.18 -150.79 8.73 Favored Glycine 0 N--CA 1.446 -0.688 0 CA-C-O 119.259 -0.745 . . . . 0.0 111.431 179.629 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -66.61 93.9 0.32 Allowed 'Trans proline' 0 CA--C 1.535 0.541 0 C-N-CA 122.158 1.905 . . . . 0.0 111.912 178.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.578 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 17.3 p -83.34 -13.59 54.73 Favored 'General case' 0 C--O 1.251 1.156 0 CA-C-O 121.905 0.86 . . . . 0.0 111.058 -177.533 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 4.7 p -92.9 121.64 43.74 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.56 0 CA-C-N 114.625 -1.17 . . . . 0.0 110.033 177.783 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 65.5 m -86.07 153.2 22.28 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 179.084 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -68.56 163.87 22.6 Favored 'General case' 0 C--O 1.26 1.64 0 CA-C-O 120.712 0.291 . . . . 0.0 111.062 178.599 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 28.1 m -47.49 115.91 1.27 Allowed 'General case' 0 C--O 1.248 1.004 0 C-N-CA 124.667 1.187 . . . . 0.0 113.276 -176.381 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 108.37 -20.83 29.7 Favored Glycine 0 N--CA 1.437 -1.282 0 CA-C-N 115.482 -0.781 . . . . 0.0 113.407 175.236 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 21.2 p -106.7 146.03 31.3 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 122.214 -0.58 . . . . 0.0 111.702 -178.251 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 14.5 p -118.92 147.65 43.79 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.558 -178.327 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 43.4 t -77.88 100.3 6.32 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-O 121.225 0.536 . . . . 0.0 109.644 -179.466 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 85.1 mm-40 -90.72 119.68 31.15 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.844 -179.063 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 46.7 t -83.76 108.71 16.47 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 -179.056 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 81.4 mt -95.03 -68.46 0.8 Allowed 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 -179.668 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.441 ' HB2' ' HB3' ' A' ' 32' ' ' TYR . 45.6 m-80 -95.61 166.82 13.83 Favored Pre-proline 0 C--N 1.296 -1.745 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 175.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -61.28 -37.91 69.62 Favored 'Trans proline' 0 C--N 1.349 0.558 0 C-N-CA 121.204 1.269 . . . . 0.0 111.009 178.624 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 49.4 m-85 -96.63 -25.03 15.73 Favored 'General case' 0 N--CA 1.441 -0.921 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.817 -178.703 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.441 ' HB3' ' HB2' ' A' ' 29' ' ' ASN . 48.9 t80 -104.6 113.43 27.0 Favored 'General case' 0 C--N 1.315 -0.898 0 C-N-CA 118.977 -1.089 . . . . 0.0 111.314 -177.506 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.604 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 26.6 m -124.68 137.91 54.33 Favored 'General case' 0 C--N 1.286 -2.193 0 N-CA-C 105.906 -1.887 . . . . 0.0 105.906 176.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.493 ' HA ' ' O ' ' A' ' 6' ' ' GLY . 30.1 tt0 -131.47 136.21 47.74 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -173.243 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.783 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 85.5 m -70.2 110.56 5.26 Favored 'General case' 0 C--O 1.245 0.831 0 CA-C-O 121.263 0.554 . . . . 0.0 110.937 177.3 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 95.8 mt . . . . . 0 C--N 1.294 -1.817 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 179.059 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 . . . . . 0 N--CA 1.44 -0.943 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 27.7 t -91.95 -178.08 4.91 Favored 'General case' 0 C--N 1.297 -1.695 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.457 -175.582 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 16.8 t-80 -63.43 118.07 7.59 Favored 'General case' 0 N--CA 1.445 -0.691 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 71.83 91.36 0.09 Allowed 'General case' 0 C--O 1.24 0.576 0 C-N-CA 124.62 1.168 . . . . 0.0 111.141 -174.431 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.583 ' O ' ' HA ' ' A' ' 34' ' ' GLN . . . -177.4 163.68 32.42 Favored Glycine 0 N--CA 1.43 -1.766 0 N-CA-C 107.121 -2.392 . . . . 0.0 107.121 179.801 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.625 ' HA ' ' O ' ' A' ' 33' ' ' SER . 53.3 tt0 -84.31 113.47 21.16 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 118.52 1.16 . . . . 0.0 109.608 -178.745 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.766 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 7.4 p -95.17 -36.6 11.41 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 113.248 0.833 . . . . 0.0 113.248 -176.594 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -164.72 66.02 0.22 Allowed Glycine 0 CA--C 1.478 -2.234 0 C-N-CA 118.523 -1.799 . . . . 0.0 112.345 -176.236 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.538 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -110.15 157.04 15.27 Favored Glycine 0 C--N 1.285 -2.284 0 N-CA-C 108.764 -1.734 . . . . 0.0 108.764 177.324 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 69.0 mt -57.49 115.96 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 CA-C-N 117.32 0.56 . . . . 0.0 110.962 -177.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 114.13 -9.66 22.77 Favored Glycine 0 N--CA 1.451 -0.366 0 CA-C-N 116.022 -0.536 . . . . 0.0 112.027 -179.522 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 91.8 t80 -93.55 120.64 34.07 Favored 'General case' 0 C--N 1.311 -1.072 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 179.008 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 12.4 p -111.5 4.55 18.9 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 112.103 0.409 . . . . 0.0 112.103 -176.088 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -82.73 -160.51 28.52 Favored Glycine 0 CA--C 1.528 0.844 0 C-N-CA 121.127 -0.559 . . . . 0.0 112.525 179.687 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -72.87 126.3 11.19 Favored 'Trans proline' 0 CA--C 1.512 -0.62 0 C-N-CA 122.286 1.991 . . . . 0.0 111.175 179.143 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.569 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 21.7 p -85.1 -14.51 46.92 Favored 'General case' 0 C--N 1.295 -1.804 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.357 -177.155 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 12.3 p -75.42 132.8 32.62 Favored 'Isoleucine or valine' 0 C--O 1.257 1.469 0 CA-C-O 121.794 0.807 . . . . 0.0 111.426 -177.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 80.5 m -93.86 167.78 11.4 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-N 114.886 -1.052 . . . . 0.0 110.182 179.219 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.13 140.89 58.25 Favored 'General case' 0 C--N 1.308 -1.196 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 175.244 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 34.6 t -55.29 125.71 21.86 Favored 'General case' 0 C--N 1.312 -1.04 0 O-C-N 123.504 0.502 . . . . 0.0 109.961 -179.719 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 112.56 -20.68 20.29 Favored Glycine 0 N--CA 1.439 -1.141 0 N-CA-C 110.662 -0.975 . . . . 0.0 110.662 -175.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 72.7 p -114.89 157.54 23.19 Favored 'General case' 0 C--N 1.311 -1.074 0 O-C-N 122.293 -0.534 . . . . 0.0 109.665 177.572 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 16.6 p -126.02 148.98 49.16 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 110.089 -0.338 . . . . 0.0 110.089 177.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 53.2 t -76.63 100.88 5.5 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 62.0 mt-30 -101.0 114.99 29.43 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-O 121.122 0.486 . . . . 0.0 110.384 -178.154 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 48.2 t -71.33 116.51 13.13 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.252 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 178.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 78.6 mt -101.15 -68.69 0.8 Allowed 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 -178.72 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.454 ' HB2' ' H ' ' A' ' 32' ' ' TYR . 80.7 m-20 -95.38 166.07 15.48 Favored Pre-proline 0 C--N 1.301 -1.541 0 N-CA-C 106.915 -1.513 . . . . 0.0 106.915 174.657 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_exo -62.6 -27.41 76.36 Favored 'Trans proline' 0 CA--C 1.536 0.583 0 C-N-CA 121.531 1.487 . . . . 0.0 111.622 176.616 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.538 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 88.1 m-85 -105.31 -25.31 12.46 Favored 'General case' 0 N--CA 1.443 -0.798 0 C-N-CA 120.135 -0.626 . . . . 0.0 111.518 179.254 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.454 ' H ' ' HB2' ' A' ' 29' ' ' ASN . 44.7 t80 -105.87 113.73 27.45 Favored 'General case' 0 C--N 1.311 -1.074 0 C-N-CA 119.548 -0.861 . . . . 0.0 112.033 179.8 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.625 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 16.9 m -120.24 135.01 55.13 Favored 'General case' 0 C--N 1.291 -1.953 0 N-CA-C 105.759 -1.941 . . . . 0.0 105.759 175.134 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.583 ' HA ' ' O ' ' A' ' 6' ' ' GLY . 28.1 tt0 -127.79 138.15 52.64 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 112.694 0.627 . . . . 0.0 112.694 -171.466 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.766 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 68.9 m -71.91 109.9 6.07 Favored 'General case' 0 C--O 1.251 1.158 0 CA-C-O 120.979 0.419 . . . . 0.0 111.073 176.875 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 94.3 mt . . . . . 0 N--CA 1.431 -1.398 0 N-CA-C 107.275 -1.38 . . . . 0.0 107.275 178.762 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 . . . . . 0 N--CA 1.446 -0.637 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 67.7 m -127.31 -170.45 2.22 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 111.602 0.223 . . . . 0.0 111.602 -177.052 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . 0.448 ' HA ' ' O ' ' A' ' 35' ' ' CYS . 37.0 t-80 -60.13 136.64 58.09 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 122.718 0.407 . . . . 0.0 110.936 -173.363 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . 0.473 ' HA ' ' CD ' ' A' ' 34' ' ' GLN . . . 74.4 8.76 4.47 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 124.143 0.977 . . . . 0.0 111.953 -179.814 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.426 ' O ' ' HA ' ' A' ' 34' ' ' GLN . . . -103.92 151.29 17.62 Favored Glycine 0 N--CA 1.431 -1.65 0 N-CA-C 111.386 -0.686 . . . . 0.0 111.386 178.537 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.612 ' HA ' ' O ' ' A' ' 33' ' ' SER . 54.3 tt0 -77.98 114.43 16.84 Favored 'General case' 0 CA--C 1.502 -0.883 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 178.608 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.705 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 8.0 p -94.27 -43.74 8.29 Favored 'General case' 0 C--N 1.288 -2.077 0 N-CA-C 113.549 0.944 . . . . 0.0 113.549 -175.64 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.449 ' H ' ' HB2' ' A' ' 33' ' ' SER . . . -159.38 69.75 0.25 Allowed Glycine 0 CA--C 1.481 -2.046 0 C-N-CA 118.541 -1.79 . . . . 0.0 112.765 -172.204 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.571 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -112.42 153.63 17.32 Favored Glycine 0 C--N 1.279 -2.584 0 N-CA-C 109.307 -1.517 . . . . 0.0 109.307 178.217 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.429 ' HB ' ' CD1' ' A' ' 31' ' ' TYR . 72.6 mt -56.24 123.89 8.38 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 O-C-N 123.974 0.455 . . . . 0.0 109.909 179.721 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 108.02 -15.27 36.93 Favored Glycine 0 N--CA 1.442 -0.9 0 N-CA-C 111.074 -0.81 . . . . 0.0 111.074 -179.218 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 80.1 t80 -101.78 109.7 21.53 Favored 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 178.602 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 13.5 p -107.68 7.34 28.44 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 112.381 0.511 . . . . 0.0 112.381 -176.629 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -82.41 -152.9 11.28 Favored Glycine 0 CA--C 1.53 0.978 0 CA-C-N 116.071 -0.513 . . . . 0.0 113.079 -179.547 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -64.49 112.25 1.88 Allowed 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 122.993 2.462 . . . . 0.0 112.294 -179.146 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.581 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 14.1 p -95.28 -4.73 45.1 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 115.375 -0.83 . . . . 0.0 113.022 -176.113 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 9.2 p -89.76 127.59 42.28 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.998 0 CA-C-O 120.896 0.379 . . . . 0.0 110.84 -178.648 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.471 ' SG ' ' HB2' ' A' ' 25' ' ' CYS . 72.9 m -87.91 154.1 20.79 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.167 178.789 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.72 143.4 57.46 Favored 'General case' 0 N--CA 1.438 -1.07 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.25 175.528 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.2 p -62.4 127.82 33.11 Favored 'General case' 0 C--N 1.297 -1.688 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.658 -179.15 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 112.5 -5.07 26.41 Favored Glycine 0 N--CA 1.438 -1.172 0 N-CA-C 110.727 -0.949 . . . . 0.0 110.727 -174.141 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 49.3 p -136.26 145.0 45.1 Favored 'General case' 0 C--O 1.239 0.547 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 174.586 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 46.4 p -112.1 145.01 40.51 Favored 'General case' 0 C--N 1.305 -1.338 0 C-N-CA 120.884 -0.326 . . . . 0.0 110.139 -179.518 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.471 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 43.6 t -79.28 97.63 6.35 Favored 'General case' 0 C--N 1.31 -1.144 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 -179.706 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 72.1 mt-30 -93.74 114.75 27.1 Favored 'General case' 0 N--CA 1.424 -1.767 0 CA-C-O 121.303 0.573 . . . . 0.0 110.716 -177.738 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 48.1 t -76.76 95.12 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 CA-C-N 114.798 -1.092 . . . . 0.0 108.404 177.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 87.7 mt -78.23 -70.91 0.46 Allowed 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 -179.388 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 75.2 m-20 -95.36 166.72 14.17 Favored Pre-proline 0 C--N 1.296 -1.738 0 N-CA-C 106.644 -1.613 . . . . 0.0 106.644 174.66 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_exo -62.95 -35.66 65.17 Favored 'Trans proline' 0 C--O 1.246 0.915 0 C-N-CA 121.171 1.247 . . . . 0.0 111.441 176.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.571 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 73.2 m-85 -97.41 -26.33 14.9 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 120.411 -0.516 . . . . 0.0 111.056 -178.639 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 68.8 t80 -105.68 114.09 28.04 Favored 'General case' 0 C--N 1.311 -1.09 0 C-N-CA 119.879 -0.728 . . . . 0.0 112.512 177.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.612 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 18.6 m -127.01 135.88 51.45 Favored 'General case' 0 C--N 1.295 -1.79 0 N-CA-C 106.45 -1.685 . . . . 0.0 106.45 175.841 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.473 ' CD ' ' HA ' ' A' ' 5' ' ' ALA . 7.9 tt0 -126.22 141.41 51.93 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-N 117.975 0.352 . . . . 0.0 111.022 -174.476 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.705 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 60.3 m -73.55 109.98 7.48 Favored 'General case' 0 C--O 1.253 1.25 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 174.075 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 87.4 mt . . . . . 0 C--N 1.289 -2.036 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 179.503 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 . . . . . 0 N--CA 1.436 -1.144 0 N-CA-C 107.767 -1.198 . . . . 0.0 107.767 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 33.4 t -114.82 179.32 3.98 Favored 'General case' 0 C--N 1.288 -2.088 0 C-N-CA 120.642 -0.423 . . . . 0.0 111.425 -173.538 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 57.4 t-80 -58.15 137.04 57.31 Favored 'General case' 0 CA--C 1.519 -0.243 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 -178.642 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 78.21 -3.69 2.29 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 124.858 1.263 . . . . 0.0 112.059 179.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -90.15 141.91 16.19 Favored Glycine 0 N--CA 1.426 -1.997 0 N-CA-C 110.76 -0.936 . . . . 0.0 110.76 178.313 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.599 ' HA ' ' O ' ' A' ' 33' ' ' SER . 54.0 tt0 -69.26 113.55 6.71 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 176.425 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.719 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 10.5 p -86.29 -40.83 15.11 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 112.764 0.654 . . . . 0.0 112.764 -176.178 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 177.4 93.25 0.09 OUTLIER Glycine 0 CA--C 1.488 -1.653 0 C-N-CA 117.788 -2.148 . . . . 0.0 113.847 -176.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.509 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -112.01 174.85 16.74 Favored Glycine 0 C--N 1.286 -2.238 0 N-CA-C 107.519 -2.232 . . . . 0.0 107.519 174.755 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 65.2 mt -60.55 113.25 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.139 0 CA-C-N 117.912 0.856 . . . . 0.0 109.469 178.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 113.8 -20.09 17.89 Favored Glycine 0 N--CA 1.438 -1.229 0 C-N-CA 121.1 -0.571 . . . . 0.0 112.165 179.206 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 71.0 t80 -81.35 118.97 23.1 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-O 121.038 0.447 . . . . 0.0 110.425 -176.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 11.7 p -102.58 5.79 39.45 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 113.055 0.761 . . . . 0.0 113.055 -175.175 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -87.89 -157.04 31.22 Favored Glycine 0 CA--C 1.524 0.628 0 C-N-CA 120.703 -0.761 . . . . 0.0 113.275 -175.262 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -70.7 113.16 3.44 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.637 2.225 . . . . 0.0 111.805 -179.586 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.628 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 18.5 p -89.04 -3.41 58.7 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.847 -177.36 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 4.0 p -98.91 120.82 48.75 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.953 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.859 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 63.1 m -85.74 164.27 17.71 Favored 'General case' 0 C--N 1.299 -1.621 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.48 179.448 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.42 146.0 55.04 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 174.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 46.1 m -61.67 130.74 47.28 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 178.049 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 112.36 -13.12 25.85 Favored Glycine 0 C--N 1.309 -0.962 0 N-CA-C 110.384 -1.086 . . . . 0.0 110.384 -173.482 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 65.0 p -127.57 155.27 44.09 Favored 'General case' 0 C--O 1.248 0.986 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 175.229 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 33.8 p -120.6 143.26 48.74 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 177.331 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 52.7 t -74.53 99.6 3.64 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 176.644 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 -97.82 119.68 36.85 Favored 'General case' 0 N--CA 1.425 -1.717 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 -177.722 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 43.1 t -77.86 93.88 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 178.091 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 82.7 mt -74.96 -70.77 0.39 Allowed 'General case' 0 C--N 1.306 -1.297 0 CA-C-N 115.278 -0.874 . . . . 0.0 109.092 -177.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 52.1 m-80 -95.58 165.91 15.7 Favored Pre-proline 0 C--N 1.295 -1.802 0 N-CA-C 106.206 -1.776 . . . . 0.0 106.206 174.006 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -63.43 -30.46 72.28 Favored 'Trans proline' 0 C--O 1.239 0.543 0 C-N-CA 121.376 1.384 . . . . 0.0 111.287 178.796 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.509 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 55.4 m-85 -103.15 -25.71 13.28 Favored 'General case' 0 N--CA 1.438 -1.073 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.464 -179.754 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 40.6 t80 -106.03 114.2 28.2 Favored 'General case' 0 C--N 1.317 -0.843 0 C-N-CA 119.413 -0.915 . . . . 0.0 111.562 178.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.599 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 15.4 m -121.03 141.04 51.12 Favored 'General case' 0 C--N 1.294 -1.824 0 N-CA-C 106.485 -1.672 . . . . 0.0 106.485 176.271 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -136.04 140.93 44.21 Favored 'General case' 0 C--N 1.297 -1.699 0 CA-C-N 118.053 0.388 . . . . 0.0 111.047 -172.623 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.719 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 66.7 m -73.17 111.24 8.1 Favored 'General case' 0 C--O 1.257 1.488 0 CA-C-O 121.108 0.48 . . . . 0.0 110.369 177.63 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 82.2 mt . . . . . 0 C--N 1.303 -1.443 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 -179.844 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.438 ' O ' ' HA ' ' A' ' 19' ' ' CYS . 8.2 tp-100 . . . . . 0 N--CA 1.442 -0.832 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . 0.413 ' O ' ' HB2' ' A' ' 35' ' ' CYS . 69.7 m -126.06 -165.62 1.46 Allowed 'General case' 0 C--N 1.276 -2.621 0 C-N-CA 120.99 -0.284 . . . . 0.0 111.518 -174.774 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 56.8 t-80 -50.3 130.58 23.35 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 113.647 0.98 . . . . 0.0 113.647 -172.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 71.52 12.06 6.52 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 114.275 -1.33 . . . . 0.0 112.649 175.671 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.442 ' O ' ' HA ' ' A' ' 34' ' ' GLN . . . -100.15 165.57 19.66 Favored Glycine 0 N--CA 1.433 -1.5 0 N-CA-C 110.846 -0.902 . . . . 0.0 110.846 176.225 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.525 ' HA ' ' O ' ' A' ' 33' ' ' SER . 54.0 tt0 -87.82 112.35 22.36 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 110.245 -0.28 . . . . 0.0 110.245 -177.562 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.772 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 14.6 p -83.03 -41.94 18.08 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 112.383 0.512 . . . . 0.0 112.383 -178.226 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 165.14 101.42 0.16 Allowed Glycine 0 CA--C 1.483 -1.923 0 C-N-CA 117.624 -2.227 . . . . 0.0 114.265 -178.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -112.63 -169.98 17.92 Favored Glycine 0 N--CA 1.423 -2.199 0 N-CA-C 107.489 -2.244 . . . . 0.0 107.489 173.4 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 70.3 mt -62.09 122.86 13.73 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.34 0 CA-C-N 117.815 0.807 . . . . 0.0 110.21 179.156 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 99.02 -5.27 59.36 Favored Glycine 0 N--CA 1.444 -0.814 0 C-N-CA 120.834 -0.698 . . . . 0.0 113.24 175.753 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 69.4 t80 -94.38 113.79 25.72 Favored 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 27.0 p -106.41 -1.18 23.52 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 116.317 -0.402 . . . . 0.0 112.039 -176.736 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -76.02 -156.7 6.54 Favored Glycine 0 CA--C 1.526 0.728 0 CA-C-N 116.121 -0.49 . . . . 0.0 113.195 -178.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -63.62 106.79 0.64 Allowed 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 122.568 2.179 . . . . 0.0 111.885 -179.662 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.676 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 4.2 p -95.51 15.14 20.52 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-N 115.401 -0.818 . . . . 0.0 112.377 -176.132 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 7.1 p -112.13 126.76 69.56 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.627 -179.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.467 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 80.1 m -88.01 150.2 23.56 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 115.652 -0.704 . . . . 0.0 109.163 177.078 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.14 153.34 43.88 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 177.509 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 24.6 m -55.97 128.43 35.2 Favored 'General case' 0 N--CA 1.435 -1.184 0 CA-C-O 121.336 0.589 . . . . 0.0 110.705 -179.677 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 111.97 -18.12 24.27 Favored Glycine 0 N--CA 1.432 -1.576 0 N-CA-C 110.927 -0.869 . . . . 0.0 110.927 -177.095 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 68.6 p -121.54 146.73 46.65 Favored 'General case' 0 N--CA 1.441 -0.886 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 178.118 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 34.2 p -114.85 144.04 44.16 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.07 179.306 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 52.9 t -78.62 106.3 10.5 Favored 'General case' 0 C--N 1.308 -1.2 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 178.607 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -111.08 130.56 55.57 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.179 -178.35 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 43.2 t -87.71 114.45 26.55 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.831 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 -177.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 86.4 mt -92.94 -72.72 0.59 Allowed 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 179.282 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 84.3 m-20 -93.63 163.23 25.04 Favored Pre-proline 0 C--N 1.305 -1.341 0 N-CA-C 106.322 -1.733 . . . . 0.0 106.322 175.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -58.07 -35.28 98.87 Favored 'Trans proline' 0 CA--C 1.534 0.477 0 C-N-CA 121.626 1.551 . . . . 0.0 111.55 179.63 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 90.3 m-85 -97.69 -25.04 15.23 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.671 -179.47 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 65.9 t80 -105.48 114.43 28.61 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 119.937 -0.705 . . . . 0.0 112.714 -179.579 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.525 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 19.9 m -119.21 143.95 46.98 Favored 'General case' 0 C--N 1.295 -1.791 0 N-CA-C 106.962 -1.496 . . . . 0.0 106.962 174.515 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.442 ' HA ' ' O ' ' A' ' 6' ' ' GLY . 35.2 tt0 -129.96 143.62 50.9 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 111.941 0.349 . . . . 0.0 111.941 -171.478 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.772 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 86.0 m -82.0 111.07 17.83 Favored 'General case' 0 C--O 1.252 1.221 0 CA-C-O 121.169 0.509 . . . . 0.0 109.892 176.345 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 96.1 mt . . . . . 0 C--N 1.298 -1.674 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.646 179.586 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 41.1 tp60 . . . . . 0 N--CA 1.432 -1.374 0 CA-C-O 121.479 0.657 . . . . 0.0 109.733 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 58.3 p -78.11 168.47 19.81 Favored 'General case' 0 C--N 1.293 -1.878 0 CA-C-N 115.316 -0.856 . . . . 0.0 112.161 -175.031 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 50.0 t-80 -57.21 137.51 55.84 Favored 'General case' 0 C--O 1.238 0.465 0 N-CA-C 109.141 -0.688 . . . . 0.0 109.141 176.018 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 72.19 15.48 5.4 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 123.784 0.834 . . . . 0.0 111.407 -179.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -105.98 160.98 14.51 Favored Glycine 0 N--CA 1.432 -1.574 0 N-CA-C 110.26 -1.136 . . . . 0.0 110.26 174.533 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.59 ' HA ' ' O ' ' A' ' 33' ' ' SER . 53.5 tt0 -80.68 109.91 15.67 Favored 'General case' 0 C--O 1.21 -0.988 0 CA-C-N 116.869 0.334 . . . . 0.0 110.331 -178.599 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.791 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 23.5 p -84.62 -15.36 45.81 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -177.188 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.426 ' HA2' ' CD1' ' A' ' 13' ' ' TYR . . . 135.14 100.69 0.65 Allowed Glycine 0 N--CA 1.42 -2.423 0 C-N-CA 117.72 -2.181 . . . . 0.0 115.253 176.119 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -112.23 -171.15 18.53 Favored Glycine 0 N--CA 1.423 -2.221 0 N-CA-C 106.991 -2.444 . . . . 0.0 106.991 172.048 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 77.7 mt -58.39 113.81 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.994 0 CA-C-N 117.946 0.873 . . . . 0.0 110.443 179.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 114.02 -16.87 20.26 Favored Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.964 -0.636 . . . . 0.0 113.028 177.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.426 ' CD1' ' HA2' ' A' ' 9' ' ' GLY . 66.3 t80 -94.36 129.06 41.21 Favored 'General case' 0 C--N 1.312 -1.046 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 -179.159 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 11.4 p -131.58 14.31 4.95 Favored 'General case' 0 C--O 1.248 0.997 0 N-CA-C 112.981 0.734 . . . . 0.0 112.981 -174.858 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -90.93 -140.73 8.92 Favored Glycine 0 C--N 1.309 -0.967 0 C-N-CA 121.19 -0.529 . . . . 0.0 111.958 178.713 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -66.14 108.97 1.43 Allowed 'Trans proline' 0 N--CA 1.46 -0.484 0 C-N-CA 122.317 2.011 . . . . 0.0 111.659 -179.411 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.474 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 17.5 p -97.06 -3.49 41.26 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-N 115.696 -0.683 . . . . 0.0 111.747 -178.817 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 7.2 p -90.28 125.09 43.16 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.941 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.933 178.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 84.8 m -84.4 161.95 20.16 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 115.699 -0.682 . . . . 0.0 112.055 -179.858 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.83 160.18 28.85 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 115.098 -0.955 . . . . 0.0 110.79 178.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 31.1 m -54.06 116.29 2.5 Favored 'General case' 0 C--N 1.31 -1.147 0 C-N-CA 124.058 0.943 . . . . 0.0 111.989 -179.062 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 105.86 -19.09 39.13 Favored Glycine 0 N--CA 1.435 -1.425 0 CA-C-N 115.779 -0.646 . . . . 0.0 112.237 178.224 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 74.9 p -106.91 145.15 32.55 Favored 'General case' 0 C--N 1.309 -1.181 0 O-C-N 122.252 -0.558 . . . . 0.0 110.813 -177.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 22.2 p -114.96 152.15 32.86 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 110.079 -0.341 . . . . 0.0 110.079 178.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 50.8 t -77.98 106.02 9.56 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 178.706 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 68.4 mt-30 -108.45 123.88 49.55 Favored 'General case' 0 N--CA 1.429 -1.49 0 CA-C-O 121.11 0.481 . . . . 0.0 109.792 -179.571 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 55.0 t -80.58 111.53 17.42 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.239 -177.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 86.6 mt -91.67 -70.06 0.71 Allowed 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 179.688 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.456 ' HB2' ' H ' ' A' ' 32' ' ' TYR . 51.2 m-20 -94.58 163.99 21.14 Favored Pre-proline 0 C--N 1.299 -1.612 0 N-CA-C 105.814 -1.921 . . . . 0.0 105.814 176.109 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_exo -62.39 -26.44 76.79 Favored 'Trans proline' 0 CA--C 1.539 0.744 0 C-N-CA 121.539 1.493 . . . . 0.0 111.798 178.25 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 41.8 m-85 -108.47 -25.26 11.03 Favored 'General case' 0 N--CA 1.444 -0.742 0 C-N-CA 120.216 -0.594 . . . . 0.0 111.11 -177.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.456 ' H ' ' HB2' ' A' ' 29' ' ' ASN . 78.6 t80 -105.58 113.96 27.83 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 120.915 0.388 . . . . 0.0 111.888 177.702 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.59 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 24.8 m -116.3 143.43 45.55 Favored 'General case' 0 C--N 1.285 -2.212 0 N-CA-C 106.426 -1.694 . . . . 0.0 106.426 175.753 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -129.4 140.04 51.47 Favored 'General case' 0 C--N 1.303 -1.434 0 CA-C-N 118.269 0.486 . . . . 0.0 111.379 -173.248 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.791 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 74.9 m -74.84 112.56 11.17 Favored 'General case' 0 C--O 1.256 1.4 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.094 175.759 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 92.6 mt . . . . . 0 N--CA 1.429 -1.477 0 C-N-CA 124.401 1.08 . . . . 0.0 108.091 179.965 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.405 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 5.8 tp-100 . . . . . 0 N--CA 1.446 -0.653 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . 0.431 ' O ' ' HB2' ' A' ' 35' ' ' CYS . 33.0 m -98.64 -177.03 3.54 Favored 'General case' 0 C--N 1.294 -1.826 0 CA-C-N 116.733 -0.212 . . . . 0.0 111.152 -175.717 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 53.4 t-80 -61.99 126.56 27.77 Favored 'General case' 0 CA--C 1.511 -0.549 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 177.203 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 71.24 102.99 0.06 Allowed 'General case' 0 C--O 1.237 0.442 0 O-C-N 124.775 1.297 . . . . 0.0 109.726 -173.394 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.464 ' O ' ' HA ' ' A' ' 34' ' ' GLN . . . 158.86 147.48 4.87 Favored Glycine 0 N--CA 1.418 -2.519 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 -176.277 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.603 ' HA ' ' O ' ' A' ' 33' ' ' SER . 53.8 tt0 -78.51 106.83 10.73 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-O 121.03 0.443 . . . . 0.0 110.333 -179.033 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.67 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 7.9 p -82.11 -41.32 20.67 Favored 'General case' 0 C--N 1.301 -1.519 0 CA-C-N 115.556 -0.747 . . . . 0.0 112.05 -179.118 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 173.47 100.26 0.13 Allowed Glycine 0 N--CA 1.432 -1.628 0 C-N-CA 117.881 -2.104 . . . . 0.0 114.397 -177.552 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -112.0 -167.8 17.98 Favored Glycine 0 C--N 1.289 -2.069 0 N-CA-C 108.252 -1.939 . . . . 0.0 108.252 174.446 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 86.1 mt -59.58 109.25 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.01 0 CA-C-N 117.724 0.762 . . . . 0.0 110.995 179.885 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 104.82 -10.08 48.27 Favored Glycine 0 N--CA 1.437 -1.243 0 CA-C-N 115.989 -0.55 . . . . 0.0 113.313 176.504 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 34.5 t80 -100.12 111.22 23.5 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 -177.62 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 5.5 p -113.33 10.96 18.49 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 113.466 0.913 . . . . 0.0 113.466 -175.367 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -74.97 -131.74 0.27 Allowed Glycine 0 CA--C 1.53 1.024 0 CA-C-N 116.16 -0.473 . . . . 0.0 113.475 -179.016 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.86 81.06 0.87 Allowed 'Trans proline' 0 N--CA 1.461 -0.439 0 C-N-CA 122.672 2.248 . . . . 0.0 112.792 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.446 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 29.2 p -81.28 -10.41 59.58 Favored 'General case' 0 N--CA 1.437 -1.084 0 CA-C-N 115.338 -0.847 . . . . 0.0 110.606 178.88 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 7.1 p -89.96 132.82 33.65 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.275 0 CA-C-N 114.833 -1.076 . . . . 0.0 108.886 176.601 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.482 ' HB3' ' OG1' ' A' ' 23' ' ' THR . 76.1 m -101.1 156.67 17.28 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.39 -177.028 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.18 175.29 3.94 Favored 'General case' 0 C--O 1.246 0.877 0 C-N-CA 123.829 0.851 . . . . 0.0 112.065 -178.545 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 5.1 m -51.72 113.05 0.87 Allowed 'General case' 0 N--CA 1.443 -0.815 0 C-N-CA 124.863 1.265 . . . . 0.0 112.275 -177.426 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 89.81 12.63 62.06 Favored Glycine 0 N--CA 1.434 -1.444 0 C-N-CA 120.509 -0.853 . . . . 0.0 113.499 174.832 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.482 ' OG1' ' HB3' ' A' ' 19' ' ' CYS . 73.6 p -124.96 143.93 50.63 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 117.294 0.547 . . . . 0.0 110.274 177.33 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 40.1 p -118.85 137.03 53.71 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.705 179.609 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.481 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 53.3 t -76.35 109.22 9.87 Favored 'General case' 0 C--N 1.312 -1.024 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 179.523 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 74.6 mt-30 -116.28 125.97 52.92 Favored 'General case' 0 C--N 1.298 -1.664 0 CA-C-O 121.026 0.441 . . . . 0.0 110.542 -179.368 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 69.1 t -70.29 115.72 10.16 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.201 0 CA-C-N 115.016 -0.993 . . . . 0.0 109.045 178.441 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 67.8 mt -98.97 -70.67 0.72 Allowed 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 81.9 m-20 -95.5 168.98 9.93 Favored Pre-proline 0 C--N 1.298 -1.644 0 N-CA-C 106.763 -1.569 . . . . 0.0 106.763 175.539 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_exo -59.54 -36.75 92.17 Favored 'Trans proline' 0 CA--C 1.542 0.924 0 C-N-CA 121.614 1.543 . . . . 0.0 113.085 -179.657 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 66.6 m-85 -104.46 -24.02 13.09 Favored 'General case' 0 C--N 1.312 -1.049 0 O-C-N 121.716 -0.615 . . . . 0.0 110.574 -178.762 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 62.8 t80 -103.32 113.59 27.2 Favored 'General case' 0 N--CA 1.431 -1.4 0 CA-C-O 121.658 0.742 . . . . 0.0 111.422 -178.344 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.603 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 26.0 m -122.67 143.67 49.63 Favored 'General case' 0 C--N 1.288 -2.094 0 N-CA-C 105.536 -2.024 . . . . 0.0 105.536 176.355 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.464 ' HA ' ' O ' ' A' ' 6' ' ' GLY . 27.1 tt0 -135.34 145.72 47.7 Favored 'General case' 0 C--N 1.297 -1.675 0 C-N-CA 120.274 -0.571 . . . . 0.0 112.465 -173.105 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.67 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 66.8 m -76.17 112.16 12.34 Favored 'General case' 0 C--O 1.251 1.165 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.335 176.304 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.436 HD21 HE21 ' A' ' 34' ' ' GLN . 94.9 mt . . . . . 0 C--N 1.3 -1.558 0 CA-C-N 115.012 -0.995 . . . . 0.0 108.397 179.081 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.524 ' HA ' ' OE1' ' A' ' 2' ' ' GLN . 3.4 tp60 . . . . . 0 N--CA 1.436 -1.144 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 87.2 p -92.39 -178.15 4.84 Favored 'General case' 0 C--N 1.294 -1.838 0 CA-C-O 121.006 0.432 . . . . 0.0 111.193 -177.508 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 50.5 t-80 -54.43 136.54 44.01 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 123.954 0.902 . . . . 0.0 110.768 178.589 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 75.75 3.5 3.85 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 124.781 1.232 . . . . 0.0 112.713 177.82 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -93.37 154.98 22.03 Favored Glycine 0 N--CA 1.437 -1.257 0 N-CA-C 110.433 -1.067 . . . . 0.0 110.433 175.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.484 ' HA ' ' O ' ' A' ' 33' ' ' SER . 52.3 tt0 -81.36 110.1 16.48 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 177.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.707 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 8.7 p -79.18 -43.39 24.0 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 123.333 0.396 . . . . 0.0 111.867 -177.573 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.442 ' H ' ' HB2' ' A' ' 33' ' ' SER . . . 157.31 115.74 0.47 Allowed Glycine 0 N--CA 1.42 -2.383 0 C-N-CA 117.145 -2.455 . . . . 0.0 114.708 179.492 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -101.81 -149.9 22.87 Favored Glycine 0 N--CA 1.418 -2.559 0 N-CA-C 108.352 -1.899 . . . . 0.0 108.352 174.417 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 84.3 mt -71.92 112.98 8.07 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.715 0 CA-C-N 117.417 0.609 . . . . 0.0 111.008 178.475 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 92.61 30.06 10.17 Favored Glycine 0 N--CA 1.449 -0.492 0 CA-C-N 115.807 -0.633 . . . . 0.0 113.597 174.604 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 36.3 t80 -111.72 117.05 31.8 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-N 117.342 0.571 . . . . 0.0 109.513 -179.104 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 39.0 p -102.78 11.27 37.81 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-O 120.864 0.364 . . . . 0.0 111.742 -177.263 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -80.01 -151.78 7.2 Favored Glycine 0 CA--C 1.529 0.965 0 CA-C-N 116.071 -0.513 . . . . 0.0 112.315 179.638 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -75.35 96.59 1.04 Allowed 'Trans proline' 0 N--CA 1.453 -0.89 0 C-N-CA 122.276 1.984 . . . . 0.0 111.163 179.352 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.568 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 15.2 p -90.52 -8.76 49.5 Favored 'General case' 0 N--CA 1.423 -1.808 0 CA-C-N 115.407 -0.815 . . . . 0.0 112.259 -175.303 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 9.3 p -95.78 130.71 44.1 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.225 0 CA-C-N 116.123 -0.49 . . . . 0.0 109.932 177.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.492 ' HA ' ' O ' ' A' ' 2' ' ' GLN . 73.6 m -91.86 159.19 15.91 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.467 -179.404 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -78.86 170.0 17.36 Favored 'General case' 0 C--O 1.251 1.138 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.261 -179.472 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 46.4 m -58.51 126.65 28.47 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.972 -179.19 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 104.37 -6.24 45.68 Favored Glycine 0 N--CA 1.431 -1.667 0 C-N-CA 120.147 -1.025 . . . . 0.0 112.207 178.786 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 38.8 p -135.07 153.08 52.16 Favored 'General case' 0 C--O 1.241 0.627 0 CA-C-O 120.653 0.263 . . . . 0.0 111.305 -179.389 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 8.8 p -124.01 153.51 41.21 Favored 'General case' 0 N--CA 1.437 -1.093 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 176.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 50.9 t -82.34 99.38 9.33 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 -179.399 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 58.5 mt-30 -99.83 122.36 42.67 Favored 'General case' 0 N--CA 1.438 -1.059 0 CA-C-O 121.123 0.487 . . . . 0.0 110.087 -177.832 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 55.8 t -82.57 107.42 14.41 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.35 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.164 -179.001 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 84.1 mt -88.47 -70.39 0.64 Allowed 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 -179.786 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 55.7 m-80 -94.39 164.41 20.16 Favored Pre-proline 0 C--N 1.303 -1.441 0 N-CA-C 106.343 -1.725 . . . . 0.0 106.343 174.235 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_exo -60.46 -24.58 78.33 Favored 'Trans proline' 0 C--N 1.35 0.624 0 C-N-CA 121.766 1.644 . . . . 0.0 111.963 179.496 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 55.8 m-85 -109.56 -24.26 11.06 Favored 'General case' 0 N--CA 1.432 -1.356 0 C-N-CA 120.276 -0.57 . . . . 0.0 111.502 -179.256 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 57.0 t80 -103.95 113.43 26.95 Favored 'General case' 0 C--N 1.315 -0.934 0 C-N-CA 119.606 -0.838 . . . . 0.0 110.461 -179.474 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.484 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 49.8 m -123.18 137.56 54.86 Favored 'General case' 0 C--N 1.28 -2.447 0 N-CA-C 105.813 -1.921 . . . . 0.0 105.813 177.065 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 29.4 tt0 -131.46 141.04 49.71 Favored 'General case' 0 C--N 1.288 -2.075 0 C-N-CA 121.077 -0.249 . . . . 0.0 111.087 -172.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.707 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 76.8 m -74.56 107.98 7.03 Favored 'General case' 0 C--O 1.255 1.39 0 CA-C-O 121.636 0.731 . . . . 0.0 110.653 177.374 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 96.2 mt . . . . . 0 N--CA 1.428 -1.543 0 N-CA-C 106.304 -1.739 . . . . 0.0 106.304 179.028 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 . . . . . 0 N--CA 1.447 -0.58 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 5.0 m -93.03 169.63 10.27 Favored 'General case' 0 C--N 1.298 -1.667 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.6 -175.417 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 42.9 t-80 -52.92 139.45 27.42 Favored 'General case' 0 C--O 1.242 0.697 0 CA-C-N 115.14 -0.936 . . . . 0.0 109.274 173.159 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 69.0 8.28 6.75 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.753 0.821 . . . . 0.0 112.836 179.141 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -100.17 159.09 19.45 Favored Glycine 0 N--CA 1.436 -1.332 0 C-N-CA 120.68 -0.772 . . . . 0.0 111.501 178.283 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.534 ' HA ' ' O ' ' A' ' 33' ' ' SER . 53.7 tt0 -80.7 112.56 18.18 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 179.033 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.688 ' O ' ' HA ' ' A' ' 17' ' ' THR . 25.4 p -91.33 -38.29 12.72 Favored 'General case' 0 C--N 1.293 -1.856 0 N-CA-C 113.304 0.853 . . . . 0.0 113.304 -174.808 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 177.79 85.1 0.06 OUTLIER Glycine 0 CA--C 1.484 -1.851 0 C-N-CA 117.85 -2.119 . . . . 0.0 113.868 -176.754 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.461 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -112.55 176.28 17.6 Favored Glycine 0 C--N 1.285 -2.29 0 N-CA-C 108.469 -1.852 . . . . 0.0 108.469 174.573 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 78.3 mt -61.62 118.82 4.52 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.042 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 176.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 110.38 -5.77 30.02 Favored Glycine 0 N--CA 1.432 -1.608 0 C-N-CA 120.845 -0.693 . . . . 0.0 111.675 -178.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 65.2 t80 -114.0 108.28 16.81 Favored 'General case' 0 C--N 1.311 -1.089 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 178.232 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 21.9 p -109.61 15.65 22.72 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.658 -177.467 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -88.23 -154.67 28.16 Favored Glycine 0 N--CA 1.45 -0.423 0 CA-C-O 119.597 -0.557 . . . . 0.0 112.32 -179.688 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_endo -62.0 109.79 0.88 Allowed 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 122.882 2.388 . . . . 0.0 111.232 177.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.688 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 7.7 p -95.04 -6.46 42.13 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 114.215 1.191 . . . . 0.0 114.215 -173.267 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 7.6 p -95.71 134.76 32.05 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.371 0 O-C-N 121.973 -0.454 . . . . 0.0 109.98 179.43 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 46.9 m -91.37 168.87 11.25 Favored 'General case' 0 C--N 1.312 -1.051 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 -179.786 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.64 141.61 53.62 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 175.082 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 46.7 m -56.46 133.66 53.36 Favored 'General case' 0 N--CA 1.433 -1.314 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.255 -179.201 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 111.9 -13.17 26.96 Favored Glycine 0 C--N 1.296 -1.69 0 N-CA-C 109.86 -1.296 . . . . 0.0 109.86 -173.733 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 55.2 p -136.28 143.63 44.33 Favored 'General case' 0 C--O 1.248 1.004 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 174.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 21.3 p -111.35 138.08 48.29 Favored 'General case' 0 C--N 1.288 -2.098 0 CA-C-N 116.654 -0.248 . . . . 0.0 110.994 -179.212 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 46.4 t -72.3 99.0 2.3 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 176.458 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 74.8 mt-30 -108.06 129.29 55.15 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-O 121.223 0.535 . . . . 0.0 110.305 -179.234 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 58.3 t -78.05 107.6 10.21 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.371 0 CA-C-N 115.137 -0.938 . . . . 0.0 109.342 -179.77 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 83.6 mt -86.48 -72.33 0.51 Allowed 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 82.2 m-20 -94.84 165.17 17.69 Favored Pre-proline 0 C--N 1.292 -1.892 0 N-CA-C 105.789 -1.93 . . . . 0.0 105.789 174.769 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -60.95 -33.6 92.12 Favored 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 121.617 1.544 . . . . 0.0 111.316 179.087 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.461 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 76.1 m-85 -100.11 -26.3 14.0 Favored 'General case' 0 C--N 1.311 -1.079 0 C-N-CA 120.396 -0.522 . . . . 0.0 111.199 -177.787 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 53.6 t80 -106.28 113.82 27.57 Favored 'General case' 0 C--N 1.311 -1.078 0 C-N-CA 120.723 -0.391 . . . . 0.0 111.946 -179.341 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.534 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 20.0 m -121.69 141.09 51.5 Favored 'General case' 0 C--N 1.288 -2.087 0 N-CA-C 106.545 -1.65 . . . . 0.0 106.545 175.353 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.507 HE21 HD21 ' A' ' 36' ' ' LEU . 29.0 tt0 -133.43 145.96 50.75 Favored 'General case' 0 C--N 1.3 -1.579 0 C-N-CA 120.092 -0.643 . . . . 0.0 111.376 -172.215 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.667 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 57.2 m -75.77 110.6 10.32 Favored 'General case' 0 C--O 1.252 1.228 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.014 177.483 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.507 HD21 HE21 ' A' ' 34' ' ' GLN . 84.7 mt . . . . . 0 C--N 1.302 -1.462 0 CA-C-N 115.042 -0.981 . . . . 0.0 109.503 -177.442 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 . . . . . 0 N--CA 1.429 -1.519 0 N-CA-C 106.301 -1.74 . . . . 0.0 106.301 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 23.2 t -127.49 -177.61 4.15 Favored 'General case' 0 C--N 1.293 -1.866 0 C-N-CA 119.991 -0.684 . . . . 0.0 110.266 -176.635 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 41.6 t-80 -49.99 132.83 23.07 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 124.113 0.965 . . . . 0.0 110.93 -179.575 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 75.6 6.15 3.98 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 124.824 1.25 . . . . 0.0 112.294 178.652 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -98.8 155.92 20.11 Favored Glycine 0 N--CA 1.433 -1.528 0 N-CA-C 110.441 -1.064 . . . . 0.0 110.441 175.653 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.459 ' HA ' ' O ' ' A' ' 33' ' ' SER . 51.6 tt0 -81.23 116.53 21.15 Favored 'General case' 0 N--CA 1.438 -1.039 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 179.824 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.738 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 10.8 p -91.08 -22.02 20.93 Favored 'General case' 0 C--N 1.292 -1.904 0 N-CA-C 113.261 0.837 . . . . 0.0 113.261 -175.102 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 157.45 90.54 0.08 OUTLIER Glycine 0 CA--C 1.473 -2.592 0 C-N-CA 117.203 -2.427 . . . . 0.0 113.818 -179.108 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.649 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -113.11 179.41 19.08 Favored Glycine 0 C--N 1.275 -2.843 0 N-CA-C 108.076 -2.01 . . . . 0.0 108.076 173.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.44 ' HB ' ' CD1' ' A' ' 31' ' ' TYR . 56.5 mt -64.67 112.22 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 178.623 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 113.41 -4.37 24.96 Favored Glycine 0 N--CA 1.441 -1.027 0 C-N-CA 121.1 -0.572 . . . . 0.0 112.036 -179.399 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 72.9 t80 -101.42 129.29 47.41 Favored 'General case' 0 C--N 1.31 -1.129 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 3.7 p -129.12 5.76 5.35 Favored 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 112.751 0.649 . . . . 0.0 112.751 -177.39 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -81.49 -149.69 7.17 Favored Glycine 0 CA--C 1.533 1.21 0 C-N-CA 121.171 -0.538 . . . . 0.0 112.04 177.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_endo -63.02 111.43 1.39 Allowed 'Trans proline' 0 C--N 1.357 1.007 0 C-N-CA 122.538 2.159 . . . . 0.0 112.225 179.102 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.645 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 3.1 p -93.71 -16.09 24.59 Favored 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 113.166 0.802 . . . . 0.0 113.166 -176.238 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 8.2 p -90.48 128.1 42.57 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 CA-C-O 121.001 0.429 . . . . 0.0 110.402 -179.74 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 69.8 m -86.75 153.24 21.85 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 177.559 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -59.57 127.42 31.93 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 174.566 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 35.3 m -53.67 130.56 36.8 Favored 'General case' 0 C--O 1.246 0.909 0 CA-C-O 121.319 0.581 . . . . 0.0 110.973 -177.717 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 113.18 -21.21 18.1 Favored Glycine 0 N--CA 1.434 -1.464 0 N-CA-C 109.263 -1.535 . . . . 0.0 109.263 -170.591 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 70.6 p -117.57 143.34 46.2 Favored 'General case' 0 N--CA 1.443 -0.783 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 172.405 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 34.1 p -112.55 144.07 42.64 Favored 'General case' 0 C--N 1.295 -1.782 0 CA-C-O 120.71 0.29 . . . . 0.0 111.007 -177.034 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 50.9 t -78.83 98.51 6.35 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 178.54 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 75.3 mt-30 -103.74 127.69 51.19 Favored 'General case' 0 N--CA 1.431 -1.379 0 CA-C-O 120.996 0.427 . . . . 0.0 110.031 -177.713 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 60.0 t -78.37 114.04 18.45 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 179.463 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 74.2 mt -94.16 -70.38 0.71 Allowed 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 -178.692 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 77.6 m-20 -94.94 164.08 20.39 Favored Pre-proline 0 C--N 1.299 -1.612 0 N-CA-C 106.608 -1.627 . . . . 0.0 106.608 175.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -57.1 -35.33 98.88 Favored 'Trans proline' 0 CA--C 1.538 0.679 0 C-N-CA 121.886 1.724 . . . . 0.0 112.586 -179.029 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.649 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 50.5 m-85 -103.89 -21.07 13.7 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.991 -178.849 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 24.1 t80 -104.44 113.3 26.78 Favored 'General case' 0 C--N 1.316 -0.859 0 C-N-CA 119.87 -0.732 . . . . 0.0 111.24 -178.736 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.459 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 16.9 m -116.93 135.71 53.51 Favored 'General case' 0 C--N 1.289 -2.064 0 N-CA-C 106.068 -1.827 . . . . 0.0 106.068 175.648 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.412 HE21 HD21 ' A' ' 36' ' ' LEU . 28.7 tt0 -129.92 144.72 51.47 Favored 'General case' 0 C--N 1.299 -1.621 0 CA-C-N 118.111 0.414 . . . . 0.0 110.832 -172.068 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.738 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 61.7 m -76.46 116.84 17.52 Favored 'General case' 0 C--O 1.259 1.592 0 CA-C-O 121.17 0.51 . . . . 0.0 110.154 177.479 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.412 HD21 HE21 ' A' ' 34' ' ' GLN . 94.5 mt . . . . . 0 C--N 1.298 -1.666 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 177.582 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 . . . . . 0 N--CA 1.446 -0.65 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . 0.434 ' O ' ' HB2' ' A' ' 35' ' ' CYS . 19.6 p -95.05 -178.13 4.38 Favored 'General case' 0 C--N 1.29 -2.013 0 C-N-CA 123.134 0.574 . . . . 0.0 111.54 -174.479 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 51.0 t-80 -64.55 123.59 19.65 Favored 'General case' 0 N--CA 1.445 -0.694 0 N-CA-C 108.023 -1.102 . . . . 0.0 108.023 176.718 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 65.03 83.95 0.16 Allowed 'General case' 0 C--N 1.319 -0.727 0 O-C-N 124.446 1.092 . . . . 0.0 111.453 -175.819 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.511 ' O ' ' HA ' ' A' ' 34' ' ' GLN . . . -167.38 159.13 32.36 Favored Glycine 0 N--CA 1.424 -2.138 0 N-CA-C 106.916 -2.474 . . . . 0.0 106.916 179.398 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.603 ' HA ' ' O ' ' A' ' 33' ' ' SER . 53.3 tt0 -82.36 110.36 17.44 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 118.281 1.04 . . . . 0.0 110.049 -179.19 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.709 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 1.8 p -86.1 -47.81 9.18 Favored 'General case' 0 C--N 1.295 -1.793 0 N-CA-C 113.237 0.829 . . . . 0.0 113.237 -177.79 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.422 ' H ' ' HB2' ' A' ' 33' ' ' SER . . . -174.22 89.16 0.08 OUTLIER Glycine 0 CA--C 1.486 -1.73 0 C-N-CA 117.716 -2.183 . . . . 0.0 114.07 -175.669 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.509 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -112.87 178.38 18.75 Favored Glycine 0 C--N 1.286 -2.213 0 N-CA-C 107.673 -2.171 . . . . 0.0 107.673 173.616 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 67.6 mt -61.58 118.44 4.08 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-N 118.239 1.019 . . . . 0.0 108.83 177.037 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 110.26 -14.85 30.64 Favored Glycine 0 N--CA 1.443 -0.897 0 C-N-CA 120.767 -0.73 . . . . 0.0 111.841 -178.852 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 25.7 t80 -114.09 121.47 43.92 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 -179.574 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 13.7 p -134.96 18.28 3.48 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-O 121.282 0.563 . . . . 0.0 111.545 -179.496 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -78.6 -128.61 0.53 Allowed Glycine 0 CA--C 1.521 0.414 0 CA-C-N 115.311 -0.859 . . . . 0.0 111.065 176.844 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -67.04 88.37 0.3 Allowed 'Trans proline' 0 CA--C 1.536 0.576 0 C-N-CA 122.201 1.934 . . . . 0.0 111.95 176.549 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.633 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 39.2 p -86.73 0.15 55.21 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.651 0.739 . . . . 0.0 110.756 -179.625 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 7.6 p -102.27 129.74 53.23 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.579 0 CA-C-N 114.89 -1.05 . . . . 0.0 108.82 178.663 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.461 ' SG ' ' HB2' ' A' ' 25' ' ' CYS . 71.4 m -92.64 153.64 18.86 Favored 'General case' 0 C--N 1.293 -1.886 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.67 -179.703 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -56.51 133.01 53.05 Favored 'General case' 0 C--O 1.249 1.039 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 174.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 9.2 p -53.97 127.51 26.63 Favored 'General case' 0 C--O 1.249 1.073 0 CA-C-O 121.528 0.68 . . . . 0.0 112.294 -177.149 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 112.43 -9.49 26.38 Favored Glycine 0 N--CA 1.431 -1.687 0 CA-C-N 114.843 -1.071 . . . . 0.0 110.784 -175.493 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 67.1 p -127.39 145.73 50.71 Favored 'General case' 0 C--O 1.246 0.899 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 176.477 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 23.6 p -111.3 140.14 46.12 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-O 120.381 0.134 . . . . 0.0 111.178 -178.337 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.461 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 53.6 t -73.31 103.07 3.87 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 179.094 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 16.7 mm-40 -91.12 113.48 25.76 Favored 'General case' 0 N--CA 1.425 -1.695 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.024 -179.005 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 45.5 t -76.19 101.36 2.59 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.114 0 N-CA-C 107.142 -1.429 . . . . 0.0 107.142 176.698 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 77.3 mt -86.87 -69.93 0.64 Allowed 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 -177.661 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 79.1 m-20 -95.74 165.31 16.82 Favored Pre-proline 0 C--N 1.298 -1.668 0 N-CA-C 107.038 -1.467 . . . . 0.0 107.038 174.727 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_exo -60.91 -29.98 89.11 Favored 'Trans proline' 0 CA--C 1.542 0.884 0 C-N-CA 121.499 1.466 . . . . 0.0 111.658 178.428 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.509 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 87.8 m-85 -101.77 -25.54 13.8 Favored 'General case' 0 N--CA 1.44 -0.969 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.553 -179.839 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 68.2 t80 -106.05 114.8 29.16 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 113.008 0.744 . . . . 0.0 113.008 -178.538 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.603 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 23.8 m -121.18 136.59 54.95 Favored 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 175.711 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.511 ' HA ' ' O ' ' A' ' 6' ' ' GLY . 35.2 tt0 -127.59 133.24 49.73 Favored 'General case' 0 C--N 1.318 -0.762 0 C-N-CA 122.202 0.201 . . . . 0.0 110.763 -173.253 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.709 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 64.1 m -74.01 109.03 7.18 Favored 'General case' 0 C--O 1.243 0.739 0 CA-C-O 120.972 0.415 . . . . 0.0 111.756 177.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 96.6 mt . . . . . 0 C--N 1.299 -1.591 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 178.689 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 . . . . . 0 N--CA 1.416 -2.133 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 61.3 p -91.99 173.9 7.6 Favored 'General case' 0 C--N 1.282 -2.332 0 CA-C-N 114.857 -1.065 . . . . 0.0 110.146 -175.027 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 55.2 t-80 -57.54 134.23 55.94 Favored 'General case' 0 C--N 1.315 -0.905 0 C-N-CA 123.453 0.701 . . . . 0.0 110.107 177.183 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 70.51 10.42 7.16 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.646 1.178 . . . . 0.0 112.908 178.169 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.526 ' O ' ' HA ' ' A' ' 34' ' ' GLN . . . -97.62 155.8 20.56 Favored Glycine 0 N--CA 1.438 -1.2 0 N-CA-C 110.726 -0.95 . . . . 0.0 110.726 176.175 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.634 ' HA ' ' O ' ' A' ' 33' ' ' SER . 64.4 tt0 -70.25 110.51 5.27 Favored 'General case' 0 C--O 1.217 -0.608 0 CA-C-N 117.14 0.47 . . . . 0.0 109.931 -178.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.742 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 21.1 p -93.13 -31.68 14.71 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 113.565 0.95 . . . . 0.0 113.565 -175.764 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 179.84 84.36 0.06 OUTLIER Glycine 0 CA--C 1.483 -1.932 0 C-N-CA 117.574 -2.251 . . . . 0.0 113.786 -174.673 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.567 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -112.44 167.2 12.3 Favored Glycine 0 C--N 1.286 -2.24 0 N-CA-C 108.748 -1.741 . . . . 0.0 108.748 174.81 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 79.7 mt -60.78 117.53 2.66 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 177.532 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 105.37 -8.75 44.79 Favored Glycine 0 N--CA 1.442 -0.965 0 C-N-CA 120.373 -0.918 . . . . 0.0 111.804 179.734 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 90.4 t80 -94.74 108.85 20.85 Favored 'General case' 0 N--CA 1.44 -0.932 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 178.06 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 3.3 p -103.87 7.71 36.9 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-N 114.806 -1.088 . . . . 0.0 111.743 -176.741 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -81.05 -163.3 30.08 Favored Glycine 0 N--CA 1.445 -0.737 0 C-N-CA 121.084 -0.579 . . . . 0.0 112.361 -179.28 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_endo -62.16 118.25 5.13 Favored 'Trans proline' 0 C--O 1.235 0.342 0 C-N-CA 122.834 2.356 . . . . 0.0 110.754 177.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.551 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 10.2 p -99.71 -14.89 18.71 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 -174.639 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 13.6 p -79.48 137.66 21.33 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 C-N-CA 120.594 -0.442 . . . . 0.0 110.004 179.882 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.405 ' HB3' ' OG1' ' A' ' 23' ' ' THR . 71.2 m -97.31 153.08 18.28 Favored 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 179.544 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.53 155.67 21.48 Favored 'General case' 0 C--O 1.251 1.159 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.238 178.107 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 4.9 p -58.3 118.55 5.64 Favored 'General case' 0 C--N 1.307 -1.254 0 C-N-CA 123.429 0.692 . . . . 0.0 111.383 -179.328 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 111.92 -11.33 27.26 Favored Glycine 0 N--CA 1.441 -0.982 0 C-N-CA 120.926 -0.654 . . . . 0.0 111.641 -178.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.405 ' OG1' ' HB3' ' A' ' 19' ' ' CYS . 76.7 p -120.22 151.78 38.65 Favored 'General case' 0 C--O 1.256 1.412 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 178.058 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.411 ' O ' ' HA ' ' A' ' 35' ' ' CYS . 16.9 p -121.87 148.83 44.21 Favored 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 110.278 -0.268 . . . . 0.0 110.278 176.478 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 49.4 t -77.47 103.88 7.66 Favored 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 179.679 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 12.7 mm-40 -98.44 117.83 33.74 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 116.052 -0.522 . . . . 0.0 109.951 -178.382 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 41.2 t -87.06 105.71 15.33 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 -178.715 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 69.1 mt -89.68 -69.46 0.72 Allowed 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 -178.168 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 48.7 m-80 -95.19 170.34 8.02 Favored Pre-proline 0 C--N 1.301 -1.522 0 N-CA-C 107.038 -1.468 . . . . 0.0 107.038 176.148 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_exo -65.97 -30.15 48.49 Favored 'Trans proline' 0 C--N 1.345 0.349 0 CA-C-N 120.57 1.239 . . . . 0.0 111.875 177.072 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.567 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 28.5 m-85 -106.43 -25.59 11.81 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 119.779 -0.768 . . . . 0.0 110.585 -177.875 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 60.4 t80 -104.76 115.3 30.07 Favored 'General case' 0 N--CA 1.443 -0.807 0 C-N-CA 119.893 -0.723 . . . . 0.0 112.563 177.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.634 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 14.5 m -131.65 141.14 49.54 Favored 'General case' 0 C--N 1.293 -1.861 0 N-CA-C 105.993 -1.854 . . . . 0.0 105.993 176.272 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.526 ' HA ' ' O ' ' A' ' 6' ' ' GLY . 4.1 pt20 -132.82 151.1 52.08 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 119.084 0.857 . . . . 0.0 111.882 -178.172 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.742 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 61.2 m -76.55 118.41 19.18 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-O 121.218 0.533 . . . . 0.0 110.517 178.082 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 97.0 mt . . . . . 0 C--N 1.303 -1.453 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 178.525 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 . . . . . 0 N--CA 1.44 -0.97 0 N-CA-C 107.429 -1.323 . . . . 0.0 107.429 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 22.7 t -110.03 -168.52 1.33 Allowed 'General case' 0 C--N 1.29 -1.987 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 -176.409 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 25.2 t-80 -56.18 126.46 26.21 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 123.249 0.62 . . . . 0.0 110.182 -178.587 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 69.57 76.94 0.22 Allowed 'General case' 0 C--N 1.328 -0.339 0 O-C-N 124.604 1.19 . . . . 0.0 111.424 -178.41 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.574 ' O ' ' HA ' ' A' ' 34' ' ' GLN . . . -169.55 155.55 25.75 Favored Glycine 0 N--CA 1.433 -1.527 0 N-CA-C 108.699 -1.761 . . . . 0.0 108.699 179.175 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.689 ' HA ' ' O ' ' A' ' 33' ' ' SER . 53.2 tt0 -77.64 107.24 9.98 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 117.591 0.696 . . . . 0.0 110.329 -178.268 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.796 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 6.1 p -87.82 -41.9 12.94 Favored 'General case' 0 C--N 1.297 -1.709 0 CA-C-N 115.395 -0.82 . . . . 0.0 113.133 -176.613 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -161.96 53.99 0.31 Allowed Glycine 0 CA--C 1.471 -2.687 0 C-N-CA 118.956 -1.592 . . . . 0.0 111.687 -173.685 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.439 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -95.69 149.68 19.41 Favored Glycine 0 N--CA 1.423 -2.202 0 N-CA-C 108.442 -1.863 . . . . 0.0 108.442 175.692 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.437 ' HB ' ' CD1' ' A' ' 31' ' ' TYR . 61.4 mt -57.97 121.03 4.76 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.913 0 CA-C-N 117.315 0.558 . . . . 0.0 110.443 -178.299 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 109.59 4.26 30.3 Favored Glycine 0 N--CA 1.445 -0.713 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.985 -179.114 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.458 ' HB2' ' NE2' ' A' ' 7' ' ' GLN . 70.0 t80 -103.54 119.94 39.88 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 177.929 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 14.3 p -99.64 1.17 43.32 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 112.397 0.517 . . . . 0.0 112.397 -177.157 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -85.68 -175.8 50.2 Favored Glycine 0 N--CA 1.444 -0.822 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.329 -179.266 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -66.16 130.41 24.08 Favored 'Trans proline' 0 CA--C 1.533 0.454 0 C-N-CA 122.759 2.306 . . . . 0.0 111.616 -179.535 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.564 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 37.1 p -88.04 10.29 19.58 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-O 121.626 0.727 . . . . 0.0 111.679 -177.911 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 7.1 p -94.19 123.41 46.29 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.496 0 CA-C-O 121.567 0.699 . . . . 0.0 110.82 -178.372 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 83.7 m -88.56 160.12 17.59 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-N 115.112 -0.949 . . . . 0.0 109.154 177.064 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -72.17 146.15 47.59 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 176.751 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 67.9 m -53.1 130.27 33.59 Favored 'General case' 0 C--O 1.25 1.1 0 CA-C-O 121.092 0.472 . . . . 0.0 110.211 176.763 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 112.18 -16.81 24.75 Favored Glycine 0 N--CA 1.43 -1.722 0 N-CA-C 110.781 -0.928 . . . . 0.0 110.781 -173.593 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 41.4 p -133.2 144.78 50.04 Favored 'General case' 0 N--CA 1.443 -0.818 0 CA-C-O 120.819 0.342 . . . . 0.0 111.327 179.577 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 23.3 p -116.77 152.32 34.62 Favored 'General case' 0 C--N 1.309 -1.161 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 177.778 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 44.8 t -77.53 111.44 13.27 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 -179.422 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 70.3 mt-30 -110.9 127.93 55.63 Favored 'General case' 0 N--CA 1.434 -1.238 0 CA-C-O 121.331 0.586 . . . . 0.0 110.273 -179.656 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 58.8 t -81.01 110.75 16.84 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.723 -178.141 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 75.4 mt -90.02 -72.65 0.55 Allowed 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 107.01 -1.478 . . . . 0.0 107.01 177.314 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 54.8 m-80 -95.79 164.29 19.13 Favored Pre-proline 0 C--N 1.298 -1.66 0 N-CA-C 106.785 -1.561 . . . . 0.0 106.785 170.536 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_exo -63.56 -33.45 67.82 Favored 'Trans proline' 0 C--O 1.241 0.637 0 C-N-CA 121.64 1.56 . . . . 0.0 111.26 176.374 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.439 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 76.8 m-85 -97.17 -26.38 14.97 Favored 'General case' 0 N--CA 1.442 -0.83 0 C-N-CA 119.633 -0.827 . . . . 0.0 110.819 -179.689 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 53.1 t80 -106.21 113.01 26.29 Favored 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 119.436 -0.906 . . . . 0.0 110.956 175.397 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.689 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 20.0 m -123.98 140.92 52.5 Favored 'General case' 0 C--N 1.288 -2.103 0 N-CA-C 106.616 -1.624 . . . . 0.0 106.616 177.393 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.574 ' HA ' ' O ' ' A' ' 6' ' ' GLY . 28.6 tt0 -129.89 140.57 50.94 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 -169.493 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.796 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 73.7 m -71.41 116.85 12.22 Favored 'General case' 0 C--O 1.258 1.522 0 CA-C-O 121.147 0.499 . . . . 0.0 110.544 175.303 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 95.5 mt . . . . . 0 C--N 1.303 -1.424 0 C-N-CA 125.156 1.382 . . . . 0.0 107.949 179.515 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 5.6 tp-100 . . . . . 0 N--CA 1.442 -0.839 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 62.4 m -126.16 -173.22 2.8 Favored 'General case' 0 C--N 1.297 -1.715 0 C-N-CA 120.176 -0.61 . . . . 0.0 111.923 -177.181 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . 0.59 ' HA ' ' O ' ' A' ' 35' ' ' CYS . 57.6 t-80 -54.29 132.27 43.41 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 123.055 0.542 . . . . 0.0 110.326 -178.702 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . 0.493 ' HA ' ' OE1' ' A' ' 34' ' ' GLN . . . 81.16 1.61 1.66 Allowed 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 125.251 1.42 . . . . 0.0 112.195 -178.423 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -98.91 153.22 19.79 Favored Glycine 0 N--CA 1.433 -1.54 0 N-CA-C 110.766 -0.934 . . . . 0.0 110.766 177.061 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.465 ' HA ' ' O ' ' A' ' 33' ' ' SER . 49.7 tt0 -82.17 111.5 18.34 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 179.856 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.77 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 14.6 p -83.45 -14.36 52.69 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.783 -178.025 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 122.94 115.24 2.23 Favored Glycine 0 N--CA 1.416 -2.674 0 C-N-CA 117.574 -2.25 . . . . 0.0 116.279 173.424 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -112.38 -153.59 11.93 Favored Glycine 0 N--CA 1.418 -2.555 0 N-CA-C 107.063 -2.415 . . . . 0.0 107.063 171.503 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 78.9 mt -64.29 124.18 18.57 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.679 0 CA-C-N 117.756 0.778 . . . . 0.0 110.493 177.836 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 95.9 6.87 59.04 Favored Glycine 0 N--CA 1.442 -0.956 0 CA-C-N 115.998 -0.546 . . . . 0.0 113.741 176.438 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 49.4 t80 -109.25 127.55 54.34 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 -179.712 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 6.7 p -128.83 15.7 6.37 Favored 'General case' 0 C--N 1.303 -1.434 0 CA-C-O 121.505 0.669 . . . . 0.0 111.144 -177.397 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -84.42 -143.83 6.16 Favored Glycine 0 C--O 1.248 0.981 0 N-CA-C 111.449 -0.66 . . . . 0.0 111.449 178.216 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -73.01 103.53 1.61 Allowed 'Trans proline' 0 N--CA 1.448 -1.154 0 C-N-CA 122.227 1.951 . . . . 0.0 111.395 177.769 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.524 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 32.8 p -94.46 -7.68 40.73 Favored 'General case' 0 N--CA 1.434 -1.234 0 CA-C-O 121.669 0.747 . . . . 0.0 110.816 -178.474 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 7.4 p -82.31 123.64 38.46 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.805 0 CA-C-N 115.239 -0.891 . . . . 0.0 110.732 178.051 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 78.4 m -90.44 148.88 22.5 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 109.481 -0.562 . . . . 0.0 109.481 176.395 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.53 150.9 17.89 Favored 'General case' 0 C--O 1.251 1.169 0 O-C-N 123.774 0.671 . . . . 0.0 110.449 177.381 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 8.9 t -59.41 115.87 3.56 Favored 'General case' 0 N--CA 1.433 -1.297 0 CA-C-N 115.663 -0.698 . . . . 0.0 109.491 -177.577 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 111.91 -5.69 27.41 Favored Glycine 0 N--CA 1.437 -1.237 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.077 -178.882 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 60.3 p -121.43 147.02 46.29 Favored 'General case' 0 C--N 1.312 -1.06 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 175.36 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 26.5 p -117.84 141.48 48.37 Favored 'General case' 0 C--N 1.304 -1.41 0 C-N-CA 121.26 -0.176 . . . . 0.0 110.586 -178.836 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 48.4 t -72.66 103.8 3.71 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 85.3 mm-40 -98.26 112.26 24.31 Favored 'General case' 0 N--CA 1.415 -2.186 0 CA-C-O 121.264 0.554 . . . . 0.0 110.24 -179.225 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 41.4 t -80.39 96.51 2.75 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.588 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 179.732 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 87.1 mt -80.9 -69.98 0.56 Allowed 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 -177.828 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 47.7 m-80 -94.27 164.55 19.87 Favored Pre-proline 0 C--N 1.298 -1.649 0 N-CA-C 106.449 -1.685 . . . . 0.0 106.449 175.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -59.77 -33.1 96.38 Favored 'Trans proline' 0 N--CA 1.475 0.42 0 C-N-CA 121.655 1.57 . . . . 0.0 111.669 178.781 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -100.27 -25.36 14.27 Favored 'General case' 0 N--CA 1.441 -0.915 0 C-N-CA 120.077 -0.649 . . . . 0.0 111.206 179.606 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 80.2 t80 -105.05 114.42 28.61 Favored 'General case' 0 C--N 1.309 -1.191 0 C-N-CA 119.798 -0.761 . . . . 0.0 112.673 -176.782 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.465 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 24.0 m -125.58 137.3 53.9 Favored 'General case' 0 C--N 1.284 -2.257 0 N-CA-C 106.858 -1.534 . . . . 0.0 106.858 178.114 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.493 ' OE1' ' HA ' ' A' ' 5' ' ' ALA . 8.0 tt0 -128.53 142.04 51.19 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 109.956 -0.386 . . . . 0.0 109.956 -175.943 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.77 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 75.2 m -75.06 110.74 9.63 Favored 'General case' 0 C--O 1.249 1.037 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 175.806 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 96.6 mt . . . . . 0 N--CA 1.423 -1.801 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 179.08 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 . . . . . 0 N--CA 1.434 -1.269 0 CA-C-O 121.383 0.611 . . . . 0.0 110.255 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 18.3 p -88.01 166.89 14.15 Favored 'General case' 0 C--N 1.285 -2.2 0 CA-C-N 115.243 -0.889 . . . . 0.0 111.575 -174.555 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 56.6 t-80 -57.82 136.75 57.01 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 107.675 -1.232 . . . . 0.0 107.675 172.63 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . 0.416 ' HA ' ' CD ' ' A' ' 34' ' ' GLN . . . 73.2 12.56 4.88 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.396 0.678 . . . . 0.0 112.665 -179.935 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.454 ' O ' ' HA ' ' A' ' 34' ' ' GLN . . . -107.58 164.42 13.0 Favored Glycine 0 C--O 1.243 0.715 0 N-CA-C 110.478 -1.049 . . . . 0.0 110.478 175.364 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.587 ' HA ' ' O ' ' A' ' 33' ' ' SER . 54.1 tt0 -84.55 107.05 16.57 Favored 'General case' 0 C--O 1.224 -0.251 0 CA-C-N 117.395 0.598 . . . . 0.0 110.894 -177.839 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.805 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 12.3 p -84.34 -37.79 21.16 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 113.705 1.002 . . . . 0.0 113.705 -175.565 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -177.43 87.81 0.07 OUTLIER Glycine 0 CA--C 1.481 -2.04 0 C-N-CA 117.96 -2.067 . . . . 0.0 113.24 -176.291 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.559 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -112.42 172.9 14.96 Favored Glycine 0 C--N 1.28 -2.548 0 N-CA-C 107.921 -2.072 . . . . 0.0 107.921 174.867 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 68.8 mt -63.07 118.0 4.64 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.208 0 CA-C-N 117.861 0.83 . . . . 0.0 109.353 178.785 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 105.73 6.21 38.07 Favored Glycine 0 C--N 1.312 -0.799 0 C-N-CA 120.421 -0.895 . . . . 0.0 112.386 178.73 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 85.2 t80 -102.47 118.48 36.97 Favored 'General case' 0 C--N 1.307 -1.262 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 178.532 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 14.3 p -109.36 0.38 19.44 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-O 121.271 0.558 . . . . 0.0 111.513 -177.703 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -77.92 -171.64 37.77 Favored Glycine 0 N--CA 1.443 -0.841 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.918 178.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_endo -64.37 119.24 6.22 Favored 'Trans proline' 0 C--O 1.237 0.454 0 C-N-CA 122.481 2.121 . . . . 0.0 111.291 178.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.564 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 70.1 p -90.71 -8.32 50.17 Favored 'General case' 0 C--O 1.24 0.558 0 CA-C-O 121.41 0.624 . . . . 0.0 111.211 -176.873 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 5.6 p -80.07 126.41 39.36 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.185 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.334 179.411 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 83.9 m -87.78 163.46 16.46 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.253 -179.017 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.29 150.89 45.16 Favored 'General case' 0 C--O 1.254 1.323 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 175.49 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 35.6 t -57.76 126.01 25.51 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-O 121.503 0.668 . . . . 0.0 110.572 -175.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 112.32 -21.11 20.25 Favored Glycine 0 N--CA 1.43 -1.766 0 CA-C-N 115.172 -0.922 . . . . 0.0 111.62 -178.412 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 50.7 p -116.02 147.09 41.6 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 120.765 -0.374 . . . . 0.0 110.384 179.569 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.405 ' O ' ' HA ' ' A' ' 35' ' ' CYS . 21.7 p -120.23 155.39 33.29 Favored 'General case' 0 C--N 1.298 -1.656 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.767 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 48.5 t -80.23 102.95 9.78 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-O 121.143 0.497 . . . . 0.0 110.433 -178.833 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.451 ' HG3' ' HB2' ' A' ' 36' ' ' LEU . 9.1 mm-40 -100.87 122.29 43.18 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 -179.166 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 57.6 t -79.84 114.8 21.21 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.715 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 -179.083 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 86.4 mt -98.25 -70.04 0.74 Allowed 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 179.192 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.465 ' HB2' ' H ' ' A' ' 32' ' ' TYR . 88.2 m-20 -94.07 166.11 16.3 Favored Pre-proline 0 C--N 1.304 -1.373 0 N-CA-C 105.986 -1.857 . . . . 0.0 105.986 174.225 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -64.49 -26.6 62.41 Favored 'Trans proline' 0 CA--C 1.538 0.691 0 C-N-CA 121.255 1.303 . . . . 0.0 111.341 177.277 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.559 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 70.1 m-85 -107.16 -26.34 11.14 Favored 'General case' 0 N--CA 1.443 -0.777 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.121 -178.935 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.465 ' H ' ' HB2' ' A' ' 29' ' ' ASN . 67.6 t80 -105.73 113.84 27.64 Favored 'General case' 0 C--N 1.304 -1.383 0 C-N-CA 119.627 -0.829 . . . . 0.0 110.978 178.418 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.587 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 21.3 m -121.72 140.92 51.7 Favored 'General case' 0 C--N 1.279 -2.494 0 N-CA-C 105.616 -1.994 . . . . 0.0 105.616 175.088 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.464 ' OE1' HD21 ' A' ' 36' ' ' LEU . 35.9 tt0 -125.81 141.36 52.03 Favored 'General case' 0 C--N 1.29 -1.999 0 C-N-CA 120.874 -0.33 . . . . 0.0 110.766 -171.407 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.805 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 85.5 m -74.38 114.21 12.5 Favored 'General case' 0 C--O 1.252 1.187 0 CA-C-O 121.176 0.512 . . . . 0.0 109.982 176.247 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.464 HD21 ' OE1' ' A' ' 34' ' ' GLN . 95.5 mt . . . . . 0 N--CA 1.426 -1.639 0 CA-C-N 115.127 -0.942 . . . . 0.0 108.84 -179.382 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 6.3 m . . . . . 0 N--CA 1.436 -1.167 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -78.74 134.89 37.02 Favored 'General case' 0 N--CA 1.426 -1.639 0 CA-C-O 121.377 0.608 . . . . 0.0 109.774 -175.419 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 22.9 t -97.97 171.82 8.02 Favored 'General case' 0 C--N 1.282 -2.345 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.213 -173.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . 0.569 ' O ' ' H5 ' ' A' ' 101' ' ' MAN . 41.8 t-80 -61.45 132.11 52.37 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 179.078 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.47 ' HA ' ' OE1' ' A' ' 34' ' ' GLN . . . 83.71 0.28 1.04 Allowed 'General case' 0 N--CA 1.48 1.053 0 O-C-N 124.915 1.384 . . . . 0.0 113.011 -177.745 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.427 ' O ' ' HA ' ' A' ' 34' ' ' GLN . . . -96.66 160.25 21.79 Favored Glycine 0 C--O 1.245 0.809 0 C-N-CA 120.474 -0.87 . . . . 0.0 111.914 178.265 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.618 ' HA ' ' O ' ' A' ' 33' ' ' SER . 51.6 tt0 -81.72 104.42 12.1 Favored 'General case' 0 C--O 1.225 -0.235 0 CA-C-O 121.451 0.643 . . . . 0.0 110.851 -179.198 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.777 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 7.7 p -80.8 -41.91 22.56 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 114.384 1.253 . . . . 0.0 114.384 -174.729 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.43 ' H ' ' HB2' ' A' ' 33' ' ' SER . . . -176.03 81.22 0.07 OUTLIER Glycine 0 CA--C 1.477 -2.324 0 C-N-CA 117.547 -2.263 . . . . 0.0 113.674 -175.432 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.437 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -112.69 175.63 16.98 Favored Glycine 0 C--N 1.283 -2.399 0 N-CA-C 107.989 -2.045 . . . . 0.0 107.989 173.352 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.46 ' HB ' ' CD2' ' A' ' 31' ' ' TYR . 55.1 mt -65.54 133.75 30.39 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 175.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 103.86 -16.23 51.12 Favored Glycine 0 C--N 1.311 -0.834 0 N-CA-C 111.251 -0.74 . . . . 0.0 111.251 -177.479 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.427 ' HB2' HE21 ' A' ' 7' ' ' GLN . 67.1 t80 -100.94 109.62 21.58 Favored 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 179.747 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 11.4 p -101.63 1.31 37.59 Favored 'General case' 0 C--N 1.3 -1.557 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.314 -178.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -79.46 -178.76 51.55 Favored Glycine 0 N--CA 1.441 -1.023 0 CA-C-N 115.887 -0.597 . . . . 0.0 112.317 179.322 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -60.48 122.4 11.24 Favored 'Trans proline' 0 C--O 1.241 0.637 0 C-N-CA 123.194 2.596 . . . . 0.0 111.825 179.536 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.562 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 22.9 p -92.6 9.12 36.05 Favored 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 113.571 0.952 . . . . 0.0 113.571 -173.372 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 7.5 p -91.82 126.79 44.39 Favored 'Isoleucine or valine' 0 C--O 1.248 1.02 0 CA-C-O 121.39 0.614 . . . . 0.0 111.551 -178.117 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 71.2 m -84.26 161.48 20.47 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.847 178.139 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.33 154.46 42.0 Favored 'General case' 0 C--O 1.25 1.088 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.494 176.129 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 3.1 p -60.2 129.13 40.17 Favored 'General case' 0 N--CA 1.433 -1.302 0 CA-C-O 121.263 0.554 . . . . 0.0 111.458 -178.495 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 111.34 -17.67 26.12 Favored Glycine 0 N--CA 1.423 -2.216 0 N-CA-C 110.666 -0.974 . . . . 0.0 110.666 -177.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 77.6 p -123.03 153.29 40.03 Favored 'General case' 0 C--O 1.252 1.215 0 CA-C-O 120.828 0.346 . . . . 0.0 110.983 -178.536 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 34.2 p -119.79 149.56 41.85 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 178.33 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 44.9 t -75.49 105.37 6.49 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 177.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 84.0 mm-40 -100.64 110.82 22.98 Favored 'General case' 0 N--CA 1.415 -2.188 0 CA-C-O 121.718 0.77 . . . . 0.0 110.556 -179.355 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 63.9 t -77.73 121.52 30.57 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.089 0 CA-C-N 114.637 -1.165 . . . . 0.0 108.267 179.493 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 84.6 mt -104.26 -67.72 0.88 Allowed 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 107.324 -1.362 . . . . 0.0 107.324 179.229 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 48.7 m-80 -95.07 163.27 22.34 Favored Pre-proline 0 C--N 1.293 -1.891 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 173.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_exo -63.96 -30.61 67.1 Favored 'Trans proline' 0 CA--C 1.531 0.355 0 C-N-CA 121.204 1.27 . . . . 0.0 111.198 178.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.46 ' CD2' ' HB ' ' A' ' 11' ' ' ILE . 22.3 m-85 -100.31 -25.9 14.08 Favored 'General case' 0 N--CA 1.437 -1.118 0 C-N-CA 120.364 -0.534 . . . . 0.0 110.834 -179.415 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 75.8 t80 -105.96 114.13 28.09 Favored 'General case' 0 C--O 1.243 0.749 0 N-CA-C 112.6 0.592 . . . . 0.0 112.6 178.374 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.618 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 15.1 m -125.55 143.45 51.01 Favored 'General case' 0 C--N 1.293 -1.871 0 N-CA-C 106.631 -1.618 . . . . 0.0 106.631 176.34 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.47 ' OE1' ' HA ' ' A' ' 5' ' ' ALA . 8.4 tt0 -132.08 141.23 49.12 Favored 'General case' 0 C--N 1.298 -1.671 0 CA-C-N 118.02 0.373 . . . . 0.0 110.464 -174.112 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.777 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 77.6 m -74.21 114.75 12.92 Favored 'General case' 0 C--O 1.253 1.245 0 C-N-CA 120.714 -0.394 . . . . 0.0 110.344 175.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 97.2 mt . . . . . 0 N--CA 1.428 -1.566 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 178.602 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' MAN . . . . . 0.569 ' H5 ' ' O ' ' A' ' 4' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 9.1 m . . . . . 0 N--CA 1.438 -1.043 0 N-CA-C 107.678 -1.231 . . . . 0.0 107.678 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 5.9 tp-100 -126.81 135.58 51.21 Favored 'General case' 0 N--CA 1.433 -1.324 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 173.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 53.3 m -107.61 -176.24 3.01 Favored 'General case' 0 C--N 1.302 -1.471 0 C-N-CA 120.505 -0.478 . . . . 0.0 111.266 -177.011 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . 0.419 ' CD2' ' HA ' ' A' ' 36' ' ' LEU . 47.9 t-80 -57.61 132.7 54.02 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 122.846 0.458 . . . . 0.0 109.957 -177.723 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.467 ' HA ' ' NE2' ' A' ' 34' ' ' GLN . . . 80.15 -4.48 1.88 Allowed 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 125.557 1.543 . . . . 0.0 112.63 -179.253 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -85.68 146.54 21.55 Favored Glycine 0 N--CA 1.437 -1.285 0 C-N-CA 120.37 -0.919 . . . . 0.0 110.912 178.172 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.552 ' HA ' ' O ' ' A' ' 33' ' ' SER . 62.1 tt0 -62.95 108.68 1.25 Allowed 'General case' 0 C--O 1.22 -0.473 0 CA-C-O 121.148 0.499 . . . . 0.0 110.382 178.267 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.744 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 23.3 p -86.04 -43.39 13.16 Favored 'General case' 0 C--N 1.297 -1.678 0 CA-C-N 115.73 -0.668 . . . . 0.0 112.678 -174.806 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -179.03 86.34 0.07 OUTLIER Glycine 0 CA--C 1.473 -2.542 0 C-N-CA 118.188 -1.958 . . . . 0.0 113.326 -174.474 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.523 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -104.7 178.46 24.01 Favored Glycine 0 N--CA 1.42 -2.418 0 N-CA-C 108.736 -1.745 . . . . 0.0 108.736 175.033 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 64.9 mt -66.12 128.03 28.4 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.757 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 176.725 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 99.51 -17.28 57.89 Favored Glycine 0 N--CA 1.44 -1.035 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.043 -179.666 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 67.7 t80 -87.22 109.07 19.23 Favored 'General case' 0 C--N 1.312 -1.042 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 -178.567 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 37.0 p -99.23 2.31 45.54 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.481 -178.67 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -74.56 -178.31 39.83 Favored Glycine 0 N--CA 1.436 -1.312 0 CA-C-N 115.357 -0.838 . . . . 0.0 112.486 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_endo -62.38 121.46 9.45 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 122.605 2.203 . . . . 0.0 112.133 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.634 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 29.1 p -92.89 0.67 57.45 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.005 -179.703 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 7.8 p -78.64 110.22 14.14 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.11 0 CA-C-O 121.993 0.901 . . . . 0.0 111.664 -179.36 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 70.9 m -83.79 152.9 24.39 Favored 'General case' 0 C--N 1.302 -1.486 0 CA-C-N 115.115 -0.948 . . . . 0.0 109.644 177.732 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.4 145.33 33.06 Favored 'General case' 0 C--O 1.25 1.079 0 O-C-N 123.459 0.475 . . . . 0.0 110.229 176.533 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 19.3 m -52.83 119.36 4.51 Favored 'General case' 0 C--N 1.318 -0.79 0 O-C-N 123.757 0.661 . . . . 0.0 111.464 -178.012 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 111.88 -11.25 27.38 Favored Glycine 0 N--CA 1.439 -1.126 0 CA-C-N 115.832 -0.622 . . . . 0.0 112.255 -179.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 68.2 p -118.42 147.29 43.72 Favored 'General case' 0 C--O 1.244 0.789 0 N-CA-C 109.808 -0.441 . . . . 0.0 109.808 178.239 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 38.9 p -113.35 149.5 33.92 Favored 'General case' 0 C--N 1.309 -1.192 0 C-N-CA 121.223 -0.191 . . . . 0.0 110.751 -178.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 51.5 t -76.42 103.6 6.51 Favored 'General case' 0 C--N 1.312 -1.047 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 178.367 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 68.6 mt-30 -102.78 120.22 40.21 Favored 'General case' 0 N--CA 1.425 -1.679 0 CA-C-O 121.887 0.851 . . . . 0.0 111.363 -178.222 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 95.2 t -83.42 104.94 12.58 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 CA-C-N 114.385 -1.28 . . . . 0.0 109.829 -178.597 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 56.1 mt -85.48 -72.04 0.5 Allowed 'General case' 0 N--CA 1.433 -1.317 0 N-CA-C 107.748 -1.205 . . . . 0.0 107.748 178.599 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 47.7 m-80 -96.31 166.8 13.52 Favored Pre-proline 0 C--N 1.302 -1.468 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 174.321 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -58.78 -42.23 55.22 Favored 'Trans proline' 0 CA--C 1.538 0.696 0 C-N-CA 121.741 1.628 . . . . 0.0 112.336 177.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.523 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 49.0 m-85 -96.49 -25.96 15.47 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 120.029 -0.669 . . . . 0.0 110.562 -177.333 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 75.3 t80 -104.15 114.03 27.99 Favored 'General case' 0 N--CA 1.435 -1.196 0 C-N-CA 119.691 -0.804 . . . . 0.0 111.312 178.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.552 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 15.9 m -135.84 139.99 43.84 Favored 'General case' 0 C--N 1.283 -2.308 0 N-CA-C 105.501 -2.037 . . . . 0.0 105.501 178.883 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.467 ' NE2' ' HA ' ' A' ' 5' ' ' ALA . 19.8 pt20 -135.82 153.83 51.38 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 118.853 0.751 . . . . 0.0 111.564 -175.789 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.744 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 63.7 m -72.58 117.0 13.72 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.527 178.438 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.419 ' HA ' ' CD2' ' A' ' 4' ' ' HIS . 96.5 mt . . . . . 0 C--N 1.289 -2.028 0 N-CA-C 106.802 -1.555 . . . . 0.0 106.802 177.328 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' MAN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 20.3 m . . . . . 0 N--CA 1.436 -1.129 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -74.12 142.97 45.52 Favored 'General case' 0 N--CA 1.438 -1.059 0 CA-C-O 121.296 0.569 . . . . 0.0 110.369 -175.151 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 30.0 t -100.21 172.15 7.35 Favored 'General case' 0 C--N 1.286 -2.166 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.072 -175.398 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . 0.514 ' O ' ' H5 ' ' A' ' 101' ' ' MAN . 18.8 t-80 -59.77 134.27 56.87 Favored 'General case' 0 C--O 1.238 0.48 0 N-CA-C 109.846 -0.428 . . . . 0.0 109.846 177.848 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 79.21 10.78 1.5 Allowed 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.818 1.247 . . . . 0.0 112.351 179.147 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -105.54 162.3 14.33 Favored Glycine 0 N--CA 1.442 -0.925 0 N-CA-C 110.505 -1.038 . . . . 0.0 110.505 176.182 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.601 ' HA ' ' O ' ' A' ' 33' ' ' SER . 53.4 tt0 -82.26 111.62 18.51 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 -179.66 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.74 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 20.7 p -87.36 -35.08 18.57 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 113.469 0.914 . . . . 0.0 113.469 -175.121 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 173.5 80.51 0.05 OUTLIER Glycine 0 CA--C 1.489 -1.559 0 C-N-CA 117.993 -2.051 . . . . 0.0 113.492 -176.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.408 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -112.48 174.11 15.88 Favored Glycine 0 C--N 1.287 -2.163 0 N-CA-C 107.731 -2.148 . . . . 0.0 107.731 174.232 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 74.5 mt -54.93 111.55 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 117.631 0.716 . . . . 0.0 110.211 178.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 114.34 -8.42 22.64 Favored Glycine 0 N--CA 1.437 -1.251 0 C-N-CA 120.606 -0.807 . . . . 0.0 113.405 179.679 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.422 ' HB2' HE21 ' A' ' 7' ' ' GLN . 70.7 t80 -101.36 110.45 22.46 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 179.03 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 4.8 p -107.72 7.02 28.2 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-N 115.83 -0.623 . . . . 0.0 112.042 -177.258 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -83.0 -165.41 37.56 Favored Glycine 0 N--CA 1.444 -0.809 0 CA-C-N 115.486 -0.779 . . . . 0.0 112.268 178.222 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -60.51 111.02 0.9 Allowed 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 123.12 2.546 . . . . 0.0 112.317 -179.46 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.616 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 6.7 p -87.04 -11.17 51.13 Favored 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 113.205 0.817 . . . . 0.0 113.205 -175.69 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 7.5 p -80.87 130.43 35.9 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.91 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.139 179.533 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 77.3 m -91.32 169.0 11.17 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-O 120.873 0.368 . . . . 0.0 110.401 179.25 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -59.81 137.67 57.99 Favored 'General case' 0 N--CA 1.438 -1.073 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 174.496 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 54.1 m -59.99 121.08 10.93 Favored 'General case' 0 N--CA 1.432 -1.37 0 CA-C-O 121.14 0.495 . . . . 0.0 110.095 -179.258 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 112.66 -10.0 25.81 Favored Glycine 0 N--CA 1.439 -1.125 0 N-CA-C 111.018 -0.833 . . . . 0.0 111.018 -175.091 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 68.2 p -121.63 142.97 49.6 Favored 'General case' 0 C--O 1.244 0.812 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 174.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 34.2 p -110.83 139.24 46.31 Favored 'General case' 0 C--N 1.295 -1.803 0 C-N-CA 120.819 -0.352 . . . . 0.0 111.652 -176.537 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 41.3 t -77.63 102.96 7.29 Favored 'General case' 0 C--N 1.312 -1.041 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 179.338 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -106.79 126.53 52.41 Favored 'General case' 0 N--CA 1.421 -1.897 0 C-N-CA 120.541 -0.464 . . . . 0.0 110.832 -178.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 51.5 t -79.21 95.18 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.207 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 179.649 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 77.6 mt -75.21 -69.77 0.46 Allowed 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 -178.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 49.0 m-80 -96.31 163.87 19.71 Favored Pre-proline 0 C--N 1.294 -1.842 0 N-CA-C 106.968 -1.493 . . . . 0.0 106.968 174.676 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -61.7 -33.17 86.53 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 121.374 1.383 . . . . 0.0 112.025 179.517 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.408 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 39.8 m-85 -101.64 -25.18 13.96 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 120.419 -0.512 . . . . 0.0 110.914 -179.18 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 61.5 t80 -106.13 113.78 27.52 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 120.076 -0.65 . . . . 0.0 112.135 178.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.601 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 19.7 m -118.13 143.94 46.08 Favored 'General case' 0 C--N 1.293 -1.855 0 N-CA-C 106.524 -1.658 . . . . 0.0 106.524 174.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.478 HE21 HD21 ' A' ' 36' ' ' LEU . 29.7 tt0 -135.93 141.94 44.56 Favored 'General case' 0 C--N 1.3 -1.563 0 C-N-CA 120.768 -0.373 . . . . 0.0 111.613 -173.769 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.74 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 58.7 m -75.29 116.67 16.26 Favored 'General case' 0 C--O 1.254 1.32 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.02 177.184 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.478 HD21 HE21 ' A' ' 34' ' ' GLN . 96.1 mt . . . . . 0 C--N 1.308 -1.204 0 C-N-CA 124.336 1.054 . . . . 0.0 108.686 178.718 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' MAN . . . . . 0.514 ' H5 ' ' O ' ' A' ' 4' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 12.0 m . . . . . 0 N--CA 1.444 -0.755 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -72.91 140.6 47.6 Favored 'General case' 0 N--CA 1.445 -0.688 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 179.472 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 12.8 m -119.57 179.73 4.13 Favored 'General case' 0 C--N 1.293 -1.887 0 C-N-CA 120.731 -0.388 . . . . 0.0 110.994 -172.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . 0.4 ' HA ' ' O ' ' A' ' 35' ' ' CYS . 51.1 t-80 -50.19 133.78 23.18 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 123.71 0.804 . . . . 0.0 111.811 -177.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 75.98 -0.69 3.1 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 125.26 1.424 . . . . 0.0 112.106 179.453 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -90.5 153.09 22.42 Favored Glycine 0 N--CA 1.428 -1.877 0 N-CA-C 111.145 -0.782 . . . . 0.0 111.145 178.348 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.514 ' HA ' ' O ' ' A' ' 33' ' ' SER . 54.5 tt0 -75.27 114.82 14.24 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 178.465 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.76 ' O ' ' HA ' ' A' ' 17' ' ' THR . 9.8 p -86.61 -48.73 8.07 Favored 'General case' 0 C--O 1.195 -1.805 0 N-CA-C 112.822 0.675 . . . . 0.0 112.822 -177.456 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -177.45 97.69 0.11 Allowed Glycine 0 CA--C 1.479 -2.169 0 C-N-CA 117.536 -2.268 . . . . 0.0 113.604 -173.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.585 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -113.23 178.34 18.57 Favored Glycine 0 C--N 1.28 -2.545 0 N-CA-C 107.582 -2.207 . . . . 0.0 107.582 174.164 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 68.6 mt -61.64 113.18 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.056 0 CA-C-N 117.749 0.774 . . . . 0.0 109.827 178.694 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 95.47 29.81 8.57 Favored Glycine 0 N--CA 1.438 -1.193 0 CA-C-N 116.023 -0.535 . . . . 0.0 113.139 178.039 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 77.6 t80 -114.14 112.15 22.72 Favored 'General case' 0 C--N 1.313 -1.017 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 177.316 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 23.4 p -95.92 -4.29 43.71 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 -176.124 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -76.57 -162.46 14.24 Favored Glycine 0 CA--C 1.532 1.138 0 C-N-CA 121.212 -0.518 . . . . 0.0 112.82 -179.415 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -61.8 112.25 1.43 Allowed 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 123.131 2.554 . . . . 0.0 111.152 178.079 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.76 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 16.2 p -93.21 -15.04 26.35 Favored 'General case' 0 N--CA 1.433 -1.295 0 CA-C-N 115.874 -0.603 . . . . 0.0 112.444 -176.42 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 10.0 p -95.57 139.03 19.73 Favored 'Isoleucine or valine' 0 C--O 1.255 1.382 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 178.719 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 81.1 m -91.61 155.74 18.13 Favored 'General case' 0 C--N 1.291 -1.978 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.935 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -58.86 137.92 57.55 Favored 'General case' 0 C--O 1.25 1.13 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 175.409 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 7.1 p -51.03 124.82 12.2 Favored 'General case' 0 C--N 1.311 -1.094 0 O-C-N 123.864 0.728 . . . . 0.0 111.828 -177.255 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 112.22 -21.05 20.58 Favored Glycine 0 N--CA 1.434 -1.441 0 CA-C-N 115.463 -0.789 . . . . 0.0 111.228 -176.405 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 75.8 p -110.86 149.26 30.85 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 176.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 22.8 p -112.06 142.54 44.36 Favored 'General case' 0 C--N 1.297 -1.698 0 CA-C-N 116.818 -0.173 . . . . 0.0 110.651 -178.196 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 44.3 t -78.6 99.19 6.45 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 176.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 75.4 mt-30 -96.26 119.26 34.42 Favored 'General case' 0 N--CA 1.415 -2.217 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.62 -178.015 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 46.5 t -75.37 102.45 2.6 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 177.114 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 56.5 mt -85.16 -74.51 0.4 Allowed 'General case' 0 N--CA 1.428 -1.55 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 -179.34 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 74.9 m-20 -95.56 166.78 13.95 Favored Pre-proline 0 C--N 1.289 -2.032 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 176.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -59.67 -36.95 90.64 Favored 'Trans proline' 0 CA--C 1.543 0.939 0 C-N-CA 121.89 1.727 . . . . 0.0 112.99 179.723 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.585 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 69.3 m-85 -102.47 -24.34 13.83 Favored 'General case' 0 C--N 1.315 -0.935 0 C-N-CA 120.192 -0.603 . . . . 0.0 110.876 -178.688 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 69.9 t80 -104.71 114.25 28.34 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 112.505 0.557 . . . . 0.0 112.505 179.626 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.514 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 26.7 m -121.67 146.37 47.07 Favored 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 175.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.515 ' OE1' HD21 ' A' ' 36' ' ' LEU . 35.8 tt0 -134.98 142.43 46.47 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-N 118.242 0.474 . . . . 0.0 111.363 -172.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.755 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 77.4 m -77.26 113.39 14.97 Favored 'General case' 0 C--O 1.247 0.949 0 CA-C-O 121.164 0.507 . . . . 0.0 110.117 176.664 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.515 HD21 ' OE1' ' A' ' 34' ' ' GLN . 97.1 mt . . . . . 0 C--N 1.291 -1.952 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.01 -179.005 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' MAN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 33.3 m . . . . . 0 N--CA 1.449 -0.487 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -76.46 149.69 36.78 Favored 'General case' 0 N--CA 1.445 -0.69 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 -174.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 14.2 m -123.67 179.39 4.8 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 -176.267 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 36.9 t-80 -56.16 143.62 32.59 Favored 'General case' 0 C--O 1.239 0.532 0 C-N-CA 123.213 0.605 . . . . 0.0 110.128 178.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 71.91 10.01 6.17 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 124.586 1.155 . . . . 0.0 111.188 -178.3 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -109.76 147.56 17.15 Favored Glycine 0 N--CA 1.422 -2.267 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.392 178.704 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.551 ' HA ' ' O ' ' A' ' 33' ' ' SER . 53.3 tt0 -79.22 115.19 18.72 Favored 'General case' 0 C--N 1.31 -1.138 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 178.22 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.656 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 7.0 p -88.16 -45.7 9.9 Favored 'General case' 0 C--N 1.285 -2.219 0 CA-C-N 115.648 -0.706 . . . . 0.0 112.86 -176.159 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -171.89 91.6 0.09 OUTLIER Glycine 0 N--CA 1.428 -1.875 0 C-N-CA 118.152 -1.975 . . . . 0.0 113.968 -174.171 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.436 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -112.74 178.27 18.75 Favored Glycine 0 N--CA 1.427 -1.955 0 N-CA-C 108.341 -1.904 . . . . 0.0 108.341 175.036 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 85.5 mt -60.01 113.33 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.074 0 CA-C-N 117.526 0.663 . . . . 0.0 111.377 179.199 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 94.57 13.04 55.03 Favored Glycine 0 N--CA 1.434 -1.457 0 CA-C-N 115.233 -0.894 . . . . 0.0 112.878 177.475 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 57.1 t80 -96.72 113.15 24.69 Favored 'General case' 0 N--CA 1.442 -0.835 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 179.415 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 11.2 p -107.3 21.26 17.78 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-O 121.681 0.753 . . . . 0.0 111.981 -177.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -94.23 -154.18 30.8 Favored Glycine 0 C--N 1.298 -1.546 0 C-N-CA 120.626 -0.797 . . . . 0.0 111.402 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -70.39 107.11 1.91 Allowed 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 122.329 2.019 . . . . 0.0 111.374 178.76 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.622 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 9.8 p -87.22 -18.17 30.91 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-N 115.415 -0.811 . . . . 0.0 111.99 -177.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 12.0 p -88.15 129.85 38.7 Favored 'Isoleucine or valine' 0 C--O 1.25 1.115 0 CA-C-O 121.177 0.513 . . . . 0.0 110.509 178.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 82.1 m -93.36 148.48 22.01 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.987 -179.638 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -59.74 147.13 38.96 Favored 'General case' 0 C--O 1.247 0.96 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.323 177.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 9.7 t -54.12 126.5 23.02 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.054 -178.033 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 112.44 -18.17 23.13 Favored Glycine 0 N--CA 1.438 -1.167 0 N-CA-C 110.716 -0.953 . . . . 0.0 110.716 -175.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 57.7 p -127.19 146.2 50.49 Favored 'General case' 0 N--CA 1.443 -0.802 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 176.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 16.4 p -120.97 143.11 49.19 Favored 'General case' 0 C--N 1.296 -1.73 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 178.248 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 42.0 t -69.74 105.38 2.72 Favored 'General case' 0 C--N 1.309 -1.163 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 178.153 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 68.5 mt-30 -107.41 119.01 38.24 Favored 'General case' 0 N--CA 1.423 -1.816 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 179.295 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 52.8 t -75.22 119.41 22.87 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 CA-C-N 115.298 -0.864 . . . . 0.0 108.752 -179.241 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 76.6 mt -100.81 -69.48 0.77 Allowed 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 179.782 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 88.7 m-20 -95.48 166.66 14.22 Favored Pre-proline 0 C--N 1.304 -1.381 0 N-CA-C 106.782 -1.562 . . . . 0.0 106.782 173.104 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -63.6 -27.15 69.31 Favored 'Trans proline' 0 CA--C 1.534 0.476 0 C-N-CA 121.089 1.193 . . . . 0.0 111.858 177.275 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.436 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 55.8 m-85 -105.55 -26.03 12.06 Favored 'General case' 0 N--CA 1.443 -0.795 0 C-N-CA 119.789 -0.765 . . . . 0.0 110.716 -179.242 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 68.2 t80 -105.28 114.24 28.3 Favored 'General case' 0 N--CA 1.439 -1.0 0 C-N-CA 119.748 -0.781 . . . . 0.0 112.061 178.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.551 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 19.3 m -126.65 134.56 50.71 Favored 'General case' 0 C--N 1.283 -2.315 0 N-CA-C 105.766 -1.939 . . . . 0.0 105.766 176.206 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 7.7 tt0 -122.05 146.92 46.72 Favored 'General case' 0 C--N 1.303 -1.422 0 C-N-CA 120.268 -0.573 . . . . 0.0 110.567 -175.055 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.656 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 85.8 m -73.35 104.9 4.52 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 172.798 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 95.8 mt . . . . . 0 C--N 1.296 -1.743 0 C-N-CA 123.993 0.917 . . . . 0.0 108.649 -177.86 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' MAN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 22.7 p . . . . . 0 N--CA 1.442 -0.868 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -82.72 134.9 35.13 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 179.738 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 39.4 m -81.09 178.33 8.48 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-O 121.145 0.498 . . . . 0.0 110.906 -178.462 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 55.1 t-80 -63.67 133.35 53.47 Favored 'General case' 0 N--CA 1.444 -0.754 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 175.098 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 65.15 75.66 0.36 Allowed 'General case' 0 C--N 1.322 -0.59 0 O-C-N 124.356 1.035 . . . . 0.0 110.76 -177.502 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.493 ' O ' ' HA ' ' A' ' 34' ' ' GLN . . . -165.75 152.36 21.61 Favored Glycine 0 N--CA 1.42 -2.425 0 N-CA-C 108.454 -1.858 . . . . 0.0 108.454 178.557 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.604 ' HA ' ' O ' ' A' ' 33' ' ' SER . 52.7 tt0 -76.97 111.24 12.3 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 117.486 0.643 . . . . 0.0 110.049 -178.286 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.783 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 2.4 p -86.13 -41.58 14.6 Favored 'General case' 0 C--N 1.296 -1.758 0 CA-C-N 115.2 -0.909 . . . . 0.0 112.66 -177.429 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.402 ' HA2' ' HB3' ' A' ' 13' ' ' TYR . . . 169.76 101.68 0.15 Allowed Glycine 0 N--CA 1.423 -2.172 0 C-N-CA 117.895 -2.098 . . . . 0.0 113.778 -177.656 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -112.52 -160.51 14.98 Favored Glycine 0 N--CA 1.422 -2.265 0 N-CA-C 108.157 -1.977 . . . . 0.0 108.157 174.527 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 76.8 mt -65.91 109.69 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 CA-C-N 117.706 0.753 . . . . 0.0 110.994 177.547 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 95.13 20.63 27.4 Favored Glycine 0 N--CA 1.441 -1.027 0 C-N-CA 121.022 -0.608 . . . . 0.0 113.853 175.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.402 ' HB3' ' HA2' ' A' ' 9' ' ' GLY . 53.1 t80 -114.16 112.08 22.6 Favored 'General case' 0 C--N 1.31 -1.129 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 178.476 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 10.3 p -109.68 18.92 19.75 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-O 121.365 0.602 . . . . 0.0 111.662 -177.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -82.18 -150.79 8.73 Favored Glycine 0 N--CA 1.446 -0.688 0 CA-C-O 119.259 -0.745 . . . . 0.0 111.431 179.629 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -66.61 93.9 0.32 Allowed 'Trans proline' 0 CA--C 1.535 0.541 0 C-N-CA 122.158 1.905 . . . . 0.0 111.912 178.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.578 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 17.3 p -83.34 -13.59 54.73 Favored 'General case' 0 C--O 1.251 1.156 0 CA-C-O 121.905 0.86 . . . . 0.0 111.058 -177.533 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 4.7 p -92.9 121.64 43.74 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.56 0 CA-C-N 114.625 -1.17 . . . . 0.0 110.033 177.783 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 65.5 m -86.07 153.2 22.28 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 179.084 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -68.56 163.87 22.6 Favored 'General case' 0 C--O 1.26 1.64 0 CA-C-O 120.712 0.291 . . . . 0.0 111.062 178.599 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 28.1 m -47.49 115.91 1.27 Allowed 'General case' 0 C--O 1.248 1.004 0 C-N-CA 124.667 1.187 . . . . 0.0 113.276 -176.381 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 108.37 -20.83 29.7 Favored Glycine 0 N--CA 1.437 -1.282 0 CA-C-N 115.482 -0.781 . . . . 0.0 113.407 175.236 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 21.2 p -106.7 146.03 31.3 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 122.214 -0.58 . . . . 0.0 111.702 -178.251 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 14.5 p -118.92 147.65 43.79 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.558 -178.327 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 43.4 t -77.88 100.3 6.32 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-O 121.225 0.536 . . . . 0.0 109.644 -179.466 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 85.1 mm-40 -90.72 119.68 31.15 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.844 -179.063 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 46.7 t -83.76 108.71 16.47 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 -179.056 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 81.4 mt -95.03 -68.46 0.8 Allowed 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 -179.668 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.441 ' HB2' ' HB3' ' A' ' 32' ' ' TYR . 45.6 m-80 -95.61 166.82 13.83 Favored Pre-proline 0 C--N 1.296 -1.745 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 175.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -61.28 -37.91 69.62 Favored 'Trans proline' 0 C--N 1.349 0.558 0 C-N-CA 121.204 1.269 . . . . 0.0 111.009 178.624 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 49.4 m-85 -96.63 -25.03 15.73 Favored 'General case' 0 N--CA 1.441 -0.921 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.817 -178.703 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.441 ' HB3' ' HB2' ' A' ' 29' ' ' ASN . 48.9 t80 -104.6 113.43 27.0 Favored 'General case' 0 C--N 1.315 -0.898 0 C-N-CA 118.977 -1.089 . . . . 0.0 111.314 -177.506 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.604 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 26.6 m -124.68 137.91 54.33 Favored 'General case' 0 C--N 1.286 -2.193 0 N-CA-C 105.906 -1.887 . . . . 0.0 105.906 176.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.493 ' HA ' ' O ' ' A' ' 6' ' ' GLY . 30.1 tt0 -131.47 136.21 47.74 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -173.243 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.783 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 85.5 m -70.2 110.56 5.26 Favored 'General case' 0 C--O 1.245 0.831 0 CA-C-O 121.263 0.554 . . . . 0.0 110.937 177.3 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 95.8 mt . . . . . 0 C--N 1.294 -1.817 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 179.059 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' MAN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 28.4 m . . . . . 0 N--CA 1.44 -0.929 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -84.23 134.26 34.55 Favored 'General case' 0 N--CA 1.44 -0.943 0 C-N-CA 119.782 -0.767 . . . . 0.0 109.221 -179.537 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.411 ' HB2' ' H2 ' ' A' ' 101' ' ' MAN . 27.7 t -91.95 -178.08 4.91 Favored 'General case' 0 C--N 1.297 -1.695 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.457 -175.582 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 16.8 t-80 -63.43 118.07 7.59 Favored 'General case' 0 N--CA 1.445 -0.691 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 71.83 91.36 0.09 Allowed 'General case' 0 C--O 1.24 0.576 0 C-N-CA 124.62 1.168 . . . . 0.0 111.141 -174.431 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.583 ' O ' ' HA ' ' A' ' 34' ' ' GLN . . . -177.4 163.68 32.42 Favored Glycine 0 N--CA 1.43 -1.766 0 N-CA-C 107.121 -2.392 . . . . 0.0 107.121 179.801 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.625 ' HA ' ' O ' ' A' ' 33' ' ' SER . 53.3 tt0 -84.31 113.47 21.16 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 118.52 1.16 . . . . 0.0 109.608 -178.745 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.766 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 7.4 p -95.17 -36.6 11.41 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 113.248 0.833 . . . . 0.0 113.248 -176.594 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -164.72 66.02 0.22 Allowed Glycine 0 CA--C 1.478 -2.234 0 C-N-CA 118.523 -1.799 . . . . 0.0 112.345 -176.236 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.538 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -110.15 157.04 15.27 Favored Glycine 0 C--N 1.285 -2.284 0 N-CA-C 108.764 -1.734 . . . . 0.0 108.764 177.324 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 69.0 mt -57.49 115.96 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 CA-C-N 117.32 0.56 . . . . 0.0 110.962 -177.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 114.13 -9.66 22.77 Favored Glycine 0 N--CA 1.451 -0.366 0 CA-C-N 116.022 -0.536 . . . . 0.0 112.027 -179.522 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 91.8 t80 -93.55 120.64 34.07 Favored 'General case' 0 C--N 1.311 -1.072 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 179.008 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 12.4 p -111.5 4.55 18.9 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 112.103 0.409 . . . . 0.0 112.103 -176.088 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -82.73 -160.51 28.52 Favored Glycine 0 CA--C 1.528 0.844 0 C-N-CA 121.127 -0.559 . . . . 0.0 112.525 179.687 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -72.87 126.3 11.19 Favored 'Trans proline' 0 CA--C 1.512 -0.62 0 C-N-CA 122.286 1.991 . . . . 0.0 111.175 179.143 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.569 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 21.7 p -85.1 -14.51 46.92 Favored 'General case' 0 C--N 1.295 -1.804 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.357 -177.155 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 12.3 p -75.42 132.8 32.62 Favored 'Isoleucine or valine' 0 C--O 1.257 1.469 0 CA-C-O 121.794 0.807 . . . . 0.0 111.426 -177.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 80.5 m -93.86 167.78 11.4 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-N 114.886 -1.052 . . . . 0.0 110.182 179.219 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.13 140.89 58.25 Favored 'General case' 0 C--N 1.308 -1.196 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 175.244 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 34.6 t -55.29 125.71 21.86 Favored 'General case' 0 C--N 1.312 -1.04 0 O-C-N 123.504 0.502 . . . . 0.0 109.961 -179.719 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 112.56 -20.68 20.29 Favored Glycine 0 N--CA 1.439 -1.141 0 N-CA-C 110.662 -0.975 . . . . 0.0 110.662 -175.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 72.7 p -114.89 157.54 23.19 Favored 'General case' 0 C--N 1.311 -1.074 0 O-C-N 122.293 -0.534 . . . . 0.0 109.665 177.572 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 16.6 p -126.02 148.98 49.16 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 110.089 -0.338 . . . . 0.0 110.089 177.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 53.2 t -76.63 100.88 5.5 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 62.0 mt-30 -101.0 114.99 29.43 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-O 121.122 0.486 . . . . 0.0 110.384 -178.154 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 48.2 t -71.33 116.51 13.13 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.252 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 178.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 78.6 mt -101.15 -68.69 0.8 Allowed 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 -178.72 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.454 ' HB2' ' H ' ' A' ' 32' ' ' TYR . 80.7 m-20 -95.38 166.07 15.48 Favored Pre-proline 0 C--N 1.301 -1.541 0 N-CA-C 106.915 -1.513 . . . . 0.0 106.915 174.657 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_exo -62.6 -27.41 76.36 Favored 'Trans proline' 0 CA--C 1.536 0.583 0 C-N-CA 121.531 1.487 . . . . 0.0 111.622 176.616 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.538 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 88.1 m-85 -105.31 -25.31 12.46 Favored 'General case' 0 N--CA 1.443 -0.798 0 C-N-CA 120.135 -0.626 . . . . 0.0 111.518 179.254 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.454 ' H ' ' HB2' ' A' ' 29' ' ' ASN . 44.7 t80 -105.87 113.73 27.45 Favored 'General case' 0 C--N 1.311 -1.074 0 C-N-CA 119.548 -0.861 . . . . 0.0 112.033 179.8 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.625 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 16.9 m -120.24 135.01 55.13 Favored 'General case' 0 C--N 1.291 -1.953 0 N-CA-C 105.759 -1.941 . . . . 0.0 105.759 175.134 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.583 ' HA ' ' O ' ' A' ' 6' ' ' GLY . 28.1 tt0 -127.79 138.15 52.64 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 112.694 0.627 . . . . 0.0 112.694 -171.466 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.766 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 68.9 m -71.91 109.9 6.07 Favored 'General case' 0 C--O 1.251 1.158 0 CA-C-O 120.979 0.419 . . . . 0.0 111.073 176.875 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 94.3 mt . . . . . 0 N--CA 1.431 -1.398 0 N-CA-C 107.275 -1.38 . . . . 0.0 107.275 178.762 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' MAN . . . . . 0.411 ' H2 ' ' HB2' ' A' ' 3' ' ' SER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 23.1 m . . . . . 0 C--O 1.248 1.014 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -77.87 153.21 32.88 Favored 'General case' 0 N--CA 1.446 -0.637 0 C-N-CA 123.268 0.627 . . . . 0.0 109.504 -176.21 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 67.7 m -127.31 -170.45 2.22 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 111.602 0.223 . . . . 0.0 111.602 -177.052 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . 0.448 ' HA ' ' O ' ' A' ' 35' ' ' CYS . 37.0 t-80 -60.13 136.64 58.09 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 122.718 0.407 . . . . 0.0 110.936 -173.363 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.473 ' HA ' ' CD ' ' A' ' 34' ' ' GLN . . . 74.4 8.76 4.47 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 124.143 0.977 . . . . 0.0 111.953 -179.814 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.426 ' O ' ' HA ' ' A' ' 34' ' ' GLN . . . -103.92 151.29 17.62 Favored Glycine 0 N--CA 1.431 -1.65 0 N-CA-C 111.386 -0.686 . . . . 0.0 111.386 178.537 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.612 ' HA ' ' O ' ' A' ' 33' ' ' SER . 54.3 tt0 -77.98 114.43 16.84 Favored 'General case' 0 CA--C 1.502 -0.883 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 178.608 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.705 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 8.0 p -94.27 -43.74 8.29 Favored 'General case' 0 C--N 1.288 -2.077 0 N-CA-C 113.549 0.944 . . . . 0.0 113.549 -175.64 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.449 ' H ' ' HB2' ' A' ' 33' ' ' SER . . . -159.38 69.75 0.25 Allowed Glycine 0 CA--C 1.481 -2.046 0 C-N-CA 118.541 -1.79 . . . . 0.0 112.765 -172.204 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.571 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -112.42 153.63 17.32 Favored Glycine 0 C--N 1.279 -2.584 0 N-CA-C 109.307 -1.517 . . . . 0.0 109.307 178.217 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.429 ' HB ' ' CD1' ' A' ' 31' ' ' TYR . 72.6 mt -56.24 123.89 8.38 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 O-C-N 123.974 0.455 . . . . 0.0 109.909 179.721 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 108.02 -15.27 36.93 Favored Glycine 0 N--CA 1.442 -0.9 0 N-CA-C 111.074 -0.81 . . . . 0.0 111.074 -179.218 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 80.1 t80 -101.78 109.7 21.53 Favored 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 178.602 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 13.5 p -107.68 7.34 28.44 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 112.381 0.511 . . . . 0.0 112.381 -176.629 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -82.41 -152.9 11.28 Favored Glycine 0 CA--C 1.53 0.978 0 CA-C-N 116.071 -0.513 . . . . 0.0 113.079 -179.547 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -64.49 112.25 1.88 Allowed 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 122.993 2.462 . . . . 0.0 112.294 -179.146 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.581 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 14.1 p -95.28 -4.73 45.1 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 115.375 -0.83 . . . . 0.0 113.022 -176.113 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 9.2 p -89.76 127.59 42.28 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.998 0 CA-C-O 120.896 0.379 . . . . 0.0 110.84 -178.648 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.471 ' SG ' ' HB2' ' A' ' 25' ' ' CYS . 72.9 m -87.91 154.1 20.79 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.167 178.789 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.72 143.4 57.46 Favored 'General case' 0 N--CA 1.438 -1.07 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.25 175.528 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.2 p -62.4 127.82 33.11 Favored 'General case' 0 C--N 1.297 -1.688 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.658 -179.15 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 112.5 -5.07 26.41 Favored Glycine 0 N--CA 1.438 -1.172 0 N-CA-C 110.727 -0.949 . . . . 0.0 110.727 -174.141 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 49.3 p -136.26 145.0 45.1 Favored 'General case' 0 C--O 1.239 0.547 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 174.586 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 46.4 p -112.1 145.01 40.51 Favored 'General case' 0 C--N 1.305 -1.338 0 C-N-CA 120.884 -0.326 . . . . 0.0 110.139 -179.518 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.471 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 43.6 t -79.28 97.63 6.35 Favored 'General case' 0 C--N 1.31 -1.144 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 -179.706 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 72.1 mt-30 -93.74 114.75 27.1 Favored 'General case' 0 N--CA 1.424 -1.767 0 CA-C-O 121.303 0.573 . . . . 0.0 110.716 -177.738 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 48.1 t -76.76 95.12 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 CA-C-N 114.798 -1.092 . . . . 0.0 108.404 177.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 87.7 mt -78.23 -70.91 0.46 Allowed 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 -179.388 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 75.2 m-20 -95.36 166.72 14.17 Favored Pre-proline 0 C--N 1.296 -1.738 0 N-CA-C 106.644 -1.613 . . . . 0.0 106.644 174.66 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_exo -62.95 -35.66 65.17 Favored 'Trans proline' 0 C--O 1.246 0.915 0 C-N-CA 121.171 1.247 . . . . 0.0 111.441 176.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.571 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 73.2 m-85 -97.41 -26.33 14.9 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 120.411 -0.516 . . . . 0.0 111.056 -178.639 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 68.8 t80 -105.68 114.09 28.04 Favored 'General case' 0 C--N 1.311 -1.09 0 C-N-CA 119.879 -0.728 . . . . 0.0 112.512 177.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.612 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 18.6 m -127.01 135.88 51.45 Favored 'General case' 0 C--N 1.295 -1.79 0 N-CA-C 106.45 -1.685 . . . . 0.0 106.45 175.841 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.473 ' CD ' ' HA ' ' A' ' 5' ' ' ALA . 7.9 tt0 -126.22 141.41 51.93 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-N 117.975 0.352 . . . . 0.0 111.022 -174.476 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.705 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 60.3 m -73.55 109.98 7.48 Favored 'General case' 0 C--O 1.253 1.25 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 174.075 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 87.4 mt . . . . . 0 C--N 1.289 -2.036 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 179.503 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' MAN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 19.6 p . . . . . 0 C--O 1.249 1.051 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -85.65 147.75 26.22 Favored 'General case' 0 N--CA 1.436 -1.144 0 N-CA-C 107.767 -1.198 . . . . 0.0 107.767 178.592 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 33.4 t -114.82 179.32 3.98 Favored 'General case' 0 C--N 1.288 -2.088 0 C-N-CA 120.642 -0.423 . . . . 0.0 111.425 -173.538 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 57.4 t-80 -58.15 137.04 57.31 Favored 'General case' 0 CA--C 1.519 -0.243 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 -178.642 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 78.21 -3.69 2.29 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 124.858 1.263 . . . . 0.0 112.059 179.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -90.15 141.91 16.19 Favored Glycine 0 N--CA 1.426 -1.997 0 N-CA-C 110.76 -0.936 . . . . 0.0 110.76 178.313 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.599 ' HA ' ' O ' ' A' ' 33' ' ' SER . 54.0 tt0 -69.26 113.55 6.71 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 176.425 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.719 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 10.5 p -86.29 -40.83 15.11 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 112.764 0.654 . . . . 0.0 112.764 -176.178 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 177.4 93.25 0.09 OUTLIER Glycine 0 CA--C 1.488 -1.653 0 C-N-CA 117.788 -2.148 . . . . 0.0 113.847 -176.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.509 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -112.01 174.85 16.74 Favored Glycine 0 C--N 1.286 -2.238 0 N-CA-C 107.519 -2.232 . . . . 0.0 107.519 174.755 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 65.2 mt -60.55 113.25 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.139 0 CA-C-N 117.912 0.856 . . . . 0.0 109.469 178.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 113.8 -20.09 17.89 Favored Glycine 0 N--CA 1.438 -1.229 0 C-N-CA 121.1 -0.571 . . . . 0.0 112.165 179.206 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 71.0 t80 -81.35 118.97 23.1 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-O 121.038 0.447 . . . . 0.0 110.425 -176.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 11.7 p -102.58 5.79 39.45 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 113.055 0.761 . . . . 0.0 113.055 -175.175 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -87.89 -157.04 31.22 Favored Glycine 0 CA--C 1.524 0.628 0 C-N-CA 120.703 -0.761 . . . . 0.0 113.275 -175.262 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -70.7 113.16 3.44 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.637 2.225 . . . . 0.0 111.805 -179.586 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.628 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 18.5 p -89.04 -3.41 58.7 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.847 -177.36 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 4.0 p -98.91 120.82 48.75 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.953 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.859 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 63.1 m -85.74 164.27 17.71 Favored 'General case' 0 C--N 1.299 -1.621 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.48 179.448 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.42 146.0 55.04 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 174.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 46.1 m -61.67 130.74 47.28 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 178.049 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 112.36 -13.12 25.85 Favored Glycine 0 C--N 1.309 -0.962 0 N-CA-C 110.384 -1.086 . . . . 0.0 110.384 -173.482 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 65.0 p -127.57 155.27 44.09 Favored 'General case' 0 C--O 1.248 0.986 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 175.229 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 33.8 p -120.6 143.26 48.74 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 177.331 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 52.7 t -74.53 99.6 3.64 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 176.644 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 -97.82 119.68 36.85 Favored 'General case' 0 N--CA 1.425 -1.717 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 -177.722 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 43.1 t -77.86 93.88 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 178.091 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 82.7 mt -74.96 -70.77 0.39 Allowed 'General case' 0 C--N 1.306 -1.297 0 CA-C-N 115.278 -0.874 . . . . 0.0 109.092 -177.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 52.1 m-80 -95.58 165.91 15.7 Favored Pre-proline 0 C--N 1.295 -1.802 0 N-CA-C 106.206 -1.776 . . . . 0.0 106.206 174.006 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -63.43 -30.46 72.28 Favored 'Trans proline' 0 C--O 1.239 0.543 0 C-N-CA 121.376 1.384 . . . . 0.0 111.287 178.796 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.509 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 55.4 m-85 -103.15 -25.71 13.28 Favored 'General case' 0 N--CA 1.438 -1.073 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.464 -179.754 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 40.6 t80 -106.03 114.2 28.2 Favored 'General case' 0 C--N 1.317 -0.843 0 C-N-CA 119.413 -0.915 . . . . 0.0 111.562 178.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.599 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 15.4 m -121.03 141.04 51.12 Favored 'General case' 0 C--N 1.294 -1.824 0 N-CA-C 106.485 -1.672 . . . . 0.0 106.485 176.271 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -136.04 140.93 44.21 Favored 'General case' 0 C--N 1.297 -1.699 0 CA-C-N 118.053 0.388 . . . . 0.0 111.047 -172.623 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.719 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 66.7 m -73.17 111.24 8.1 Favored 'General case' 0 C--O 1.257 1.488 0 CA-C-O 121.108 0.48 . . . . 0.0 110.369 177.63 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 82.2 mt . . . . . 0 C--N 1.303 -1.443 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 -179.844 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' MAN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 25.5 m . . . . . 0 C--O 1.225 -0.205 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.438 ' O ' ' HA ' ' A' ' 19' ' ' CYS . 8.2 tp-100 -80.63 134.07 35.83 Favored 'General case' 0 N--CA 1.442 -0.832 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 178.781 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.413 ' O ' ' HB2' ' A' ' 35' ' ' CYS . 69.7 m -126.06 -165.62 1.46 Allowed 'General case' 0 C--N 1.276 -2.621 0 C-N-CA 120.99 -0.284 . . . . 0.0 111.518 -174.774 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 56.8 t-80 -50.3 130.58 23.35 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 113.647 0.98 . . . . 0.0 113.647 -172.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 71.52 12.06 6.52 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 114.275 -1.33 . . . . 0.0 112.649 175.671 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.442 ' O ' ' HA ' ' A' ' 34' ' ' GLN . . . -100.15 165.57 19.66 Favored Glycine 0 N--CA 1.433 -1.5 0 N-CA-C 110.846 -0.902 . . . . 0.0 110.846 176.225 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.525 ' HA ' ' O ' ' A' ' 33' ' ' SER . 54.0 tt0 -87.82 112.35 22.36 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 110.245 -0.28 . . . . 0.0 110.245 -177.562 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.772 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 14.6 p -83.03 -41.94 18.08 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 112.383 0.512 . . . . 0.0 112.383 -178.226 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 165.14 101.42 0.16 Allowed Glycine 0 CA--C 1.483 -1.923 0 C-N-CA 117.624 -2.227 . . . . 0.0 114.265 -178.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -112.63 -169.98 17.92 Favored Glycine 0 N--CA 1.423 -2.199 0 N-CA-C 107.489 -2.244 . . . . 0.0 107.489 173.4 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 70.3 mt -62.09 122.86 13.73 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.34 0 CA-C-N 117.815 0.807 . . . . 0.0 110.21 179.156 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 99.02 -5.27 59.36 Favored Glycine 0 N--CA 1.444 -0.814 0 C-N-CA 120.834 -0.698 . . . . 0.0 113.24 175.753 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 69.4 t80 -94.38 113.79 25.72 Favored 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 27.0 p -106.41 -1.18 23.52 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 116.317 -0.402 . . . . 0.0 112.039 -176.736 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -76.02 -156.7 6.54 Favored Glycine 0 CA--C 1.526 0.728 0 CA-C-N 116.121 -0.49 . . . . 0.0 113.195 -178.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -63.62 106.79 0.64 Allowed 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 122.568 2.179 . . . . 0.0 111.885 -179.662 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.676 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 4.2 p -95.51 15.14 20.52 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-N 115.401 -0.818 . . . . 0.0 112.377 -176.132 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 7.1 p -112.13 126.76 69.56 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.627 -179.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.467 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 80.1 m -88.01 150.2 23.56 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 115.652 -0.704 . . . . 0.0 109.163 177.078 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.449 ' HB2' ' H2 ' ' A' ' 101' ' ' MAN . . . -69.14 153.34 43.88 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 177.509 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 24.6 m -55.97 128.43 35.2 Favored 'General case' 0 N--CA 1.435 -1.184 0 CA-C-O 121.336 0.589 . . . . 0.0 110.705 -179.677 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 111.97 -18.12 24.27 Favored Glycine 0 N--CA 1.432 -1.576 0 N-CA-C 110.927 -0.869 . . . . 0.0 110.927 -177.095 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 68.6 p -121.54 146.73 46.65 Favored 'General case' 0 N--CA 1.441 -0.886 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 178.118 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 34.2 p -114.85 144.04 44.16 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.07 179.306 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 52.9 t -78.62 106.3 10.5 Favored 'General case' 0 C--N 1.308 -1.2 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 178.607 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -111.08 130.56 55.57 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.179 -178.35 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 43.2 t -87.71 114.45 26.55 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.831 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 -177.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 86.4 mt -92.94 -72.72 0.59 Allowed 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 179.282 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 84.3 m-20 -93.63 163.23 25.04 Favored Pre-proline 0 C--N 1.305 -1.341 0 N-CA-C 106.322 -1.733 . . . . 0.0 106.322 175.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -58.07 -35.28 98.87 Favored 'Trans proline' 0 CA--C 1.534 0.477 0 C-N-CA 121.626 1.551 . . . . 0.0 111.55 179.63 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 90.3 m-85 -97.69 -25.04 15.23 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.671 -179.47 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 65.9 t80 -105.48 114.43 28.61 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 119.937 -0.705 . . . . 0.0 112.714 -179.579 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.525 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 19.9 m -119.21 143.95 46.98 Favored 'General case' 0 C--N 1.295 -1.791 0 N-CA-C 106.962 -1.496 . . . . 0.0 106.962 174.515 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.442 ' HA ' ' O ' ' A' ' 6' ' ' GLY . 35.2 tt0 -129.96 143.62 50.9 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 111.941 0.349 . . . . 0.0 111.941 -171.478 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.772 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 86.0 m -82.0 111.07 17.83 Favored 'General case' 0 C--O 1.252 1.221 0 CA-C-O 121.169 0.509 . . . . 0.0 109.892 176.345 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 96.1 mt . . . . . 0 C--N 1.298 -1.674 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.646 179.586 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' MAN . . . . . 0.449 ' H2 ' ' HB2' ' A' ' 20' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 7.8 m . . . . . 0 N--CA 1.438 -1.066 0 N-CA-C 108.072 -1.085 . . . . 0.0 108.072 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 41.1 tp60 -83.66 118.09 23.63 Favored 'General case' 0 N--CA 1.432 -1.374 0 CA-C-O 121.479 0.657 . . . . 0.0 109.733 -177.543 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 58.3 p -78.11 168.47 19.81 Favored 'General case' 0 C--N 1.293 -1.878 0 CA-C-N 115.316 -0.856 . . . . 0.0 112.161 -175.031 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 50.0 t-80 -57.21 137.51 55.84 Favored 'General case' 0 C--O 1.238 0.465 0 N-CA-C 109.141 -0.688 . . . . 0.0 109.141 176.018 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 72.19 15.48 5.4 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 123.784 0.834 . . . . 0.0 111.407 -179.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -105.98 160.98 14.51 Favored Glycine 0 N--CA 1.432 -1.574 0 N-CA-C 110.26 -1.136 . . . . 0.0 110.26 174.533 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.59 ' HA ' ' O ' ' A' ' 33' ' ' SER . 53.5 tt0 -80.68 109.91 15.67 Favored 'General case' 0 C--O 1.21 -0.988 0 CA-C-N 116.869 0.334 . . . . 0.0 110.331 -178.599 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.791 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 23.5 p -84.62 -15.36 45.81 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -177.188 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.426 ' HA2' ' CD1' ' A' ' 13' ' ' TYR . . . 135.14 100.69 0.65 Allowed Glycine 0 N--CA 1.42 -2.423 0 C-N-CA 117.72 -2.181 . . . . 0.0 115.253 176.119 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -112.23 -171.15 18.53 Favored Glycine 0 N--CA 1.423 -2.221 0 N-CA-C 106.991 -2.444 . . . . 0.0 106.991 172.048 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 77.7 mt -58.39 113.81 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.994 0 CA-C-N 117.946 0.873 . . . . 0.0 110.443 179.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 114.02 -16.87 20.26 Favored Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.964 -0.636 . . . . 0.0 113.028 177.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.426 ' CD1' ' HA2' ' A' ' 9' ' ' GLY . 66.3 t80 -94.36 129.06 41.21 Favored 'General case' 0 C--N 1.312 -1.046 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 -179.159 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 11.4 p -131.58 14.31 4.95 Favored 'General case' 0 C--O 1.248 0.997 0 N-CA-C 112.981 0.734 . . . . 0.0 112.981 -174.858 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -90.93 -140.73 8.92 Favored Glycine 0 C--N 1.309 -0.967 0 C-N-CA 121.19 -0.529 . . . . 0.0 111.958 178.713 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -66.14 108.97 1.43 Allowed 'Trans proline' 0 N--CA 1.46 -0.484 0 C-N-CA 122.317 2.011 . . . . 0.0 111.659 -179.411 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.474 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 17.5 p -97.06 -3.49 41.26 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-N 115.696 -0.683 . . . . 0.0 111.747 -178.817 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 7.2 p -90.28 125.09 43.16 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.941 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.933 178.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 84.8 m -84.4 161.95 20.16 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 115.699 -0.682 . . . . 0.0 112.055 -179.858 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.83 160.18 28.85 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 115.098 -0.955 . . . . 0.0 110.79 178.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 31.1 m -54.06 116.29 2.5 Favored 'General case' 0 C--N 1.31 -1.147 0 C-N-CA 124.058 0.943 . . . . 0.0 111.989 -179.062 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 105.86 -19.09 39.13 Favored Glycine 0 N--CA 1.435 -1.425 0 CA-C-N 115.779 -0.646 . . . . 0.0 112.237 178.224 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 74.9 p -106.91 145.15 32.55 Favored 'General case' 0 C--N 1.309 -1.181 0 O-C-N 122.252 -0.558 . . . . 0.0 110.813 -177.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 22.2 p -114.96 152.15 32.86 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 110.079 -0.341 . . . . 0.0 110.079 178.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 50.8 t -77.98 106.02 9.56 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 178.706 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 68.4 mt-30 -108.45 123.88 49.55 Favored 'General case' 0 N--CA 1.429 -1.49 0 CA-C-O 121.11 0.481 . . . . 0.0 109.792 -179.571 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 55.0 t -80.58 111.53 17.42 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.239 -177.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 86.6 mt -91.67 -70.06 0.71 Allowed 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 179.688 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.456 ' HB2' ' H ' ' A' ' 32' ' ' TYR . 51.2 m-20 -94.58 163.99 21.14 Favored Pre-proline 0 C--N 1.299 -1.612 0 N-CA-C 105.814 -1.921 . . . . 0.0 105.814 176.109 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_exo -62.39 -26.44 76.79 Favored 'Trans proline' 0 CA--C 1.539 0.744 0 C-N-CA 121.539 1.493 . . . . 0.0 111.798 178.25 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 41.8 m-85 -108.47 -25.26 11.03 Favored 'General case' 0 N--CA 1.444 -0.742 0 C-N-CA 120.216 -0.594 . . . . 0.0 111.11 -177.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.456 ' H ' ' HB2' ' A' ' 29' ' ' ASN . 78.6 t80 -105.58 113.96 27.83 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 120.915 0.388 . . . . 0.0 111.888 177.702 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.59 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 24.8 m -116.3 143.43 45.55 Favored 'General case' 0 C--N 1.285 -2.212 0 N-CA-C 106.426 -1.694 . . . . 0.0 106.426 175.753 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -129.4 140.04 51.47 Favored 'General case' 0 C--N 1.303 -1.434 0 CA-C-N 118.269 0.486 . . . . 0.0 111.379 -173.248 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.791 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 74.9 m -74.84 112.56 11.17 Favored 'General case' 0 C--O 1.256 1.4 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.094 175.759 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 92.6 mt . . . . . 0 N--CA 1.429 -1.477 0 C-N-CA 124.401 1.08 . . . . 0.0 108.091 179.965 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' MAN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 19.3 m . . . . . 0 N--CA 1.438 -1.073 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.405 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 5.8 tp-100 -87.58 138.3 31.59 Favored 'General case' 0 N--CA 1.446 -0.653 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 -177.775 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.431 ' O ' ' HB2' ' A' ' 35' ' ' CYS . 33.0 m -98.64 -177.03 3.54 Favored 'General case' 0 C--N 1.294 -1.826 0 CA-C-N 116.733 -0.212 . . . . 0.0 111.152 -175.717 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 53.4 t-80 -61.99 126.56 27.77 Favored 'General case' 0 CA--C 1.511 -0.549 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 177.203 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 71.24 102.99 0.06 Allowed 'General case' 0 C--O 1.237 0.442 0 O-C-N 124.775 1.297 . . . . 0.0 109.726 -173.394 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.464 ' O ' ' HA ' ' A' ' 34' ' ' GLN . . . 158.86 147.48 4.87 Favored Glycine 0 N--CA 1.418 -2.519 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 -176.277 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.603 ' HA ' ' O ' ' A' ' 33' ' ' SER . 53.8 tt0 -78.51 106.83 10.73 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-O 121.03 0.443 . . . . 0.0 110.333 -179.033 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.67 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 7.9 p -82.11 -41.32 20.67 Favored 'General case' 0 C--N 1.301 -1.519 0 CA-C-N 115.556 -0.747 . . . . 0.0 112.05 -179.118 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 173.47 100.26 0.13 Allowed Glycine 0 N--CA 1.432 -1.628 0 C-N-CA 117.881 -2.104 . . . . 0.0 114.397 -177.552 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -112.0 -167.8 17.98 Favored Glycine 0 C--N 1.289 -2.069 0 N-CA-C 108.252 -1.939 . . . . 0.0 108.252 174.446 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 86.1 mt -59.58 109.25 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.01 0 CA-C-N 117.724 0.762 . . . . 0.0 110.995 179.885 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 104.82 -10.08 48.27 Favored Glycine 0 N--CA 1.437 -1.243 0 CA-C-N 115.989 -0.55 . . . . 0.0 113.313 176.504 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 34.5 t80 -100.12 111.22 23.5 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 -177.62 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 5.5 p -113.33 10.96 18.49 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 113.466 0.913 . . . . 0.0 113.466 -175.367 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -74.97 -131.74 0.27 Allowed Glycine 0 CA--C 1.53 1.024 0 CA-C-N 116.16 -0.473 . . . . 0.0 113.475 -179.016 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.86 81.06 0.87 Allowed 'Trans proline' 0 N--CA 1.461 -0.439 0 C-N-CA 122.672 2.248 . . . . 0.0 112.792 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.446 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 29.2 p -81.28 -10.41 59.58 Favored 'General case' 0 N--CA 1.437 -1.084 0 CA-C-N 115.338 -0.847 . . . . 0.0 110.606 178.88 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 7.1 p -89.96 132.82 33.65 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.275 0 CA-C-N 114.833 -1.076 . . . . 0.0 108.886 176.601 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.482 ' HB3' ' OG1' ' A' ' 23' ' ' THR . 76.1 m -101.1 156.67 17.28 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.39 -177.028 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.18 175.29 3.94 Favored 'General case' 0 C--O 1.246 0.877 0 C-N-CA 123.829 0.851 . . . . 0.0 112.065 -178.545 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 5.1 m -51.72 113.05 0.87 Allowed 'General case' 0 N--CA 1.443 -0.815 0 C-N-CA 124.863 1.265 . . . . 0.0 112.275 -177.426 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 89.81 12.63 62.06 Favored Glycine 0 N--CA 1.434 -1.444 0 C-N-CA 120.509 -0.853 . . . . 0.0 113.499 174.832 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.482 ' OG1' ' HB3' ' A' ' 19' ' ' CYS . 73.6 p -124.96 143.93 50.63 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 117.294 0.547 . . . . 0.0 110.274 177.33 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 40.1 p -118.85 137.03 53.71 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.705 179.609 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.481 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 53.3 t -76.35 109.22 9.87 Favored 'General case' 0 C--N 1.312 -1.024 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 179.523 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 74.6 mt-30 -116.28 125.97 52.92 Favored 'General case' 0 C--N 1.298 -1.664 0 CA-C-O 121.026 0.441 . . . . 0.0 110.542 -179.368 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 69.1 t -70.29 115.72 10.16 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.201 0 CA-C-N 115.016 -0.993 . . . . 0.0 109.045 178.441 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 67.8 mt -98.97 -70.67 0.72 Allowed 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 81.9 m-20 -95.5 168.98 9.93 Favored Pre-proline 0 C--N 1.298 -1.644 0 N-CA-C 106.763 -1.569 . . . . 0.0 106.763 175.539 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_exo -59.54 -36.75 92.17 Favored 'Trans proline' 0 CA--C 1.542 0.924 0 C-N-CA 121.614 1.543 . . . . 0.0 113.085 -179.657 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 66.6 m-85 -104.46 -24.02 13.09 Favored 'General case' 0 C--N 1.312 -1.049 0 O-C-N 121.716 -0.615 . . . . 0.0 110.574 -178.762 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 62.8 t80 -103.32 113.59 27.2 Favored 'General case' 0 N--CA 1.431 -1.4 0 CA-C-O 121.658 0.742 . . . . 0.0 111.422 -178.344 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.603 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 26.0 m -122.67 143.67 49.63 Favored 'General case' 0 C--N 1.288 -2.094 0 N-CA-C 105.536 -2.024 . . . . 0.0 105.536 176.355 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.464 ' HA ' ' O ' ' A' ' 6' ' ' GLY . 27.1 tt0 -135.34 145.72 47.7 Favored 'General case' 0 C--N 1.297 -1.675 0 C-N-CA 120.274 -0.571 . . . . 0.0 112.465 -173.105 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.67 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 66.8 m -76.17 112.16 12.34 Favored 'General case' 0 C--O 1.251 1.165 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.335 176.304 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.436 HD21 HE21 ' A' ' 34' ' ' GLN . 94.9 mt . . . . . 0 C--N 1.3 -1.558 0 CA-C-N 115.012 -0.995 . . . . 0.0 108.397 179.081 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' MAN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 22.9 m . . . . . 0 N--CA 1.438 -1.025 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.524 ' HA ' ' OE1' ' A' ' 2' ' ' GLN . 3.4 tp60 -89.01 125.92 35.2 Favored 'General case' 0 N--CA 1.436 -1.144 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 -174.644 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 87.2 p -92.39 -178.15 4.84 Favored 'General case' 0 C--N 1.294 -1.838 0 CA-C-O 121.006 0.432 . . . . 0.0 111.193 -177.508 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . 0.495 ' O ' ' H3 ' ' A' ' 101' ' ' MAN . 50.5 t-80 -54.43 136.54 44.01 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 123.954 0.902 . . . . 0.0 110.768 178.589 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 75.75 3.5 3.85 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 124.781 1.232 . . . . 0.0 112.713 177.82 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -93.37 154.98 22.03 Favored Glycine 0 N--CA 1.437 -1.257 0 N-CA-C 110.433 -1.067 . . . . 0.0 110.433 175.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.484 ' HA ' ' O ' ' A' ' 33' ' ' SER . 52.3 tt0 -81.36 110.1 16.48 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 177.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.707 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 8.7 p -79.18 -43.39 24.0 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 123.333 0.396 . . . . 0.0 111.867 -177.573 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.442 ' H ' ' HB2' ' A' ' 33' ' ' SER . . . 157.31 115.74 0.47 Allowed Glycine 0 N--CA 1.42 -2.383 0 C-N-CA 117.145 -2.455 . . . . 0.0 114.708 179.492 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -101.81 -149.9 22.87 Favored Glycine 0 N--CA 1.418 -2.559 0 N-CA-C 108.352 -1.899 . . . . 0.0 108.352 174.417 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 84.3 mt -71.92 112.98 8.07 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.715 0 CA-C-N 117.417 0.609 . . . . 0.0 111.008 178.475 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 92.61 30.06 10.17 Favored Glycine 0 N--CA 1.449 -0.492 0 CA-C-N 115.807 -0.633 . . . . 0.0 113.597 174.604 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 36.3 t80 -111.72 117.05 31.8 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-N 117.342 0.571 . . . . 0.0 109.513 -179.104 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 39.0 p -102.78 11.27 37.81 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-O 120.864 0.364 . . . . 0.0 111.742 -177.263 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -80.01 -151.78 7.2 Favored Glycine 0 CA--C 1.529 0.965 0 CA-C-N 116.071 -0.513 . . . . 0.0 112.315 179.638 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -75.35 96.59 1.04 Allowed 'Trans proline' 0 N--CA 1.453 -0.89 0 C-N-CA 122.276 1.984 . . . . 0.0 111.163 179.352 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.568 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 15.2 p -90.52 -8.76 49.5 Favored 'General case' 0 N--CA 1.423 -1.808 0 CA-C-N 115.407 -0.815 . . . . 0.0 112.259 -175.303 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 9.3 p -95.78 130.71 44.1 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.225 0 CA-C-N 116.123 -0.49 . . . . 0.0 109.932 177.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.492 ' HA ' ' O ' ' A' ' 2' ' ' GLN . 73.6 m -91.86 159.19 15.91 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.467 -179.404 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -78.86 170.0 17.36 Favored 'General case' 0 C--O 1.251 1.138 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.261 -179.472 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 46.4 m -58.51 126.65 28.47 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.972 -179.19 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 104.37 -6.24 45.68 Favored Glycine 0 N--CA 1.431 -1.667 0 C-N-CA 120.147 -1.025 . . . . 0.0 112.207 178.786 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 38.8 p -135.07 153.08 52.16 Favored 'General case' 0 C--O 1.241 0.627 0 CA-C-O 120.653 0.263 . . . . 0.0 111.305 -179.389 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 8.8 p -124.01 153.51 41.21 Favored 'General case' 0 N--CA 1.437 -1.093 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 176.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 50.9 t -82.34 99.38 9.33 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 -179.399 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 58.5 mt-30 -99.83 122.36 42.67 Favored 'General case' 0 N--CA 1.438 -1.059 0 CA-C-O 121.123 0.487 . . . . 0.0 110.087 -177.832 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 55.8 t -82.57 107.42 14.41 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.35 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.164 -179.001 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 84.1 mt -88.47 -70.39 0.64 Allowed 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 -179.786 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 55.7 m-80 -94.39 164.41 20.16 Favored Pre-proline 0 C--N 1.303 -1.441 0 N-CA-C 106.343 -1.725 . . . . 0.0 106.343 174.235 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_exo -60.46 -24.58 78.33 Favored 'Trans proline' 0 C--N 1.35 0.624 0 C-N-CA 121.766 1.644 . . . . 0.0 111.963 179.496 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 55.8 m-85 -109.56 -24.26 11.06 Favored 'General case' 0 N--CA 1.432 -1.356 0 C-N-CA 120.276 -0.57 . . . . 0.0 111.502 -179.256 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 57.0 t80 -103.95 113.43 26.95 Favored 'General case' 0 C--N 1.315 -0.934 0 C-N-CA 119.606 -0.838 . . . . 0.0 110.461 -179.474 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.484 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 49.8 m -123.18 137.56 54.86 Favored 'General case' 0 C--N 1.28 -2.447 0 N-CA-C 105.813 -1.921 . . . . 0.0 105.813 177.065 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 29.4 tt0 -131.46 141.04 49.71 Favored 'General case' 0 C--N 1.288 -2.075 0 C-N-CA 121.077 -0.249 . . . . 0.0 111.087 -172.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.707 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 76.8 m -74.56 107.98 7.03 Favored 'General case' 0 C--O 1.255 1.39 0 CA-C-O 121.636 0.731 . . . . 0.0 110.653 177.374 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 96.2 mt . . . . . 0 N--CA 1.428 -1.543 0 N-CA-C 106.304 -1.739 . . . . 0.0 106.304 179.028 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' MAN . . . . . 0.495 ' H3 ' ' O ' ' A' ' 4' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 3.6 p . . . . . 0 C--O 1.241 0.653 0 N-CA-C 110.302 -0.258 . . . . 0.0 110.302 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -79.53 147.43 32.18 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 178.415 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 5.0 m -93.03 169.63 10.27 Favored 'General case' 0 C--N 1.298 -1.667 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.6 -175.417 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 42.9 t-80 -52.92 139.45 27.42 Favored 'General case' 0 C--O 1.242 0.697 0 CA-C-N 115.14 -0.936 . . . . 0.0 109.274 173.159 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 69.0 8.28 6.75 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.753 0.821 . . . . 0.0 112.836 179.141 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -100.17 159.09 19.45 Favored Glycine 0 N--CA 1.436 -1.332 0 C-N-CA 120.68 -0.772 . . . . 0.0 111.501 178.283 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.534 ' HA ' ' O ' ' A' ' 33' ' ' SER . 53.7 tt0 -80.7 112.56 18.18 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 179.033 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.688 ' O ' ' HA ' ' A' ' 17' ' ' THR . 25.4 p -91.33 -38.29 12.72 Favored 'General case' 0 C--N 1.293 -1.856 0 N-CA-C 113.304 0.853 . . . . 0.0 113.304 -174.808 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 177.79 85.1 0.06 OUTLIER Glycine 0 CA--C 1.484 -1.851 0 C-N-CA 117.85 -2.119 . . . . 0.0 113.868 -176.754 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.461 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -112.55 176.28 17.6 Favored Glycine 0 C--N 1.285 -2.29 0 N-CA-C 108.469 -1.852 . . . . 0.0 108.469 174.573 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 78.3 mt -61.62 118.82 4.52 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.042 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 176.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 110.38 -5.77 30.02 Favored Glycine 0 N--CA 1.432 -1.608 0 C-N-CA 120.845 -0.693 . . . . 0.0 111.675 -178.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 65.2 t80 -114.0 108.28 16.81 Favored 'General case' 0 C--N 1.311 -1.089 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 178.232 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 21.9 p -109.61 15.65 22.72 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.658 -177.467 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -88.23 -154.67 28.16 Favored Glycine 0 N--CA 1.45 -0.423 0 CA-C-O 119.597 -0.557 . . . . 0.0 112.32 -179.688 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_endo -62.0 109.79 0.88 Allowed 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 122.882 2.388 . . . . 0.0 111.232 177.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.688 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 7.7 p -95.04 -6.46 42.13 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 114.215 1.191 . . . . 0.0 114.215 -173.267 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 7.6 p -95.71 134.76 32.05 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.371 0 O-C-N 121.973 -0.454 . . . . 0.0 109.98 179.43 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 46.9 m -91.37 168.87 11.25 Favored 'General case' 0 C--N 1.312 -1.051 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 -179.786 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.64 141.61 53.62 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 175.082 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 46.7 m -56.46 133.66 53.36 Favored 'General case' 0 N--CA 1.433 -1.314 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.255 -179.201 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 111.9 -13.17 26.96 Favored Glycine 0 C--N 1.296 -1.69 0 N-CA-C 109.86 -1.296 . . . . 0.0 109.86 -173.733 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 55.2 p -136.28 143.63 44.33 Favored 'General case' 0 C--O 1.248 1.004 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 174.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 21.3 p -111.35 138.08 48.29 Favored 'General case' 0 C--N 1.288 -2.098 0 CA-C-N 116.654 -0.248 . . . . 0.0 110.994 -179.212 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 46.4 t -72.3 99.0 2.3 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 176.458 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 74.8 mt-30 -108.06 129.29 55.15 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-O 121.223 0.535 . . . . 0.0 110.305 -179.234 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 58.3 t -78.05 107.6 10.21 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.371 0 CA-C-N 115.137 -0.938 . . . . 0.0 109.342 -179.77 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 83.6 mt -86.48 -72.33 0.51 Allowed 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 82.2 m-20 -94.84 165.17 17.69 Favored Pre-proline 0 C--N 1.292 -1.892 0 N-CA-C 105.789 -1.93 . . . . 0.0 105.789 174.769 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -60.95 -33.6 92.12 Favored 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 121.617 1.544 . . . . 0.0 111.316 179.087 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.461 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 76.1 m-85 -100.11 -26.3 14.0 Favored 'General case' 0 C--N 1.311 -1.079 0 C-N-CA 120.396 -0.522 . . . . 0.0 111.199 -177.787 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 53.6 t80 -106.28 113.82 27.57 Favored 'General case' 0 C--N 1.311 -1.078 0 C-N-CA 120.723 -0.391 . . . . 0.0 111.946 -179.341 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.534 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 20.0 m -121.69 141.09 51.5 Favored 'General case' 0 C--N 1.288 -2.087 0 N-CA-C 106.545 -1.65 . . . . 0.0 106.545 175.353 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.507 HE21 HD21 ' A' ' 36' ' ' LEU . 29.0 tt0 -133.43 145.96 50.75 Favored 'General case' 0 C--N 1.3 -1.579 0 C-N-CA 120.092 -0.643 . . . . 0.0 111.376 -172.215 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.667 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 57.2 m -75.77 110.6 10.32 Favored 'General case' 0 C--O 1.252 1.228 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.014 177.483 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.507 HD21 HE21 ' A' ' 34' ' ' GLN . 84.7 mt . . . . . 0 C--N 1.302 -1.462 0 CA-C-N 115.042 -0.981 . . . . 0.0 109.503 -177.442 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' MAN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 3.9 m . . . . . 0 N--CA 1.436 -1.135 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -115.2 152.68 32.22 Favored 'General case' 0 N--CA 1.429 -1.519 0 N-CA-C 106.301 -1.74 . . . . 0.0 106.301 172.512 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 23.2 t -127.49 -177.61 4.15 Favored 'General case' 0 C--N 1.293 -1.866 0 C-N-CA 119.991 -0.684 . . . . 0.0 110.266 -176.635 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 41.6 t-80 -49.99 132.83 23.07 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 124.113 0.965 . . . . 0.0 110.93 -179.575 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 75.6 6.15 3.98 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 124.824 1.25 . . . . 0.0 112.294 178.652 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -98.8 155.92 20.11 Favored Glycine 0 N--CA 1.433 -1.528 0 N-CA-C 110.441 -1.064 . . . . 0.0 110.441 175.653 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.459 ' HA ' ' O ' ' A' ' 33' ' ' SER . 51.6 tt0 -81.23 116.53 21.15 Favored 'General case' 0 N--CA 1.438 -1.039 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 179.824 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.738 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 10.8 p -91.08 -22.02 20.93 Favored 'General case' 0 C--N 1.292 -1.904 0 N-CA-C 113.261 0.837 . . . . 0.0 113.261 -175.102 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 157.45 90.54 0.08 OUTLIER Glycine 0 CA--C 1.473 -2.592 0 C-N-CA 117.203 -2.427 . . . . 0.0 113.818 -179.108 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.649 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -113.11 179.41 19.08 Favored Glycine 0 C--N 1.275 -2.843 0 N-CA-C 108.076 -2.01 . . . . 0.0 108.076 173.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.44 ' HB ' ' CD1' ' A' ' 31' ' ' TYR . 56.5 mt -64.67 112.22 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 178.623 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 113.41 -4.37 24.96 Favored Glycine 0 N--CA 1.441 -1.027 0 C-N-CA 121.1 -0.572 . . . . 0.0 112.036 -179.399 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 72.9 t80 -101.42 129.29 47.41 Favored 'General case' 0 C--N 1.31 -1.129 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 3.7 p -129.12 5.76 5.35 Favored 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 112.751 0.649 . . . . 0.0 112.751 -177.39 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -81.49 -149.69 7.17 Favored Glycine 0 CA--C 1.533 1.21 0 C-N-CA 121.171 -0.538 . . . . 0.0 112.04 177.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_endo -63.02 111.43 1.39 Allowed 'Trans proline' 0 C--N 1.357 1.007 0 C-N-CA 122.538 2.159 . . . . 0.0 112.225 179.102 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.645 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 3.1 p -93.71 -16.09 24.59 Favored 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 113.166 0.802 . . . . 0.0 113.166 -176.238 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 8.2 p -90.48 128.1 42.57 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 CA-C-O 121.001 0.429 . . . . 0.0 110.402 -179.74 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 69.8 m -86.75 153.24 21.85 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 177.559 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -59.57 127.42 31.93 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 174.566 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 35.3 m -53.67 130.56 36.8 Favored 'General case' 0 C--O 1.246 0.909 0 CA-C-O 121.319 0.581 . . . . 0.0 110.973 -177.717 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 113.18 -21.21 18.1 Favored Glycine 0 N--CA 1.434 -1.464 0 N-CA-C 109.263 -1.535 . . . . 0.0 109.263 -170.591 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 70.6 p -117.57 143.34 46.2 Favored 'General case' 0 N--CA 1.443 -0.783 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 172.405 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 34.1 p -112.55 144.07 42.64 Favored 'General case' 0 C--N 1.295 -1.782 0 CA-C-O 120.71 0.29 . . . . 0.0 111.007 -177.034 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 50.9 t -78.83 98.51 6.35 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 178.54 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 75.3 mt-30 -103.74 127.69 51.19 Favored 'General case' 0 N--CA 1.431 -1.379 0 CA-C-O 120.996 0.427 . . . . 0.0 110.031 -177.713 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 60.0 t -78.37 114.04 18.45 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 179.463 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 74.2 mt -94.16 -70.38 0.71 Allowed 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 -178.692 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 77.6 m-20 -94.94 164.08 20.39 Favored Pre-proline 0 C--N 1.299 -1.612 0 N-CA-C 106.608 -1.627 . . . . 0.0 106.608 175.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -57.1 -35.33 98.88 Favored 'Trans proline' 0 CA--C 1.538 0.679 0 C-N-CA 121.886 1.724 . . . . 0.0 112.586 -179.029 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.649 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 50.5 m-85 -103.89 -21.07 13.7 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.991 -178.849 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 24.1 t80 -104.44 113.3 26.78 Favored 'General case' 0 C--N 1.316 -0.859 0 C-N-CA 119.87 -0.732 . . . . 0.0 111.24 -178.736 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.459 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 16.9 m -116.93 135.71 53.51 Favored 'General case' 0 C--N 1.289 -2.064 0 N-CA-C 106.068 -1.827 . . . . 0.0 106.068 175.648 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.412 HE21 HD21 ' A' ' 36' ' ' LEU . 28.7 tt0 -129.92 144.72 51.47 Favored 'General case' 0 C--N 1.299 -1.621 0 CA-C-N 118.111 0.414 . . . . 0.0 110.832 -172.068 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.738 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 61.7 m -76.46 116.84 17.52 Favored 'General case' 0 C--O 1.259 1.592 0 CA-C-O 121.17 0.51 . . . . 0.0 110.154 177.479 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.412 HD21 HE21 ' A' ' 34' ' ' GLN . 94.5 mt . . . . . 0 C--N 1.298 -1.666 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 177.582 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' MAN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 6.8 m . . . . . 0 N--CA 1.441 -0.899 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -82.26 142.05 32.44 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.434 ' O ' ' HB2' ' A' ' 35' ' ' CYS . 19.6 p -95.05 -178.13 4.38 Favored 'General case' 0 C--N 1.29 -2.013 0 C-N-CA 123.134 0.574 . . . . 0.0 111.54 -174.479 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 51.0 t-80 -64.55 123.59 19.65 Favored 'General case' 0 N--CA 1.445 -0.694 0 N-CA-C 108.023 -1.102 . . . . 0.0 108.023 176.718 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 65.03 83.95 0.16 Allowed 'General case' 0 C--N 1.319 -0.727 0 O-C-N 124.446 1.092 . . . . 0.0 111.453 -175.819 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.511 ' O ' ' HA ' ' A' ' 34' ' ' GLN . . . -167.38 159.13 32.36 Favored Glycine 0 N--CA 1.424 -2.138 0 N-CA-C 106.916 -2.474 . . . . 0.0 106.916 179.398 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.603 ' HA ' ' O ' ' A' ' 33' ' ' SER . 53.3 tt0 -82.36 110.36 17.44 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 118.281 1.04 . . . . 0.0 110.049 -179.19 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.709 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 1.8 p -86.1 -47.81 9.18 Favored 'General case' 0 C--N 1.295 -1.793 0 N-CA-C 113.237 0.829 . . . . 0.0 113.237 -177.79 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.422 ' H ' ' HB2' ' A' ' 33' ' ' SER . . . -174.22 89.16 0.08 OUTLIER Glycine 0 CA--C 1.486 -1.73 0 C-N-CA 117.716 -2.183 . . . . 0.0 114.07 -175.669 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.509 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -112.87 178.38 18.75 Favored Glycine 0 C--N 1.286 -2.213 0 N-CA-C 107.673 -2.171 . . . . 0.0 107.673 173.616 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 67.6 mt -61.58 118.44 4.08 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-N 118.239 1.019 . . . . 0.0 108.83 177.037 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 110.26 -14.85 30.64 Favored Glycine 0 N--CA 1.443 -0.897 0 C-N-CA 120.767 -0.73 . . . . 0.0 111.841 -178.852 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 25.7 t80 -114.09 121.47 43.92 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 -179.574 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 13.7 p -134.96 18.28 3.48 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-O 121.282 0.563 . . . . 0.0 111.545 -179.496 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -78.6 -128.61 0.53 Allowed Glycine 0 CA--C 1.521 0.414 0 CA-C-N 115.311 -0.859 . . . . 0.0 111.065 176.844 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -67.04 88.37 0.3 Allowed 'Trans proline' 0 CA--C 1.536 0.576 0 C-N-CA 122.201 1.934 . . . . 0.0 111.95 176.549 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.633 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 39.2 p -86.73 0.15 55.21 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.651 0.739 . . . . 0.0 110.756 -179.625 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 7.6 p -102.27 129.74 53.23 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.579 0 CA-C-N 114.89 -1.05 . . . . 0.0 108.82 178.663 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.461 ' SG ' ' HB2' ' A' ' 25' ' ' CYS . 71.4 m -92.64 153.64 18.86 Favored 'General case' 0 C--N 1.293 -1.886 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.67 -179.703 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -56.51 133.01 53.05 Favored 'General case' 0 C--O 1.249 1.039 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 174.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 9.2 p -53.97 127.51 26.63 Favored 'General case' 0 C--O 1.249 1.073 0 CA-C-O 121.528 0.68 . . . . 0.0 112.294 -177.149 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 112.43 -9.49 26.38 Favored Glycine 0 N--CA 1.431 -1.687 0 CA-C-N 114.843 -1.071 . . . . 0.0 110.784 -175.493 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 67.1 p -127.39 145.73 50.71 Favored 'General case' 0 C--O 1.246 0.899 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 176.477 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 23.6 p -111.3 140.14 46.12 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-O 120.381 0.134 . . . . 0.0 111.178 -178.337 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.461 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 53.6 t -73.31 103.07 3.87 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 179.094 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 16.7 mm-40 -91.12 113.48 25.76 Favored 'General case' 0 N--CA 1.425 -1.695 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.024 -179.005 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 45.5 t -76.19 101.36 2.59 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.114 0 N-CA-C 107.142 -1.429 . . . . 0.0 107.142 176.698 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 77.3 mt -86.87 -69.93 0.64 Allowed 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 -177.661 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 79.1 m-20 -95.74 165.31 16.82 Favored Pre-proline 0 C--N 1.298 -1.668 0 N-CA-C 107.038 -1.467 . . . . 0.0 107.038 174.727 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_exo -60.91 -29.98 89.11 Favored 'Trans proline' 0 CA--C 1.542 0.884 0 C-N-CA 121.499 1.466 . . . . 0.0 111.658 178.428 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.509 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 87.8 m-85 -101.77 -25.54 13.8 Favored 'General case' 0 N--CA 1.44 -0.969 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.553 -179.839 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 68.2 t80 -106.05 114.8 29.16 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 113.008 0.744 . . . . 0.0 113.008 -178.538 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.603 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 23.8 m -121.18 136.59 54.95 Favored 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 175.711 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.511 ' HA ' ' O ' ' A' ' 6' ' ' GLY . 35.2 tt0 -127.59 133.24 49.73 Favored 'General case' 0 C--N 1.318 -0.762 0 C-N-CA 122.202 0.201 . . . . 0.0 110.763 -173.253 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.709 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 64.1 m -74.01 109.03 7.18 Favored 'General case' 0 C--O 1.243 0.739 0 CA-C-O 120.972 0.415 . . . . 0.0 111.756 177.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 96.6 mt . . . . . 0 C--N 1.299 -1.591 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 178.689 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' MAN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 8.1 t . . . . . 0 C--O 1.242 0.665 0 N-CA-C 107.467 -1.308 . . . . 0.0 107.467 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -93.61 135.94 34.38 Favored 'General case' 0 N--CA 1.416 -2.133 0 C-N-CA 119.815 -0.754 . . . . 0.0 109.045 178.217 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 61.3 p -91.99 173.9 7.6 Favored 'General case' 0 C--N 1.282 -2.332 0 CA-C-N 114.857 -1.065 . . . . 0.0 110.146 -175.027 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 55.2 t-80 -57.54 134.23 55.94 Favored 'General case' 0 C--N 1.315 -0.905 0 C-N-CA 123.453 0.701 . . . . 0.0 110.107 177.183 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 70.51 10.42 7.16 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.646 1.178 . . . . 0.0 112.908 178.169 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.526 ' O ' ' HA ' ' A' ' 34' ' ' GLN . . . -97.62 155.8 20.56 Favored Glycine 0 N--CA 1.438 -1.2 0 N-CA-C 110.726 -0.95 . . . . 0.0 110.726 176.175 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.634 ' HA ' ' O ' ' A' ' 33' ' ' SER . 64.4 tt0 -70.25 110.51 5.27 Favored 'General case' 0 C--O 1.217 -0.608 0 CA-C-N 117.14 0.47 . . . . 0.0 109.931 -178.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.742 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 21.1 p -93.13 -31.68 14.71 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 113.565 0.95 . . . . 0.0 113.565 -175.764 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 179.84 84.36 0.06 OUTLIER Glycine 0 CA--C 1.483 -1.932 0 C-N-CA 117.574 -2.251 . . . . 0.0 113.786 -174.673 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.567 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -112.44 167.2 12.3 Favored Glycine 0 C--N 1.286 -2.24 0 N-CA-C 108.748 -1.741 . . . . 0.0 108.748 174.81 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 79.7 mt -60.78 117.53 2.66 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 177.532 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 105.37 -8.75 44.79 Favored Glycine 0 N--CA 1.442 -0.965 0 C-N-CA 120.373 -0.918 . . . . 0.0 111.804 179.734 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 90.4 t80 -94.74 108.85 20.85 Favored 'General case' 0 N--CA 1.44 -0.932 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 178.06 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 3.3 p -103.87 7.71 36.9 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-N 114.806 -1.088 . . . . 0.0 111.743 -176.741 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -81.05 -163.3 30.08 Favored Glycine 0 N--CA 1.445 -0.737 0 C-N-CA 121.084 -0.579 . . . . 0.0 112.361 -179.28 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_endo -62.16 118.25 5.13 Favored 'Trans proline' 0 C--O 1.235 0.342 0 C-N-CA 122.834 2.356 . . . . 0.0 110.754 177.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.551 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 10.2 p -99.71 -14.89 18.71 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 -174.639 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 13.6 p -79.48 137.66 21.33 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 C-N-CA 120.594 -0.442 . . . . 0.0 110.004 179.882 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.405 ' HB3' ' OG1' ' A' ' 23' ' ' THR . 71.2 m -97.31 153.08 18.28 Favored 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 179.544 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.53 155.67 21.48 Favored 'General case' 0 C--O 1.251 1.159 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.238 178.107 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 4.9 p -58.3 118.55 5.64 Favored 'General case' 0 C--N 1.307 -1.254 0 C-N-CA 123.429 0.692 . . . . 0.0 111.383 -179.328 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 111.92 -11.33 27.26 Favored Glycine 0 N--CA 1.441 -0.982 0 C-N-CA 120.926 -0.654 . . . . 0.0 111.641 -178.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.405 ' OG1' ' HB3' ' A' ' 19' ' ' CYS . 76.7 p -120.22 151.78 38.65 Favored 'General case' 0 C--O 1.256 1.412 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 178.058 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.411 ' O ' ' HA ' ' A' ' 35' ' ' CYS . 16.9 p -121.87 148.83 44.21 Favored 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 110.278 -0.268 . . . . 0.0 110.278 176.478 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 49.4 t -77.47 103.88 7.66 Favored 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 179.679 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 12.7 mm-40 -98.44 117.83 33.74 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 116.052 -0.522 . . . . 0.0 109.951 -178.382 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 41.2 t -87.06 105.71 15.33 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 -178.715 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 69.1 mt -89.68 -69.46 0.72 Allowed 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 -178.168 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 48.7 m-80 -95.19 170.34 8.02 Favored Pre-proline 0 C--N 1.301 -1.522 0 N-CA-C 107.038 -1.468 . . . . 0.0 107.038 176.148 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_exo -65.97 -30.15 48.49 Favored 'Trans proline' 0 C--N 1.345 0.349 0 CA-C-N 120.57 1.239 . . . . 0.0 111.875 177.072 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.567 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 28.5 m-85 -106.43 -25.59 11.81 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 119.779 -0.768 . . . . 0.0 110.585 -177.875 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 60.4 t80 -104.76 115.3 30.07 Favored 'General case' 0 N--CA 1.443 -0.807 0 C-N-CA 119.893 -0.723 . . . . 0.0 112.563 177.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.634 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 14.5 m -131.65 141.14 49.54 Favored 'General case' 0 C--N 1.293 -1.861 0 N-CA-C 105.993 -1.854 . . . . 0.0 105.993 176.272 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.526 ' HA ' ' O ' ' A' ' 6' ' ' GLY . 4.1 pt20 -132.82 151.1 52.08 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 119.084 0.857 . . . . 0.0 111.882 -178.172 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.742 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 61.2 m -76.55 118.41 19.18 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-O 121.218 0.533 . . . . 0.0 110.517 178.082 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 97.0 mt . . . . . 0 C--N 1.303 -1.453 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 178.525 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' MAN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 20.0 m . . . . . 0 N--CA 1.445 -0.676 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -79.92 131.72 35.9 Favored 'General case' 0 N--CA 1.44 -0.97 0 N-CA-C 107.429 -1.323 . . . . 0.0 107.429 178.847 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.413 ' HB2' ' H2 ' ' A' ' 101' ' ' MAN . 22.7 t -110.03 -168.52 1.33 Allowed 'General case' 0 C--N 1.29 -1.987 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 -176.409 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 25.2 t-80 -56.18 126.46 26.21 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 123.249 0.62 . . . . 0.0 110.182 -178.587 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 69.57 76.94 0.22 Allowed 'General case' 0 C--N 1.328 -0.339 0 O-C-N 124.604 1.19 . . . . 0.0 111.424 -178.41 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.574 ' O ' ' HA ' ' A' ' 34' ' ' GLN . . . -169.55 155.55 25.75 Favored Glycine 0 N--CA 1.433 -1.527 0 N-CA-C 108.699 -1.761 . . . . 0.0 108.699 179.175 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.689 ' HA ' ' O ' ' A' ' 33' ' ' SER . 53.2 tt0 -77.64 107.24 9.98 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 117.591 0.696 . . . . 0.0 110.329 -178.268 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.796 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 6.1 p -87.82 -41.9 12.94 Favored 'General case' 0 C--N 1.297 -1.709 0 CA-C-N 115.395 -0.82 . . . . 0.0 113.133 -176.613 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -161.96 53.99 0.31 Allowed Glycine 0 CA--C 1.471 -2.687 0 C-N-CA 118.956 -1.592 . . . . 0.0 111.687 -173.685 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.439 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -95.69 149.68 19.41 Favored Glycine 0 N--CA 1.423 -2.202 0 N-CA-C 108.442 -1.863 . . . . 0.0 108.442 175.692 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.437 ' HB ' ' CD1' ' A' ' 31' ' ' TYR . 61.4 mt -57.97 121.03 4.76 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.913 0 CA-C-N 117.315 0.558 . . . . 0.0 110.443 -178.299 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 109.59 4.26 30.3 Favored Glycine 0 N--CA 1.445 -0.713 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.985 -179.114 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.458 ' HB2' ' NE2' ' A' ' 7' ' ' GLN . 70.0 t80 -103.54 119.94 39.88 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 177.929 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 14.3 p -99.64 1.17 43.32 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 112.397 0.517 . . . . 0.0 112.397 -177.157 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -85.68 -175.8 50.2 Favored Glycine 0 N--CA 1.444 -0.822 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.329 -179.266 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -66.16 130.41 24.08 Favored 'Trans proline' 0 CA--C 1.533 0.454 0 C-N-CA 122.759 2.306 . . . . 0.0 111.616 -179.535 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.564 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 37.1 p -88.04 10.29 19.58 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-O 121.626 0.727 . . . . 0.0 111.679 -177.911 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 7.1 p -94.19 123.41 46.29 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.496 0 CA-C-O 121.567 0.699 . . . . 0.0 110.82 -178.372 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 83.7 m -88.56 160.12 17.59 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-N 115.112 -0.949 . . . . 0.0 109.154 177.064 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -72.17 146.15 47.59 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 176.751 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 67.9 m -53.1 130.27 33.59 Favored 'General case' 0 C--O 1.25 1.1 0 CA-C-O 121.092 0.472 . . . . 0.0 110.211 176.763 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 112.18 -16.81 24.75 Favored Glycine 0 N--CA 1.43 -1.722 0 N-CA-C 110.781 -0.928 . . . . 0.0 110.781 -173.593 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 41.4 p -133.2 144.78 50.04 Favored 'General case' 0 N--CA 1.443 -0.818 0 CA-C-O 120.819 0.342 . . . . 0.0 111.327 179.577 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 23.3 p -116.77 152.32 34.62 Favored 'General case' 0 C--N 1.309 -1.161 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 177.778 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 44.8 t -77.53 111.44 13.27 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 -179.422 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 70.3 mt-30 -110.9 127.93 55.63 Favored 'General case' 0 N--CA 1.434 -1.238 0 CA-C-O 121.331 0.586 . . . . 0.0 110.273 -179.656 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 58.8 t -81.01 110.75 16.84 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.723 -178.141 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 75.4 mt -90.02 -72.65 0.55 Allowed 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 107.01 -1.478 . . . . 0.0 107.01 177.314 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 54.8 m-80 -95.79 164.29 19.13 Favored Pre-proline 0 C--N 1.298 -1.66 0 N-CA-C 106.785 -1.561 . . . . 0.0 106.785 170.536 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_exo -63.56 -33.45 67.82 Favored 'Trans proline' 0 C--O 1.241 0.637 0 C-N-CA 121.64 1.56 . . . . 0.0 111.26 176.374 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.439 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 76.8 m-85 -97.17 -26.38 14.97 Favored 'General case' 0 N--CA 1.442 -0.83 0 C-N-CA 119.633 -0.827 . . . . 0.0 110.819 -179.689 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 53.1 t80 -106.21 113.01 26.29 Favored 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 119.436 -0.906 . . . . 0.0 110.956 175.397 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.689 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 20.0 m -123.98 140.92 52.5 Favored 'General case' 0 C--N 1.288 -2.103 0 N-CA-C 106.616 -1.624 . . . . 0.0 106.616 177.393 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.574 ' HA ' ' O ' ' A' ' 6' ' ' GLY . 28.6 tt0 -129.89 140.57 50.94 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 -169.493 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.796 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 73.7 m -71.41 116.85 12.22 Favored 'General case' 0 C--O 1.258 1.522 0 CA-C-O 121.147 0.499 . . . . 0.0 110.544 175.303 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 95.5 mt . . . . . 0 C--N 1.303 -1.424 0 C-N-CA 125.156 1.382 . . . . 0.0 107.949 179.515 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' MAN . . . . . 0.413 ' H2 ' ' HB2' ' A' ' 3' ' ' SER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 28.9 m . . . . . 0 N--CA 1.444 -0.749 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 5.6 tp-100 -80.37 144.15 32.94 Favored 'General case' 0 N--CA 1.442 -0.839 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 -177.31 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 62.4 m -126.16 -173.22 2.8 Favored 'General case' 0 C--N 1.297 -1.715 0 C-N-CA 120.176 -0.61 . . . . 0.0 111.923 -177.181 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . 0.59 ' HA ' ' O ' ' A' ' 35' ' ' CYS . 57.6 t-80 -54.29 132.27 43.41 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 123.055 0.542 . . . . 0.0 110.326 -178.702 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.493 ' HA ' ' OE1' ' A' ' 34' ' ' GLN . . . 81.16 1.61 1.66 Allowed 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 125.251 1.42 . . . . 0.0 112.195 -178.423 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -98.91 153.22 19.79 Favored Glycine 0 N--CA 1.433 -1.54 0 N-CA-C 110.766 -0.934 . . . . 0.0 110.766 177.061 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.465 ' HA ' ' O ' ' A' ' 33' ' ' SER . 49.7 tt0 -82.17 111.5 18.34 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 179.856 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.77 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 14.6 p -83.45 -14.36 52.69 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.783 -178.025 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 122.94 115.24 2.23 Favored Glycine 0 N--CA 1.416 -2.674 0 C-N-CA 117.574 -2.25 . . . . 0.0 116.279 173.424 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -112.38 -153.59 11.93 Favored Glycine 0 N--CA 1.418 -2.555 0 N-CA-C 107.063 -2.415 . . . . 0.0 107.063 171.503 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 78.9 mt -64.29 124.18 18.57 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.679 0 CA-C-N 117.756 0.778 . . . . 0.0 110.493 177.836 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 95.9 6.87 59.04 Favored Glycine 0 N--CA 1.442 -0.956 0 CA-C-N 115.998 -0.546 . . . . 0.0 113.741 176.438 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 49.4 t80 -109.25 127.55 54.34 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 -179.712 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 6.7 p -128.83 15.7 6.37 Favored 'General case' 0 C--N 1.303 -1.434 0 CA-C-O 121.505 0.669 . . . . 0.0 111.144 -177.397 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -84.42 -143.83 6.16 Favored Glycine 0 C--O 1.248 0.981 0 N-CA-C 111.449 -0.66 . . . . 0.0 111.449 178.216 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -73.01 103.53 1.61 Allowed 'Trans proline' 0 N--CA 1.448 -1.154 0 C-N-CA 122.227 1.951 . . . . 0.0 111.395 177.769 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.524 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 32.8 p -94.46 -7.68 40.73 Favored 'General case' 0 N--CA 1.434 -1.234 0 CA-C-O 121.669 0.747 . . . . 0.0 110.816 -178.474 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 7.4 p -82.31 123.64 38.46 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.805 0 CA-C-N 115.239 -0.891 . . . . 0.0 110.732 178.051 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 78.4 m -90.44 148.88 22.5 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 109.481 -0.562 . . . . 0.0 109.481 176.395 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.53 150.9 17.89 Favored 'General case' 0 C--O 1.251 1.169 0 O-C-N 123.774 0.671 . . . . 0.0 110.449 177.381 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 8.9 t -59.41 115.87 3.56 Favored 'General case' 0 N--CA 1.433 -1.297 0 CA-C-N 115.663 -0.698 . . . . 0.0 109.491 -177.577 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 111.91 -5.69 27.41 Favored Glycine 0 N--CA 1.437 -1.237 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.077 -178.882 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 60.3 p -121.43 147.02 46.29 Favored 'General case' 0 C--N 1.312 -1.06 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 175.36 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 26.5 p -117.84 141.48 48.37 Favored 'General case' 0 C--N 1.304 -1.41 0 C-N-CA 121.26 -0.176 . . . . 0.0 110.586 -178.836 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 48.4 t -72.66 103.8 3.71 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 85.3 mm-40 -98.26 112.26 24.31 Favored 'General case' 0 N--CA 1.415 -2.186 0 CA-C-O 121.264 0.554 . . . . 0.0 110.24 -179.225 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 41.4 t -80.39 96.51 2.75 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.588 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 179.732 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 87.1 mt -80.9 -69.98 0.56 Allowed 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 -177.828 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 47.7 m-80 -94.27 164.55 19.87 Favored Pre-proline 0 C--N 1.298 -1.649 0 N-CA-C 106.449 -1.685 . . . . 0.0 106.449 175.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -59.77 -33.1 96.38 Favored 'Trans proline' 0 N--CA 1.475 0.42 0 C-N-CA 121.655 1.57 . . . . 0.0 111.669 178.781 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -100.27 -25.36 14.27 Favored 'General case' 0 N--CA 1.441 -0.915 0 C-N-CA 120.077 -0.649 . . . . 0.0 111.206 179.606 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 80.2 t80 -105.05 114.42 28.61 Favored 'General case' 0 C--N 1.309 -1.191 0 C-N-CA 119.798 -0.761 . . . . 0.0 112.673 -176.782 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.465 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 24.0 m -125.58 137.3 53.9 Favored 'General case' 0 C--N 1.284 -2.257 0 N-CA-C 106.858 -1.534 . . . . 0.0 106.858 178.114 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.493 ' OE1' ' HA ' ' A' ' 5' ' ' ALA . 8.0 tt0 -128.53 142.04 51.19 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 109.956 -0.386 . . . . 0.0 109.956 -175.943 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.77 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 75.2 m -75.06 110.74 9.63 Favored 'General case' 0 C--O 1.249 1.037 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 175.806 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 96.6 mt . . . . . 0 N--CA 1.423 -1.801 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 179.08 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' MAN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . 0.448 HG22 HG13 ' A' ' 18' ' ' VAL . 15.9 p . . . . . 0 N--CA 1.442 -0.849 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.735 ' OE1' ' H3 ' ' A' ' 101' ' ' MAN . 6.3 tp-100 -79.7 135.85 36.64 Favored 'General case' 0 N--CA 1.434 -1.269 0 C-N-CA 119.804 -0.759 . . . . 0.0 110.255 -178.425 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 18.3 p -88.01 166.89 14.15 Favored 'General case' 0 C--N 1.285 -2.2 0 CA-C-N 115.243 -0.889 . . . . 0.0 111.575 -174.555 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 56.6 t-80 -57.82 136.75 57.01 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 107.675 -1.232 . . . . 0.0 107.675 172.63 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.416 ' HA ' ' CD ' ' A' ' 34' ' ' GLN . . . 73.2 12.56 4.88 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.396 0.678 . . . . 0.0 112.665 -179.935 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.454 ' O ' ' HA ' ' A' ' 34' ' ' GLN . . . -107.58 164.42 13.0 Favored Glycine 0 C--O 1.243 0.715 0 N-CA-C 110.478 -1.049 . . . . 0.0 110.478 175.364 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.587 ' HA ' ' O ' ' A' ' 33' ' ' SER . 54.1 tt0 -84.55 107.05 16.57 Favored 'General case' 0 C--O 1.224 -0.251 0 CA-C-N 117.395 0.598 . . . . 0.0 110.894 -177.839 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.805 ' HB3' ' SG ' ' A' ' 35' ' ' CYS . 12.3 p -84.34 -37.79 21.16 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 113.705 1.002 . . . . 0.0 113.705 -175.565 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -177.43 87.81 0.07 OUTLIER Glycine 0 CA--C 1.481 -2.04 0 C-N-CA 117.96 -2.067 . . . . 0.0 113.24 -176.291 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.559 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -112.42 172.9 14.96 Favored Glycine 0 C--N 1.28 -2.548 0 N-CA-C 107.921 -2.072 . . . . 0.0 107.921 174.867 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 68.8 mt -63.07 118.0 4.64 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.208 0 CA-C-N 117.861 0.83 . . . . 0.0 109.353 178.785 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 105.73 6.21 38.07 Favored Glycine 0 C--N 1.312 -0.799 0 C-N-CA 120.421 -0.895 . . . . 0.0 112.386 178.73 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 85.2 t80 -102.47 118.48 36.97 Favored 'General case' 0 C--N 1.307 -1.262 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 178.532 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 14.3 p -109.36 0.38 19.44 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-O 121.271 0.558 . . . . 0.0 111.513 -177.703 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -77.92 -171.64 37.77 Favored Glycine 0 N--CA 1.443 -0.841 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.918 178.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_endo -64.37 119.24 6.22 Favored 'Trans proline' 0 C--O 1.237 0.454 0 C-N-CA 122.481 2.121 . . . . 0.0 111.291 178.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.564 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 70.1 p -90.71 -8.32 50.17 Favored 'General case' 0 C--O 1.24 0.558 0 CA-C-O 121.41 0.624 . . . . 0.0 111.211 -176.873 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.448 HG13 HG22 ' A' ' 1' ' ' THR . 5.6 p -80.07 126.41 39.36 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.185 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.334 179.411 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 83.9 m -87.78 163.46 16.46 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.253 -179.017 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.29 150.89 45.16 Favored 'General case' 0 C--O 1.254 1.323 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 175.49 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 35.6 t -57.76 126.01 25.51 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-O 121.503 0.668 . . . . 0.0 110.572 -175.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 112.32 -21.11 20.25 Favored Glycine 0 N--CA 1.43 -1.766 0 CA-C-N 115.172 -0.922 . . . . 0.0 111.62 -178.412 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 50.7 p -116.02 147.09 41.6 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 120.765 -0.374 . . . . 0.0 110.384 179.569 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.405 ' O ' ' HA ' ' A' ' 35' ' ' CYS . 21.7 p -120.23 155.39 33.29 Favored 'General case' 0 C--N 1.298 -1.656 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.767 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 48.5 t -80.23 102.95 9.78 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-O 121.143 0.497 . . . . 0.0 110.433 -178.833 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.451 ' HG3' ' HB2' ' A' ' 36' ' ' LEU . 9.1 mm-40 -100.87 122.29 43.18 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 -179.166 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 57.6 t -79.84 114.8 21.21 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.715 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 -179.083 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 86.4 mt -98.25 -70.04 0.74 Allowed 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 179.192 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.465 ' HB2' ' H ' ' A' ' 32' ' ' TYR . 88.2 m-20 -94.07 166.11 16.3 Favored Pre-proline 0 C--N 1.304 -1.373 0 N-CA-C 105.986 -1.857 . . . . 0.0 105.986 174.225 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -64.49 -26.6 62.41 Favored 'Trans proline' 0 CA--C 1.538 0.691 0 C-N-CA 121.255 1.303 . . . . 0.0 111.341 177.277 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.559 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 70.1 m-85 -107.16 -26.34 11.14 Favored 'General case' 0 N--CA 1.443 -0.777 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.121 -178.935 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.465 ' H ' ' HB2' ' A' ' 29' ' ' ASN . 67.6 t80 -105.73 113.84 27.64 Favored 'General case' 0 C--N 1.304 -1.383 0 C-N-CA 119.627 -0.829 . . . . 0.0 110.978 178.418 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.587 ' O ' ' HA ' ' A' ' 7' ' ' GLN . 21.3 m -121.72 140.92 51.7 Favored 'General case' 0 C--N 1.279 -2.494 0 N-CA-C 105.616 -1.994 . . . . 0.0 105.616 175.088 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.464 ' OE1' HD21 ' A' ' 36' ' ' LEU . 35.9 tt0 -125.81 141.36 52.03 Favored 'General case' 0 C--N 1.29 -1.999 0 C-N-CA 120.874 -0.33 . . . . 0.0 110.766 -171.407 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.805 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 85.5 m -74.38 114.21 12.5 Favored 'General case' 0 C--O 1.252 1.187 0 CA-C-O 121.176 0.512 . . . . 0.0 109.982 176.247 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.464 HD21 ' OE1' ' A' ' 34' ' ' GLN . 95.5 mt . . . . . 0 N--CA 1.426 -1.639 0 CA-C-N 115.127 -0.942 . . . . 0.0 108.84 -179.382 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' MAN . . . . . 0.735 ' H3 ' ' OE1' ' A' ' 2' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 stop_ save_